data_5gjl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5gjl _Structure_validation_residue.Date_analyzed 2017-07-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 38.9 m80 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.681 0.277 . . . . 71.25 110.4 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 1.081 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 25.8 mm -109.4 158.18 9.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.913 -0.402 . . . . 74.02 109.913 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -144.43 134.67 24.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.585 -0.524 . . . . 71.43 109.585 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 48' ' ' LEU . 5.0 p -142.63 140.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 123.658 0.599 . . . . 74.14 109.646 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . 23.4 mtmt -110.41 118.86 37.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.244 0.545 . . . . 74.44 111.182 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.752 HG23 ' HB ' ' A' ' 89' ' ' ILE . 88.6 t -94.46 97.68 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 105.999 -1.852 . . . . 73.33 105.999 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 32.7 ttt-85 -67.76 106.13 2.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.189 -1.041 . . . . 74.22 108.189 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.515 ' HA ' ' HH ' ' A' ' 52' ' ' TYR . 9.5 p -58.46 124.54 72.18 Favored Pre-proline 0 N--CA 1.422 -1.863 0 N-CA-C 107.111 -1.44 . . . . 75.05 107.111 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 90.5 Cg_endo -71.43 38.49 0.34 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.357 2.704 . . . . 73.44 114.217 -162.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -131.13 15.63 5.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.3 0.572 . . . . 63.12 111.326 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.5 24.93 19.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.362 -0.923 . . . . 64.32 111.844 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.34 161.57 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.433 -0.58 . . . . 65.54 109.433 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 38.2 tt0 -151.12 115.35 5.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.87 -0.418 . . . . 71.52 109.87 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.34 128.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.771 -0.455 . . . . 73.02 109.771 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.41 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 24.5 p90 -72.25 119.85 17.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.698 0.761 . . . . 64.24 110.845 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -111.29 166.35 11.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.873 -1.058 . . . . 62.41 108.421 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -144.98 146.13 31.81 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.403 -0.519 . . . . 74.31 111.224 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.081 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 56.9 mt -115.13 134.89 56.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.507 -0.923 . . . . 75.24 108.507 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -109.0 -65.03 1.18 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.556 -0.457 . . . . 73.51 110.978 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.2 ptp180 -91.45 -177.79 4.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.192 -1.04 . . . . 73.4 108.192 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.549 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.95 101.26 0.37 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.776 0.798 . . . . 73.12 109.25 172.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.28 6.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.644 -0.707 . . . . 72.42 110.269 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.924 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 14.1 ptpt -58.99 -179.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.231 -0.895 . . . . 74.31 112.075 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.721 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 37.3 mt -67.34 -10.48 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 72.43 112.376 -169.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 49' ' ' MET . 70.2 mt-10 -57.5 -53.79 54.22 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.835 0.309 . . . . 73.33 111.835 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -30.09 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.341 -0.543 . . . . 74.1 110.913 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 HD12 ' A' ' 39' ' ' ILE . 95.2 mt -60.27 -36.86 78.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.943 0.401 . . . . 73.21 110.392 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.6 ptt? -85.78 -34.01 21.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.019 -0.537 . . . . 74.23 111.176 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 42.0 mt-10 -74.61 -39.65 62.04 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.817 0.303 . . . . 64.22 111.817 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.87 -29.37 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.152 -0.684 . . . . 74.55 109.152 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HH ' ' HA ' ' A' ' 29' ' ' SER . 59.1 t80 -73.94 -43.58 57.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.78 . . . . 73.13 109.999 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 84.5 m -50.11 -52.05 38.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.382 0.611 . . . . 62.33 110.699 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -27.34 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.834 . . . . 71.51 110.723 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -71.44 -41.57 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.453 -0.34 . . . . 74.42 111.586 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.38 -6.4 34.19 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.898 -0.321 . . . . 75.42 111.4 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.51 59.3 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.513 -0.851 . . . . 60.04 111.775 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.2 tt0 -150.83 129.73 12.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.592 -0.892 . . . . 75.33 108.592 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.0 p -87.9 178.23 6.75 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.834 0.679 . . . . 52.13 112.834 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.561 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -74.48 -16.16 60.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.982 1.104 . . . . 75.4 113.982 -164.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.02 -13.67 60.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.884 -0.726 . . . . 75.51 109.957 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.02 2.98 23.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.532 -0.758 . . . . 70.02 110.336 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 91' ' ' ALA . 7.0 m -139.63 103.34 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.386 0.613 . . . . 73.14 110.73 171.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.646 ' HD2' HD12 ' A' ' 66' ' ' LEU . 25.8 ttm180 -69.24 112.05 5.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.759 -0.655 . . . . 73.44 109.616 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.76 109.95 21.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.551 0.691 . . . . 74.42 111.64 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.835 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 5.2 mp -106.21 130.94 53.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.333 -0.849 . . . . 74.2 109.481 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HE2' HG22 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -127.62 143.47 51.16 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.206 -0.998 . . . . 74.01 110.618 176.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.465 ' HB2' HG21 ' A' ' 83' ' ' ILE . 35.2 t70 59.67 21.9 10.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.921 0.867 . . . . 75.51 109.764 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.84 -17.49 58.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.543 -0.753 . . . . 73.33 113.237 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -122.72 125.78 46.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.15 0.475 . . . . 72.13 111.609 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.835 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -65.28 151.45 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 73.24 110.901 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 73' ' ' HIS . 12.5 tt -170.81 -173.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.942 -0.762 . . . . 75.3 108.942 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.603 ' H ' HG12 ' A' ' 72' ' ' ILE . 94.1 m-70 -86.01 149.23 25.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.254 0.479 . . . . 74.0 110.435 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.721 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -67.94 -20.9 73.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.632 -0.794 . . . . 60.44 112.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.924 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 4.6 p-10 -78.78 -4.66 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.599 0.222 . . . . 72.23 111.599 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -23.45 61.98 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.854 -0.157 . . . . 74.23 111.293 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.866 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.1 p 66.28 159.15 0.13 Allowed Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 72.04 111.788 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.43 -60.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 73.22 113.432 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -63.57 -19.07 64.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.901 0.334 . . . . 74.52 111.901 -170.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -63.24 -25.5 68.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.035 0.445 . . . . 74.25 110.811 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.42 -29.16 17.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.109 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.79 -18.87 8.52 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.842 -0.694 . . . . 71.35 111.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 87' ' ' ASP . 15.4 tt -101.92 136.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.999 -0.371 . . . . 75.31 109.999 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.798 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 26.5 tt0 -148.39 -153.32 0.48 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.942 -0.762 . . . . 72.03 108.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.798 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.3 p-10 -20.94 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.651 1.18 . . . . 63.13 113.792 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.5 5.16 30.06 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.993 -0.843 . . . . 60.32 110.993 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.494 ' HB3' HG12 ' A' ' 83' ' ' ILE . 11.3 p-10 -85.79 173.09 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.151 -0.525 . . . . 72.14 110.915 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.32 158.59 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 65.24 111.137 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.752 ' HB ' HG23 ' A' ' 27' ' ' VAL . 69.6 mt -134.64 138.46 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.649 -0.871 . . . . 71.31 108.649 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.51 126.42 51.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.433 -0.58 . . . . 61.32 109.433 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . . . -111.89 116.8 31.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.695 -0.402 . . . . 71.15 110.388 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 62.6 mtt -101.26 168.82 9.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.109 -0.496 . . . . 73.12 110.114 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.24 101.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 75.1 111.311 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.635 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 43.4 mt-30 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 74.3 112.23 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 22.4 m170 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.889 0.376 . . . . 71.25 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.909 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 17.8 mt -110.59 166.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.402 -0.592 . . . . 74.02 109.402 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.595 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 8.6 tt0 -148.49 139.75 23.32 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.771 -0.455 . . . . 71.43 109.771 -174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 48' ' ' LEU . 29.0 m -140.82 172.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.077 0.465 . . . . 74.14 110.741 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 3.7 mtmt -141.71 115.42 9.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 74.44 109.487 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 89' ' ' ILE . 52.3 t -95.19 95.08 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.589 -1.634 . . . . 73.33 106.589 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -68.49 103.57 1.7 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.996 -1.483 . . . . 74.22 106.996 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 31' ' ' ASP . 67.6 m -62.86 158.38 53.35 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 113.498 -1.683 . . . . 75.05 109.03 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 35.9 Cg_endo -64.8 36.2 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.666 2.911 . . . . 73.44 114.051 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 29' ' ' SER . 30.7 t70 -131.75 -14.9 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.46 0.647 . . . . 63.12 110.282 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.85 -3.57 52.64 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.227 -0.749 . . . . 64.32 111.227 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.01 118.16 23.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.364 -0.418 . . . . 65.54 110.014 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.567 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 23.4 tt0 -116.04 101.43 8.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.396 -0.594 . . . . 71.52 109.396 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' OH ' ' A' ' 52' ' ' TYR . 44.3 t -102.75 135.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.801 -0.444 . . . . 73.02 109.801 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.2 p90 -71.25 132.04 44.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.578 0.704 . . . . 64.24 111.358 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.635 ' HE1' ' HZ1' ' A' ' 47' ' ' LYS . 4.9 t80 -126.72 162.8 24.95 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.657 -1.238 . . . . 62.41 107.657 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -136.99 157.15 47.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.845 0.831 . . . . 74.31 112.712 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.909 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -119.68 136.1 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 75.24 108.11 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -111.75 -28.14 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.838 -0.745 . . . . 73.51 111.834 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 35.4 ttm180 -145.78 -177.6 5.67 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.055 -1.461 . . . . 73.4 107.055 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 20.5 pttp -60.57 99.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.527 -0.869 . . . . 73.12 110.0 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.53 ' OG1' HG22 ' A' ' 39' ' ' ILE . 74.0 p -129.38 114.46 16.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.77 -1.104 . . . . 72.42 108.893 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.684 ' HA ' HG21 ' A' ' 77' ' ' THR . 0.4 OUTLIER -49.27 153.75 0.96 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 74.31 111.688 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.789 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 36.1 mt -63.0 -12.57 26.75 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.29 -0.868 . . . . 72.43 111.76 -173.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.659 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 54.5 mt-10 -57.36 -44.43 84.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 73.33 111.345 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HZ1' ' HE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -69.72 -30.43 68.05 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.561 -0.456 . . . . 74.1 110.582 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 HD11 ' A' ' 39' ' ' ILE . 98.0 mt -61.55 -33.06 73.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 73.21 110.356 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.659 ' HE1' ' HA ' ' A' ' 46' ' ' GLU . 26.8 ptt? -98.3 -28.98 13.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 74.23 112.029 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.722 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 46.4 mt-10 -78.01 -33.73 51.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.478 -0.489 . . . . 64.22 111.257 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.14 -31.89 55.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.021 -0.733 . . . . 74.55 109.021 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.553 ' OH ' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -71.22 -31.91 68.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 73.13 111.151 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.746 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 66.3 m -50.28 -47.09 55.53 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 62.33 110.63 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.88 -31.99 51.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.02 -0.537 . . . . 71.51 110.728 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -68.57 -40.28 80.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 74.42 110.617 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.15 -21.71 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.415 -0.357 . . . . 75.42 111.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.08 -2.65 69.1 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.768 -0.729 . . . . 60.04 112.163 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.3 tp60 -124.49 129.79 51.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.106 -0.702 . . . . 75.33 109.106 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.746 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.0 p -81.25 178.65 8.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 52.13 112.366 -174.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.639 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -76.64 -16.12 59.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.665 1.357 . . . . 75.4 114.665 -162.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -74.28 -9.88 59.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 75.51 110.363 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.611 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -109.38 10.62 25.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.765 -0.652 . . . . 70.02 110.268 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.893 ' HB ' ' HB2' ' A' ' 91' ' ' ALA . 18.0 m -139.38 121.74 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.59 . . . . 73.14 111.465 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 20.3 tpp180 -85.56 113.81 22.09 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.616 -0.513 . . . . 73.44 109.616 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -83.43 118.07 23.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.487 -0.779 . . . . 74.42 112.376 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 10.2 mp -110.42 129.38 55.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.618 -0.719 . . . . 74.2 109.863 172.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HD1' HG12 ' A' ' 89' ' ' ILE . 62.4 m-85 -106.89 129.87 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.439 -0.208 . . . . 74.01 110.439 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.76 23.34 9.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.999 0.904 . . . . 75.51 109.77 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.03 -0.28 78.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.458 -0.792 . . . . 73.33 112.567 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 72' ' ' ILE . 37.3 t0 -127.15 122.91 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.578 0.704 . . . . 72.13 111.14 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -59.61 110.6 1.17 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.125 -0.943 . . . . 73.24 112.37 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.86 HG22 ' H ' ' A' ' 73' ' ' HIS . 11.2 mm -125.68 -167.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.171 -1.418 . . . . 75.3 107.171 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.86 ' H ' HG22 ' A' ' 72' ' ' ILE . 3.6 p80 -116.41 149.25 39.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.205 0.457 . . . . 74.0 110.091 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.789 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -64.54 -34.47 89.98 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.705 -0.68 . . . . 60.44 114.295 -168.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.95 -12.12 52.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.853 0.327 . . . . 72.23 111.584 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.637 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 3.5 t30 -70.87 -25.7 62.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.04 -0.356 . . . . 74.23 110.04 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.684 HG21 ' HA ' ' A' ' 44' ' ' LYS . 44.8 p 61.16 153.74 0.11 Allowed Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.639 1.176 . . . . 72.04 112.627 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 30.8 Cg_endo -64.91 -46.79 5.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.462 2.108 . . . . 73.22 111.833 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -46.17 -43.35 15.05 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.328 -0.851 . . . . 74.52 111.728 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 47.8 mt-30 -88.55 -15.7 34.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.25 111.704 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.7 -30.66 18.94 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.0 -0.28 . . . . 73.11 111.351 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.28 -18.93 25.18 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.315 -0.945 . . . . 71.35 110.916 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.3 tp -93.01 144.16 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.136 -1.061 . . . . 75.31 108.136 170.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 85' ' ' ASP . 1.7 tt0 -141.09 -152.22 0.4 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.325 -0.62 . . . . 72.03 109.325 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.595 ' OD1' ' HB3' ' A' ' 24' ' ' GLN . 7.2 t70 -45.99 118.41 1.86 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.06 0.457 . . . . 63.13 112.021 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.93 3.51 17.81 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.434 -0.803 . . . . 60.32 111.664 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.455 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.1 t0 -73.97 158.48 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 72.14 111.19 -175.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 32.7 m -129.96 147.28 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.815 -0.629 . . . . 65.24 110.357 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.4 mt -119.57 119.27 59.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.632 -0.713 . . . . 71.31 109.288 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -102.86 126.96 50.21 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.677 -0.49 . . . . 61.32 109.677 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.893 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -109.87 117.82 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.939 0.4 . . . . 71.15 111.786 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 1.8 mpt? -90.91 170.13 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 73.12 110.476 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.98 109.6 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 75.1 111.299 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 48.9 mt-30 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.017 -0.992 . . . . 74.3 111.515 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.805 -0.443 . . . . 71.25 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.5 mt -109.98 166.96 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.715 -0.846 . . . . 74.02 108.715 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.477 ' H ' HG22 ' A' ' 23' ' ' ILE . 41.6 tt0 -144.24 138.26 27.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.232 -0.284 . . . . 71.43 110.232 -173.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.743 HG11 HD12 ' A' ' 48' ' ' LEU . 14.7 p -150.79 140.97 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.983 -0.553 . . . . 74.14 110.005 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.777 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 2.4 mtmp? -102.0 123.24 45.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.782 -0.451 . . . . 74.44 109.782 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 89' ' ' ILE . 73.4 t -101.33 95.26 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 105.472 -2.047 . . . . 73.33 105.472 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 21.1 ttt180 -68.3 105.07 2.02 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 114.819 -1.082 . . . . 74.22 108.386 -172.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . 68.5 m -63.38 139.39 97.57 Favored Pre-proline 0 N--CA 1.418 -2.037 0 N-CA-C 107.424 -1.325 . . . . 75.05 107.424 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.23 33.48 0.16 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.542 2.828 . . . . 73.44 114.643 -166.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 29' ' ' SER . 24.6 t70 -131.36 3.46 4.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.617 0.722 . . . . 63.12 109.567 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.26 16.52 53.25 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.885 -0.886 . . . . 64.32 110.885 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 29' ' ' SER . . . -99.44 74.91 1.93 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.618 . . . . 65.54 109.805 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 27.7 tt0 -87.44 102.67 14.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.843 -0.617 . . . . 71.52 109.822 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.36 136.34 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.976 -0.556 . . . . 73.02 109.71 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -80.47 121.68 26.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.464 0.65 . . . . 64.24 111.192 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.97 165.21 13.12 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.301 -1.37 . . . . 62.41 107.301 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -138.72 168.57 19.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.666 -0.814 . . . . 74.31 112.23 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 58.0 mt -114.2 134.93 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.662 -1.154 . . . . 75.24 109.369 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.92 -81.91 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.003 0.43 . . . . 73.51 109.992 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 59.6 ttt180 -101.97 -177.18 3.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.123 -1.436 . . . . 73.4 107.123 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 47.3 pttt -53.09 102.01 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.465 0.65 . . . . 73.12 111.42 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.547 ' OG1' HG22 ' A' ' 39' ' ' ILE . 1.6 p -142.47 107.47 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 72.42 110.626 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 37.6 pttt -51.6 175.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.158 -0.928 . . . . 74.31 113.493 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.769 ' HA ' HD13 ' A' ' 48' ' ' LEU . 44.7 mt -66.43 -21.69 66.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.657 -1.156 . . . . 72.43 113.03 -169.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HA ' ' CE ' ' A' ' 49' ' ' MET . 34.0 mt-10 -58.5 -33.49 69.87 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.569 0.581 . . . . 73.33 112.569 -171.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -23.39 32.59 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.351 -0.54 . . . . 74.1 110.837 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' A' ' 45' ' ' LEU . 73.0 mt -64.84 -35.34 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.361 . . . . 73.21 111.456 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.3 -39.37 14.43 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.497 -0.881 . . . . 74.23 111.268 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' N ' ' HG2' ' A' ' 49' ' ' MET . 12.4 mm-40 -68.95 -37.96 79.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.431 0.53 . . . . 64.22 112.431 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.48 -31.45 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.268 -0.573 . . . . 74.55 109.664 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.478 ' HD2' HD22 ' A' ' 56' ' ' LEU . 8.3 t80 -83.01 -29.84 28.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.149 -0.478 . . . . 73.13 110.13 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.998 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 73.6 m -58.34 -37.25 74.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.296 0.569 . . . . 62.33 110.758 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.17 -32.78 74.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 71.51 110.825 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -73.25 -50.55 21.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 74.42 111.496 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HD2' ' A' ' 52' ' ' TYR . 2.9 pp -76.01 -20.99 57.37 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.713 -0.221 . . . . 75.42 111.583 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.83 13.24 37.9 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.755 -0.735 . . . . 60.04 113.527 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -150.3 130.12 13.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.083 -0.71 . . . . 75.33 109.083 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.998 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.2 p -78.37 167.13 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.447 0.641 . . . . 52.13 112.595 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.719 ' HA ' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -64.47 -15.85 61.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.821 -1.081 . . . . 75.4 112.897 -169.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.51 -17.36 62.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.052 0.453 . . . . 75.51 110.46 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.06 8.99 18.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.112 -0.494 . . . . 70.02 110.088 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.719 HG21 ' HA ' ' A' ' 60' ' ' MET . 3.0 m -143.49 103.17 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.935 -0.575 . . . . 73.14 110.086 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 25.0 tpt180 -73.24 125.68 28.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.533 . . . . 73.44 110.378 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -87.03 112.4 21.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.459 -0.791 . . . . 74.42 112.314 -175.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 7.9 mp -93.79 124.89 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.865 -0.607 . . . . 74.2 109.538 172.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HD2' HG12 ' A' ' 89' ' ' ILE . 83.1 m-85 -103.3 113.69 27.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.323 -0.251 . . . . 74.01 110.323 -177.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 t70 57.88 26.99 13.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 122.079 0.942 . . . . 75.51 109.869 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.12 -16.89 58.79 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.228 -0.896 . . . . 73.33 112.787 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -111.96 116.41 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.513 0.673 . . . . 72.13 110.623 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.613 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 12.0 ptt-85 -80.24 111.5 16.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.655 -0.702 . . . . 73.24 111.401 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.9 -165.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.935 -0.575 . . . . 75.3 110.187 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -85.22 140.87 30.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.083 -0.34 . . . . 74.0 110.083 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.48 -18.14 76.8 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.225 -0.512 . . . . 60.44 113.005 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 33.9 t70 -70.08 -12.97 61.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.033 0.444 . . . . 72.23 111.084 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -66.33 -41.44 89.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.899 -0.591 . . . . 74.23 110.746 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 m 68.55 136.58 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.903 -0.589 . . . . 72.04 111.091 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HD3' ' HG ' ' A' ' 45' ' ' LEU . 76.4 Cg_exo -51.66 -36.86 62.67 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.215 2.61 . . . . 73.22 113.725 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.63 -34.24 36.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.267 0.469 . . . . 74.52 112.267 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -88.6 -18.06 28.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 74.25 111.254 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.05 -30.37 19.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.497 -0.32 . . . . 73.11 111.756 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.76 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.24 -0.981 . . . . 71.35 110.654 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 84' ' ' GLU . 10.1 tp -91.85 159.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.235 -1.394 . . . . 75.31 107.235 169.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 25.0 tt0 -154.05 -171.62 3.94 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.763 -0.829 . . . . 72.03 108.763 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.795 ' HB3' HG21 ' A' ' 23' ' ' ILE . 8.4 p-10 -47.51 126.28 9.58 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.77 0.795 . . . . 63.13 112.358 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.56 4.26 15.57 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.86 -1.064 . . . . 60.32 110.844 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.41 -173.58 4.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.088 0.471 . . . . 72.14 111.072 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.03 148.37 22.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.563 0.697 . . . . 65.24 111.348 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 27' ' ' VAL . 64.8 mt -119.0 114.04 43.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.036 -0.984 . . . . 71.31 108.976 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -99.81 118.0 35.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.721 -0.474 . . . . 61.32 109.721 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . . . -109.81 117.36 33.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.107 0.48 . . . . 71.15 111.207 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.7 144.89 35.89 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.093 -0.706 . . . . 73.12 109.093 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.39 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.397 0.435 . . . . 75.1 111.356 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.475 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 3.2 pt20 . . . . . 0 N--CA 1.469 0.513 0 O-C-N 124.658 1.224 . . . . 74.3 112.552 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.503 0.668 . . . . 71.25 112.235 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.735 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 28.4 mt -110.5 166.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.734 -1.21 . . . . 74.02 107.734 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.667 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 31.5 tt0 -162.38 123.99 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 71.43 111.004 -171.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 48' ' ' LEU . 15.5 m -137.09 141.93 38.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.428 -0.582 . . . . 74.14 109.428 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.9 ttmt -100.01 111.32 23.63 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.793 -0.763 . . . . 74.44 109.02 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 89' ' ' ILE . 67.5 t -95.3 99.29 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.419 -0.956 . . . . 73.33 108.419 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 36.2 ttt180 -70.2 104.66 2.69 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.368 -1.345 . . . . 74.22 107.368 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.665 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 10.0 p -65.74 164.89 23.15 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.044 -0.98 . . . . 75.05 109.39 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 52.2 Cg_endo -67.69 30.63 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 123.115 2.543 . . . . 73.44 114.769 -169.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 29' ' ' SER . 2.6 p-10 -131.74 -23.36 2.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.67 -0.492 . . . . 63.12 109.67 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.761 ' HA2' ' HE ' ' A' ' 28' ' ' ARG . . . 126.67 -11.25 7.07 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.757 -0.656 . . . . 64.32 112.293 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.33 94.67 3.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.158 0.504 . . . . 65.54 110.796 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.764 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 35.8 tt0 -92.5 99.33 12.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 71.52 109.586 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.22 134.31 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.191 -0.459 . . . . 73.02 110.173 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.525 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 21.0 p90 -75.98 105.14 6.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.589 0.709 . . . . 64.24 110.31 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HE1' ' HZ3' ' A' ' 47' ' ' LYS . 6.2 t80 -111.72 151.35 29.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.516 -0.92 . . . . 62.41 108.516 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HG2' ' HG3' ' A' ' 24' ' ' GLN . 78.4 mttt -125.87 168.64 13.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.664 0.745 . . . . 74.31 111.735 -169.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.735 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -115.42 134.22 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.397 -1.334 . . . . 75.24 107.397 170.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -103.03 -58.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.137 -0.625 . . . . 73.51 110.161 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -106.48 -178.95 3.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.93 101.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.999 0.363 . . . . 73.12 110.417 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.02 133.19 40.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.98 0.419 . . . . 72.42 110.515 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' HB2' ' HZ1' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -72.98 167.3 21.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 74.31 111.081 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.698 HD22 ' HD3' ' A' ' 78' ' ' PRO . 96.6 mt -67.47 -23.87 65.55 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.464 0.542 . . . . 72.43 112.464 -170.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 34.0 mp0 -59.21 -24.68 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.033 0.383 . . . . 73.33 112.033 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.575 ' HZ3' ' HE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -76.38 -37.66 56.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.202 -0.599 . . . . 74.1 109.949 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 39' ' ' ILE . 59.5 mt -62.53 -38.33 89.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.195 0.521 . . . . 73.21 109.99 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 20.0 ptm -80.01 -37.13 34.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.586 -0.734 . . . . 74.23 111.5 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.554 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 49.8 mm-40 -67.91 -30.46 69.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.955 -0.298 . . . . 64.22 111.719 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.57 HG21 ' O ' ' A' ' 47' ' ' LYS . 76.5 t -54.88 -39.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.465 -0.494 . . . . 74.55 110.296 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -75.97 -35.12 59.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 73.13 111.507 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 64.4 m -49.88 -48.13 51.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.909 0.385 . . . . 62.33 111.044 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.71 -32.77 62.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 71.51 111.289 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 74.42 111.08 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.49 -21.55 26.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.468 -0.333 . . . . 75.42 111.275 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.05 12.98 83.85 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.501 -1.04 . . . . 60.04 110.501 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.4 tt0 -136.2 129.94 32.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.492 -0.929 . . . . 75.33 108.492 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 6.2 p -81.42 171.64 14.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.456 0.646 . . . . 52.13 112.158 -173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.525 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.34 -15.08 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.902 -1.045 . . . . 75.4 112.935 -174.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.62 -15.28 57.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.976 0.361 . . . . 75.51 111.976 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.593 ' HA ' ' CG ' ' A' ' 94' ' ' GLN . . . -109.95 9.25 24.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.125 0.488 . . . . 70.02 110.177 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.704 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 18.3 m -140.5 172.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.595 . . . . 73.14 110.495 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 tpp85 -143.75 130.49 20.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.607 -0.516 . . . . 73.44 109.607 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.451 ' CD1' ' HE2' ' A' ' 49' ' ' MET . 91.3 m-85 -99.99 116.38 31.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 74.42 111.441 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -111.03 113.45 26.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.392 -0.822 . . . . 74.2 110.015 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.661 ' HB3' HG12 ' A' ' 89' ' ' ILE . 23.2 p90 -112.47 146.15 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.098 -0.641 . . . . 74.01 110.175 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.1 t70 60.44 21.94 11.58 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.352 1.072 . . . . 75.51 109.3 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.92 -12.09 68.57 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.118 -0.946 . . . . 73.33 113.109 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -130.63 127.55 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.427 0.613 . . . . 72.13 112.054 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -63.96 159.21 20.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.681 -0.69 . . . . 73.24 111.839 175.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.769 HG12 ' H ' ' A' ' 73' ' ' HIS . 10.2 tt -173.03 -171.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.428 -0.582 . . . . 75.3 109.428 175.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.769 ' H ' HG12 ' A' ' 72' ' ' ILE . 11.5 m170 -75.51 151.79 37.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.878 0.371 . . . . 74.0 110.687 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -72.69 -19.85 79.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.794 -0.717 . . . . 60.44 112.217 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.97 -19.21 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.57 0.211 . . . . 72.23 111.57 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 73' ' ' HIS . 18.7 m120 -68.15 -44.14 76.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.018 -0.364 . . . . 74.23 110.018 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.0 p 61.96 162.54 0.11 Allowed Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.871 0.869 . . . . 72.04 111.512 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.698 ' HD3' HD22 ' A' ' 45' ' ' LEU . 24.9 Cg_exo -64.3 -39.21 30.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.463 2.109 . . . . 73.22 112.356 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.54 -49.11 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 74.52 110.976 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.793 ' HA ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -67.06 -22.74 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.686 -173.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.7 tp -86.63 -29.5 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 73.11 110.241 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.41 -18.44 27.72 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.112 -0.795 . . . . 71.35 111.112 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.61 126.87 54.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.089 -0.708 . . . . 75.31 109.089 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.698 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.0 tt0 -131.37 -151.52 0.47 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.408 -0.36 . . . . 72.03 110.344 -169.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.698 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 4.0 p-10 -43.4 131.73 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.551 0.691 . . . . 63.13 112.631 -172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.38 -9.5 24.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.547 -0.751 . . . . 60.32 112.007 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.68 169.86 10.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.945 -0.391 . . . . 72.14 109.945 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.9 161.95 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.306 0.574 . . . . 65.24 111.261 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.661 HG12 ' HB3' ' A' ' 67' ' ' TYR . 35.6 mt -132.94 117.22 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.424 -0.954 . . . . 71.31 108.424 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.577 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 3.4 t70 -98.69 125.98 44.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.84 -0.43 . . . . 61.32 109.84 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' ARG . . . -97.79 117.04 31.21 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.174 0.511 . . . . 71.15 110.512 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.0 163.64 12.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.713 -0.676 . . . . 73.12 109.37 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.06 101.42 3.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.912 -0.315 . . . . 75.1 111.345 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.704 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 45.2 mt-30 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.452 -0.794 . . . . 74.3 111.692 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.462 -0.57 . . . . 71.25 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.737 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 14.8 mt -110.76 168.1 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.909 -0.404 . . . . 74.02 109.909 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 41.7 mt-30 -150.8 131.72 14.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.877 0.471 . . . . 71.43 110.674 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 48' ' ' LEU . 35.8 m -130.35 -177.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.356 -0.609 . . . . 74.14 109.356 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.756 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mtmt -138.77 114.75 10.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.767 0.318 . . . . 74.44 110.554 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' HB ' ' A' ' 89' ' ' ILE . 66.9 t -97.17 100.94 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -69.9 106.68 3.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.925 -1.139 . . . . 74.22 107.925 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' ASP . 66.1 p -60.34 160.28 18.59 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.256 -0.884 . . . . 75.05 108.954 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HD3' ' HB1' ' A' ' 91' ' ' ALA . 36.7 Cg_endo -65.2 31.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 123.165 2.576 . . . . 73.44 114.076 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 29' ' ' SER . 27.7 t70 -131.44 -21.45 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.272 0.558 . . . . 63.12 110.77 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.65 -15.73 24.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.268 -0.733 . . . . 64.32 111.268 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.09 104.17 1.71 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.539 -0.541 . . . . 65.54 109.539 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.756 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 34.0 tt0 -113.44 96.86 6.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.36 -0.836 . . . . 71.52 109.289 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.27 134.57 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.221 -0.659 . . . . 73.02 109.221 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 34.9 p90 -68.32 130.5 43.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.227 0.536 . . . . 64.24 110.191 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 51' ' ' VAL . 3.9 t80 -128.12 130.17 47.72 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.983 -1.117 . . . . 62.41 107.983 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 44.4 pttt -105.29 163.69 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.88 0.848 . . . . 74.31 112.555 -165.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 65.2 mt -114.83 134.77 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.419 -1.264 . . . . 75.24 108.063 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.15 -81.68 0.37 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.281 0.562 . . . . 73.51 110.628 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -102.1 -176.57 3.16 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.022 -1.103 . . . . 73.4 108.022 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.76 101.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.258 0.551 . . . . 73.12 109.967 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 1.7 p -141.47 105.23 4.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.968 -1.015 . . . . 72.42 109.776 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -39.24 152.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.841 -1.072 . . . . 74.31 113.308 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' HD3' ' A' ' 78' ' ' PRO . 90.5 mt -64.47 -15.4 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.118 -0.947 . . . . 72.43 111.236 -177.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 42.5 mt-10 -62.73 -26.28 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 73.33 111.181 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -78.13 -36.24 48.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.44 -0.504 . . . . 74.1 109.905 177.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.534 HD12 HG21 ' A' ' 25' ' ' VAL . 74.3 mt -59.38 -29.72 67.91 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.763 -0.828 . . . . 73.21 108.763 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.945 ' HE2' ' HB2' ' A' ' 60' ' ' MET . 24.9 ttt -78.62 -51.09 10.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.111 -1.404 . . . . 74.23 111.049 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 42.7 mt-10 -70.43 -30.19 66.98 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.511 0.559 . . . . 64.22 112.511 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' LYS . 54.5 t -55.71 -38.47 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.442 -0.503 . . . . 74.55 111.101 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.8 -30.44 65.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.579 -0.282 . . . . 73.13 111.504 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 62.2 m -51.36 -39.78 57.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.33 0.586 . . . . 62.33 110.57 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -76.57 -41.26 47.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.533 -0.758 . . . . 71.51 111.147 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -64.22 -50.77 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.02 0.748 . . . . 74.42 113.02 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 58' ' ' GLN . 1.2 pp -98.63 8.51 44.83 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.564 -0.454 . . . . 75.42 111.914 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.17 27.36 72.89 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.158 -0.544 . . . . 60.04 113.386 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 10.2 tt0 -143.22 130.84 21.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.482 -0.933 . . . . 75.33 108.482 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 p -89.33 174.3 7.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.952 0.723 . . . . 52.13 112.952 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.945 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -70.11 -14.92 62.88 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 115.023 1.49 . . . . 75.4 115.023 -163.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.38 -12.68 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.08 -1.012 . . . . 75.51 109.76 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.764 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -101.54 -7.6 22.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.429 -0.805 . . . . 70.02 110.272 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' MET . 5.1 m -138.72 104.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.223 172.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.426 ' HE ' HD13 ' A' ' 66' ' ' LEU . 54.1 ttp180 -88.01 125.9 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.293 -0.412 . . . . 73.44 110.099 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.625 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 54.7 m-85 -92.93 122.95 35.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.18 0.514 . . . . 74.42 111.347 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.971 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -106.73 113.33 26.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.674 -0.693 . . . . 74.2 109.838 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.562 ' HB3' HG12 ' A' ' 89' ' ' ILE . 47.1 p90 -112.73 145.71 40.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.836 -0.746 . . . . 74.01 111.149 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.26 22.51 11.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.071 0.938 . . . . 75.51 109.058 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.98 2.27 86.54 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.979 -1.009 . . . . 73.33 112.14 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -122.17 117.72 26.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.145 0.498 . . . . 72.13 111.324 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.971 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -66.74 119.26 11.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.219 0.533 . . . . 73.24 111.189 173.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 67' ' ' TYR . 8.0 tt -161.3 157.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.407 -0.59 . . . . 75.3 109.407 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.34 135.37 48.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.099 0.476 . . . . 74.0 111.877 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.48 82.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.586 -0.734 . . . . 60.44 114.419 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.2 -33.35 75.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.207 0.503 . . . . 72.23 111.364 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.83 0.67 30.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.386 -0.37 . . . . 74.23 111.23 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.671 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 80.9 p 59.89 163.83 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.28 1.032 . . . . 72.04 112.833 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.671 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 73.0 Cg_endo -76.17 -31.73 4.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.149 1.899 . . . . 73.22 112.127 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.6 -34.34 67.11 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.786 -0.643 . . . . 74.52 110.758 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -77.09 -19.03 57.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.064 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -93.88 -30.88 14.57 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 73.11 111.23 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.16 -19.04 23.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.463 -0.875 . . . . 71.35 110.97 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -85.65 147.92 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.878 -1.156 . . . . 75.31 107.878 169.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.751 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 23.1 tt0 -151.23 -152.35 0.43 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.191 -0.67 . . . . 72.03 109.191 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.751 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t70 -47.32 114.84 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.865 0.364 . . . . 63.13 110.855 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.09 3.9 14.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.978 -0.629 . . . . 60.32 111.536 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.55 ' HB2' HG13 ' A' ' 83' ' ' ILE . 17.7 t70 -76.09 142.05 41.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 72.14 111.049 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 17.7 m -114.47 141.47 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 121.345 0.593 . . . . 65.24 109.796 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.562 HG12 ' HB3' ' A' ' 67' ' ' TYR . 22.8 mt -121.37 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.497 -0.774 . . . . 71.31 109.651 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.64 -0.255 . . . . 61.32 110.906 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.563 ' HB1' ' HD3' ' A' ' 30' ' ' PRO . . . -94.93 118.16 31.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 71.15 111.282 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 66.9 mmm -105.37 168.04 9.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 73.12 110.621 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.05 109.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 75.1 111.371 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.764 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 89.6 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 74.3 113.13 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 110.061 -0.348 . . . . 71.25 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 1.09 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 23.6 mt -126.01 160.12 33.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.055 -1.091 . . . . 74.02 108.055 172.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 2.0 tt0 -145.8 135.85 23.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.567 0.222 . . . . 71.43 110.96 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.559 HG21 HD12 ' A' ' 48' ' ' LEU . 26.8 m -139.47 149.07 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 74.14 110.196 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.651 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 mtmt -119.36 114.94 23.12 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.217 -0.302 . . . . 74.44 110.427 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.529 HG22 HD11 ' A' ' 89' ' ' ILE . 53.2 t -97.36 98.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.946 -1.501 . . . . 73.33 106.946 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 27.6 ttp180 -68.99 103.74 1.92 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.055 -1.461 . . . . 74.22 107.055 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 70.8 m -64.63 158.46 67.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 114.073 -1.421 . . . . 75.05 108.699 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 37.1 Cg_endo -64.31 32.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 123.63 2.887 . . . . 73.44 114.756 -170.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 29' ' ' SER . 28.8 t70 -134.06 -8.58 2.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.449 0.642 . . . . 63.12 110.302 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.85 57.01 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.88 -0.888 . . . . 64.32 110.88 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 99.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 65.54 110.246 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.651 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 35.1 tt0 -104.92 99.78 9.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.526 -0.761 . . . . 71.52 109.515 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.56 134.77 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 73.02 110.338 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.507 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 20.8 p90 -76.59 117.37 18.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.78 0.8 . . . . 64.24 111.691 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -112.02 171.59 7.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.696 -1.224 . . . . 62.41 107.696 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -145.66 165.53 28.45 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.358 -0.937 . . . . 74.31 112.476 -170.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.09 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 48.5 mt -123.1 147.59 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.602 -1.181 . . . . 75.24 108.958 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -128.96 -77.63 0.56 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.2 -0.667 . . . . 73.51 109.2 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -72.62 150.14 43.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.185 -1.413 . . . . 73.4 107.185 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 59.7 pttt -56.64 101.24 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.902 0.858 . . . . 73.12 111.219 -175.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.441 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -134.68 103.31 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.063 -0.971 . . . . 72.42 109.465 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.68 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 13.1 pttp -63.54 -178.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.328 0.862 . . . . 74.31 113.328 -173.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.853 ' HA ' HD13 ' A' ' 48' ' ' LEU . 37.4 mt -60.91 -16.73 45.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.626 -1.17 . . . . 72.43 113.611 -164.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.648 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 53.1 mt-10 -58.09 -57.37 13.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.83 0.307 . . . . 73.33 111.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -68.2 -28.42 67.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.878 -0.329 . . . . 74.1 111.008 -175.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD13 ' HA ' ' A' ' 45' ' ' LEU . 86.1 mt -58.96 -37.59 77.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 73.21 110.73 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.648 ' HE1' ' HA ' ' A' ' 46' ' ' GLU . 26.1 ptt? -90.98 -32.79 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.628 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 27.6 mt-10 -67.91 -34.63 77.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.072 0.397 . . . . 64.22 112.072 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' LYS . 62.3 t -55.8 -37.68 48.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.207 0.527 . . . . 74.55 109.946 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.86 -36.76 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 73.13 111.287 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.065 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 58.5 m -52.21 -53.44 43.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.15 0.5 . . . . 62.33 110.638 173.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -67.22 -32.32 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.652 . . . . 71.51 110.938 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -69.26 -38.87 78.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.297 -0.41 . . . . 74.42 111.244 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.03 -13.93 37.61 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.874 -0.33 . . . . 75.42 111.422 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.4 8.46 52.75 Favored Glycine 0 CA--C 1.517 0.158 0 C-N-CA 120.556 -0.831 . . . . 60.04 113.822 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -151.17 135.18 16.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.7 -0.481 . . . . 75.33 109.7 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 1.065 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 3.6 p -78.37 179.33 7.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.191 0.811 . . . . 52.13 113.191 -171.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.566 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.2 -14.15 62.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.893 1.442 . . . . 75.4 114.893 -163.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -1.8 27.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.093 -1.004 . . . . 75.51 109.982 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . . . -113.76 1.8 14.96 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 70.02 109.953 173.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.83 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -142.52 102.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.362 0.601 . . . . 73.14 110.19 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 22.9 tpt180 -71.17 114.19 8.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 73.44 111.192 -172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -80.43 110.87 16.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.277 -0.874 . . . . 74.42 112.306 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 9.9 mp -104.8 125.51 50.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.797 -0.638 . . . . 74.2 109.783 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' HD1' HG12 ' A' ' 89' ' ' ILE . 74.0 m-85 -103.26 123.77 47.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.211 -0.292 . . . . 74.01 110.211 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.2 t70 57.82 22.95 9.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.147 0.975 . . . . 75.51 110.039 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.75 63.17 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.5 -0.773 . . . . 73.33 112.691 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.42 117.88 26.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 72.13 111.523 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.99 122.43 16.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 73.24 111.467 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.438 HG13 ' HD2' ' A' ' 67' ' ' TYR . 8.3 pt -147.66 -162.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -89.64 159.52 17.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.862 0.363 . . . . 74.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.649 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -76.59 -17.56 79.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.883 -0.675 . . . . 60.44 111.496 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.68 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 p30 -74.61 -9.21 58.35 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.468 0.307 . . . . 72.23 111.387 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 81' ' ' LEU . 7.2 t30 -67.7 -38.26 83.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.414 -0.357 . . . . 74.23 110.877 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.5 p 63.27 144.72 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 124.356 1.063 . . . . 72.04 111.461 -174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.0 -51.08 10.37 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.981 2.454 . . . . 73.22 113.219 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -56.95 -31.64 65.2 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.297 0.48 . . . . 74.52 112.297 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.83 -19.52 58.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.085 0.469 . . . . 74.25 110.667 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.416 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 44.4 tp -91.5 -30.88 16.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.356 . . . . 73.11 111.51 -171.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.1 -18.85 13.91 Favored Glycine 0 CA--C 1.502 -0.767 0 N-CA-C 110.1 -1.2 . . . . 71.35 110.1 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tp -89.3 159.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.957 -1.127 . . . . 75.31 107.957 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.76 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 28.3 tt0 -154.55 -152.4 0.4 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.983 -1.117 . . . . 72.03 107.983 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.76 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.9 t70 -43.85 119.36 1.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.603 0.638 . . . . 63.13 111.616 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.46 4.71 32.47 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.724 -0.75 . . . . 60.32 111.539 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.67 151.52 28.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.607 -0.297 . . . . 72.14 110.644 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 23.5 m -128.61 148.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.432 0.634 . . . . 65.24 110.607 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.553 HG12 ' HD1' ' A' ' 67' ' ' TYR . 54.6 mt -127.85 113.05 29.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.368 -0.975 . . . . 71.31 108.368 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -102.76 126.17 49.78 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.969 -0.382 . . . . 61.32 109.969 -173.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.83 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -104.62 118.01 35.53 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.429 0.455 . . . . 71.15 112.146 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.534 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.3 mpt? -95.14 171.23 8.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.565 -0.532 . . . . 73.12 109.565 172.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.94 117.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.719 0.295 . . . . 75.1 111.345 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 48.8 mt-30 . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 124.013 0.925 . . . . 74.3 112.22 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.2 m80 . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.927 -0.397 . . . . 71.25 109.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.801 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 10.2 mt -109.83 169.63 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.614 -0.513 . . . . 74.02 109.614 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.585 ' H ' HG23 ' A' ' 23' ' ' ILE . 4.1 tt0 -145.9 138.26 25.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.483 -0.562 . . . . 71.43 109.483 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.861 HG13 HD13 ' A' ' 48' ' ' LEU . 7.4 p -150.73 138.38 13.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.188 0.518 . . . . 74.14 110.234 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 36' ' ' PHE . 39.6 mttt -102.41 140.83 36.18 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.314 -0.403 . . . . 74.44 110.508 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 77.1 t -119.81 100.69 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.871 -1.529 . . . . 73.33 106.871 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 6.6 ttp180 -69.51 111.31 5.27 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.326 -0.99 . . . . 74.22 108.326 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 31' ' ' ASP . 78.4 p -60.28 157.65 32.74 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.645 -0.872 . . . . 75.05 108.645 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 36.2 Cg_endo -64.68 27.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.31 2.673 . . . . 73.44 114.504 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 29' ' ' SER . 12.3 t70 -130.52 -22.64 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.25 0.547 . . . . 63.12 110.615 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.63 -5.56 24.49 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.604 -0.808 . . . . 64.32 111.577 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.56 91.61 3.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.311 0.576 . . . . 65.54 109.538 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' OE2' ' HB2' ' A' ' 28' ' ' ARG . 37.9 tt0 -101.27 110.69 22.74 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.513 -0.767 . . . . 71.52 110.123 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.35 134.52 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.961 -0.563 . . . . 73.02 109.641 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.501 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 31.1 p90 -77.1 120.18 21.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.264 0.554 . . . . 64.24 110.509 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.722 ' HE2' ' HZ2' ' A' ' 47' ' ' LYS . 13.5 t80 -111.69 170.33 8.21 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.339 -1.356 . . . . 62.41 107.339 174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 42.4 mtmt -139.75 168.14 20.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.761 -0.776 . . . . 74.31 111.7 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.801 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 54.0 mt -117.41 134.66 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 75.24 108.875 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -115.69 -68.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.349 -0.611 . . . . 73.51 109.349 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -84.02 152.6 24.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.334 -1.728 . . . . 73.4 106.334 166.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -59.04 101.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 118.903 0.774 . . . . 73.12 109.764 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.46 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -126.03 118.82 26.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.758 -0.656 . . . . 72.42 111.653 -174.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -28.1 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.612 -1.631 . . . . 74.31 113.821 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.92 ' HA ' HD11 ' A' ' 48' ' ' LEU . 48.6 mt -65.18 -18.06 65.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.008 -0.997 . . . . 72.43 110.06 173.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 49' ' ' MET . 41.7 mt-10 -59.41 -52.47 65.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.646 -0.706 . . . . 73.33 111.025 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.722 ' HZ2' ' HE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -66.44 -30.42 70.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 74.1 110.297 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.92 HD11 ' HA ' ' A' ' 45' ' ' LEU . 73.4 mt -60.55 -32.29 71.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.966 -0.561 . . . . 73.21 110.62 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 21.3 ptp -95.74 -29.85 14.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.885 -0.326 . . . . 74.23 110.917 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 48.5 mt-10 -66.47 -34.08 77.14 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.45 0.167 . . . . 64.22 111.45 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' LYS . 78.7 t -57.64 -39.25 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.062 0.458 . . . . 74.55 110.027 173.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -76.81 -31.46 56.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 73.13 111.342 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.025 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 61.5 m -54.58 -49.5 70.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.443 0.639 . . . . 62.33 110.729 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -73.92 -23.4 59.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.678 -0.692 . . . . 71.51 111.006 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 2.6 tpm_? -80.54 -33.44 36.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.405 -0.361 . . . . 74.42 110.828 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.07 -21.57 31.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 75.42 110.812 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 1.22 64.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.871 -0.68 . . . . 60.04 111.891 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 6.5 tp-100 -136.32 131.1 33.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.148 -0.686 . . . . 75.33 109.148 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 1.025 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.6 p -86.84 179.32 6.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.066 0.765 . . . . 52.13 113.066 -168.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.782 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.48 -16.42 61.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.266 1.21 . . . . 75.4 114.266 -164.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.57 -0.29 37.13 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.453 -0.779 . . . . 75.51 110.409 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.855 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -115.11 11.4 16.35 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.481 -0.781 . . . . 70.02 109.835 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.782 HG23 ' HA ' ' A' ' 60' ' ' MET . 33.2 m -134.13 153.44 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.9 -0.591 . . . . 73.14 110.382 173.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.2 OUTLIER -113.32 112.46 23.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.212 -0.662 . . . . 73.44 109.212 175.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -85.67 116.41 23.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.287 0.565 . . . . 74.42 111.715 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -113.55 142.27 46.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 74.2 109.819 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.616 ' CD1' HG23 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -104.18 102.97 12.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.829 -0.168 . . . . 74.01 110.676 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 46.78 49.42 14.22 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.982 0.801 . . . . 75.51 111.557 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.13 -22.02 41.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.014 -0.612 . . . . 73.33 113.829 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 30.0 t70 -126.44 121.76 33.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.0 0.9 . . . . 72.13 111.638 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.884 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.33 143.38 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 73.24 111.74 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.662 HG12 ' H ' ' A' ' 73' ' ' HIS . 11.9 tt -135.33 -178.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.685 -0.689 . . . . 75.3 109.997 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.662 ' H ' HG12 ' A' ' 72' ' ' ILE . 98.1 m-70 -111.36 148.27 33.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.42 -0.585 . . . . 74.0 109.42 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -68.73 -16.96 70.66 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.287 0.475 . . . . 60.44 114.287 -171.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.67 -4.81 54.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.299 0.549 . . . . 72.23 111.386 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.95 -43.26 65.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.834 0.309 . . . . 74.23 111.834 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 28.1 p 67.68 148.11 0.11 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.74 1.216 . . . . 72.04 112.159 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.896 ' HD3' HD23 ' A' ' 45' ' ' LEU . 22.1 Cg_endo -61.57 -47.63 11.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.184 2.589 . . . . 73.22 113.618 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.98 -24.27 64.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.546 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -58.98 -39.95 83.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.938 -0.573 . . . . 74.25 110.81 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.65 -31.99 15.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.852 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.83 -19.91 13.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.685 -0.769 . . . . 71.35 111.798 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 87' ' ' ASP . 10.1 tt -75.85 116.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.303 -0.999 . . . . 75.31 108.303 170.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.836 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 13.1 tt0 -131.2 -174.54 3.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.449 -0.341 . . . . 72.03 110.632 -168.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.836 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 26.0 t70 -4.71 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.768 1.627 . . . . 63.13 114.531 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.89 4.07 33.99 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.575 -0.739 . . . . 60.32 111.603 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 83' ' ' ILE . 5.8 p-10 -79.56 167.15 21.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.745 0.307 . . . . 72.14 110.571 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 26' ' ' LYS . 20.5 m -137.32 153.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.561 0.696 . . . . 65.24 112.136 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 54.3 mt -129.68 127.63 64.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.868 -1.06 . . . . 71.31 108.439 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.18 136.7 39.68 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.439 -0.208 . . . . 61.32 110.439 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.49 117.71 34.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.018 0.437 . . . . 71.15 110.838 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 83.8 mtp -98.97 170.27 8.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 73.12 109.454 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -74.16 104.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.868 0.366 . . . . 75.1 111.203 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.855 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 90.8 mt-30 . . . . . 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 74.3 111.742 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.9 m170 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 121.185 0.517 . . . . 71.25 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 31.6 mm -116.01 164.28 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.453 -0.794 . . . . 74.02 108.918 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.629 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 88.0 mt-30 -151.59 116.25 5.13 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.712 0.805 . . . . 71.43 109.681 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 48' ' ' LEU . 10.3 m -113.17 -179.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.199 -0.667 . . . . 74.14 109.199 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.638 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 mtmt -144.83 114.43 7.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 74.44 110.776 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 89' ' ' ILE . 94.8 t -93.71 94.8 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 107.082 -1.451 . . . . 73.33 107.082 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 9.0 ttp180 -69.62 105.58 2.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.517 -1.29 . . . . 74.22 107.517 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.552 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 59.4 p -59.1 163.03 6.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 114.678 -1.147 . . . . 75.05 108.941 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 46.1 Cg_endo -67.21 28.14 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.824 2.35 . . . . 73.44 113.759 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 29' ' ' SER . 18.0 t70 -130.52 -23.82 2.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 63.12 110.65 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.12 -7.62 27.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.521 -0.847 . . . . 64.32 111.108 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.33 90.34 0.94 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.17 -0.678 . . . . 65.54 109.17 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 38.1 tt0 -99.57 102.21 13.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.1 -0.955 . . . . 71.52 109.657 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.11 129.98 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.886 -0.597 . . . . 73.02 109.999 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.525 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 27.8 p90 -71.41 122.58 20.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.432 0.634 . . . . 64.24 110.554 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.519 ' HD2' HD21 ' A' ' 48' ' ' LEU . 3.5 t80 -120.53 128.74 53.38 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.618 -1.252 . . . . 62.41 107.618 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HG2' ' HG2' ' A' ' 24' ' ' GLN . 21.6 mtmt -105.3 162.67 13.23 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.383 -0.527 . . . . 74.31 110.951 -165.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 43.1 mt -115.27 134.64 57.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.867 -0.79 . . . . 75.24 108.867 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -93.47 -78.75 0.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.784 -0.45 . . . . 73.51 109.784 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -97.59 169.71 9.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.118 -1.438 . . . . 73.4 107.118 164.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.863 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -54.85 101.59 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 73.12 110.532 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.8 116.03 23.02 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.23 -0.895 . . . . 72.42 109.755 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -36.37 134.19 0.46 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.575 -1.193 . . . . 74.31 111.985 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.458 ' HG ' ' HD3' ' A' ' 78' ' ' PRO . 91.7 mt -57.11 -20.28 24.62 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.958 -1.019 . . . . 72.43 113.276 -168.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 49' ' ' MET . 58.6 mt-10 -65.59 -24.69 67.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.111 0.412 . . . . 73.33 112.111 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -28.98 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.752 -0.379 . . . . 74.1 110.483 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 25' ' ' VAL . 28.3 mt -59.25 -39.49 82.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.975 -0.557 . . . . 73.21 111.512 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.612 ' HE1' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -94.47 -23.82 17.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.84 -0.744 . . . . 74.23 111.307 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 45.9 mt-10 -73.27 -37.74 66.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.276 -0.57 . . . . 64.22 111.046 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.99 -25.08 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.525 0.679 . . . . 74.55 109.512 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -81.72 -34.76 30.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.277 -0.874 . . . . 73.13 110.338 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.994 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 79.7 m -53.75 -56.96 12.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.335 0.588 . . . . 62.33 111.155 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -68.69 -19.99 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.585 -0.734 . . . . 71.51 110.993 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -66.59 -46.51 75.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 74.42 111.354 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -98.7 -11.09 22.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.973 0.36 . . . . 75.42 111.973 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 29.82 8.22 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.5 -0.857 . . . . 60.04 113.498 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.485 HE21 HG13 ' A' ' 63' ' ' VAL . 28.5 tt0 -150.55 129.04 12.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.823 -0.806 . . . . 75.33 108.823 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.994 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 24.2 p -92.43 178.25 5.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.995 0.739 . . . . 52.13 112.995 -168.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.501 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -76.21 -13.8 60.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.006 1.113 . . . . 75.4 114.006 -163.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 3.9 pm0 -80.07 -9.14 59.68 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.403 -0.811 . . . . 75.51 109.659 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.728 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.66 -22.35 12.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.617 -0.72 . . . . 70.02 109.965 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.485 HG13 HE21 ' A' ' 58' ' ' GLN . 3.7 m -128.51 101.26 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 166.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 14.0 tpt180 -83.77 149.53 26.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.747 -0.66 . . . . 73.44 111.395 -168.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.619 ' HD2' ' HE1' ' A' ' 67' ' ' TYR . 1.6 p90 -94.74 104.27 16.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.28 -0.873 . . . . 74.42 111.96 -175.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.792 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.5 mp -99.58 131.96 45.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.468 -0.787 . . . . 74.2 109.015 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.619 ' HE1' ' HD2' ' A' ' 65' ' ' PHE . 47.7 m-85 -103.42 110.35 22.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.485 -0.486 . . . . 74.01 110.99 -175.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t70 54.19 37.16 26.63 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.103 -0.953 . . . . 75.51 110.228 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -21.48 45.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.399 -0.819 . . . . 73.33 112.985 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -113.49 116.28 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.364 0.602 . . . . 72.13 110.846 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.792 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 23.6 ptt180 -72.61 118.21 15.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.381 -0.827 . . . . 73.24 112.344 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.93 -163.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.802 -0.814 . . . . 75.3 108.802 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -108.84 138.14 45.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.958 -0.297 . . . . 74.0 110.612 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.8 -10.56 64.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.1 -0.571 . . . . 60.44 112.273 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.15 -28.36 64.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 72.23 110.532 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 80' ' ' GLN . 6.1 t30 -67.64 -17.7 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.647 -0.706 . . . . 74.23 111.062 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.58 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 66.6 p 60.18 156.72 0.1 Allowed Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.375 1.07 . . . . 72.04 113.18 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.893 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 59.2 Cg_endo -72.37 -43.43 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.544 2.163 . . . . 73.22 112.431 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.68 -28.12 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.684 . . . . 74.52 111.966 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 76' ' ' ASN . 53.8 tt0 -83.32 -34.65 25.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.268 -0.423 . . . . 74.25 111.547 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 29.5 tp -89.56 -28.31 19.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 73.11 110.659 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.24 -18.63 38.79 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.672 -0.775 . . . . 71.35 111.509 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.5 tt -89.87 120.99 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.45 -0.574 . . . . 75.31 109.45 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -155.83 -154.16 0.47 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 118.974 -0.536 . . . . 72.03 110.353 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -21.82 109.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.718 1.261 . . . . 63.13 113.276 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.4 -6.88 20.84 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.919 -1.037 . . . . 60.32 111.819 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.65 170.91 15.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 72.14 110.882 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.89 158.17 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.637 0.732 . . . . 65.24 111.413 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.603 ' HB ' HG23 ' A' ' 27' ' ' VAL . 66.1 mt -128.59 125.92 64.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.98 -1.009 . . . . 71.31 108.724 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.09 126.23 44.79 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.772 -0.455 . . . . 61.32 109.772 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.732 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -87.96 117.93 27.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.144 0.497 . . . . 71.15 111.377 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.7 ttt -101.74 150.7 22.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.738 -0.665 . . . . 73.12 109.973 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.21 102.98 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.942 0.401 . . . . 75.1 110.505 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.728 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 38.8 mt-30 . . . . . 0 C--N 1.332 -0.161 0 CA-C-N 115.046 -0.979 . . . . 74.3 112.206 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 38.3 m80 . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 110.059 -0.348 . . . . 71.25 110.059 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 1.022 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.2 mm -110.75 163.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.014 -0.539 . . . . 74.02 109.63 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.439 ' N ' HG23 ' A' ' 23' ' ' ILE . 58.6 tt0 -137.0 125.46 23.49 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.531 -0.544 . . . . 71.43 109.531 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.68 HG12 HD13 ' A' ' 48' ' ' LEU . 7.0 p -130.99 139.16 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.2 -0.454 . . . . 74.14 110.502 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.791 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -110.5 118.43 36.22 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.699 -0.4 . . . . 74.44 110.714 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.446 HG23 ' HB ' ' A' ' 89' ' ' ILE . 73.5 t -94.95 104.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.314 -1.365 . . . . 73.33 107.314 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 72.8 ttt-85 -69.64 110.23 4.74 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.983 -1.117 . . . . 74.22 107.983 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 62.3 p -60.22 159.77 20.48 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 115.322 -0.854 . . . . 75.05 108.714 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 27.3 Cg_endo -62.1 22.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 123.353 2.702 . . . . 73.44 115.021 -174.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 29' ' ' SER . 31.8 t70 -131.78 -24.07 2.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 63.12 110.9 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.05 2.55 20.22 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.44 -0.886 . . . . 64.32 112.114 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 88.47 7.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.186 -0.672 . . . . 65.54 109.186 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.791 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 11.1 tt0 -82.5 113.5 20.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.787 -0.642 . . . . 71.52 110.187 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.02 134.32 44.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.708 -0.479 . . . . 73.02 109.708 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -79.35 121.69 25.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.92 0.867 . . . . 64.24 111.543 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -116.92 174.35 6.14 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.485 -1.234 . . . . 62.41 107.805 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -136.26 153.48 51.18 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.97 -0.456 . . . . 74.31 111.174 -167.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.022 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 55.1 mt -114.99 134.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.729 -0.841 . . . . 75.24 108.729 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 22' ' ' HIS . 55.0 mtpt -127.83 -58.52 1.23 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.912 0.387 . . . . 73.51 110.793 -171.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -95.54 177.8 5.69 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.16 -1.052 . . . . 73.4 108.16 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.587 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.98 100.71 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.136 0.969 . . . . 73.12 109.073 172.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -138.95 102.17 4.48 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.307 -0.86 . . . . 72.42 110.606 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.713 ' HB3' HG21 ' A' ' 77' ' ' THR . 9.4 pttp -68.56 -176.63 0.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.205 -0.907 . . . . 74.31 111.212 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.667 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 60.6 mt -55.67 -27.13 48.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 72.43 111.988 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.604 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 39.8 mt-10 -57.92 -35.48 71.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.01 0.434 . . . . 73.33 111.4 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 51' ' ' VAL . 46.3 tptt -69.9 -52.48 24.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 74.1 110.287 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 25' ' ' VAL . 26.8 mt -62.65 -28.36 69.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 73.21 111.32 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.701 ' HE1' ' HB2' ' A' ' 60' ' ' MET . 14.2 ptm -85.59 -37.45 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 74.23 111.011 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 35.8 mm-40 -71.31 -30.43 66.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.829 0.307 . . . . 64.22 111.829 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 47' ' ' LYS . 87.8 t -62.98 -37.78 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.142 0.496 . . . . 74.55 109.706 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 55' ' ' ARG . 35.3 m-85 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.027 -0.533 . . . . 73.13 111.169 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 86.0 m -54.35 -48.59 71.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.315 0.579 . . . . 62.33 109.83 170.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.27 -40.52 67.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 71.51 110.833 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 52' ' ' TYR . 55.1 ttt180 -65.79 -45.54 82.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.42 111.683 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.24 -13.79 42.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.685 0.278 . . . . 75.42 111.316 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.79 10.86 83.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.665 -0.779 . . . . 60.04 111.893 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.641 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 5.3 tp-100 -133.61 130.33 38.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.996 -0.742 . . . . 75.33 108.996 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.478 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 32.6 p -83.09 163.48 20.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.333 0.587 . . . . 52.13 112.263 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.701 ' HB2' ' HE1' ' A' ' 49' ' ' MET . 0.0 OUTLIER -67.1 -15.69 63.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.245 -0.889 . . . . 75.4 112.328 -174.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -87.02 -4.29 59.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 75.51 110.476 177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -115.81 -25.94 7.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.593 -0.73 . . . . 70.02 109.455 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 11.5 m -125.78 117.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.637 -0.71 . . . . 73.14 109.639 168.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -88.1 139.74 30.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.583 -0.525 . . . . 73.44 109.583 -174.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' HB3' ' CG2' ' A' ' 89' ' ' ILE . 60.9 m-85 -101.38 119.01 38.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.913 -0.585 . . . . 74.42 111.353 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.889 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.2 mp -99.34 127.1 45.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.193 -0.912 . . . . 74.2 108.784 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HE1' HG21 ' A' ' 83' ' ' ILE . 1.6 p90 -101.65 124.79 47.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.207 -0.997 . . . . 74.01 110.234 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.34 29.75 13.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.848 -1.069 . . . . 75.51 110.264 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.66 0.29 64.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.681 -0.69 . . . . 73.33 113.241 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.29 116.37 19.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.506 0.653 . . . . 72.13 111.368 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.889 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 22.6 ptt180 -66.68 137.81 56.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.286 -0.87 . . . . 73.24 112.408 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 73' ' ' HIS . 11.0 tp -162.63 164.86 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 75.3 109.741 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.407 ' N ' HG13 ' A' ' 72' ' ' ILE . 1.4 p-80 -70.39 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.0 110.919 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.667 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -65.76 -23.82 70.97 Favored Glycine 0 CA--C 1.518 0.242 0 CA-C-N 116.131 -0.486 . . . . 60.44 113.896 -171.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.77 3.84 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.763 0.281 . . . . 72.23 111.501 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -67.39 -39.1 85.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.453 -0.203 . . . . 74.23 110.453 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.713 HG21 ' HB3' ' A' ' 44' ' ' LYS . 49.9 p 62.41 143.0 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.596 1.158 . . . . 72.04 112.597 -178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.85 -42.22 15.64 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.049 2.499 . . . . 73.22 112.56 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.84 -14.76 55.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 74.52 111.802 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -59.9 -38.4 82.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 74.25 110.837 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.54 ' HB3' HG23 ' A' ' 83' ' ' ILE . 45.4 tp -104.85 -30.01 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 73.11 110.886 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.08 -19.32 13.62 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.774 -0.931 . . . . 71.35 110.774 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 81' ' ' LEU . 5.4 tt -66.48 112.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.719 -0.845 . . . . 75.31 108.719 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 15.8 tt0 -134.07 -152.8 0.49 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.751 -0.658 . . . . 72.03 109.864 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.566 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 33.1 t70 -30.57 112.9 0.09 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.254 0.971 . . . . 63.13 113.032 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.04 4.94 22.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.924 -0.58 . . . . 60.32 111.679 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -78.93 170.51 16.57 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.992 0.425 . . . . 72.14 111.094 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 13.7 m -138.27 154.83 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 65.24 111.013 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 36.4 mt -136.66 114.99 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.637 -0.71 . . . . 71.31 109.101 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.401 ' CG ' HH11 ' A' ' 28' ' ' ARG . 48.2 t0 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.446 -0.343 . . . . 61.32 110.372 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.2 131.69 53.15 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.148 0.425 . . . . 71.15 112.148 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.654 ' SD ' HD11 ' A' ' 66' ' ' LEU . 2.4 mpt? -126.21 163.28 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.449 -0.575 . . . . 73.12 109.449 173.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.53 95.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.564 0.221 . . . . 75.1 111.465 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 28.4 mt-30 . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 123.495 0.718 . . . . 74.3 112.113 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 30.7 m80 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 110.311 -0.255 . . . . 71.25 110.311 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 30.1 mt -108.93 159.39 8.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.983 0.42 . . . . 74.02 110.808 -169.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.716 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp0 -146.11 126.12 13.68 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.985 0.914 . . . . 71.43 109.238 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.39 144.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.741 -0.466 . . . . 74.14 109.741 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.97 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.51 115.9 31.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.977 0.418 . . . . 74.44 111.302 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HB ' ' A' ' 89' ' ' ILE . 47.0 t -99.93 101.99 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.92 -1.141 . . . . 73.33 107.92 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 2.1 ttp180 -69.91 111.16 5.43 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 107.893 -1.151 . . . . 74.22 107.893 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.632 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 93.1 p -62.47 165.66 8.69 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.696 -0.801 . . . . 75.05 108.871 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 43.7 Cg_endo -66.65 20.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 122.66 2.24 . . . . 73.44 113.909 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' SER . 36.0 t70 -131.26 -11.77 3.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.205 0.526 . . . . 63.12 110.892 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.52 -0.16 43.08 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.193 -1.003 . . . . 64.32 111.976 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 97.6 6.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.353 -0.61 . . . . 65.54 109.353 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 48.5 tt0 -115.98 97.45 6.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.882 -0.599 . . . . 71.52 110.29 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.6 t -102.97 145.0 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.444 -0.947 . . . . 73.02 108.444 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.97 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.3 p90 -67.3 123.54 20.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 64.24 110.231 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' HE2' ' HZ1' ' A' ' 47' ' ' LYS . 6.4 t80 -110.52 170.11 8.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.943 -1.132 . . . . 62.41 107.943 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 34.8 mttt -140.71 165.87 26.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.46 0.573 . . . . 74.31 111.402 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 69.4 mt -122.68 135.21 63.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 75.24 108.877 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -117.44 -77.73 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.312 . . . . 73.51 110.969 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 42' ' ' LYS . 4.9 tpt180 -76.95 177.47 7.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.257 -1.016 . . . . 73.4 108.257 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 5.9 ttpm? -62.47 99.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.052 -1.092 . . . . 73.12 108.052 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 2.8 p -135.17 106.55 6.8 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.666 -0.697 . . . . 72.42 110.845 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.756 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 45.0 mttm -51.49 170.45 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.483 -1.235 . . . . 74.31 111.154 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.861 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 47.6 mt -62.61 -10.95 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.595 . . . . 72.43 110.487 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 5.3 mm-40 -53.94 -57.22 11.78 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.631 -0.713 . . . . 73.33 111.361 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HG2' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.62 -23.92 63.57 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.427 . . . . 74.1 110.877 -175.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD13 ' HA ' ' A' ' 45' ' ' LEU . 86.7 mt -63.32 -35.3 79.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 73.21 110.558 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 46' ' ' GLU . 26.5 ptt? -89.31 -33.91 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 74.23 110.564 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 9.2 mm-40 -66.48 -32.87 74.5 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.982 0.364 . . . . 64.22 111.982 -176.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 47' ' ' LYS . 93.2 t -60.89 -34.94 61.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.502 -0.479 . . . . 74.55 110.124 174.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -73.44 -44.47 58.14 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.873 -0.331 . . . . 73.13 110.315 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 61.7 m -48.1 -44.52 31.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.334 0.588 . . . . 62.33 110.409 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -64.62 -56.2 15.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.226 -0.897 . . . . 71.51 110.724 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -68.58 -42.96 77.5 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.494 0.553 . . . . 74.42 112.494 -171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.87 -20.32 53.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.721 -0.218 . . . . 75.42 111.01 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.5 19.28 74.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.686 -0.768 . . . . 60.04 111.254 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.667 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 35.1 tt0 -142.72 130.05 21.06 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.522 -0.918 . . . . 75.33 108.522 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.3 p -84.35 167.28 16.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 52.13 111.749 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.34 -15.15 59.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.475 -0.784 . . . . 75.4 112.39 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 12.5 pt-20 -59.28 -23.78 62.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.617 0.246 . . . . 75.51 110.489 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 1.009 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -105.74 -12.82 15.75 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.977 -0.556 . . . . 70.02 111.085 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.4 m -144.24 103.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 73.14 110.635 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -95.77 145.7 25.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.726 -0.39 . . . . 73.44 110.655 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.666 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 26.5 p90 -95.21 133.08 39.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 74.42 111.774 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 1.084 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -115.9 114.05 24.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 74.2 109.987 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -103.76 138.8 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.013 -0.675 . . . . 74.01 110.423 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 t70 54.53 22.89 4.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.822 0.82 . . . . 75.51 109.977 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.53 -18.73 56.54 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.652 -0.704 . . . . 73.33 113.367 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -118.16 120.66 38.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.742 0.771 . . . . 72.13 111.739 -176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 1.084 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -69.19 142.89 54.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.723 -0.672 . . . . 73.24 111.685 176.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 76' ' ' ASN . 37.6 pt -142.55 -163.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.151 -0.685 . . . . 75.3 109.151 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -98.21 140.35 32.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.009 -0.737 . . . . 74.0 109.009 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.861 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -60.33 -23.62 60.31 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.161 -0.542 . . . . 60.44 113.482 -172.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.756 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 23.8 t70 -63.06 -23.39 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.393 0.516 . . . . 72.23 112.393 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.656 ' HB3' HD12 ' A' ' 72' ' ' ILE . 2.1 t-20 -74.13 -19.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.841 -0.344 . . . . 74.23 111.205 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.61 HG23 ' HA ' ' A' ' 44' ' ' LYS . 7.7 p 59.15 151.79 0.08 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.063 1.135 . . . . 72.04 114.063 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 -32.76 23.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.821 2.347 . . . . 73.22 113.492 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.609 ' OE1' ' HB ' ' A' ' 77' ' ' THR . 4.3 pm0 -63.15 -14.85 53.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.674 0.273 . . . . 74.52 111.543 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -68.62 -30.93 69.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.301 -0.409 . . . . 74.25 111.006 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.18 -30.35 16.72 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.368 -0.533 . . . . 73.11 111.388 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 -18.99 32.52 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.472 -1.051 . . . . 71.35 110.472 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -84.47 148.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.95 -1.13 . . . . 75.31 107.95 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.608 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.7 tt0 -155.07 -149.19 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.817 -1.179 . . . . 72.03 107.817 -176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.608 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 5.2 p-10 -36.49 114.53 0.3 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.854 0.835 . . . . 63.13 112.194 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.45 -5.71 14.77 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.462 -0.79 . . . . 60.32 111.853 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.8 t0 -80.63 161.71 24.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.782 0.325 . . . . 72.14 110.38 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.09 154.8 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.356 0.598 . . . . 65.24 110.51 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.666 ' CG2' ' HB2' ' A' ' 65' ' ' PHE . 59.5 mt -131.72 126.37 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.408 -0.814 . . . . 71.31 109.471 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.98 134.35 43.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.554 0.216 . . . . 61.32 110.855 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -99.69 119.06 37.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.05 0.452 . . . . 71.15 110.622 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 65.4 mtt -103.32 152.25 21.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 73.12 110.016 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.32 95.89 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.861 0.362 . . . . 75.1 110.288 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 1.009 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 44.7 mt-30 . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 115.334 -0.848 . . . . 74.3 110.852 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.101 -0.703 . . . . 73.11 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.67 104.87 2.03 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.753 -0.658 . . . . 72.34 114.004 -167.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -95.44 140.92 29.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.779 -0.822 . . . . 64.1 108.779 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.09 -26.81 33.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 73.11 111.209 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -58.96 -42.72 90.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 72.02 111.639 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 t -74.12 -10.95 60.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.578 -0.283 . . . . 75.43 111.557 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.41 15.04 6.63 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.942 -0.303 . . . . 62.41 111.659 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.62 -14.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.616 0.246 . . . . 74.32 111.61 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' CG ' ' H ' ' A' ' 10' ' ' ASN . 62.7 t30 64.61 -163.65 0.26 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.249 -0.649 . . . . 75.34 109.249 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.555 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 46.1 m-80 67.81 24.11 8.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.126 0.489 . . . . 71.34 110.512 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -74.75 156.97 36.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 75.25 110.439 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.12 166.68 10.86 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.962 -0.637 . . . . 60.41 111.715 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 m -130.37 102.44 6.18 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.14 0.495 . . . . 74.44 110.525 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -80.83 159.39 68.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.78 -0.645 . . . . 63.33 109.753 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.98 46.27 1.06 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 73.34 112.627 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 70.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 122.184 0.992 . . . . 75.44 109.959 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -172.39 138.38 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.812 -1.085 . . . . 70.43 109.372 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -114.11 157.17 22.95 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.428 -0.582 . . . . 63.4 109.428 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.8 -40.45 97.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.724 0.297 . . . . 74.43 111.565 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.1 21.23 28.84 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 65.4 113.005 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.11 -30.64 62.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.474 0.654 . . . . 73.1 109.925 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 38.9 m80 -90.6 -169.85 2.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.24 -0.891 . . . . 71.25 110.4 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 1.081 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 25.8 mm -109.4 158.18 9.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.913 -0.402 . . . . 74.02 109.913 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -144.43 134.67 24.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.585 -0.524 . . . . 71.43 109.585 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 48' ' ' LEU . 5.0 p -142.63 140.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 123.658 0.599 . . . . 74.14 109.646 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . 23.4 mtmt -110.41 118.86 37.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.244 0.545 . . . . 74.44 111.182 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.752 HG23 ' HB ' ' A' ' 89' ' ' ILE . 88.6 t -94.46 97.68 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 105.999 -1.852 . . . . 73.33 105.999 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 32.7 ttt-85 -67.76 106.13 2.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.189 -1.041 . . . . 74.22 108.189 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.515 ' HA ' ' HH ' ' A' ' 52' ' ' TYR . 9.5 p -58.46 124.54 72.18 Favored Pre-proline 0 N--CA 1.422 -1.863 0 N-CA-C 107.111 -1.44 . . . . 75.05 107.111 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 90.5 Cg_endo -71.43 38.49 0.34 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.357 2.704 . . . . 73.44 114.217 -162.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -131.13 15.63 5.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.3 0.572 . . . . 63.12 111.326 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.5 24.93 19.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.362 -0.923 . . . . 64.32 111.844 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.34 161.57 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.433 -0.58 . . . . 65.54 109.433 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 38.2 tt0 -151.12 115.35 5.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.87 -0.418 . . . . 71.52 109.87 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.34 128.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.771 -0.455 . . . . 73.02 109.771 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.41 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 24.5 p90 -72.25 119.85 17.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.698 0.761 . . . . 64.24 110.845 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -111.29 166.35 11.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.873 -1.058 . . . . 62.41 108.421 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -144.98 146.13 31.81 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.403 -0.519 . . . . 74.31 111.224 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.081 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 56.9 mt -115.13 134.89 56.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.507 -0.923 . . . . 75.24 108.507 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -109.0 -65.03 1.18 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.556 -0.457 . . . . 73.51 110.978 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.2 ptp180 -91.45 -177.79 4.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.192 -1.04 . . . . 73.4 108.192 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.549 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.95 101.26 0.37 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.776 0.798 . . . . 73.12 109.25 172.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.28 6.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.644 -0.707 . . . . 72.42 110.269 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.924 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 14.1 ptpt -58.99 -179.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.231 -0.895 . . . . 74.31 112.075 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.721 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 37.3 mt -67.34 -10.48 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 72.43 112.376 -169.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 49' ' ' MET . 70.2 mt-10 -57.5 -53.79 54.22 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.835 0.309 . . . . 73.33 111.835 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -30.09 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.341 -0.543 . . . . 74.1 110.913 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD13 HD12 ' A' ' 39' ' ' ILE . 95.2 mt -60.27 -36.86 78.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.943 0.401 . . . . 73.21 110.392 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.6 ptt? -85.78 -34.01 21.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.019 -0.537 . . . . 74.23 111.176 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 42.0 mt-10 -74.61 -39.65 62.04 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.817 0.303 . . . . 64.22 111.817 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.87 -29.37 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.152 -0.684 . . . . 74.55 109.152 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HH ' ' HA ' ' A' ' 29' ' ' SER . 59.1 t80 -73.94 -43.58 57.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.78 . . . . 73.13 109.999 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 84.5 m -50.11 -52.05 38.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.382 0.611 . . . . 62.33 110.699 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -27.34 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.834 . . . . 71.51 110.723 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -71.44 -41.57 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.453 -0.34 . . . . 74.42 111.586 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.38 -6.4 34.19 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.898 -0.321 . . . . 75.42 111.4 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.51 59.3 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.513 -0.851 . . . . 60.04 111.775 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.2 tt0 -150.83 129.73 12.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.592 -0.892 . . . . 75.33 108.592 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.0 p -87.9 178.23 6.75 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.834 0.679 . . . . 52.13 112.834 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.561 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -74.48 -16.16 60.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.982 1.104 . . . . 75.4 113.982 -164.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.02 -13.67 60.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.884 -0.726 . . . . 75.51 109.957 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.02 2.98 23.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.532 -0.758 . . . . 70.02 110.336 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 91' ' ' ALA . 7.0 m -139.63 103.34 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.386 0.613 . . . . 73.14 110.73 171.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.646 ' HD2' HD12 ' A' ' 66' ' ' LEU . 25.8 ttm180 -69.24 112.05 5.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.759 -0.655 . . . . 73.44 109.616 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.76 109.95 21.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.551 0.691 . . . . 74.42 111.64 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.835 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 5.2 mp -106.21 130.94 53.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.333 -0.849 . . . . 74.2 109.481 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HE2' HG22 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -127.62 143.47 51.16 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.206 -0.998 . . . . 74.01 110.618 176.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.465 ' HB2' HG21 ' A' ' 83' ' ' ILE . 35.2 t70 59.67 21.9 10.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.921 0.867 . . . . 75.51 109.764 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.84 -17.49 58.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.543 -0.753 . . . . 73.33 113.237 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -122.72 125.78 46.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.15 0.475 . . . . 72.13 111.609 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.835 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -65.28 151.45 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 73.24 110.901 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 73' ' ' HIS . 12.5 tt -170.81 -173.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.942 -0.762 . . . . 75.3 108.942 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.603 ' H ' HG12 ' A' ' 72' ' ' ILE . 94.1 m-70 -86.01 149.23 25.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.254 0.479 . . . . 74.0 110.435 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.721 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -67.94 -20.9 73.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.632 -0.794 . . . . 60.44 112.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.924 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 4.6 p-10 -78.78 -4.66 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.599 0.222 . . . . 72.23 111.599 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -23.45 61.98 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.854 -0.157 . . . . 74.23 111.293 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.866 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.1 p 66.28 159.15 0.13 Allowed Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 72.04 111.788 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.43 -60.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 73.22 113.432 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -63.57 -19.07 64.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.901 0.334 . . . . 74.52 111.901 -170.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -63.24 -25.5 68.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.035 0.445 . . . . 74.25 110.811 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.42 -29.16 17.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.109 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.79 -18.87 8.52 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.842 -0.694 . . . . 71.35 111.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 87' ' ' ASP . 15.4 tt -101.92 136.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.999 -0.371 . . . . 75.31 109.999 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.798 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 26.5 tt0 -148.39 -153.32 0.48 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.942 -0.762 . . . . 72.03 108.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.798 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.3 p-10 -20.94 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.651 1.18 . . . . 63.13 113.792 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.5 5.16 30.06 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.993 -0.843 . . . . 60.32 110.993 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.494 ' HB3' HG12 ' A' ' 83' ' ' ILE . 11.3 p-10 -85.79 173.09 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.151 -0.525 . . . . 72.14 110.915 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.32 158.59 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 65.24 111.137 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.752 ' HB ' HG23 ' A' ' 27' ' ' VAL . 69.6 mt -134.64 138.46 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.649 -0.871 . . . . 71.31 108.649 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.51 126.42 51.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.433 -0.58 . . . . 61.32 109.433 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . . . -111.89 116.8 31.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.695 -0.402 . . . . 71.15 110.388 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 62.6 mtt -101.26 168.82 9.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.109 -0.496 . . . . 73.12 110.114 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.24 101.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 75.1 111.311 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.635 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 43.4 mt-30 64.52 173.73 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 74.3 112.23 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -72.81 -40.07 66.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.34 111.941 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.32 9.83 27.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.195 0.522 . . . . 70.43 110.806 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.35 -13.71 61.25 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 55.11 111.289 -175.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 110.417 -1.073 . . . . 74.45 110.417 179.384 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.045 -0.354 . . . . 73.11 110.045 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.47 126.04 2.13 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.929 -0.653 . . . . 72.34 111.641 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.73 145.21 27.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.215 0.531 . . . . 64.1 111.011 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.44 -17.21 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.529 -0.76 . . . . 73.11 110.827 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.04 -24.13 51.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.549 -0.75 . . . . 72.02 112.876 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -56.21 -26.08 49.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.861 0.319 . . . . 75.43 111.861 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.88 78.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.236 -0.438 . . . . 62.41 111.695 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.44 -20.99 5.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.097 0.475 . . . . 74.32 110.391 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -64.37 -28.61 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 75.34 111.999 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -76.4 112.05 12.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.598 0.714 . . . . 71.34 111.306 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.33 89.12 3.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 75.25 110.49 174.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.75 75.79 2.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.874 -0.679 . . . . 60.41 112.136 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -99.4 -174.21 2.68 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.713 -0.477 . . . . 74.44 109.713 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -142.13 67.14 21.45 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.895 0.378 . . . . 63.33 111.458 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' HG2' ' A' ' 80' ' ' GLN . 3.6 Cg_exo -81.57 -62.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.796 2.331 . . . . 73.34 111.623 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.458 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . 21.8 t 57.87 74.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.499 -0.773 . . . . 75.44 111.521 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.42 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 53.5 t30 -84.65 69.91 10.7 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.697 -0.683 . . . . 70.43 109.518 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.75 101.33 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.57 -0.741 . . . . 63.4 110.462 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -112.06 -0.8 15.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.748 -0.66 . . . . 74.43 109.897 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.28 24.07 38.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.781 -0.723 . . . . 65.4 111.709 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.82 151.32 35.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 73.1 110.348 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -94.72 129.3 41.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.086 -0.506 . . . . 71.25 110.151 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.909 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 17.8 mt -110.59 166.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.402 -0.592 . . . . 74.02 109.402 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.595 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 8.6 tt0 -148.49 139.75 23.32 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.771 -0.455 . . . . 71.43 109.771 -174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 48' ' ' LEU . 29.0 m -140.82 172.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.077 0.465 . . . . 74.14 110.741 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 3.7 mtmt -141.71 115.42 9.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 74.44 109.487 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 89' ' ' ILE . 52.3 t -95.19 95.08 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.589 -1.634 . . . . 73.33 106.589 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -68.49 103.57 1.7 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.996 -1.483 . . . . 74.22 106.996 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 31' ' ' ASP . 67.6 m -62.86 158.38 53.35 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 113.498 -1.683 . . . . 75.05 109.03 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 35.9 Cg_endo -64.8 36.2 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.666 2.911 . . . . 73.44 114.051 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 29' ' ' SER . 30.7 t70 -131.75 -14.9 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.46 0.647 . . . . 63.12 110.282 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.85 -3.57 52.64 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.227 -0.749 . . . . 64.32 111.227 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.01 118.16 23.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.364 -0.418 . . . . 65.54 110.014 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.567 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 23.4 tt0 -116.04 101.43 8.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.396 -0.594 . . . . 71.52 109.396 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' OH ' ' A' ' 52' ' ' TYR . 44.3 t -102.75 135.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.801 -0.444 . . . . 73.02 109.801 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.2 p90 -71.25 132.04 44.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.578 0.704 . . . . 64.24 111.358 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.635 ' HE1' ' HZ1' ' A' ' 47' ' ' LYS . 4.9 t80 -126.72 162.8 24.95 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.657 -1.238 . . . . 62.41 107.657 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -136.99 157.15 47.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.845 0.831 . . . . 74.31 112.712 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.909 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -119.68 136.1 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 75.24 108.11 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -111.75 -28.14 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.838 -0.745 . . . . 73.51 111.834 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 35.4 ttm180 -145.78 -177.6 5.67 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.055 -1.461 . . . . 73.4 107.055 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 20.5 pttp -60.57 99.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.527 -0.869 . . . . 73.12 110.0 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.53 ' OG1' HG22 ' A' ' 39' ' ' ILE . 74.0 p -129.38 114.46 16.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.77 -1.104 . . . . 72.42 108.893 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.684 ' HA ' HG21 ' A' ' 77' ' ' THR . 0.4 OUTLIER -49.27 153.75 0.96 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 74.31 111.688 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.789 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 36.1 mt -63.0 -12.57 26.75 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.29 -0.868 . . . . 72.43 111.76 -173.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.659 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 54.5 mt-10 -57.36 -44.43 84.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 73.33 111.345 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.635 ' HZ1' ' HE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -69.72 -30.43 68.05 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.561 -0.456 . . . . 74.1 110.582 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 HD11 ' A' ' 39' ' ' ILE . 98.0 mt -61.55 -33.06 73.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 73.21 110.356 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.659 ' HE1' ' HA ' ' A' ' 46' ' ' GLU . 26.8 ptt? -98.3 -28.98 13.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 74.23 112.029 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.722 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 46.4 mt-10 -78.01 -33.73 51.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.478 -0.489 . . . . 64.22 111.257 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.14 -31.89 55.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.021 -0.733 . . . . 74.55 109.021 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.553 ' OH ' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -71.22 -31.91 68.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 73.13 111.151 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.746 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 66.3 m -50.28 -47.09 55.53 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 62.33 110.63 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.88 -31.99 51.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.02 -0.537 . . . . 71.51 110.728 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -68.57 -40.28 80.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 74.42 110.617 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.15 -21.71 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.415 -0.357 . . . . 75.42 111.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.08 -2.65 69.1 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.768 -0.729 . . . . 60.04 112.163 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.3 tp60 -124.49 129.79 51.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.106 -0.702 . . . . 75.33 109.106 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.746 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.0 p -81.25 178.65 8.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 52.13 112.366 -174.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.639 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -76.64 -16.12 59.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.665 1.357 . . . . 75.4 114.665 -162.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -74.28 -9.88 59.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 75.51 110.363 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.611 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -109.38 10.62 25.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.765 -0.652 . . . . 70.02 110.268 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.893 ' HB ' ' HB2' ' A' ' 91' ' ' ALA . 18.0 m -139.38 121.74 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.59 . . . . 73.14 111.465 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 20.3 tpp180 -85.56 113.81 22.09 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.616 -0.513 . . . . 73.44 109.616 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -83.43 118.07 23.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.487 -0.779 . . . . 74.42 112.376 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 10.2 mp -110.42 129.38 55.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.618 -0.719 . . . . 74.2 109.863 172.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HD1' HG12 ' A' ' 89' ' ' ILE . 62.4 m-85 -106.89 129.87 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.439 -0.208 . . . . 74.01 110.439 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.76 23.34 9.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.999 0.904 . . . . 75.51 109.77 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.03 -0.28 78.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.458 -0.792 . . . . 73.33 112.567 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 72' ' ' ILE . 37.3 t0 -127.15 122.91 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.578 0.704 . . . . 72.13 111.14 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -59.61 110.6 1.17 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.125 -0.943 . . . . 73.24 112.37 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.86 HG22 ' H ' ' A' ' 73' ' ' HIS . 11.2 mm -125.68 -167.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.171 -1.418 . . . . 75.3 107.171 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.86 ' H ' HG22 ' A' ' 72' ' ' ILE . 3.6 p80 -116.41 149.25 39.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.205 0.457 . . . . 74.0 110.091 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.789 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -64.54 -34.47 89.98 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.705 -0.68 . . . . 60.44 114.295 -168.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.95 -12.12 52.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.853 0.327 . . . . 72.23 111.584 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.637 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 3.5 t30 -70.87 -25.7 62.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.04 -0.356 . . . . 74.23 110.04 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.684 HG21 ' HA ' ' A' ' 44' ' ' LYS . 44.8 p 61.16 153.74 0.11 Allowed Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.639 1.176 . . . . 72.04 112.627 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 30.8 Cg_endo -64.91 -46.79 5.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.462 2.108 . . . . 73.22 111.833 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 15.5 tp10 -46.17 -43.35 15.05 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.328 -0.851 . . . . 74.52 111.728 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 47.8 mt-30 -88.55 -15.7 34.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.25 111.704 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.7 -30.66 18.94 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.0 -0.28 . . . . 73.11 111.351 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.28 -18.93 25.18 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.315 -0.945 . . . . 71.35 110.916 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.3 tp -93.01 144.16 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.136 -1.061 . . . . 75.31 108.136 170.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 85' ' ' ASP . 1.7 tt0 -141.09 -152.22 0.4 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.325 -0.62 . . . . 72.03 109.325 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.595 ' OD1' ' HB3' ' A' ' 24' ' ' GLN . 7.2 t70 -45.99 118.41 1.86 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.06 0.457 . . . . 63.13 112.021 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.93 3.51 17.81 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.434 -0.803 . . . . 60.32 111.664 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.455 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.1 t0 -73.97 158.48 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 72.14 111.19 -175.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 32.7 m -129.96 147.28 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.815 -0.629 . . . . 65.24 110.357 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.4 mt -119.57 119.27 59.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.632 -0.713 . . . . 71.31 109.288 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -102.86 126.96 50.21 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.677 -0.49 . . . . 61.32 109.677 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.893 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . . . -109.87 117.82 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.939 0.4 . . . . 71.15 111.786 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 1.8 mpt? -90.91 170.13 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 73.12 110.476 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.98 109.6 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 75.1 111.299 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 48.9 mt-30 61.97 -177.53 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.017 -0.992 . . . . 74.3 111.515 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.84 4.32 8.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.166 -0.47 . . . . 74.34 111.756 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 m 63.34 78.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.605 0.717 . . . . 70.43 110.193 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.3 -23.5 0.12 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.129 -0.941 . . . . 55.11 111.345 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.805 -0.997 . . . . 74.45 111.758 176.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.644 0.259 . . . . 73.11 110.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.45 -159.89 48.83 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.626 -0.797 . . . . 72.34 111.186 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -160.8 -159.33 0.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.988 -0.745 . . . . 64.1 108.988 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -79.02 -29.69 43.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.968 0.413 . . . . 73.11 110.598 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -69.49 -27.86 65.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 72.02 111.278 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.2 p -76.89 -10.71 59.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.542 -0.299 . . . . 75.43 111.775 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.46 11.81 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 62.41 111.621 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.56 -19.89 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.865 0.364 . . . . 74.32 111.315 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -90.65 24.08 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.046 0.451 . . . . 75.34 110.237 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.6 -58.99 5.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.138 -0.483 . . . . 71.34 111.106 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -157.19 77.51 0.87 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 75.25 110.571 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.67 -141.46 47.52 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.715 -0.675 . . . . 60.41 113.013 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -155.63 25.93 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.826 -0.435 . . . . 74.44 109.826 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t 71.94 102.59 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 115.061 -0.972 . . . . 63.33 110.497 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.36 23.3 0.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.071 2.514 . . . . 73.34 113.034 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.64 -8.28 10.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 75.44 109.64 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -78.53 89.95 4.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.356 -0.838 . . . . 70.43 110.924 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -117.23 75.97 1.01 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.589 0.709 . . . . 63.4 109.809 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -127.54 19.14 6.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.319 -0.855 . . . . 74.43 108.71 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.81 74.48 1.35 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.065 -0.971 . . . . 65.4 113.439 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.87 -31.33 66.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 73.1 108.602 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -129.5 158.79 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.915 -1.039 . . . . 71.25 109.805 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.5 mt -109.98 166.96 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.715 -0.846 . . . . 74.02 108.715 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.477 ' H ' HG22 ' A' ' 23' ' ' ILE . 41.6 tt0 -144.24 138.26 27.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.232 -0.284 . . . . 71.43 110.232 -173.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.743 HG11 HD12 ' A' ' 48' ' ' LEU . 14.7 p -150.79 140.97 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.983 -0.553 . . . . 74.14 110.005 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.777 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 2.4 mtmp? -102.0 123.24 45.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.782 -0.451 . . . . 74.44 109.782 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 89' ' ' ILE . 73.4 t -101.33 95.26 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 105.472 -2.047 . . . . 73.33 105.472 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 21.1 ttt180 -68.3 105.07 2.02 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 114.819 -1.082 . . . . 74.22 108.386 -172.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . 68.5 m -63.38 139.39 97.57 Favored Pre-proline 0 N--CA 1.418 -2.037 0 N-CA-C 107.424 -1.325 . . . . 75.05 107.424 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.23 33.48 0.16 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.542 2.828 . . . . 73.44 114.643 -166.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 29' ' ' SER . 24.6 t70 -131.36 3.46 4.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.617 0.722 . . . . 63.12 109.567 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.26 16.52 53.25 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.885 -0.886 . . . . 64.32 110.885 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 29' ' ' SER . . . -99.44 74.91 1.93 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.618 . . . . 65.54 109.805 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 27.7 tt0 -87.44 102.67 14.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.843 -0.617 . . . . 71.52 109.822 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.36 136.34 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.976 -0.556 . . . . 73.02 109.71 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -80.47 121.68 26.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.464 0.65 . . . . 64.24 111.192 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.97 165.21 13.12 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.301 -1.37 . . . . 62.41 107.301 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -138.72 168.57 19.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.666 -0.814 . . . . 74.31 112.23 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 58.0 mt -114.2 134.93 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.662 -1.154 . . . . 75.24 109.369 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.92 -81.91 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.003 0.43 . . . . 73.51 109.992 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 59.6 ttt180 -101.97 -177.18 3.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.123 -1.436 . . . . 73.4 107.123 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 47.3 pttt -53.09 102.01 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.465 0.65 . . . . 73.12 111.42 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.547 ' OG1' HG22 ' A' ' 39' ' ' ILE . 1.6 p -142.47 107.47 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 72.42 110.626 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 37.6 pttt -51.6 175.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.158 -0.928 . . . . 74.31 113.493 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.769 ' HA ' HD13 ' A' ' 48' ' ' LEU . 44.7 mt -66.43 -21.69 66.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.657 -1.156 . . . . 72.43 113.03 -169.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HA ' ' CE ' ' A' ' 49' ' ' MET . 34.0 mt-10 -58.5 -33.49 69.87 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.569 0.581 . . . . 73.33 112.569 -171.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -23.39 32.59 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.351 -0.54 . . . . 74.1 110.837 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' A' ' 45' ' ' LEU . 73.0 mt -64.84 -35.34 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.361 . . . . 73.21 111.456 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.3 -39.37 14.43 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.497 -0.881 . . . . 74.23 111.268 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' N ' ' HG2' ' A' ' 49' ' ' MET . 12.4 mm-40 -68.95 -37.96 79.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.431 0.53 . . . . 64.22 112.431 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.8 t -60.48 -31.45 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.268 -0.573 . . . . 74.55 109.664 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.478 ' HD2' HD22 ' A' ' 56' ' ' LEU . 8.3 t80 -83.01 -29.84 28.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.149 -0.478 . . . . 73.13 110.13 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.998 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 73.6 m -58.34 -37.25 74.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.296 0.569 . . . . 62.33 110.758 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.17 -32.78 74.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 71.51 110.825 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -73.25 -50.55 21.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 74.42 111.496 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HD2' ' A' ' 52' ' ' TYR . 2.9 pp -76.01 -20.99 57.37 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.713 -0.221 . . . . 75.42 111.583 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.83 13.24 37.9 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.755 -0.735 . . . . 60.04 113.527 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -150.3 130.12 13.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.083 -0.71 . . . . 75.33 109.083 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.998 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.2 p -78.37 167.13 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.447 0.641 . . . . 52.13 112.595 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.719 ' HA ' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -64.47 -15.85 61.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.821 -1.081 . . . . 75.4 112.897 -169.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.51 -17.36 62.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.052 0.453 . . . . 75.51 110.46 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.06 8.99 18.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.112 -0.494 . . . . 70.02 110.088 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.719 HG21 ' HA ' ' A' ' 60' ' ' MET . 3.0 m -143.49 103.17 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.935 -0.575 . . . . 73.14 110.086 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 25.0 tpt180 -73.24 125.68 28.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.533 . . . . 73.44 110.378 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -87.03 112.4 21.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.459 -0.791 . . . . 74.42 112.314 -175.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 7.9 mp -93.79 124.89 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.865 -0.607 . . . . 74.2 109.538 172.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HD2' HG12 ' A' ' 89' ' ' ILE . 83.1 m-85 -103.3 113.69 27.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.323 -0.251 . . . . 74.01 110.323 -177.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 t70 57.88 26.99 13.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 122.079 0.942 . . . . 75.51 109.869 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.12 -16.89 58.79 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.228 -0.896 . . . . 73.33 112.787 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -111.96 116.41 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.513 0.673 . . . . 72.13 110.623 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.613 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 12.0 ptt-85 -80.24 111.5 16.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.655 -0.702 . . . . 73.24 111.401 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.9 -165.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.935 -0.575 . . . . 75.3 110.187 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -85.22 140.87 30.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.083 -0.34 . . . . 74.0 110.083 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.48 -18.14 76.8 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.225 -0.512 . . . . 60.44 113.005 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 33.9 t70 -70.08 -12.97 61.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.033 0.444 . . . . 72.23 111.084 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -66.33 -41.44 89.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.899 -0.591 . . . . 74.23 110.746 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 m 68.55 136.58 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.903 -0.589 . . . . 72.04 111.091 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HD3' ' HG ' ' A' ' 45' ' ' LEU . 76.4 Cg_exo -51.66 -36.86 62.67 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.215 2.61 . . . . 73.22 113.725 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.63 -34.24 36.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.267 0.469 . . . . 74.52 112.267 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -88.6 -18.06 28.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 74.25 111.254 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.05 -30.37 19.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.497 -0.32 . . . . 73.11 111.756 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.76 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.24 -0.981 . . . . 71.35 110.654 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 84' ' ' GLU . 10.1 tp -91.85 159.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.235 -1.394 . . . . 75.31 107.235 169.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.65 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 25.0 tt0 -154.05 -171.62 3.94 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.763 -0.829 . . . . 72.03 108.763 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.795 ' HB3' HG21 ' A' ' 23' ' ' ILE . 8.4 p-10 -47.51 126.28 9.58 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.77 0.795 . . . . 63.13 112.358 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.56 4.26 15.57 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.86 -1.064 . . . . 60.32 110.844 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.41 -173.58 4.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.088 0.471 . . . . 72.14 111.072 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.03 148.37 22.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.563 0.697 . . . . 65.24 111.348 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 27' ' ' VAL . 64.8 mt -119.0 114.04 43.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.036 -0.984 . . . . 71.31 108.976 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -99.81 118.0 35.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.721 -0.474 . . . . 61.32 109.721 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . . . -109.81 117.36 33.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.107 0.48 . . . . 71.15 111.207 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.7 144.89 35.89 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.093 -0.706 . . . . 73.12 109.093 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.39 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.397 0.435 . . . . 75.1 111.356 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.475 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 3.2 pt20 26.99 57.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.658 1.224 . . . . 74.3 112.552 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -60.43 -38.06 82.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.827 -0.624 . . . . 74.34 110.579 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 m -129.3 119.76 24.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.51 -0.768 . . . . 70.43 109.632 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 59.59 1.77 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.379 -0.915 . . . . 55.11 112.28 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.905 -0.942 . . . . 74.45 111.656 178.199 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.847 -0.427 . . . . 73.11 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.38 -102.38 2.88 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.63 -0.795 . . . . 72.34 111.812 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.79 157.1 23.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.818 0.342 . . . . 64.1 110.29 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.72 -26.05 23.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.47 . . . . 73.11 111.449 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.31 -26.37 66.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 72.02 112.067 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -59.46 -27.54 66.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.751 0.31 . . . . 75.43 111.416 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.92 65.67 0.82 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.898 0.38 . . . . 62.41 110.974 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.21 89.28 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.037 -0.529 . . . . 74.32 110.66 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -85.25 85.15 7.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.295 -0.632 . . . . 75.34 109.295 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -164.85 74.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 71.34 109.489 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -94.1 171.43 8.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.73 -0.668 . . . . 75.25 110.883 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.72 123.99 2.62 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.706 -0.679 . . . . 60.41 111.407 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.9 t -90.39 -163.14 0.97 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.053 -0.351 . . . . 74.44 110.053 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -61.86 148.53 87.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.33 110.375 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.3 75.16 1.46 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.909 2.406 . . . . 73.34 112.57 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.3 t -71.89 -33.56 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.189 0.519 . . . . 75.44 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.47 -55.47 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 70.43 109.377 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.471 ' O ' ' HE1' ' A' ' 22' ' ' HIS . 60.9 t30 68.62 -67.34 0.21 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.935 -1.03 . . . . 63.4 112.725 173.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -82.9 6.92 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 74.43 112.918 -170.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 124.3 30.8 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.908 -1.277 . . . . 65.4 109.908 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -48.56 124.44 8.22 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.248 0.547 . . . . 73.1 110.771 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.471 ' HE1' ' O ' ' A' ' 18' ' ' ASN . 3.0 m-70 -76.06 171.16 14.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 71.25 112.235 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.735 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 28.4 mt -110.5 166.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.734 -1.21 . . . . 74.02 107.734 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.667 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 31.5 tt0 -162.38 123.99 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 71.43 111.004 -171.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 48' ' ' LEU . 15.5 m -137.09 141.93 38.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.428 -0.582 . . . . 74.14 109.428 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.9 ttmt -100.01 111.32 23.63 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.793 -0.763 . . . . 74.44 109.02 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 89' ' ' ILE . 67.5 t -95.3 99.29 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.419 -0.956 . . . . 73.33 108.419 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 36.2 ttt180 -70.2 104.66 2.69 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.368 -1.345 . . . . 74.22 107.368 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.665 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 10.0 p -65.74 164.89 23.15 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.044 -0.98 . . . . 75.05 109.39 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 52.2 Cg_endo -67.69 30.63 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 123.115 2.543 . . . . 73.44 114.769 -169.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 29' ' ' SER . 2.6 p-10 -131.74 -23.36 2.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.67 -0.492 . . . . 63.12 109.67 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.761 ' HA2' ' HE ' ' A' ' 28' ' ' ARG . . . 126.67 -11.25 7.07 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.757 -0.656 . . . . 64.32 112.293 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.33 94.67 3.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.158 0.504 . . . . 65.54 110.796 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.764 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 35.8 tt0 -92.5 99.33 12.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 71.52 109.586 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.22 134.31 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.191 -0.459 . . . . 73.02 110.173 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 21.0 p90 -75.98 105.14 6.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.589 0.709 . . . . 64.24 110.31 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HE1' ' HZ3' ' A' ' 47' ' ' LYS . 6.2 t80 -111.72 151.35 29.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.516 -0.92 . . . . 62.41 108.516 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HG2' ' HG3' ' A' ' 24' ' ' GLN . 78.4 mttt -125.87 168.64 13.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.664 0.745 . . . . 74.31 111.735 -169.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.735 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -115.42 134.22 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.397 -1.334 . . . . 75.24 107.397 170.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -103.03 -58.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.137 -0.625 . . . . 73.51 110.161 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -106.48 -178.95 3.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.93 101.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.999 0.363 . . . . 73.12 110.417 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.02 133.19 40.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.98 0.419 . . . . 72.42 110.515 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' HB2' ' HZ1' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -72.98 167.3 21.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 74.31 111.081 178.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.698 HD22 ' HD3' ' A' ' 78' ' ' PRO . 96.6 mt -67.47 -23.87 65.55 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.464 0.542 . . . . 72.43 112.464 -170.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 34.0 mp0 -59.21 -24.68 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.033 0.383 . . . . 73.33 112.033 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.575 ' HZ3' ' HE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -76.38 -37.66 56.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.202 -0.599 . . . . 74.1 109.949 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 39' ' ' ILE . 59.5 mt -62.53 -38.33 89.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.195 0.521 . . . . 73.21 109.99 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 20.0 ptm -80.01 -37.13 34.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.586 -0.734 . . . . 74.23 111.5 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.554 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 49.8 mm-40 -67.91 -30.46 69.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.955 -0.298 . . . . 64.22 111.719 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.57 HG21 ' O ' ' A' ' 47' ' ' LYS . 76.5 t -54.88 -39.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.465 -0.494 . . . . 74.55 110.296 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -75.97 -35.12 59.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 73.13 111.507 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 64.4 m -49.88 -48.13 51.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.909 0.385 . . . . 62.33 111.044 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.71 -32.77 62.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 71.51 111.289 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 74.42 111.08 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.49 -21.55 26.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.468 -0.333 . . . . 75.42 111.275 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.05 12.98 83.85 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.501 -1.04 . . . . 60.04 110.501 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.4 tt0 -136.2 129.94 32.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.492 -0.929 . . . . 75.33 108.492 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 6.2 p -81.42 171.64 14.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.456 0.646 . . . . 52.13 112.158 -173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.525 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.34 -15.08 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.902 -1.045 . . . . 75.4 112.935 -174.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.62 -15.28 57.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.976 0.361 . . . . 75.51 111.976 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.593 ' HA ' ' CG ' ' A' ' 94' ' ' GLN . . . -109.95 9.25 24.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.125 0.488 . . . . 70.02 110.177 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.704 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 18.3 m -140.5 172.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.595 . . . . 73.14 110.495 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 tpp85 -143.75 130.49 20.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.607 -0.516 . . . . 73.44 109.607 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.451 ' CD1' ' HE2' ' A' ' 49' ' ' MET . 91.3 m-85 -99.99 116.38 31.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 74.42 111.441 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -111.03 113.45 26.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.392 -0.822 . . . . 74.2 110.015 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.661 ' HB3' HG12 ' A' ' 89' ' ' ILE . 23.2 p90 -112.47 146.15 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.098 -0.641 . . . . 74.01 110.175 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.1 t70 60.44 21.94 11.58 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.352 1.072 . . . . 75.51 109.3 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.92 -12.09 68.57 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.118 -0.946 . . . . 73.33 113.109 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -130.63 127.55 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.427 0.613 . . . . 72.13 112.054 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -63.96 159.21 20.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.681 -0.69 . . . . 73.24 111.839 175.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.769 HG12 ' H ' ' A' ' 73' ' ' HIS . 10.2 tt -173.03 -171.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.428 -0.582 . . . . 75.3 109.428 175.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.769 ' H ' HG12 ' A' ' 72' ' ' ILE . 11.5 m170 -75.51 151.79 37.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.878 0.371 . . . . 74.0 110.687 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -72.69 -19.85 79.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.794 -0.717 . . . . 60.44 112.217 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.97 -19.21 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.57 0.211 . . . . 72.23 111.57 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 73' ' ' HIS . 18.7 m120 -68.15 -44.14 76.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.018 -0.364 . . . . 74.23 110.018 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.0 p 61.96 162.54 0.11 Allowed Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.871 0.869 . . . . 72.04 111.512 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.698 ' HD3' HD22 ' A' ' 45' ' ' LEU . 24.9 Cg_exo -64.3 -39.21 30.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.463 2.109 . . . . 73.22 112.356 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.54 -49.11 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 74.52 110.976 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.793 ' HA ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -67.06 -22.74 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.686 -173.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.7 tp -86.63 -29.5 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 73.11 110.241 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.41 -18.44 27.72 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.112 -0.795 . . . . 71.35 111.112 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.61 126.87 54.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.089 -0.708 . . . . 75.31 109.089 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.698 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.0 tt0 -131.37 -151.52 0.47 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.408 -0.36 . . . . 72.03 110.344 -169.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.698 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 4.0 p-10 -43.4 131.73 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.551 0.691 . . . . 63.13 112.631 -172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.38 -9.5 24.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.547 -0.751 . . . . 60.32 112.007 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.68 169.86 10.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.945 -0.391 . . . . 72.14 109.945 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.9 161.95 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.306 0.574 . . . . 65.24 111.261 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.661 HG12 ' HB3' ' A' ' 67' ' ' TYR . 35.6 mt -132.94 117.22 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.424 -0.954 . . . . 71.31 108.424 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.577 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 3.4 t70 -98.69 125.98 44.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.84 -0.43 . . . . 61.32 109.84 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' ARG . . . -97.79 117.04 31.21 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.174 0.511 . . . . 71.15 110.512 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.0 163.64 12.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.713 -0.676 . . . . 73.12 109.37 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.06 101.42 3.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.912 -0.315 . . . . 75.1 111.345 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.704 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 45.2 mt-30 56.72 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.452 -0.794 . . . . 74.3 111.692 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' A' ' 96' ' ' THR . 8.2 tt0 -173.24 36.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.489 -1.3 . . . . 74.34 107.489 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 95' ' ' GLN . 54.9 m 75.98 -45.17 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.042 -0.981 . . . . 70.43 110.419 -171.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.79 -58.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.378 -0.689 . . . . 55.11 111.378 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.851 0 CA-C-O 119.055 -0.858 . . . . 74.45 111.648 177.37 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.375 0.607 . . . . 73.11 110.028 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.56 -122.7 5.13 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.341 -1.104 . . . . 72.34 110.341 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -128.19 123.2 33.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.968 -0.382 . . . . 64.1 109.968 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -67.49 -22.09 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.221 -0.659 . . . . 73.11 109.221 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 8' ' ' VAL . 30.0 m-20 -61.78 -25.06 67.24 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.381 -0.827 . . . . 72.02 111.181 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -82.87 -15.37 51.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.056 0.455 . . . . 75.43 110.9 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.32 14.33 17.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.137 -0.483 . . . . 62.41 111.35 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 5' ' ' ASP . 87.5 t -67.53 102.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.532 . . . . 74.32 110.639 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -127.89 73.11 1.44 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.111 -0.7 . . . . 75.34 109.111 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -100.38 -17.58 17.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.244 -0.889 . . . . 71.34 110.557 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -89.64 127.2 35.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.012 -0.54 . . . . 75.25 110.051 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.44 93.52 1.28 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.746 -0.74 . . . . 60.41 111.785 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.6 m -66.84 131.57 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.859 0.361 . . . . 74.44 110.632 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -120.49 93.34 48.3 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 63.33 110.839 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.35 93.69 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.63 2.22 . . . . 73.34 110.875 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.36 125.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.879 -0.601 . . . . 75.44 111.418 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -59.97 -71.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.087 -0.961 . . . . 70.43 111.278 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -99.33 88.35 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 63.4 110.659 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -127.39 -48.38 1.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.234 -0.893 . . . . 74.43 110.391 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.58 -12.33 1.01 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 65.4 111.572 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -85.37 3.61 39.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.47 0.652 . . . . 73.1 110.505 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 71.25 109.462 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.737 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 14.8 mt -110.76 168.1 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.909 -0.404 . . . . 74.02 109.909 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 41.7 mt-30 -150.8 131.72 14.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.877 0.471 . . . . 71.43 110.674 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 48' ' ' LEU . 35.8 m -130.35 -177.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.356 -0.609 . . . . 74.14 109.356 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.756 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mtmt -138.77 114.75 10.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.767 0.318 . . . . 74.44 110.554 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' HB ' ' A' ' 89' ' ' ILE . 66.9 t -97.17 100.94 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -69.9 106.68 3.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.925 -1.139 . . . . 74.22 107.925 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' ASP . 66.1 p -60.34 160.28 18.59 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.256 -0.884 . . . . 75.05 108.954 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HD3' ' HB1' ' A' ' 91' ' ' ALA . 36.7 Cg_endo -65.2 31.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 123.165 2.576 . . . . 73.44 114.076 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 29' ' ' SER . 27.7 t70 -131.44 -21.45 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.272 0.558 . . . . 63.12 110.77 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.65 -15.73 24.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.268 -0.733 . . . . 64.32 111.268 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.09 104.17 1.71 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.539 -0.541 . . . . 65.54 109.539 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.756 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 34.0 tt0 -113.44 96.86 6.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.36 -0.836 . . . . 71.52 109.289 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.27 134.57 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.221 -0.659 . . . . 73.02 109.221 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 34.9 p90 -68.32 130.5 43.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.227 0.536 . . . . 64.24 110.191 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 51' ' ' VAL . 3.9 t80 -128.12 130.17 47.72 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.983 -1.117 . . . . 62.41 107.983 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 44.4 pttt -105.29 163.69 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.88 0.848 . . . . 74.31 112.555 -165.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 65.2 mt -114.83 134.77 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.419 -1.264 . . . . 75.24 108.063 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.15 -81.68 0.37 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.281 0.562 . . . . 73.51 110.628 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -102.1 -176.57 3.16 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.022 -1.103 . . . . 73.4 108.022 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.76 101.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.258 0.551 . . . . 73.12 109.967 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 1.7 p -141.47 105.23 4.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.968 -1.015 . . . . 72.42 109.776 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -39.24 152.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.841 -1.072 . . . . 74.31 113.308 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' HD3' ' A' ' 78' ' ' PRO . 90.5 mt -64.47 -15.4 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.118 -0.947 . . . . 72.43 111.236 -177.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 42.5 mt-10 -62.73 -26.28 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 73.33 111.181 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -78.13 -36.24 48.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.44 -0.504 . . . . 74.1 109.905 177.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.534 HD12 HG21 ' A' ' 25' ' ' VAL . 74.3 mt -59.38 -29.72 67.91 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.763 -0.828 . . . . 73.21 108.763 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.945 ' HE2' ' HB2' ' A' ' 60' ' ' MET . 24.9 ttt -78.62 -51.09 10.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.111 -1.404 . . . . 74.23 111.049 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 42.7 mt-10 -70.43 -30.19 66.98 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.511 0.559 . . . . 64.22 112.511 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' LYS . 54.5 t -55.71 -38.47 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.442 -0.503 . . . . 74.55 111.101 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.8 -30.44 65.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.579 -0.282 . . . . 73.13 111.504 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 62.2 m -51.36 -39.78 57.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.33 0.586 . . . . 62.33 110.57 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -76.57 -41.26 47.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.533 -0.758 . . . . 71.51 111.147 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -64.22 -50.77 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.02 0.748 . . . . 74.42 113.02 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 58' ' ' GLN . 1.2 pp -98.63 8.51 44.83 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.564 -0.454 . . . . 75.42 111.914 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.17 27.36 72.89 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.158 -0.544 . . . . 60.04 113.386 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 10.2 tt0 -143.22 130.84 21.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.482 -0.933 . . . . 75.33 108.482 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 p -89.33 174.3 7.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.952 0.723 . . . . 52.13 112.952 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.945 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -70.11 -14.92 62.88 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 115.023 1.49 . . . . 75.4 115.023 -163.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.38 -12.68 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.08 -1.012 . . . . 75.51 109.76 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.764 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -101.54 -7.6 22.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.429 -0.805 . . . . 70.02 110.272 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' MET . 5.1 m -138.72 104.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.223 172.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.555 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 54.1 ttp180 -88.01 125.9 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.293 -0.412 . . . . 73.44 110.099 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.625 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 54.7 m-85 -92.93 122.95 35.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.18 0.514 . . . . 74.42 111.347 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.971 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -106.73 113.33 26.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.674 -0.693 . . . . 74.2 109.838 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.562 ' HB3' HG12 ' A' ' 89' ' ' ILE . 47.1 p90 -112.73 145.71 40.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.836 -0.746 . . . . 74.01 111.149 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.26 22.51 11.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.071 0.938 . . . . 75.51 109.058 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.98 2.27 86.54 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.979 -1.009 . . . . 73.33 112.14 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -122.17 117.72 26.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.145 0.498 . . . . 72.13 111.324 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.971 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -66.74 119.26 11.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.219 0.533 . . . . 73.24 111.189 173.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 67' ' ' TYR . 8.0 tt -161.3 157.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.407 -0.59 . . . . 75.3 109.407 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.34 135.37 48.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.099 0.476 . . . . 74.0 111.877 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.48 82.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.586 -0.734 . . . . 60.44 114.419 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.2 -33.35 75.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.207 0.503 . . . . 72.23 111.364 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.83 0.67 30.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.386 -0.37 . . . . 74.23 111.23 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.671 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 80.9 p 59.89 163.83 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.28 1.032 . . . . 72.04 112.833 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.671 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 73.0 Cg_endo -76.17 -31.73 4.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.149 1.899 . . . . 73.22 112.127 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.6 -34.34 67.11 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.786 -0.643 . . . . 74.52 110.758 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -77.09 -19.03 57.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.064 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -93.88 -30.88 14.57 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 73.11 111.23 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.16 -19.04 23.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.463 -0.875 . . . . 71.35 110.97 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -85.65 147.92 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.878 -1.156 . . . . 75.31 107.878 169.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.751 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 23.1 tt0 -151.23 -152.35 0.43 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.191 -0.67 . . . . 72.03 109.191 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.751 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t70 -47.32 114.84 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.865 0.364 . . . . 63.13 110.855 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.09 3.9 14.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.978 -0.629 . . . . 60.32 111.536 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.55 ' HB2' HG13 ' A' ' 83' ' ' ILE . 17.7 t70 -76.09 142.05 41.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 72.14 111.049 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 17.7 m -114.47 141.47 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 121.345 0.593 . . . . 65.24 109.796 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.562 HG12 ' HB3' ' A' ' 67' ' ' TYR . 22.8 mt -121.37 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.497 -0.774 . . . . 71.31 109.651 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.64 -0.255 . . . . 61.32 110.906 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.563 ' HB1' ' HD3' ' A' ' 30' ' ' PRO . . . -94.93 118.16 31.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 71.15 111.282 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 66.9 mmm -105.37 168.04 9.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 73.12 110.621 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.05 109.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 75.1 111.371 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.764 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 89.6 mt-30 62.38 170.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 74.3 113.13 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.555 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 4.7 pt20 -72.37 -21.13 61.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.057 -0.974 . . . . 74.34 112.017 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 m -136.15 22.56 3.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.489 0.662 . . . . 70.43 110.96 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.71 4.52 84.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.448 -0.882 . . . . 55.11 111.891 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.105 -1.386 . . . . 74.45 110.777 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.027 -0.36 . . . . 73.11 110.027 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.11 4.46 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.732 -0.747 . . . . 72.34 111.293 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -65.73 162.62 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 64.1 111.673 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.01 -29.88 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.397 -0.82 . . . . 73.11 110.887 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 8' ' ' VAL . 60.2 m-20 -68.19 -17.17 64.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.947 0.404 . . . . 72.02 110.816 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.2 t -81.78 -15.26 54.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.576 0.703 . . . . 75.43 109.433 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.89 48.78 1.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.766 . . . . 62.41 110.333 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 5' ' ' ASP . 73.8 t -76.08 106.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.27 0.557 . . . . 74.32 110.311 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -125.84 12.92 7.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 75.34 109.322 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -76.98 64.79 2.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.497 -0.774 . . . . 71.34 111.267 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -143.55 87.97 1.97 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.813 -0.81 . . . . 75.25 108.813 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.1 58.23 4.34 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.998 -0.62 . . . . 60.41 112.9 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m 64.41 -174.7 0.17 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.038 0.535 . . . . 74.44 111.017 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 7.5 t -155.91 130.54 5.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.671 -0.492 . . . . 63.33 109.671 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 4.5 Cg_exo -76.76 77.92 3.54 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.089 2.526 . . . . 73.34 112.025 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.61 121.51 63.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 75.44 110.864 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' A' ' 17' ' ' ASN . 11.3 m120 58.81 76.83 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 70.43 111.862 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.403 HD21 ' NE2' ' A' ' 24' ' ' GLN . 23.4 p-10 -60.88 -35.18 75.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.692 -0.686 . . . . 63.4 110.493 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -94.23 16.52 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.49 0.662 . . . . 74.43 109.903 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.78 -83.93 0.42 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.744 -0.662 . . . . 65.4 111.476 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.87 34.26 5.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.891 0.853 . . . . 73.1 108.966 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -139.41 169.57 17.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.914 . . . . 71.25 110.061 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 1.09 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 23.6 mt -126.01 160.12 33.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.055 -1.091 . . . . 74.02 108.055 172.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 2.0 tt0 -145.8 135.85 23.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.567 0.222 . . . . 71.43 110.96 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.559 HG21 HD12 ' A' ' 48' ' ' LEU . 26.8 m -139.47 149.07 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 74.14 110.196 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.651 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 mtmt -119.36 114.94 23.12 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.217 -0.302 . . . . 74.44 110.427 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.529 HG22 HD11 ' A' ' 89' ' ' ILE . 53.2 t -97.36 98.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.946 -1.501 . . . . 73.33 106.946 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 27.6 ttp180 -68.99 103.74 1.92 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.055 -1.461 . . . . 74.22 107.055 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 70.8 m -64.63 158.46 67.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 114.073 -1.421 . . . . 75.05 108.699 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 37.1 Cg_endo -64.31 32.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 123.63 2.887 . . . . 73.44 114.756 -170.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 29' ' ' SER . 28.8 t70 -134.06 -8.58 2.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.449 0.642 . . . . 63.12 110.302 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.85 57.01 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.88 -0.888 . . . . 64.32 110.88 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 99.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 65.54 110.246 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.651 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 35.1 tt0 -104.92 99.78 9.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.526 -0.761 . . . . 71.52 109.515 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.56 134.77 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 73.02 110.338 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.507 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 20.8 p90 -76.59 117.37 18.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.78 0.8 . . . . 64.24 111.691 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -112.02 171.59 7.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.696 -1.224 . . . . 62.41 107.696 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -145.66 165.53 28.45 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.358 -0.937 . . . . 74.31 112.476 -170.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.09 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 48.5 mt -123.1 147.59 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.602 -1.181 . . . . 75.24 108.958 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -128.96 -77.63 0.56 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.2 -0.667 . . . . 73.51 109.2 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -72.62 150.14 43.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.185 -1.413 . . . . 73.4 107.185 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 59.7 pttt -56.64 101.24 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.902 0.858 . . . . 73.12 111.219 -175.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.441 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -134.68 103.31 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.063 -0.971 . . . . 72.42 109.465 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.68 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 13.1 pttp -63.54 -178.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.328 0.862 . . . . 74.31 113.328 -173.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.853 ' HA ' HD13 ' A' ' 48' ' ' LEU . 37.4 mt -60.91 -16.73 45.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.626 -1.17 . . . . 72.43 113.611 -164.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.648 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 53.1 mt-10 -58.09 -57.37 13.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.83 0.307 . . . . 73.33 111.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -68.2 -28.42 67.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.878 -0.329 . . . . 74.1 111.008 -175.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD13 ' HA ' ' A' ' 45' ' ' LEU . 86.1 mt -58.96 -37.59 77.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 73.21 110.73 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.648 ' HE1' ' HA ' ' A' ' 46' ' ' GLU . 26.1 ptt? -90.98 -32.79 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.628 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 27.6 mt-10 -67.91 -34.63 77.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.072 0.397 . . . . 64.22 112.072 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' LYS . 62.3 t -55.8 -37.68 48.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.207 0.527 . . . . 74.55 109.946 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.86 -36.76 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 73.13 111.287 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.065 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 58.5 m -52.21 -53.44 43.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.15 0.5 . . . . 62.33 110.638 173.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -67.22 -32.32 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.652 . . . . 71.51 110.938 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -69.26 -38.87 78.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.297 -0.41 . . . . 74.42 111.244 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.03 -13.93 37.61 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.874 -0.33 . . . . 75.42 111.422 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.4 8.46 52.75 Favored Glycine 0 CA--C 1.517 0.158 0 C-N-CA 120.556 -0.831 . . . . 60.04 113.822 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -151.17 135.18 16.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.7 -0.481 . . . . 75.33 109.7 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 1.065 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 3.6 p -78.37 179.33 7.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.191 0.811 . . . . 52.13 113.191 -171.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.566 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.2 -14.15 62.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.893 1.442 . . . . 75.4 114.893 -163.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -1.8 27.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.093 -1.004 . . . . 75.51 109.982 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . . . -113.76 1.8 14.96 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 70.02 109.953 173.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.83 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -142.52 102.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.362 0.601 . . . . 73.14 110.19 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 22.9 tpt180 -71.17 114.19 8.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 73.44 111.192 -172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -80.43 110.87 16.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.277 -0.874 . . . . 74.42 112.306 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 9.9 mp -104.8 125.51 50.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.797 -0.638 . . . . 74.2 109.783 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' HD1' HG12 ' A' ' 89' ' ' ILE . 74.0 m-85 -103.26 123.77 47.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.211 -0.292 . . . . 74.01 110.211 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.2 t70 57.82 22.95 9.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.147 0.975 . . . . 75.51 110.039 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.75 63.17 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.5 -0.773 . . . . 73.33 112.691 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.42 117.88 26.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 72.13 111.523 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.99 122.43 16.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 73.24 111.467 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.438 HG13 ' HD2' ' A' ' 67' ' ' TYR . 8.3 pt -147.66 -162.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -89.64 159.52 17.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.862 0.363 . . . . 74.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.649 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -76.59 -17.56 79.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.883 -0.675 . . . . 60.44 111.496 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.68 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 p30 -74.61 -9.21 58.35 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.468 0.307 . . . . 72.23 111.387 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 81' ' ' LEU . 7.2 t30 -67.7 -38.26 83.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.414 -0.357 . . . . 74.23 110.877 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.5 p 63.27 144.72 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 124.356 1.063 . . . . 72.04 111.461 -174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.0 -51.08 10.37 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.981 2.454 . . . . 73.22 113.219 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -56.95 -31.64 65.2 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.297 0.48 . . . . 74.52 112.297 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.83 -19.52 58.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.085 0.469 . . . . 74.25 110.667 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.416 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 44.4 tp -91.5 -30.88 16.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.356 . . . . 73.11 111.51 -171.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.1 -18.85 13.91 Favored Glycine 0 CA--C 1.502 -0.767 0 N-CA-C 110.1 -1.2 . . . . 71.35 110.1 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tp -89.3 159.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.957 -1.127 . . . . 75.31 107.957 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.76 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 28.3 tt0 -154.55 -152.4 0.4 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.983 -1.117 . . . . 72.03 107.983 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.76 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.9 t70 -43.85 119.36 1.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.603 0.638 . . . . 63.13 111.616 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.46 4.71 32.47 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.724 -0.75 . . . . 60.32 111.539 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.67 151.52 28.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.607 -0.297 . . . . 72.14 110.644 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 23.5 m -128.61 148.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.432 0.634 . . . . 65.24 110.607 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.553 HG12 ' HD1' ' A' ' 67' ' ' TYR . 54.6 mt -127.85 113.05 29.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.368 -0.975 . . . . 71.31 108.368 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -102.76 126.17 49.78 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.969 -0.382 . . . . 61.32 109.969 -173.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.83 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -104.62 118.01 35.53 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.429 0.455 . . . . 71.15 112.146 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.534 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.3 mpt? -95.14 171.23 8.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.565 -0.532 . . . . 73.12 109.565 172.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.94 117.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.719 0.295 . . . . 75.1 111.345 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 48.8 mt-30 59.05 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.013 0.925 . . . . 74.3 112.22 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.588 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 72.8 mt-30 -136.79 17.78 3.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 74.34 110.01 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 m 63.06 51.54 2.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.621 -0.718 . . . . 70.43 109.137 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.62 -71.41 0.49 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.304 -0.862 . . . . 55.11 111.622 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.26 -1.3 . . . . 74.45 111.474 -179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.882 0.372 . . . . 73.11 110.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.24 69.83 0.25 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.345 -0.702 . . . . 72.34 111.345 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.06 149.08 41.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.695 0.283 . . . . 64.1 110.626 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.45 -37.55 81.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 73.11 111.061 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.33 -31.09 69.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.381 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -83.04 -27.0 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.831 0.348 . . . . 75.43 110.961 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.27 -59.77 2.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.238 -0.437 . . . . 62.41 110.644 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.43 91.91 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.588 . . . . 74.32 110.861 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -136.61 -176.6 4.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.555 -0.748 . . . . 75.34 109.041 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 63.18 32.28 15.15 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.871 -0.418 . . . . 71.34 109.871 -172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -93.56 100.98 13.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 75.25 111.165 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.21 125.07 6.46 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.796 -0.922 . . . . 60.41 110.796 174.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.504 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 44.9 m -59.63 131.94 52.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 74.44 111.504 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.5 t -78.94 118.21 71.15 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 109.121 -0.696 . . . . 63.33 109.121 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 6.9 Cg_exo -73.6 64.66 4.71 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.234 2.622 . . . . 73.34 112.981 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.4 t 67.54 110.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 123.696 0.623 . . . . 75.44 111.609 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -109.4 111.34 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 70.43 111.07 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 20' ' ' GLY . 4.1 p-10 -156.05 36.08 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 63.4 110.081 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.75 23.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.867 -0.606 . . . . 74.43 112.261 -176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 18' ' ' ASN . . . 90.59 10.36 63.53 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.904 -0.665 . . . . 65.4 112.126 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.57 155.03 21.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.944 0.402 . . . . 73.1 110.133 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -94.93 161.01 14.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.828 -0.624 . . . . 71.25 109.927 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.801 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 10.2 mt -109.83 169.63 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.614 -0.513 . . . . 74.02 109.614 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.585 ' H ' HG23 ' A' ' 23' ' ' ILE . 4.1 tt0 -145.9 138.26 25.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.483 -0.562 . . . . 71.43 109.483 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.861 HG13 HD13 ' A' ' 48' ' ' LEU . 7.4 p -150.73 138.38 13.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.188 0.518 . . . . 74.14 110.234 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 36' ' ' PHE . 39.6 mttt -102.41 140.83 36.18 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.314 -0.403 . . . . 74.44 110.508 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 77.1 t -119.81 100.69 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.871 -1.529 . . . . 73.33 106.871 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 6.6 ttp180 -69.51 111.31 5.27 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.326 -0.99 . . . . 74.22 108.326 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 31' ' ' ASP . 78.4 p -60.28 157.65 32.74 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.645 -0.872 . . . . 75.05 108.645 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 36.2 Cg_endo -64.68 27.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.31 2.673 . . . . 73.44 114.504 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 29' ' ' SER . 12.3 t70 -130.52 -22.64 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.25 0.547 . . . . 63.12 110.615 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.63 -5.56 24.49 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.604 -0.808 . . . . 64.32 111.577 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.56 91.61 3.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.311 0.576 . . . . 65.54 109.538 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' OE2' ' HB2' ' A' ' 28' ' ' ARG . 37.9 tt0 -101.27 110.69 22.74 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.513 -0.767 . . . . 71.52 110.123 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.35 134.52 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.961 -0.563 . . . . 73.02 109.641 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.501 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 31.1 p90 -77.1 120.18 21.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.264 0.554 . . . . 64.24 110.509 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.722 ' HE2' ' HZ2' ' A' ' 47' ' ' LYS . 13.5 t80 -111.69 170.33 8.21 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.339 -1.356 . . . . 62.41 107.339 174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 42.4 mtmt -139.75 168.14 20.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.761 -0.776 . . . . 74.31 111.7 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.801 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 54.0 mt -117.41 134.66 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 75.24 108.875 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -115.69 -68.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.349 -0.611 . . . . 73.51 109.349 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -84.02 152.6 24.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.334 -1.728 . . . . 73.4 106.334 166.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -59.04 101.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 118.903 0.774 . . . . 73.12 109.764 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.46 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -126.03 118.82 26.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.758 -0.656 . . . . 72.42 111.653 -174.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -28.1 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.612 -1.631 . . . . 74.31 113.821 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.92 ' HA ' HD11 ' A' ' 48' ' ' LEU . 48.6 mt -65.18 -18.06 65.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.008 -0.997 . . . . 72.43 110.06 173.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 49' ' ' MET . 41.7 mt-10 -59.41 -52.47 65.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.646 -0.706 . . . . 73.33 111.025 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.722 ' HZ2' ' HE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -66.44 -30.42 70.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 74.1 110.297 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.92 HD11 ' HA ' ' A' ' 45' ' ' LEU . 73.4 mt -60.55 -32.29 71.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.966 -0.561 . . . . 73.21 110.62 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 21.3 ptp -95.74 -29.85 14.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.885 -0.326 . . . . 74.23 110.917 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 48.5 mt-10 -66.47 -34.08 77.14 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.45 0.167 . . . . 64.22 111.45 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' LYS . 78.7 t -57.64 -39.25 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.062 0.458 . . . . 74.55 110.027 173.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -76.81 -31.46 56.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 73.13 111.342 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.025 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 61.5 m -54.58 -49.5 70.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.443 0.639 . . . . 62.33 110.729 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -73.92 -23.4 59.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.678 -0.692 . . . . 71.51 111.006 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 2.6 tpm_? -80.54 -33.44 36.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.405 -0.361 . . . . 74.42 110.828 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.07 -21.57 31.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 75.42 110.812 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 1.22 64.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.871 -0.68 . . . . 60.04 111.891 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 6.5 tp-100 -136.32 131.1 33.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.148 -0.686 . . . . 75.33 109.148 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 1.025 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.6 p -86.84 179.32 6.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.066 0.765 . . . . 52.13 113.066 -168.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.782 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.48 -16.42 61.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.266 1.21 . . . . 75.4 114.266 -164.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.57 -0.29 37.13 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.453 -0.779 . . . . 75.51 110.409 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.855 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -115.11 11.4 16.35 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.481 -0.781 . . . . 70.02 109.835 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.782 HG23 ' HA ' ' A' ' 60' ' ' MET . 33.2 m -134.13 153.44 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.9 -0.591 . . . . 73.14 110.382 173.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.742 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -113.32 112.46 23.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.212 -0.662 . . . . 73.44 109.212 175.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -85.67 116.41 23.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.287 0.565 . . . . 74.42 111.715 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -113.55 142.27 46.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 74.2 109.819 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.616 ' CD1' HG23 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -104.18 102.97 12.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.829 -0.168 . . . . 74.01 110.676 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 46.78 49.42 14.22 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.982 0.801 . . . . 75.51 111.557 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.13 -22.02 41.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.014 -0.612 . . . . 73.33 113.829 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 30.0 t70 -126.44 121.76 33.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.0 0.9 . . . . 72.13 111.638 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.884 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.33 143.38 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 73.24 111.74 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.662 HG12 ' H ' ' A' ' 73' ' ' HIS . 11.9 tt -135.33 -178.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.685 -0.689 . . . . 75.3 109.997 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.662 ' H ' HG12 ' A' ' 72' ' ' ILE . 98.1 m-70 -111.36 148.27 33.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.42 -0.585 . . . . 74.0 109.42 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -68.73 -16.96 70.66 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.287 0.475 . . . . 60.44 114.287 -171.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.67 -4.81 54.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.299 0.549 . . . . 72.23 111.386 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.95 -43.26 65.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.834 0.309 . . . . 74.23 111.834 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 28.1 p 67.68 148.11 0.11 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.74 1.216 . . . . 72.04 112.159 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.896 ' HD3' HD23 ' A' ' 45' ' ' LEU . 22.1 Cg_endo -61.57 -47.63 11.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.184 2.589 . . . . 73.22 113.618 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.98 -24.27 64.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.546 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -58.98 -39.95 83.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.938 -0.573 . . . . 74.25 110.81 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.65 -31.99 15.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.852 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 13' ' ' SER . . . 115.83 -19.91 13.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.685 -0.769 . . . . 71.35 111.798 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 87' ' ' ASP . 10.1 tt -75.85 116.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.303 -0.999 . . . . 75.31 108.303 170.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.836 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 13.1 tt0 -131.2 -174.54 3.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.449 -0.341 . . . . 72.03 110.632 -168.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.836 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 26.0 t70 -4.71 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.768 1.627 . . . . 63.13 114.531 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.89 4.07 33.99 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.575 -0.739 . . . . 60.32 111.603 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 83' ' ' ILE . 5.8 p-10 -79.56 167.15 21.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.745 0.307 . . . . 72.14 110.571 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 26' ' ' LYS . 20.5 m -137.32 153.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.561 0.696 . . . . 65.24 112.136 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 54.3 mt -129.68 127.63 64.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.868 -1.06 . . . . 71.31 108.439 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.18 136.7 39.68 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.439 -0.208 . . . . 61.32 110.439 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.49 117.71 34.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.018 0.437 . . . . 71.15 110.838 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 83.8 mtp -98.97 170.27 8.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 73.12 109.454 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -74.16 104.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.868 0.366 . . . . 75.1 111.203 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.855 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 90.8 mt-30 60.66 176.25 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 74.3 111.742 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.742 ' HA ' ' HG2' ' A' ' 64' ' ' ARG . 79.2 mt-30 -78.76 94.06 5.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 74.34 111.219 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m 78.54 -29.79 0.15 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.045 -0.98 . . . . 70.43 111.758 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.8 -39.5 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.607 -0.597 . . . . 55.11 111.607 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 CA-C-O 118.532 -1.149 . . . . 74.45 111.592 179.469 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.961 -0.385 . . . . 73.11 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.46 166.82 11.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.451 -0.88 . . . . 72.34 112.956 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.47 126.21 54.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.401 . . . . 64.1 110.072 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -86.47 -29.72 22.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 73.11 110.954 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.24 -35.87 80.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.957 -0.565 . . . . 72.02 111.995 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.5 p -77.06 -10.76 59.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.101 -0.499 . . . . 75.43 111.99 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 15.43 28.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.657 0.265 . . . . 62.41 111.632 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.32 -41.54 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.258 -0.275 . . . . 74.32 110.258 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 p30 44.37 44.97 7.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 75.34 112.209 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.14 83.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.17 0.51 . . . . 71.34 110.698 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -174.14 120.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.315 -0.857 . . . . 75.25 109.03 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.91 105.05 3.0 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.672 -0.775 . . . . 60.41 112.533 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 m -73.99 101.92 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.974 -0.38 . . . . 74.44 109.974 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 27.4 p -78.44 123.09 85.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.299 -0.41 . . . . 63.33 110.342 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 8.0 Cg_exo -73.31 10.68 1.14 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.265 2.643 . . . . 73.34 112.862 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.57 91.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.544 -0.298 . . . . 75.44 110.749 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 67.68 1.32 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.86 -0.609 . . . . 70.43 111.465 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 -69.71 0.31 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.115 0.484 . . . . 63.4 110.47 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -128.3 -53.67 1.28 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.84 -0.618 . . . . 74.43 110.913 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.51 -170.57 29.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.939 -0.648 . . . . 65.4 111.769 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.48 114.01 27.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.878 0.37 . . . . 73.1 110.217 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -67.4 127.23 31.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 71.25 111.205 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 31.6 mm -116.01 164.28 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.453 -0.794 . . . . 74.02 108.918 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.629 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 88.0 mt-30 -151.59 116.25 5.13 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.712 0.805 . . . . 71.43 109.681 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 48' ' ' LEU . 10.3 m -113.17 -179.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.199 -0.667 . . . . 74.14 109.199 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.638 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 mtmt -144.83 114.43 7.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 74.44 110.776 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 89' ' ' ILE . 94.8 t -93.71 94.8 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 107.082 -1.451 . . . . 73.33 107.082 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 9.0 ttp180 -69.62 105.58 2.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.517 -1.29 . . . . 74.22 107.517 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.552 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 59.4 p -59.1 163.03 6.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 114.678 -1.147 . . . . 75.05 108.941 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 46.1 Cg_endo -67.21 28.14 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.824 2.35 . . . . 73.44 113.759 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 29' ' ' SER . 18.0 t70 -130.52 -23.82 2.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 63.12 110.65 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.12 -7.62 27.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.521 -0.847 . . . . 64.32 111.108 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.33 90.34 0.94 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.17 -0.678 . . . . 65.54 109.17 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 38.1 tt0 -99.57 102.21 13.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.1 -0.955 . . . . 71.52 109.657 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.11 129.98 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.886 -0.597 . . . . 73.02 109.999 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 27.8 p90 -71.41 122.58 20.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.432 0.634 . . . . 64.24 110.554 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.519 ' HD2' HD21 ' A' ' 48' ' ' LEU . 3.5 t80 -120.53 128.74 53.38 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.618 -1.252 . . . . 62.41 107.618 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HG2' ' HG2' ' A' ' 24' ' ' GLN . 21.6 mtmt -105.3 162.67 13.23 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.383 -0.527 . . . . 74.31 110.951 -165.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 43.1 mt -115.27 134.64 57.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.867 -0.79 . . . . 75.24 108.867 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -93.47 -78.75 0.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.784 -0.45 . . . . 73.51 109.784 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -97.59 169.71 9.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.118 -1.438 . . . . 73.4 107.118 164.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.863 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -54.85 101.59 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 73.12 110.532 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.8 116.03 23.02 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.23 -0.895 . . . . 72.42 109.755 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -36.37 134.19 0.46 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.575 -1.193 . . . . 74.31 111.985 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.458 ' HG ' ' HD3' ' A' ' 78' ' ' PRO . 91.7 mt -57.11 -20.28 24.62 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.958 -1.019 . . . . 72.43 113.276 -168.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 49' ' ' MET . 58.6 mt-10 -65.59 -24.69 67.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.111 0.412 . . . . 73.33 112.111 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -28.98 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.752 -0.379 . . . . 74.1 110.483 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 25' ' ' VAL . 28.3 mt -59.25 -39.49 82.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.975 -0.557 . . . . 73.21 111.512 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.612 ' HE1' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -94.47 -23.82 17.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.84 -0.744 . . . . 74.23 111.307 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 45.9 mt-10 -73.27 -37.74 66.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.276 -0.57 . . . . 64.22 111.046 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.99 -25.08 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.525 0.679 . . . . 74.55 109.512 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -81.72 -34.76 30.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.277 -0.874 . . . . 73.13 110.338 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.994 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 79.7 m -53.75 -56.96 12.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.335 0.588 . . . . 62.33 111.155 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -68.69 -19.99 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.585 -0.734 . . . . 71.51 110.993 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -66.59 -46.51 75.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 74.42 111.354 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -98.7 -11.09 22.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.973 0.36 . . . . 75.42 111.973 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 29.82 8.22 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.5 -0.857 . . . . 60.04 113.498 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.485 HE21 HG13 ' A' ' 63' ' ' VAL . 28.5 tt0 -150.55 129.04 12.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.823 -0.806 . . . . 75.33 108.823 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.994 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 24.2 p -92.43 178.25 5.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.995 0.739 . . . . 52.13 112.995 -168.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.501 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -76.21 -13.8 60.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.006 1.113 . . . . 75.4 114.006 -163.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 3.9 pm0 -80.07 -9.14 59.68 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.403 -0.811 . . . . 75.51 109.659 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.728 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.66 -22.35 12.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.617 -0.72 . . . . 70.02 109.965 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.485 HG13 HE21 ' A' ' 58' ' ' GLN . 3.7 m -128.51 101.26 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 166.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 14.0 tpt180 -83.77 149.53 26.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.747 -0.66 . . . . 73.44 111.395 -168.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.619 ' HD2' ' HE1' ' A' ' 67' ' ' TYR . 1.6 p90 -94.74 104.27 16.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.28 -0.873 . . . . 74.42 111.96 -175.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.792 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.5 mp -99.58 131.96 45.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.468 -0.787 . . . . 74.2 109.015 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.619 ' HE1' ' HD2' ' A' ' 65' ' ' PHE . 47.7 m-85 -103.42 110.35 22.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.485 -0.486 . . . . 74.01 110.99 -175.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t70 54.19 37.16 26.63 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.103 -0.953 . . . . 75.51 110.228 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -21.48 45.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.399 -0.819 . . . . 73.33 112.985 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -113.49 116.28 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.364 0.602 . . . . 72.13 110.846 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.792 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 23.6 ptt180 -72.61 118.21 15.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.381 -0.827 . . . . 73.24 112.344 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.93 -163.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.802 -0.814 . . . . 75.3 108.802 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -108.84 138.14 45.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.958 -0.297 . . . . 74.0 110.612 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.8 -10.56 64.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.1 -0.571 . . . . 60.44 112.273 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.15 -28.36 64.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 72.23 110.532 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 80' ' ' GLN . 6.1 t30 -67.64 -17.7 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.647 -0.706 . . . . 74.23 111.062 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.58 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 66.6 p 60.18 156.72 0.1 Allowed Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.375 1.07 . . . . 72.04 113.18 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.893 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 59.2 Cg_endo -72.37 -43.43 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.544 2.163 . . . . 73.22 112.431 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.68 -28.12 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.684 . . . . 74.52 111.966 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 76' ' ' ASN . 53.8 tt0 -83.32 -34.65 25.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.268 -0.423 . . . . 74.25 111.547 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 29.5 tp -89.56 -28.31 19.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 73.11 110.659 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.24 -18.63 38.79 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.672 -0.775 . . . . 71.35 111.509 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.5 tt -89.87 120.99 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.45 -0.574 . . . . 75.31 109.45 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -155.83 -154.16 0.47 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 118.974 -0.536 . . . . 72.03 110.353 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -21.82 109.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.718 1.261 . . . . 63.13 113.276 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.4 -6.88 20.84 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.919 -1.037 . . . . 60.32 111.819 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.65 170.91 15.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 72.14 110.882 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.89 158.17 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.637 0.732 . . . . 65.24 111.413 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.603 ' HB ' HG23 ' A' ' 27' ' ' VAL . 66.1 mt -128.59 125.92 64.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.98 -1.009 . . . . 71.31 108.724 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.09 126.23 44.79 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.772 -0.455 . . . . 61.32 109.772 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.732 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -87.96 117.93 27.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.144 0.497 . . . . 71.15 111.377 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.7 ttt -101.74 150.7 22.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.738 -0.665 . . . . 73.12 109.973 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.21 102.98 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.942 0.401 . . . . 75.1 110.505 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.728 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 38.8 mt-30 62.21 179.52 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.046 -0.979 . . . . 74.3 112.206 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.438 ' O ' ' HB ' ' A' ' 96' ' ' THR . 25.7 pt20 -91.82 39.46 1.01 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.579 -0.737 . . . . 74.34 110.229 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 95' ' ' GLN . 94.2 m 74.89 -38.07 0.37 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.606 -0.725 . . . . 70.43 111.21 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.69 104.78 0.4 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.806 -0.712 . . . . 55.11 112.028 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.962 0 CA-C-O 118.784 -1.009 . . . . 74.45 111.742 177.026 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.029 -0.73 . . . . 73.11 109.029 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.53 58.22 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.73 -1.348 . . . . 72.34 109.73 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -87.37 -177.81 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.479 0.657 . . . . 64.1 112.72 -165.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.06 -12.16 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.765 -1.107 . . . . 73.11 112.234 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -51.34 -26.73 8.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.939 0.718 . . . . 72.02 112.939 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -71.63 -20.6 61.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 75.43 111.752 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.92 30.08 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.036 0.384 . . . . 62.41 112.036 -172.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -74.83 96.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.603 0.716 . . . . 74.32 110.633 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.06 17.06 4.18 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.008 -0.996 . . . . 75.34 110.921 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.62 85.57 3.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 71.34 109.305 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -138.21 121.85 17.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.239 -0.437 . . . . 75.25 111.071 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.76 179.87 30.4 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.006 -0.838 . . . . 60.41 111.006 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -78.05 -49.19 14.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.014 0.407 . . . . 74.44 110.556 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.438 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 37.5 t 67.76 108.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 123.914 0.759 . . . . 63.33 111.6 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 14' ' ' SER . 18.7 Cg_endo -61.62 -31.71 86.92 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.586 2.191 . . . . 73.34 111.205 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.1 t -81.56 129.25 37.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.567 -0.742 . . . . 75.44 109.976 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -145.41 139.44 26.93 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 70.43 109.949 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -99.7 23.51 9.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.49 . . . . 63.4 111.283 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -102.29 26.89 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.988 -0.551 . . . . 74.43 109.811 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.76 105.03 0.07 OUTLIER Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 65.4 113.94 -174.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.91 -16.55 15.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.502 0.668 . . . . 73.1 109.429 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 38.3 m80 -114.01 142.93 45.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.343 -0.844 . . . . 71.25 110.059 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 1.022 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.2 mm -110.75 163.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.014 -0.539 . . . . 74.02 109.63 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.439 ' N ' HG23 ' A' ' 23' ' ' ILE . 58.6 tt0 -137.0 125.46 23.49 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.531 -0.544 . . . . 71.43 109.531 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.68 HG12 HD13 ' A' ' 48' ' ' LEU . 7.0 p -130.99 139.16 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.2 -0.454 . . . . 74.14 110.502 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.791 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -110.5 118.43 36.22 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.699 -0.4 . . . . 74.44 110.714 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.446 HG23 ' HB ' ' A' ' 89' ' ' ILE . 73.5 t -94.95 104.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.314 -1.365 . . . . 73.33 107.314 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 72.8 ttt-85 -69.64 110.23 4.74 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.983 -1.117 . . . . 74.22 107.983 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 62.3 p -60.22 159.77 20.48 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 115.322 -0.854 . . . . 75.05 108.714 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 27.3 Cg_endo -62.1 22.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 123.353 2.702 . . . . 73.44 115.021 -174.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 29' ' ' SER . 31.8 t70 -131.78 -24.07 2.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 63.12 110.9 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.05 2.55 20.22 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.44 -0.886 . . . . 64.32 112.114 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 88.47 7.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.186 -0.672 . . . . 65.54 109.186 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.791 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 11.1 tt0 -82.5 113.5 20.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.787 -0.642 . . . . 71.52 110.187 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.02 134.32 44.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.708 -0.479 . . . . 73.02 109.708 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -79.35 121.69 25.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.92 0.867 . . . . 64.24 111.543 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -116.92 174.35 6.14 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.485 -1.234 . . . . 62.41 107.805 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -136.26 153.48 51.18 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.97 -0.456 . . . . 74.31 111.174 -167.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.022 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 55.1 mt -114.99 134.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.729 -0.841 . . . . 75.24 108.729 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 22' ' ' HIS . 55.0 mtpt -127.83 -58.52 1.23 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.912 0.387 . . . . 73.51 110.793 -171.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -95.54 177.8 5.69 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.16 -1.052 . . . . 73.4 108.16 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.587 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.98 100.71 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.136 0.969 . . . . 73.12 109.073 172.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -138.95 102.17 4.48 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.307 -0.86 . . . . 72.42 110.606 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.713 ' HB3' HG21 ' A' ' 77' ' ' THR . 9.4 pttp -68.56 -176.63 0.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.205 -0.907 . . . . 74.31 111.212 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.667 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 60.6 mt -55.67 -27.13 48.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 72.43 111.988 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.604 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 39.8 mt-10 -57.92 -35.48 71.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.01 0.434 . . . . 73.33 111.4 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 51' ' ' VAL . 46.3 tptt -69.9 -52.48 24.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 74.1 110.287 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 25' ' ' VAL . 26.8 mt -62.65 -28.36 69.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 73.21 111.32 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.701 ' HE1' ' HB2' ' A' ' 60' ' ' MET . 14.2 ptm -85.59 -37.45 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 74.23 111.011 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.67 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 35.8 mm-40 -71.31 -30.43 66.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.829 0.307 . . . . 64.22 111.829 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 47' ' ' LYS . 87.8 t -62.98 -37.78 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.142 0.496 . . . . 74.55 109.706 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 55' ' ' ARG . 35.3 m-85 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.027 -0.533 . . . . 73.13 111.169 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 86.0 m -54.35 -48.59 71.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.315 0.579 . . . . 62.33 109.83 170.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.27 -40.52 67.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 71.51 110.833 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 52' ' ' TYR . 55.1 ttt180 -65.79 -45.54 82.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.42 111.683 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.24 -13.79 42.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.685 0.278 . . . . 75.42 111.316 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.79 10.86 83.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.665 -0.779 . . . . 60.04 111.893 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.641 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 5.3 tp-100 -133.61 130.33 38.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.996 -0.742 . . . . 75.33 108.996 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.478 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 32.6 p -83.09 163.48 20.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.333 0.587 . . . . 52.13 112.263 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.701 ' HB2' ' HE1' ' A' ' 49' ' ' MET . 0.0 OUTLIER -67.1 -15.69 63.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.245 -0.889 . . . . 75.4 112.328 -174.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -87.02 -4.29 59.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 75.51 110.476 177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -115.81 -25.94 7.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.593 -0.73 . . . . 70.02 109.455 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 11.5 m -125.78 117.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.637 -0.71 . . . . 73.14 109.639 168.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -88.1 139.74 30.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.583 -0.525 . . . . 73.44 109.583 -174.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' HB3' ' CG2' ' A' ' 89' ' ' ILE . 60.9 m-85 -101.38 119.01 38.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.913 -0.585 . . . . 74.42 111.353 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.889 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.2 mp -99.34 127.1 45.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.193 -0.912 . . . . 74.2 108.784 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.408 ' HE1' HG21 ' A' ' 83' ' ' ILE . 1.6 p90 -101.65 124.79 47.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.207 -0.997 . . . . 74.01 110.234 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.34 29.75 13.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.848 -1.069 . . . . 75.51 110.264 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.66 0.29 64.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.681 -0.69 . . . . 73.33 113.241 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.29 116.37 19.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.506 0.653 . . . . 72.13 111.368 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.889 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 22.6 ptt180 -66.68 137.81 56.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.286 -0.87 . . . . 73.24 112.408 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 73' ' ' HIS . 11.0 tp -162.63 164.86 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 75.3 109.741 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.407 ' N ' HG13 ' A' ' 72' ' ' ILE . 1.4 p-80 -70.39 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.0 110.919 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.667 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -65.76 -23.82 70.97 Favored Glycine 0 CA--C 1.518 0.242 0 CA-C-N 116.131 -0.486 . . . . 60.44 113.896 -171.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.77 3.84 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.763 0.281 . . . . 72.23 111.501 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -67.39 -39.1 85.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.453 -0.203 . . . . 74.23 110.453 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.713 HG21 ' HB3' ' A' ' 44' ' ' LYS . 49.9 p 62.41 143.0 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.596 1.158 . . . . 72.04 112.597 -178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.85 -42.22 15.64 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.049 2.499 . . . . 73.22 112.56 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.84 -14.76 55.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 74.52 111.802 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -59.9 -38.4 82.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 74.25 110.837 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.54 ' HB3' HG23 ' A' ' 83' ' ' ILE . 45.4 tp -104.85 -30.01 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 73.11 110.886 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.08 -19.32 13.62 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.774 -0.931 . . . . 71.35 110.774 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 81' ' ' LEU . 5.4 tt -66.48 112.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.719 -0.845 . . . . 75.31 108.719 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 15.8 tt0 -134.07 -152.8 0.49 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.751 -0.658 . . . . 72.03 109.864 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.566 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 33.1 t70 -30.57 112.9 0.09 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.254 0.971 . . . . 63.13 113.032 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.04 4.94 22.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.924 -0.58 . . . . 60.32 111.679 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -78.93 170.51 16.57 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.992 0.425 . . . . 72.14 111.094 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 13.7 m -138.27 154.83 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 65.24 111.013 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 36.4 mt -136.66 114.99 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.637 -0.71 . . . . 71.31 109.101 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.401 ' CG ' HH11 ' A' ' 28' ' ' ARG . 48.2 t0 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.446 -0.343 . . . . 61.32 110.372 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.2 131.69 53.15 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.148 0.425 . . . . 71.15 112.148 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.654 ' SD ' HD11 ' A' ' 66' ' ' LEU . 2.4 mpt? -126.21 163.28 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.449 -0.575 . . . . 73.12 109.449 173.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.53 95.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.564 0.221 . . . . 75.1 111.465 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 28.4 mt-30 45.52 39.08 4.38 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.495 0.718 . . . . 74.3 112.113 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 92' ' ' MET . 50.3 tp60 -72.46 71.49 0.94 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.382 0.61 . . . . 74.34 111.304 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 64' ' ' ARG . 86.7 m -164.83 -40.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.508 -0.923 . . . . 70.43 108.508 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.33 52.05 0.77 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.17 -0.923 . . . . 55.11 111.175 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.224 -1.32 . . . . 74.45 111.453 -178.004 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.237 -0.283 . . . . 73.11 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.75 -155.16 12.36 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.405 -0.903 . . . . 72.34 112.346 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -152.97 161.97 41.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 64.1 110.323 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.35 -14.8 42.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 73.11 110.125 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.42 -28.32 69.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.679 . . . . 72.02 111.031 -174.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 p -78.44 -9.99 59.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 75.43 111.961 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.82 41.16 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.206 0.527 . . . . 62.41 110.184 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.23 105.87 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.574 . . . . 74.32 112.206 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 73.61 160.86 0.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.108 -0.951 . . . . 75.34 111.85 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.46 -71.9 0.13 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.584 0.754 . . . . 71.34 110.918 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -85.91 102.64 13.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.136 0.493 . . . . 75.25 109.841 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.25 77.2 1.57 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.791 -0.64 . . . . 60.41 112.734 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -89.69 8.58 30.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.303 0.573 . . . . 74.44 110.545 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 p -102.17 108.76 58.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.69 . . . . 63.33 110.283 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.95 168.22 15.96 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.871 2.381 . . . . 73.34 112.245 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 t -66.75 159.57 4.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 75.44 110.716 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 53.6 t30 -63.11 157.9 21.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.214 -0.448 . . . . 70.43 110.507 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 86.5 m-20 75.14 5.85 4.23 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.648 0.779 . . . . 63.4 111.431 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -88.35 -3.67 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.443 -0.344 . . . . 74.43 111.079 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.29 11.83 83.83 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.782 -0.723 . . . . 65.4 112.193 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -84.99 -37.13 20.79 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.597 . . . . 73.1 109.387 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 30.7 m80 -90.18 176.99 6.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 71.25 110.311 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 30.1 mt -108.93 159.39 8.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.983 0.42 . . . . 74.02 110.808 -169.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.716 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp0 -146.11 126.12 13.68 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.985 0.914 . . . . 71.43 109.238 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.39 144.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.741 -0.466 . . . . 74.14 109.741 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.97 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.51 115.9 31.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.977 0.418 . . . . 74.44 111.302 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HB ' ' A' ' 89' ' ' ILE . 47.0 t -99.93 101.99 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.92 -1.141 . . . . 73.33 107.92 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 2.1 ttp180 -69.91 111.16 5.43 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 107.893 -1.151 . . . . 74.22 107.893 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.632 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 93.1 p -62.47 165.66 8.69 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.696 -0.801 . . . . 75.05 108.871 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 43.7 Cg_endo -66.65 20.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 122.66 2.24 . . . . 73.44 113.909 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' SER . 36.0 t70 -131.26 -11.77 3.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.205 0.526 . . . . 63.12 110.892 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.52 -0.16 43.08 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.193 -1.003 . . . . 64.32 111.976 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 97.6 6.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.353 -0.61 . . . . 65.54 109.353 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 48.5 tt0 -115.98 97.45 6.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.882 -0.599 . . . . 71.52 110.29 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.6 t -102.97 145.0 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.444 -0.947 . . . . 73.02 108.444 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.97 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.3 p90 -67.3 123.54 20.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 64.24 110.231 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' HE2' ' HZ1' ' A' ' 47' ' ' LYS . 6.4 t80 -110.52 170.11 8.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.943 -1.132 . . . . 62.41 107.943 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 34.8 mttt -140.71 165.87 26.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.46 0.573 . . . . 74.31 111.402 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 69.4 mt -122.68 135.21 63.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 75.24 108.877 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -117.44 -77.73 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.312 . . . . 73.51 110.969 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 42' ' ' LYS . 4.9 tpt180 -76.95 177.47 7.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.257 -1.016 . . . . 73.4 108.257 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 5.9 ttpm? -62.47 99.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.052 -1.092 . . . . 73.12 108.052 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 2.8 p -135.17 106.55 6.8 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.666 -0.697 . . . . 72.42 110.845 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.756 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 45.0 mttm -51.49 170.45 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.483 -1.235 . . . . 74.31 111.154 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.861 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 47.6 mt -62.61 -10.95 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.595 . . . . 72.43 110.487 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 5.3 mm-40 -53.94 -57.22 11.78 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.631 -0.713 . . . . 73.33 111.361 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HG2' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.62 -23.92 63.57 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.427 . . . . 74.1 110.877 -175.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD13 ' HA ' ' A' ' 45' ' ' LEU . 86.7 mt -63.32 -35.3 79.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 73.21 110.558 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 46' ' ' GLU . 26.5 ptt? -89.31 -33.91 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 74.23 110.564 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 9.2 mm-40 -66.48 -32.87 74.5 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.982 0.364 . . . . 64.22 111.982 -176.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 47' ' ' LYS . 93.2 t -60.89 -34.94 61.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.502 -0.479 . . . . 74.55 110.124 174.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -73.44 -44.47 58.14 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.873 -0.331 . . . . 73.13 110.315 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 61.7 m -48.1 -44.52 31.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.334 0.588 . . . . 62.33 110.409 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -64.62 -56.2 15.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.226 -0.897 . . . . 71.51 110.724 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -68.58 -42.96 77.5 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.494 0.553 . . . . 74.42 112.494 -171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.87 -20.32 53.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.721 -0.218 . . . . 75.42 111.01 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.5 19.28 74.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.686 -0.768 . . . . 60.04 111.254 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.667 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 35.1 tt0 -142.72 130.05 21.06 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.522 -0.918 . . . . 75.33 108.522 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.3 p -84.35 167.28 16.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 52.13 111.749 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.34 -15.15 59.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.475 -0.784 . . . . 75.4 112.39 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 12.5 pt-20 -59.28 -23.78 62.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.617 0.246 . . . . 75.51 110.489 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 1.009 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -105.74 -12.82 15.75 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.977 -0.556 . . . . 70.02 111.085 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.4 m -144.24 103.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 73.14 110.635 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -95.77 145.7 25.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.726 -0.39 . . . . 73.44 110.655 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.666 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 26.5 p90 -95.21 133.08 39.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 74.42 111.774 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 1.084 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -115.9 114.05 24.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 74.2 109.987 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -103.76 138.8 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.013 -0.675 . . . . 74.01 110.423 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 t70 54.53 22.89 4.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.822 0.82 . . . . 75.51 109.977 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.53 -18.73 56.54 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.652 -0.704 . . . . 73.33 113.367 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -118.16 120.66 38.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.742 0.771 . . . . 72.13 111.739 -176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 1.084 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -69.19 142.89 54.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.723 -0.672 . . . . 73.24 111.685 176.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 76' ' ' ASN . 37.6 pt -142.55 -163.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.151 -0.685 . . . . 75.3 109.151 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -98.21 140.35 32.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.009 -0.737 . . . . 74.0 109.009 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.861 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -60.33 -23.62 60.31 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.161 -0.542 . . . . 60.44 113.482 -172.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.756 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 23.8 t70 -63.06 -23.39 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.393 0.516 . . . . 72.23 112.393 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.656 ' HB3' HD12 ' A' ' 72' ' ' ILE . 2.1 t-20 -74.13 -19.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.841 -0.344 . . . . 74.23 111.205 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.61 HG23 ' HA ' ' A' ' 44' ' ' LYS . 7.7 p 59.15 151.79 0.08 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.063 1.135 . . . . 72.04 114.063 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 -32.76 23.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.821 2.347 . . . . 73.22 113.492 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.609 ' OE1' ' HB ' ' A' ' 77' ' ' THR . 4.3 pm0 -63.15 -14.85 53.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.674 0.273 . . . . 74.52 111.543 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -68.62 -30.93 69.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.301 -0.409 . . . . 74.25 111.006 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.18 -30.35 16.72 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.368 -0.533 . . . . 73.11 111.388 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 -18.99 32.52 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.472 -1.051 . . . . 71.35 110.472 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -84.47 148.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.95 -1.13 . . . . 75.31 107.95 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.608 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.7 tt0 -155.07 -149.19 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.817 -1.179 . . . . 72.03 107.817 -176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.608 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 5.2 p-10 -36.49 114.53 0.3 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.854 0.835 . . . . 63.13 112.194 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.45 -5.71 14.77 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.462 -0.79 . . . . 60.32 111.853 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.8 t0 -80.63 161.71 24.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.782 0.325 . . . . 72.14 110.38 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.09 154.8 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.356 0.598 . . . . 65.24 110.51 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.666 ' CG2' ' HB2' ' A' ' 65' ' ' PHE . 59.5 mt -131.72 126.37 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.408 -0.814 . . . . 71.31 109.471 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.98 134.35 43.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.554 0.216 . . . . 61.32 110.855 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -99.69 119.06 37.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.05 0.452 . . . . 71.15 110.622 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 65.4 mtt -103.32 152.25 21.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 73.12 110.016 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.32 95.89 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.861 0.362 . . . . 75.1 110.288 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 1.009 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 44.7 mt-30 56.51 23.59 7.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.334 -0.848 . . . . 74.3 110.852 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.551 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 6.8 tt0 64.58 78.07 0.3 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.793 -0.64 . . . . 74.34 110.283 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' ' 95' ' ' GLN . 76.3 p 59.45 10.55 1.9 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.268 1.027 . . . . 70.43 113.146 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 116.68 99.25 2.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.527 -0.844 . . . . 55.11 112.483 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.705 -1.053 . . . . 74.45 112.181 -178.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 38.9 m80 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.681 0.277 . . . . 71.14 110.4 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 25.8 mm -109.4 158.18 9.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.913 -0.402 . . . . 44.31 109.913 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -144.43 134.67 24.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.585 -0.524 . . . . 71.43 109.585 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 48' ' ' LEU . 5.0 p -142.63 140.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 123.658 0.599 . . . . 73.23 109.646 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . 23.4 mtmt -110.41 118.86 37.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.244 0.545 . . . . 74.44 111.182 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.768 HG22 ' HB ' ' A' ' 89' ' ' ILE . 88.6 t -94.46 97.68 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 105.999 -1.852 . . . . 73.33 105.999 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 32.7 ttt-85 -67.76 106.13 2.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.189 -1.041 . . . . 71.22 108.189 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 p -58.46 124.54 72.18 Favored Pre-proline 0 N--CA 1.422 -1.863 0 N-CA-C 107.111 -1.44 . . . . 72.53 107.111 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 90.5 Cg_endo -71.43 38.49 0.34 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.357 2.704 . . . . 72.52 114.217 -162.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -131.13 15.63 5.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.3 0.572 . . . . 63.12 111.326 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.5 24.93 19.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.362 -0.923 . . . . 64.22 111.844 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.34 161.57 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.433 -0.58 . . . . 44.21 109.433 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 38.2 tt0 -151.12 115.35 5.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.87 -0.418 . . . . 70.41 109.87 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.34 128.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.771 -0.455 . . . . 73.02 109.771 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 24.5 p90 -72.25 119.85 17.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.698 0.761 . . . . 63.02 110.845 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -111.29 166.35 11.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.873 -1.058 . . . . 62.04 108.421 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -144.98 146.13 31.81 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.403 -0.519 . . . . 64.22 111.224 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 56.9 mt -115.13 134.89 56.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.507 -0.923 . . . . 43.02 108.507 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -109.0 -65.03 1.18 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.556 -0.457 . . . . 65.1 110.978 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -91.45 -177.79 4.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.192 -1.04 . . . . 73.4 108.192 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.546 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.95 101.26 0.37 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.776 0.798 . . . . 73.02 109.25 172.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.28 6.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.644 -0.707 . . . . 71.22 110.269 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 14.1 ptpt -58.99 -179.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.231 -0.895 . . . . 62.32 112.075 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 37.3 mt -67.34 -10.48 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 72.43 112.376 -169.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' ' HG2' ' A' ' 49' ' ' MET . 70.2 mt-10 -57.5 -53.79 54.22 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.835 0.309 . . . . 72.42 111.835 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -30.09 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.341 -0.543 . . . . 62.41 110.913 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 39' ' ' ILE . 95.2 mt -60.27 -36.86 78.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.943 0.401 . . . . 70.35 110.392 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.6 ptt? -85.78 -34.01 21.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.019 -0.537 . . . . 63.31 111.176 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 42.0 mt-10 -74.61 -39.65 62.04 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.817 0.303 . . . . 64.22 111.817 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.87 -29.37 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.152 -0.684 . . . . 72.35 109.152 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.94 -43.58 57.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.78 . . . . 70.14 109.999 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 84.5 m -50.11 -52.05 38.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.382 0.611 . . . . 62.33 110.699 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -27.34 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.834 . . . . 62.25 110.723 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -71.44 -41.57 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.453 -0.34 . . . . 74.42 111.586 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.38 -6.4 34.19 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.898 -0.321 . . . . 75.42 111.4 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.51 59.3 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.513 -0.851 . . . . 60.04 111.775 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.7 tt0 -150.83 129.73 12.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.592 -0.892 . . . . 75.33 108.592 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.0 p -87.9 178.23 6.75 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.834 0.679 . . . . 31.2 112.834 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -74.48 -16.16 60.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.982 1.104 . . . . 74.42 113.982 -164.176 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.02 -13.67 60.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.884 -0.726 . . . . 75.51 109.957 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.667 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.02 2.98 23.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.532 -0.758 . . . . 65.21 110.336 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.718 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 7.0 m -139.63 103.34 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.386 0.613 . . . . 73.14 110.73 171.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.673 ' HD2' HD11 ' A' ' 66' ' ' LEU . 25.8 ttm180 -69.24 112.05 5.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.759 -0.655 . . . . 70.22 109.616 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.76 109.95 21.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.551 0.691 . . . . 74.42 111.64 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 5.2 mp -106.21 130.94 53.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.333 -0.849 . . . . 63.15 109.481 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HE2' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -127.62 143.47 51.16 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.206 -0.998 . . . . 74.01 110.618 176.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB2' HG21 ' A' ' 83' ' ' ILE . 35.2 t70 59.67 21.9 10.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.921 0.867 . . . . 75.51 109.764 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.84 -17.49 58.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.543 -0.753 . . . . 73.33 113.237 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -122.72 125.78 46.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.15 0.475 . . . . 72.13 111.609 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.846 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -65.28 151.45 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 73.24 110.901 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG12 ' H ' ' A' ' 73' ' ' HIS . 12.5 tt -170.81 -173.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.942 -0.762 . . . . 75.3 108.942 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.623 ' H ' HG12 ' A' ' 72' ' ' ILE . 94.1 m-70 -86.01 149.23 25.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.254 0.479 . . . . 61.52 110.435 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.748 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -67.94 -20.9 73.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.632 -0.794 . . . . 50.31 112.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.921 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 4.6 p-10 -78.78 -4.66 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.599 0.222 . . . . 72.23 111.599 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -23.45 61.98 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.854 -0.157 . . . . 71.25 111.293 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.905 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.1 p 66.28 159.15 0.13 Allowed Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 70.12 111.788 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.43 -60.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 73.22 113.432 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -63.57 -19.07 64.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.901 0.334 . . . . 74.52 111.901 -170.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -63.24 -25.5 68.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.035 0.445 . . . . 74.25 110.811 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.42 -29.16 17.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.109 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.79 -18.87 8.52 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.842 -0.694 . . . . 62.2 111.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 87' ' ' ASP . 15.4 tt -101.92 136.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.999 -0.371 . . . . 63.43 109.999 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 26.5 tt0 -148.39 -153.32 0.48 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.942 -0.762 . . . . 64.03 108.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.789 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.3 p-10 -20.94 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.651 1.18 . . . . 63.13 113.792 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.5 5.16 30.06 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.993 -0.843 . . . . 60.32 110.993 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 83' ' ' ILE . 11.3 p-10 -85.79 173.09 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.151 -0.525 . . . . 70.52 110.915 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.32 158.59 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 62.31 111.137 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 27' ' ' VAL . 69.6 mt -134.64 138.46 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.649 -0.871 . . . . 71.31 108.649 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.51 126.42 51.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.433 -0.58 . . . . 54.3 109.433 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.718 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -111.89 116.8 31.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.695 -0.402 . . . . 62.41 110.388 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 62.6 mtt -101.26 168.82 9.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.109 -0.496 . . . . 71.52 110.114 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.24 101.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 75.1 111.311 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.667 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 43.4 mt-30 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 74.3 112.23 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 22.4 m170 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.889 0.376 . . . . 71.14 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 17.8 mt -110.59 166.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.402 -0.592 . . . . 44.31 109.402 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 60.9 tt0 -148.49 139.75 23.32 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.771 -0.455 . . . . 71.43 109.771 -174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 48' ' ' LEU . 29.0 m -140.82 172.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.077 0.465 . . . . 73.23 110.741 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 3.7 mtmt -141.71 115.42 9.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 74.44 109.487 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 89' ' ' ILE . 52.3 t -95.19 95.08 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.589 -1.634 . . . . 73.33 106.589 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -68.49 103.57 1.7 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.996 -1.483 . . . . 71.22 106.996 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 31' ' ' ASP . 67.6 m -62.86 158.38 53.35 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 113.498 -1.683 . . . . 72.53 109.03 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 35.9 Cg_endo -64.8 36.2 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.666 2.911 . . . . 72.52 114.051 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 29' ' ' SER . 30.7 t70 -131.75 -14.9 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.46 0.647 . . . . 63.12 110.282 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.85 -3.57 52.64 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.227 -0.749 . . . . 64.22 111.227 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.01 118.16 23.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.364 -0.418 . . . . 44.21 110.014 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 23.4 tt0 -116.04 101.43 8.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.396 -0.594 . . . . 70.41 109.396 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.564 ' HB ' ' OH ' ' A' ' 52' ' ' TYR . 44.3 t -102.75 135.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.801 -0.444 . . . . 73.02 109.801 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.2 p90 -71.25 132.04 44.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.578 0.704 . . . . 63.02 111.358 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -126.72 162.8 24.95 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.657 -1.238 . . . . 62.04 107.657 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -136.99 157.15 47.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.845 0.831 . . . . 64.22 112.712 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -119.68 136.1 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 43.02 108.11 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -111.75 -28.14 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.838 -0.745 . . . . 65.1 111.834 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 35.4 ttm180 -145.78 -177.6 5.67 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.055 -1.461 . . . . 73.4 107.055 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 20.5 pttp -60.57 99.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.527 -0.869 . . . . 73.02 110.0 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' HG23 ' A' ' 39' ' ' ILE . 74.0 p -129.38 114.46 16.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.77 -1.104 . . . . 71.22 108.893 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HA ' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -49.27 153.75 0.96 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 62.32 111.688 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.809 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 36.1 mt -63.0 -12.57 26.75 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.29 -0.868 . . . . 72.43 111.76 -173.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' OE1' ' HG3' ' A' ' 44' ' ' LYS . 54.5 mt-10 -57.36 -44.43 84.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 72.42 111.345 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -30.43 68.05 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.561 -0.456 . . . . 62.41 110.582 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 39' ' ' ILE . 98.0 mt -61.55 -33.06 73.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 70.35 110.356 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -98.3 -28.98 13.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 63.31 112.029 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.72 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 46.4 mt-10 -78.01 -33.73 51.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.478 -0.489 . . . . 64.22 111.257 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.14 -31.89 55.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.021 -0.733 . . . . 72.35 109.021 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.564 ' OH ' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -71.22 -31.91 68.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 70.14 111.151 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 66.3 m -50.28 -47.09 55.53 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 62.33 110.63 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.88 -31.99 51.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.02 -0.537 . . . . 62.25 110.728 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -68.57 -40.28 80.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 74.42 110.617 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.15 -21.71 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.415 -0.357 . . . . 75.42 111.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.08 -2.65 69.1 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.768 -0.729 . . . . 60.04 112.163 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 7.5 tp-100 -124.49 129.79 51.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.106 -0.702 . . . . 75.33 109.106 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.738 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.0 p -81.25 178.65 8.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 31.2 112.366 -174.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.676 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -76.64 -16.12 59.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.665 1.357 . . . . 74.42 114.665 -162.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -74.28 -9.88 59.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 75.51 110.363 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -109.38 10.62 25.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.765 -0.652 . . . . 65.21 110.268 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.889 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 18.0 m -139.38 121.74 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.59 . . . . 73.14 111.465 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 20.3 tpp180 -85.56 113.81 22.09 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.616 -0.513 . . . . 70.22 109.616 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -83.43 118.07 23.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.487 -0.779 . . . . 74.42 112.376 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 10.2 mp -110.42 129.38 55.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.618 -0.719 . . . . 63.15 109.863 172.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.497 ' HD2' ' HB ' ' A' ' 72' ' ' ILE . 62.4 m-85 -106.89 129.87 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.439 -0.208 . . . . 74.01 110.439 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.76 23.34 9.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.999 0.904 . . . . 75.51 109.77 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.03 -0.28 78.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.458 -0.792 . . . . 73.33 112.567 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 37.3 t0 -127.15 122.91 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.578 0.704 . . . . 72.13 111.14 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -59.61 110.6 1.17 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.125 -0.943 . . . . 73.24 112.37 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' H ' ' A' ' 73' ' ' HIS . 11.2 mm -125.68 -167.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.171 -1.418 . . . . 75.3 107.171 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.865 ' H ' HG22 ' A' ' 72' ' ' ILE . 3.6 p80 -116.41 149.25 39.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.205 0.457 . . . . 61.52 110.091 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.809 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -64.54 -34.47 89.98 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.705 -0.68 . . . . 50.31 114.295 -168.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.95 -12.12 52.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.853 0.327 . . . . 72.23 111.584 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.645 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 3.5 t30 -70.87 -25.7 62.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.04 -0.356 . . . . 71.25 110.04 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' HA ' ' A' ' 44' ' ' LYS . 44.8 p 61.16 153.74 0.11 Allowed Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.639 1.176 . . . . 70.12 112.627 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 30.8 Cg_endo -64.91 -46.79 5.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.462 2.108 . . . . 73.22 111.833 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -46.17 -43.35 15.05 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.328 -0.851 . . . . 74.52 111.728 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.645 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 47.8 mt-30 -88.55 -15.7 34.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.25 111.704 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.7 -30.66 18.94 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.0 -0.28 . . . . 73.11 111.351 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.28 -18.93 25.18 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.315 -0.945 . . . . 62.2 110.916 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.3 tp -93.01 144.16 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.136 -1.061 . . . . 63.43 108.136 170.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CG ' ' H ' ' A' ' 85' ' ' ASP . 1.7 tt0 -141.09 -152.22 0.4 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.325 -0.62 . . . . 64.03 109.325 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 24' ' ' GLN . 7.2 t70 -45.99 118.41 1.86 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.06 0.457 . . . . 63.13 112.021 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.93 3.51 17.81 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.434 -0.803 . . . . 60.32 111.664 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.479 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.1 t0 -73.97 158.48 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 70.52 111.19 -175.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 32.7 m -129.96 147.28 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.815 -0.629 . . . . 62.31 110.357 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.4 mt -119.57 119.27 59.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.632 -0.713 . . . . 71.31 109.288 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -102.86 126.96 50.21 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.677 -0.49 . . . . 54.3 109.677 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.87 117.82 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.939 0.4 . . . . 62.41 111.786 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 1.8 mpt? -90.91 170.13 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 71.52 110.476 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.98 109.6 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 75.1 111.299 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.637 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 48.9 mt-30 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.017 -0.992 . . . . 74.3 111.515 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.805 -0.443 . . . . 71.14 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.5 mt -109.98 166.96 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.715 -0.846 . . . . 44.31 108.715 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.441 ' N ' HG22 ' A' ' 23' ' ' ILE . 41.6 tt0 -144.24 138.26 27.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.232 -0.284 . . . . 71.43 110.232 -173.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 48' ' ' LEU . 14.7 p -150.79 140.97 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.983 -0.553 . . . . 73.23 110.005 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.791 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 2.4 mtmp? -102.0 123.24 45.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.782 -0.451 . . . . 74.44 109.782 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.4 t -101.33 95.26 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 105.472 -2.047 . . . . 73.33 105.472 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 21.1 ttt180 -68.3 105.07 2.02 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 114.819 -1.082 . . . . 71.22 108.386 -172.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 68.5 m -63.38 139.39 97.57 Favored Pre-proline 0 N--CA 1.418 -2.037 0 N-CA-C 107.424 -1.325 . . . . 72.53 107.424 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.23 33.48 0.16 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.542 2.828 . . . . 72.52 114.643 -166.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -131.36 3.46 4.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.617 0.722 . . . . 63.12 109.567 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.26 16.52 53.25 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.885 -0.886 . . . . 64.22 110.885 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 29' ' ' SER . . . -99.44 74.91 1.93 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.618 . . . . 44.21 109.805 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.791 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 27.7 tt0 -87.44 102.67 14.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.843 -0.617 . . . . 70.41 109.822 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.36 136.34 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.976 -0.556 . . . . 73.02 109.71 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -80.47 121.68 26.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.464 0.65 . . . . 63.02 111.192 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.97 165.21 13.12 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.301 -1.37 . . . . 62.04 107.301 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -138.72 168.57 19.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.666 -0.814 . . . . 64.22 112.23 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 58.0 mt -114.2 134.93 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.662 -1.154 . . . . 43.02 109.369 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.92 -81.91 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.003 0.43 . . . . 65.1 109.992 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 59.6 ttt180 -101.97 -177.18 3.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.123 -1.436 . . . . 73.4 107.123 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.497 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 47.3 pttt -53.09 102.01 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.465 0.65 . . . . 73.02 111.42 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 39' ' ' ILE . 1.6 p -142.47 107.47 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 71.22 110.626 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 37.6 pttt -51.6 175.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.158 -0.928 . . . . 62.32 113.493 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 48' ' ' LEU . 44.7 mt -66.43 -21.69 66.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.657 -1.156 . . . . 72.43 113.03 -169.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.53 ' HA ' ' CE ' ' A' ' 49' ' ' MET . 34.0 mt-10 -58.5 -33.49 69.87 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.569 0.581 . . . . 72.42 112.569 -171.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -23.39 32.59 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.351 -0.54 . . . . 62.41 110.837 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.759 HD13 HG11 ' A' ' 25' ' ' VAL . 73.0 mt -64.84 -35.34 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.361 . . . . 70.35 111.456 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.3 -39.37 14.43 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.497 -0.881 . . . . 63.31 111.268 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' N ' ' HG2' ' A' ' 49' ' ' MET . 12.4 mm-40 -68.95 -37.96 79.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.431 0.53 . . . . 64.22 112.431 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 55' ' ' ARG . 69.8 t -60.48 -31.45 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.268 -0.573 . . . . 72.35 109.664 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.49 ' HD2' HD23 ' A' ' 56' ' ' LEU . 8.3 t80 -83.01 -29.84 28.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.149 -0.478 . . . . 70.14 110.13 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.031 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 73.6 m -58.34 -37.25 74.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.296 0.569 . . . . 62.33 110.758 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.17 -32.78 74.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 62.25 110.825 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 51' ' ' VAL . 9.4 mpt_? -73.25 -50.55 21.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 74.42 111.496 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 52' ' ' TYR . 2.9 pp -76.01 -20.99 57.37 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.713 -0.221 . . . . 75.42 111.583 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.83 13.24 37.9 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.755 -0.735 . . . . 60.04 113.527 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -150.3 130.12 13.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.083 -0.71 . . . . 75.33 109.083 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 1.031 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.2 p -78.37 167.13 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.447 0.641 . . . . 31.2 112.595 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.726 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -64.47 -15.85 61.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.821 -1.081 . . . . 74.42 112.897 -169.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.51 -17.36 62.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.052 0.453 . . . . 75.51 110.46 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.06 8.99 18.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.112 -0.494 . . . . 65.21 110.088 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 60' ' ' MET . 3.0 m -143.49 103.17 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.935 -0.575 . . . . 73.14 110.086 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 25.0 tpt180 -73.24 125.68 28.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.533 . . . . 70.22 110.378 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -87.03 112.4 21.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.459 -0.791 . . . . 74.42 112.314 -175.086 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.626 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 7.9 mp -93.79 124.89 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.865 -0.607 . . . . 63.15 109.538 172.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HD2' HG12 ' A' ' 89' ' ' ILE . 83.1 m-85 -103.3 113.69 27.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.323 -0.251 . . . . 74.01 110.323 -177.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 t70 57.88 26.99 13.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 122.079 0.942 . . . . 75.51 109.869 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.12 -16.89 58.79 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.228 -0.896 . . . . 73.33 112.787 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -111.96 116.41 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.513 0.673 . . . . 72.13 110.623 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 12.0 ptt-85 -80.24 111.5 16.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.655 -0.702 . . . . 73.24 111.401 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.9 -165.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.935 -0.575 . . . . 75.3 110.187 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -85.22 140.87 30.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.083 -0.34 . . . . 61.52 110.083 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.48 -18.14 76.8 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.225 -0.512 . . . . 50.31 113.005 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 33.9 t70 -70.08 -12.97 61.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.033 0.444 . . . . 72.23 111.084 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -66.33 -41.44 89.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.899 -0.591 . . . . 71.25 110.746 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 m 68.55 136.58 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.903 -0.589 . . . . 70.12 111.091 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD3' ' HG ' ' A' ' 45' ' ' LEU . 76.4 Cg_exo -51.66 -36.86 62.67 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.215 2.61 . . . . 73.22 113.725 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.63 -34.24 36.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.267 0.469 . . . . 74.52 112.267 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -88.6 -18.06 28.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 74.25 111.254 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.05 -30.37 19.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.497 -0.32 . . . . 73.11 111.756 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.76 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.24 -0.981 . . . . 62.2 110.654 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 84' ' ' GLU . 10.1 tp -91.85 159.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.235 -1.394 . . . . 63.43 107.235 169.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.647 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 25.0 tt0 -154.05 -171.62 3.94 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.763 -0.829 . . . . 64.03 108.763 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 23' ' ' ILE . 8.4 p-10 -47.51 126.28 9.58 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.77 0.795 . . . . 63.13 112.358 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.56 4.26 15.57 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.86 -1.064 . . . . 60.32 110.844 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.41 -173.58 4.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.088 0.471 . . . . 70.52 111.072 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.03 148.37 22.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.563 0.697 . . . . 62.31 111.348 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 27' ' ' VAL . 64.8 mt -119.0 114.04 43.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.036 -0.984 . . . . 71.31 108.976 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -99.81 118.0 35.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.721 -0.474 . . . . 54.3 109.721 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.81 117.36 33.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.107 0.48 . . . . 62.41 111.207 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.7 144.89 35.89 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.093 -0.706 . . . . 71.52 109.093 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.39 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.397 0.435 . . . . 75.1 111.356 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 3.2 pt20 . . . . . 0 N--CA 1.469 0.513 0 O-C-N 124.658 1.224 . . . . 74.3 112.552 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.503 0.668 . . . . 71.14 112.235 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 28.4 mt -110.5 166.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.734 -1.21 . . . . 44.31 107.734 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.684 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 21.1 tt0 -162.38 123.99 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 71.43 111.004 -171.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 48' ' ' LEU . 15.5 m -137.09 141.93 38.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.428 -0.582 . . . . 73.23 109.428 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.607 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.9 ttmt -100.01 111.32 23.63 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.793 -0.763 . . . . 74.44 109.02 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 89' ' ' ILE . 67.5 t -95.3 99.29 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.419 -0.956 . . . . 73.33 108.419 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.804 ' HE ' ' HA2' ' A' ' 32' ' ' GLY . 36.2 ttt180 -70.2 104.66 2.69 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.368 -1.345 . . . . 71.22 107.368 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.684 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 10.0 p -65.74 164.89 23.15 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.044 -0.98 . . . . 72.53 109.39 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 52.2 Cg_endo -67.69 30.63 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 123.115 2.543 . . . . 72.52 114.769 -169.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -131.74 -23.36 2.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.67 -0.492 . . . . 63.12 109.67 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.804 ' HA2' ' HE ' ' A' ' 28' ' ' ARG . . . 126.67 -11.25 7.07 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.757 -0.656 . . . . 64.22 112.293 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.33 94.67 3.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.158 0.504 . . . . 44.21 110.796 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.78 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 35.8 tt0 -92.5 99.33 12.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 70.41 109.586 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.22 134.31 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.191 -0.459 . . . . 73.02 110.173 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 21.0 p90 -75.98 105.14 6.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.589 0.709 . . . . 63.02 110.31 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.414 ' HD1' ' CD2' ' A' ' 48' ' ' LEU . 6.2 t80 -111.72 151.35 29.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.516 -0.92 . . . . 62.04 108.516 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 24' ' ' GLN . 78.4 mttt -125.87 168.64 13.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.664 0.745 . . . . 64.22 111.735 -169.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -115.42 134.22 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.397 -1.334 . . . . 43.02 107.397 170.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -103.03 -58.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.137 -0.625 . . . . 65.1 110.161 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -106.48 -178.95 3.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.93 101.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.999 0.363 . . . . 73.02 110.417 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.401 ' CG2' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -134.02 133.19 40.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.98 0.419 . . . . 71.22 110.515 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 167.3 21.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 62.32 111.081 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.705 HD21 ' HD3' ' A' ' 78' ' ' PRO . 96.6 mt -67.47 -23.87 65.55 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.464 0.542 . . . . 72.43 112.464 -170.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 34.0 mp0 -59.21 -24.68 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.033 0.383 . . . . 72.42 112.033 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -76.38 -37.66 56.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.202 -0.599 . . . . 62.41 109.949 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 39' ' ' ILE . 59.5 mt -62.53 -38.33 89.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.195 0.521 . . . . 70.35 109.99 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 20.0 ptm -80.01 -37.13 34.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.586 -0.734 . . . . 63.31 111.5 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 49.8 mm-40 -67.91 -30.46 69.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.955 -0.298 . . . . 64.22 111.719 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 47' ' ' LYS . 76.5 t -54.88 -39.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.465 -0.494 . . . . 72.35 110.296 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -75.97 -35.12 59.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 70.14 111.507 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 64.4 m -49.88 -48.13 51.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.909 0.385 . . . . 62.33 111.044 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.71 -32.77 62.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 62.25 111.289 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 74.42 111.08 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.49 -21.55 26.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.468 -0.333 . . . . 75.42 111.275 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.05 12.98 83.85 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.501 -1.04 . . . . 60.04 110.501 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.4 tt0 -136.2 129.94 32.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.492 -0.929 . . . . 75.33 108.492 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 6.2 p -81.42 171.64 14.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.456 0.646 . . . . 31.2 112.158 -173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.562 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.34 -15.08 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.902 -1.045 . . . . 74.42 112.935 -174.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.62 -15.28 57.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.976 0.361 . . . . 75.51 111.976 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HA ' ' CG ' ' A' ' 94' ' ' GLN . . . -109.95 9.25 24.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.125 0.488 . . . . 65.21 110.177 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.742 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 18.3 m -140.5 172.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.595 . . . . 73.14 110.495 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 tpp85 -143.75 130.49 20.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.607 -0.516 . . . . 70.22 109.607 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 49' ' ' MET . 91.3 m-85 -99.99 116.38 31.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 74.42 111.441 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -111.03 113.45 26.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.392 -0.822 . . . . 63.15 110.015 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.667 ' HB3' HG12 ' A' ' 89' ' ' ILE . 23.2 p90 -112.47 146.15 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.098 -0.641 . . . . 74.01 110.175 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.1 t70 60.44 21.94 11.58 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.352 1.072 . . . . 75.51 109.3 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.92 -12.09 68.57 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.118 -0.946 . . . . 73.33 113.109 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -130.63 127.55 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.427 0.613 . . . . 72.13 112.054 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -63.96 159.21 20.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.681 -0.69 . . . . 73.24 111.839 175.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.756 HG12 ' H ' ' A' ' 73' ' ' HIS . 10.2 tt -173.03 -171.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.428 -0.582 . . . . 75.3 109.428 175.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.756 ' H ' HG12 ' A' ' 72' ' ' ILE . 11.5 m170 -75.51 151.79 37.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.878 0.371 . . . . 61.52 110.687 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -72.69 -19.85 79.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.794 -0.717 . . . . 50.31 112.217 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.97 -19.21 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.57 0.211 . . . . 72.23 111.57 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.671 ' OD1' ' HB2' ' A' ' 73' ' ' HIS . 18.7 m120 -68.15 -44.14 76.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.018 -0.364 . . . . 71.25 110.018 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.0 p 61.96 162.54 0.11 Allowed Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.871 0.869 . . . . 70.12 111.512 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.705 ' HD3' HD21 ' A' ' 45' ' ' LEU . 24.9 Cg_exo -64.3 -39.21 30.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.463 2.109 . . . . 73.22 112.356 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.54 -49.11 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 74.52 110.976 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -67.06 -22.74 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.686 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.7 tp -86.63 -29.5 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 73.11 110.241 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.41 -18.44 27.72 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.112 -0.795 . . . . 62.2 111.112 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.61 126.87 54.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.089 -0.708 . . . . 63.43 109.089 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.0 tt0 -131.37 -151.52 0.47 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.408 -0.36 . . . . 64.03 110.344 -169.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 4.0 p-10 -43.4 131.73 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.551 0.691 . . . . 63.13 112.631 -172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.38 -9.5 24.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.547 -0.751 . . . . 60.32 112.007 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.68 169.86 10.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.945 -0.391 . . . . 70.52 109.945 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.9 161.95 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.306 0.574 . . . . 62.31 111.261 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.667 HG12 ' HB3' ' A' ' 67' ' ' TYR . 35.6 mt -132.94 117.22 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.424 -0.954 . . . . 71.31 108.424 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 3.4 t70 -98.69 125.98 44.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.84 -0.43 . . . . 54.3 109.84 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 64' ' ' ARG . . . -97.79 117.04 31.21 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.174 0.511 . . . . 62.41 110.512 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.0 163.64 12.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.713 -0.676 . . . . 71.52 109.37 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.06 101.42 3.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.912 -0.315 . . . . 75.1 111.345 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.742 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 45.2 mt-30 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.452 -0.794 . . . . 74.3 111.692 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.462 -0.57 . . . . 71.14 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 14.8 mt -110.76 168.1 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.909 -0.404 . . . . 44.31 109.909 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 41.7 mt-30 -150.8 131.72 14.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.877 0.471 . . . . 71.43 110.674 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 48' ' ' LEU . 35.8 m -130.35 -177.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.356 -0.609 . . . . 73.23 109.356 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.74 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mtmt -138.77 114.75 10.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.767 0.318 . . . . 74.44 110.554 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 89' ' ' ILE . 66.9 t -97.17 100.94 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -69.9 106.68 3.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.925 -1.139 . . . . 71.22 107.925 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 66.1 p -60.34 160.28 18.59 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.256 -0.884 . . . . 72.53 108.954 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 36.7 Cg_endo -65.2 31.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 123.165 2.576 . . . . 72.52 114.076 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 29' ' ' SER . 27.7 t70 -131.44 -21.45 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.272 0.558 . . . . 63.12 110.77 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.65 -15.73 24.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.268 -0.733 . . . . 64.22 111.268 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.09 104.17 1.71 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.539 -0.541 . . . . 44.21 109.539 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.74 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 34.0 tt0 -113.44 96.86 6.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.36 -0.836 . . . . 70.41 109.289 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.27 134.57 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.221 -0.659 . . . . 73.02 109.221 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 34.9 p90 -68.32 130.5 43.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.227 0.536 . . . . 63.02 110.191 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG11 ' A' ' 51' ' ' VAL . 3.9 t80 -128.12 130.17 47.72 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.983 -1.117 . . . . 62.04 107.983 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 44.4 pttt -105.29 163.69 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.88 0.848 . . . . 64.22 112.555 -165.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 65.2 mt -114.83 134.77 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.419 -1.264 . . . . 43.02 108.063 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.15 -81.68 0.37 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.281 0.562 . . . . 65.1 110.628 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -102.1 -176.57 3.16 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.022 -1.103 . . . . 73.4 108.022 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.76 101.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.258 0.551 . . . . 73.02 109.967 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 1.7 p -141.47 105.23 4.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.968 -1.015 . . . . 71.22 109.776 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -39.24 152.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.841 -1.072 . . . . 62.32 113.308 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.47 -15.4 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.118 -0.947 . . . . 72.43 111.236 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 42.5 mt-10 -62.73 -26.28 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 72.42 111.181 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -78.13 -36.24 48.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.44 -0.504 . . . . 62.41 109.905 177.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 25' ' ' VAL . 74.3 mt -59.38 -29.72 67.91 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.763 -0.828 . . . . 70.35 108.763 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.638 ' HG3' ' CD1' ' A' ' 65' ' ' PHE . 24.9 ttt -78.62 -51.09 10.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.111 -1.404 . . . . 63.31 111.049 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 42.7 mt-10 -70.43 -30.19 66.98 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.511 0.559 . . . . 64.22 112.511 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 47' ' ' LYS . 54.5 t -55.71 -38.47 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.442 -0.503 . . . . 72.35 111.101 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.8 -30.44 65.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.579 -0.282 . . . . 70.14 111.504 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 62.2 m -51.36 -39.78 57.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.33 0.586 . . . . 62.33 110.57 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -76.57 -41.26 47.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.533 -0.758 . . . . 62.25 111.147 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -64.22 -50.77 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.02 0.748 . . . . 74.42 113.02 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 58' ' ' GLN . 1.2 pp -98.63 8.51 44.83 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.564 -0.454 . . . . 75.42 111.914 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.17 27.36 72.89 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.158 -0.544 . . . . 60.04 113.386 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 58.3 tt0 -143.22 130.84 21.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.482 -0.933 . . . . 75.33 108.482 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 p -89.33 174.3 7.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.952 0.723 . . . . 31.2 112.952 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.461 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -70.11 -14.92 62.88 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 115.023 1.49 . . . . 74.42 115.023 -163.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.38 -12.68 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.08 -1.012 . . . . 75.51 109.76 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -101.54 -7.6 22.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.429 -0.805 . . . . 65.21 110.272 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 92' ' ' MET . 5.1 m -138.72 104.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.223 172.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HE ' HD11 ' A' ' 66' ' ' LEU . 54.1 ttp180 -88.01 125.9 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.293 -0.412 . . . . 70.22 110.099 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 54.7 m-85 -92.93 122.95 35.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.18 0.514 . . . . 74.42 111.347 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.98 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -106.73 113.33 26.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.674 -0.693 . . . . 63.15 109.838 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 89' ' ' ILE . 47.1 p90 -112.73 145.71 40.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.836 -0.746 . . . . 74.01 111.149 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.26 22.51 11.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.071 0.938 . . . . 75.51 109.058 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.98 2.27 86.54 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.979 -1.009 . . . . 73.33 112.14 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -122.17 117.72 26.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.145 0.498 . . . . 72.13 111.324 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.98 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -66.74 119.26 11.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.219 0.533 . . . . 73.24 111.189 173.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.478 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 8.0 tt -161.3 157.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.407 -0.59 . . . . 75.3 109.407 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.34 135.37 48.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.099 0.476 . . . . 61.52 111.877 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.48 82.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.586 -0.734 . . . . 50.31 114.419 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.2 -33.35 75.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.207 0.503 . . . . 72.23 111.364 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -79.83 0.67 30.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.386 -0.37 . . . . 71.25 111.23 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.708 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 80.9 p 59.89 163.83 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.28 1.032 . . . . 70.12 112.833 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 73.0 Cg_endo -76.17 -31.73 4.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.149 1.899 . . . . 73.22 112.127 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.6 -34.34 67.11 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.786 -0.643 . . . . 74.52 110.758 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -77.09 -19.03 57.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.064 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -93.88 -30.88 14.57 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 73.11 111.23 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.16 -19.04 23.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.463 -0.875 . . . . 62.2 110.97 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.587 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -85.65 147.92 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.878 -1.156 . . . . 63.43 107.878 169.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.73 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 23.1 tt0 -151.23 -152.35 0.43 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.191 -0.67 . . . . 64.03 109.191 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.73 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t70 -47.32 114.84 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.865 0.364 . . . . 63.13 110.855 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.09 3.9 14.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.978 -0.629 . . . . 60.32 111.536 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HB2' HG13 ' A' ' 83' ' ' ILE . 17.7 t70 -76.09 142.05 41.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 70.52 111.049 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 17.7 m -114.47 141.47 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 121.345 0.593 . . . . 62.31 109.796 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.572 HG12 ' HB3' ' A' ' 67' ' ' TYR . 22.8 mt -121.37 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.497 -0.774 . . . . 71.31 109.651 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.64 -0.255 . . . . 54.3 110.906 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -94.93 118.16 31.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 62.41 111.282 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 66.9 mmm -105.37 168.04 9.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 71.52 110.621 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.05 109.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 75.1 111.371 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.792 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 89.6 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 74.3 113.13 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 110.061 -0.348 . . . . 71.14 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 23.6 mt -126.01 160.12 33.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.055 -1.091 . . . . 44.31 108.055 172.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 21.9 tt0 -145.8 135.85 23.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.567 0.222 . . . . 71.43 110.96 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 48' ' ' LEU . 26.8 m -139.47 149.07 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 73.23 110.196 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.635 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 mtmt -119.36 114.94 23.12 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.217 -0.302 . . . . 74.44 110.427 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 89' ' ' ILE . 53.2 t -97.36 98.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.946 -1.501 . . . . 73.33 106.946 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 27.6 ttp180 -68.99 103.74 1.92 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.055 -1.461 . . . . 71.22 107.055 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 70.8 m -64.63 158.46 67.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 114.073 -1.421 . . . . 72.53 108.699 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 37.1 Cg_endo -64.31 32.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 123.63 2.887 . . . . 72.52 114.756 -170.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 29' ' ' SER . 28.8 t70 -134.06 -8.58 2.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.449 0.642 . . . . 63.12 110.302 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.85 57.01 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.88 -0.888 . . . . 64.22 110.88 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 99.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 44.21 110.246 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 35.1 tt0 -104.92 99.78 9.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.526 -0.761 . . . . 70.41 109.515 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.56 134.77 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 73.02 110.338 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 20.8 p90 -76.59 117.37 18.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.78 0.8 . . . . 63.02 111.691 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -112.02 171.59 7.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.696 -1.224 . . . . 62.04 107.696 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -145.66 165.53 28.45 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.358 -0.937 . . . . 64.22 112.476 -170.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 48.5 mt -123.1 147.59 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.602 -1.181 . . . . 43.02 108.958 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -128.96 -77.63 0.56 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.2 -0.667 . . . . 65.1 109.2 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -72.62 150.14 43.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.185 -1.413 . . . . 73.4 107.185 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 59.7 pttt -56.64 101.24 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.902 0.858 . . . . 73.02 111.219 -175.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.46 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -134.68 103.31 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.063 -0.971 . . . . 71.22 109.465 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 13.1 pttp -63.54 -178.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.328 0.862 . . . . 62.32 113.328 -173.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.863 ' HA ' HD12 ' A' ' 48' ' ' LEU . 37.4 mt -60.91 -16.73 45.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.626 -1.17 . . . . 72.43 113.611 -164.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 49' ' ' MET . 53.1 mt-10 -58.09 -57.37 13.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.83 0.307 . . . . 72.42 111.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -68.2 -28.42 67.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.878 -0.329 . . . . 62.41 111.008 -175.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.1 mt -58.96 -37.59 77.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 70.35 110.73 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.1 ptt? -90.98 -32.79 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 63.31 110.628 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 27.6 mt-10 -67.91 -34.63 77.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.072 0.397 . . . . 64.22 112.072 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 62.3 t -55.8 -37.68 48.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.207 0.527 . . . . 72.35 109.946 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.86 -36.76 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 70.14 111.287 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.054 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 58.5 m -52.21 -53.44 43.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.15 0.5 . . . . 62.33 110.638 173.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -67.22 -32.32 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.652 . . . . 62.25 110.938 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -69.26 -38.87 78.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.297 -0.41 . . . . 74.42 111.244 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.03 -13.93 37.61 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.874 -0.33 . . . . 75.42 111.422 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.4 8.46 52.75 Favored Glycine 0 CA--C 1.517 0.158 0 C-N-CA 120.556 -0.831 . . . . 60.04 113.822 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -151.17 135.18 16.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.7 -0.481 . . . . 75.33 109.7 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 1.054 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 3.6 p -78.37 179.33 7.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.191 0.811 . . . . 31.2 113.191 -171.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.586 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.2 -14.15 62.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.893 1.442 . . . . 74.42 114.893 -163.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -1.8 27.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.093 -1.004 . . . . 75.51 109.982 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . . . -113.76 1.8 14.96 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 65.21 109.953 173.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.859 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -142.52 102.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.362 0.601 . . . . 73.14 110.19 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.642 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 22.9 tpt180 -71.17 114.19 8.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 70.22 111.192 -172.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -80.43 110.87 16.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.277 -0.874 . . . . 74.42 112.306 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 9.9 mp -104.8 125.51 50.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.797 -0.638 . . . . 63.15 109.783 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HD1' HG12 ' A' ' 89' ' ' ILE . 74.0 m-85 -103.26 123.77 47.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.211 -0.292 . . . . 74.01 110.211 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.2 t70 57.82 22.95 9.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.147 0.975 . . . . 75.51 110.039 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.75 63.17 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.5 -0.773 . . . . 73.33 112.691 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.42 117.88 26.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 72.13 111.523 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.99 122.43 16.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 73.24 111.467 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 67' ' ' TYR . 8.3 pt -147.66 -162.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.411 ' H ' ' HB ' ' A' ' 72' ' ' ILE . 38.8 m170 -89.64 159.52 17.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.862 0.363 . . . . 61.52 110.88 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.679 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -76.59 -17.56 79.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.883 -0.675 . . . . 50.31 111.496 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.714 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 p30 -74.61 -9.21 58.35 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.468 0.307 . . . . 72.23 111.387 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -67.7 -38.26 83.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.414 -0.357 . . . . 71.25 110.877 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.5 p 63.27 144.72 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 124.356 1.063 . . . . 70.12 111.461 -174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.0 -51.08 10.37 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.981 2.454 . . . . 73.22 113.219 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -56.95 -31.64 65.2 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.297 0.48 . . . . 74.52 112.297 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -75.83 -19.52 58.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.085 0.469 . . . . 74.25 110.667 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.4 tp -91.5 -30.88 16.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.356 . . . . 73.11 111.51 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.1 -18.85 13.91 Favored Glycine 0 CA--C 1.502 -0.767 0 N-CA-C 110.1 -1.2 . . . . 62.2 110.1 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tp -89.3 159.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.957 -1.127 . . . . 63.43 107.957 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 28.3 tt0 -154.55 -152.4 0.4 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.983 -1.117 . . . . 64.03 107.983 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.749 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.9 t70 -43.85 119.36 1.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.603 0.638 . . . . 63.13 111.616 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.46 4.71 32.47 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.724 -0.75 . . . . 60.32 111.539 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB3' HG12 ' A' ' 25' ' ' VAL . 18.3 t70 -60.67 151.52 28.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.607 -0.297 . . . . 70.52 110.644 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 23.5 m -128.61 148.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.432 0.634 . . . . 62.31 110.607 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 27' ' ' VAL . 54.6 mt -127.85 113.05 29.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.368 -0.975 . . . . 71.31 108.368 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -102.76 126.17 49.78 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.969 -0.382 . . . . 54.3 109.969 -173.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.859 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -104.62 118.01 35.53 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.429 0.455 . . . . 62.41 112.146 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.3 mpt? -95.14 171.23 8.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.565 -0.532 . . . . 71.52 109.565 172.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.94 117.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.719 0.295 . . . . 75.1 111.345 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 48.8 mt-30 . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 124.013 0.925 . . . . 74.3 112.22 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.2 m80 . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.927 -0.397 . . . . 71.14 109.927 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 10.2 mt -109.83 169.63 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.614 -0.513 . . . . 44.31 109.614 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 23' ' ' ILE . 4.1 tt0 -145.9 138.26 25.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.483 -0.562 . . . . 71.43 109.483 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.862 HG11 HD13 ' A' ' 48' ' ' LEU . 7.4 p -150.73 138.38 13.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.188 0.518 . . . . 73.23 110.234 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' A' ' 36' ' ' PHE . 39.6 mttt -102.41 140.83 36.18 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.314 -0.403 . . . . 74.44 110.508 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 77.1 t -119.81 100.69 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.871 -1.529 . . . . 73.33 106.871 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 6.6 ttp180 -69.51 111.31 5.27 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.326 -0.99 . . . . 71.22 108.326 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 78.4 p -60.28 157.65 32.74 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.645 -0.872 . . . . 72.53 108.645 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 36.2 Cg_endo -64.68 27.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.31 2.673 . . . . 72.52 114.504 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 29' ' ' SER . 12.3 t70 -130.52 -22.64 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.25 0.547 . . . . 63.12 110.615 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.63 -5.56 24.49 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.604 -0.808 . . . . 64.22 111.577 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.56 91.61 3.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.311 0.576 . . . . 44.21 109.538 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 28' ' ' ARG . 37.9 tt0 -101.27 110.69 22.74 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.513 -0.767 . . . . 70.41 110.123 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.35 134.52 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.961 -0.563 . . . . 73.02 109.641 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 31.1 p90 -77.1 120.18 21.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.264 0.554 . . . . 63.02 110.509 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -111.69 170.33 8.21 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.339 -1.356 . . . . 62.04 107.339 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 42.4 mtmt -139.75 168.14 20.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.761 -0.776 . . . . 64.22 111.7 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 54.0 mt -117.41 134.66 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 43.02 108.875 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -115.69 -68.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.349 -0.611 . . . . 65.1 109.349 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -84.02 152.6 24.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.334 -1.728 . . . . 73.4 106.334 166.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -59.04 101.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 118.903 0.774 . . . . 73.02 109.764 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.478 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -126.03 118.82 26.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.758 -0.656 . . . . 71.22 111.653 -174.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -28.1 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.612 -1.631 . . . . 62.32 113.821 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.937 ' HA ' HD12 ' A' ' 48' ' ' LEU . 48.6 mt -65.18 -18.06 65.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.008 -0.997 . . . . 72.43 110.06 173.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 49' ' ' MET . 41.7 mt-10 -59.41 -52.47 65.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.646 -0.706 . . . . 72.42 111.025 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.44 -30.42 70.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 62.41 110.297 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 45' ' ' LEU . 73.4 mt -60.55 -32.29 71.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.966 -0.561 . . . . 70.35 110.62 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 21.3 ptp -95.74 -29.85 14.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.885 -0.326 . . . . 63.31 110.917 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 48.5 mt-10 -66.47 -34.08 77.14 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.45 0.167 . . . . 64.22 111.45 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 47' ' ' LYS . 78.7 t -57.64 -39.25 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.062 0.458 . . . . 72.35 110.027 173.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -76.81 -31.46 56.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 70.14 111.342 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.987 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 61.5 m -54.58 -49.5 70.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.443 0.639 . . . . 62.33 110.729 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -73.92 -23.4 59.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.678 -0.692 . . . . 62.25 111.006 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 2.6 tpm_? -80.54 -33.44 36.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.405 -0.361 . . . . 74.42 110.828 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.07 -21.57 31.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 75.42 110.812 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 1.22 64.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.871 -0.68 . . . . 60.04 111.891 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 6.5 tp-100 -136.32 131.1 33.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.148 -0.686 . . . . 75.33 109.148 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.987 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.6 p -86.84 179.32 6.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.066 0.765 . . . . 31.2 113.066 -168.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.825 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.48 -16.42 61.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.266 1.21 . . . . 74.42 114.266 -164.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.57 -0.29 37.13 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.453 -0.779 . . . . 75.51 110.409 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.882 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -115.11 11.4 16.35 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.481 -0.781 . . . . 65.21 109.835 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 60' ' ' MET . 33.2 m -134.13 153.44 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.9 -0.591 . . . . 73.14 110.382 173.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.611 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.2 OUTLIER -113.32 112.46 23.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.212 -0.662 . . . . 70.22 109.212 175.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -85.67 116.41 23.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.287 0.565 . . . . 74.42 111.715 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.906 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -113.55 142.27 46.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 63.15 109.819 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -104.18 102.97 12.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.829 -0.168 . . . . 74.01 110.676 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 46.78 49.42 14.22 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.982 0.801 . . . . 75.51 111.557 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.13 -22.02 41.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.014 -0.612 . . . . 73.33 113.829 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.548 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 30.0 t70 -126.44 121.76 33.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.0 0.9 . . . . 72.13 111.638 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.906 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.33 143.38 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 73.24 111.74 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' HIS . 11.9 tt -135.33 -178.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.685 -0.689 . . . . 75.3 109.997 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' ILE . 98.1 m-70 -111.36 148.27 33.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.42 -0.585 . . . . 61.52 109.42 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -68.73 -16.96 70.66 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.287 0.475 . . . . 50.31 114.287 -171.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.67 -4.81 54.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.299 0.549 . . . . 72.23 111.386 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.95 -43.26 65.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.834 0.309 . . . . 71.25 111.834 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 28.1 p 67.68 148.11 0.11 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.74 1.216 . . . . 70.12 112.159 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.912 ' HD3' HD21 ' A' ' 45' ' ' LEU . 22.1 Cg_endo -61.57 -47.63 11.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.184 2.589 . . . . 73.22 113.618 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.98 -24.27 64.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.546 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -58.98 -39.95 83.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.938 -0.573 . . . . 74.25 110.81 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.65 -31.99 15.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.852 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.83 -19.91 13.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.685 -0.769 . . . . 62.2 111.798 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' A' ' 87' ' ' ASP . 10.1 tt -75.85 116.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.303 -0.999 . . . . 63.43 108.303 170.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.817 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 13.1 tt0 -131.2 -174.54 3.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.449 -0.341 . . . . 64.03 110.632 -168.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 26.0 t70 -4.71 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.768 1.627 . . . . 63.13 114.531 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.89 4.07 33.99 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.575 -0.739 . . . . 60.32 111.603 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.452 ' HB3' HG12 ' A' ' 83' ' ' ILE . 5.8 p-10 -79.56 167.15 21.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.745 0.307 . . . . 70.52 110.571 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 26' ' ' LYS . 20.5 m -137.32 153.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.561 0.696 . . . . 62.31 112.136 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 54.3 mt -129.68 127.63 64.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.868 -1.06 . . . . 71.31 108.439 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.18 136.7 39.68 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.439 -0.208 . . . . 54.3 110.439 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.49 117.71 34.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.018 0.437 . . . . 62.41 110.838 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 83.8 mtp -98.97 170.27 8.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 71.52 109.454 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -74.16 104.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.868 0.366 . . . . 75.1 111.203 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.882 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 90.8 mt-30 . . . . . 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 74.3 111.742 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.9 m170 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 121.185 0.517 . . . . 71.14 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 31.6 mm -116.01 164.28 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.453 -0.794 . . . . 44.31 108.918 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.631 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 88.0 mt-30 -151.59 116.25 5.13 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.712 0.805 . . . . 71.43 109.681 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 48' ' ' LEU . 10.3 m -113.17 -179.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.199 -0.667 . . . . 73.23 109.199 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 mtmt -144.83 114.43 7.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 74.44 110.776 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 89' ' ' ILE . 94.8 t -93.71 94.8 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 107.082 -1.451 . . . . 73.33 107.082 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 9.0 ttp180 -69.62 105.58 2.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.517 -1.29 . . . . 71.22 107.517 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.569 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 59.4 p -59.1 163.03 6.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 114.678 -1.147 . . . . 72.53 108.941 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 46.1 Cg_endo -67.21 28.14 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.824 2.35 . . . . 72.52 113.759 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 29' ' ' SER . 18.0 t70 -130.52 -23.82 2.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 63.12 110.65 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.12 -7.62 27.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.521 -0.847 . . . . 64.22 111.108 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 29' ' ' SER . . . -71.33 90.34 0.94 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.17 -0.678 . . . . 44.21 109.17 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 38.1 tt0 -99.57 102.21 13.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.1 -0.955 . . . . 70.41 109.657 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.11 129.98 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.886 -0.597 . . . . 73.02 109.999 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 27.8 p90 -71.41 122.58 20.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.432 0.634 . . . . 63.02 110.554 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HD2' HD23 ' A' ' 48' ' ' LEU . 3.5 t80 -120.53 128.74 53.38 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.618 -1.252 . . . . 62.04 107.618 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 24' ' ' GLN . 21.6 mtmt -105.3 162.67 13.23 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.383 -0.527 . . . . 64.22 110.951 -165.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 43.1 mt -115.27 134.64 57.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.867 -0.79 . . . . 43.02 108.867 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -93.47 -78.75 0.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.784 -0.45 . . . . 65.1 109.784 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 41' ' ' ARG . 48.8 mtt180 -97.59 169.71 9.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.118 -1.438 . . . . 73.4 107.118 164.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.548 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -54.85 101.59 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 73.02 110.532 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.8 116.03 23.02 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.23 -0.895 . . . . 71.22 109.755 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' LYS . 23.5 mtpp -36.37 134.19 0.46 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.575 -1.193 . . . . 62.32 111.985 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' HD3' ' A' ' 78' ' ' PRO . 91.7 mt -57.11 -20.28 24.62 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.958 -1.019 . . . . 72.43 113.276 -168.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 58.6 mt-10 -65.59 -24.69 67.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.111 0.412 . . . . 72.42 112.111 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -71.22 -28.98 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.752 -0.379 . . . . 62.41 110.483 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 25' ' ' VAL . 28.3 mt -59.25 -39.49 82.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.975 -0.557 . . . . 70.35 111.512 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -94.47 -23.82 17.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.84 -0.744 . . . . 63.31 111.307 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 45.9 mt-10 -73.27 -37.74 66.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.276 -0.57 . . . . 64.22 111.046 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 88.6 t -63.99 -25.08 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.525 0.679 . . . . 72.35 109.512 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -81.72 -34.76 30.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.277 -0.874 . . . . 70.14 110.338 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.01 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 79.7 m -53.75 -56.96 12.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.335 0.588 . . . . 62.33 111.155 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -68.69 -19.99 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.585 -0.734 . . . . 62.25 110.993 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -66.59 -46.51 75.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 74.42 111.354 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -98.7 -11.09 22.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.973 0.36 . . . . 75.42 111.973 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 29.82 8.22 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.5 -0.857 . . . . 60.04 113.498 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -150.55 129.04 12.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.823 -0.806 . . . . 75.33 108.823 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 1.01 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 24.2 p -92.43 178.25 5.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.995 0.739 . . . . 31.2 112.995 -168.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.494 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -76.21 -13.8 60.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.006 1.113 . . . . 74.42 114.006 -163.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 3.9 pm0 -80.07 -9.14 59.68 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.403 -0.811 . . . . 75.51 109.659 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.66 -22.35 12.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.617 -0.72 . . . . 65.21 109.965 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.7 m -128.51 101.26 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 166.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 14.0 tpt180 -83.77 149.53 26.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.747 -0.66 . . . . 70.22 111.395 -168.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' HD2' ' HE1' ' A' ' 67' ' ' TYR . 1.6 p90 -94.74 104.27 16.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.28 -0.873 . . . . 74.42 111.96 -175.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.798 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.5 mp -99.58 131.96 45.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.468 -0.787 . . . . 63.15 109.015 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HE1' ' HD2' ' A' ' 65' ' ' PHE . 47.7 m-85 -103.42 110.35 22.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.485 -0.486 . . . . 74.01 110.99 -175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t70 54.19 37.16 26.63 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.103 -0.953 . . . . 75.51 110.228 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -21.48 45.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.399 -0.819 . . . . 73.33 112.985 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -113.49 116.28 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.364 0.602 . . . . 72.13 110.846 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.798 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 23.6 ptt180 -72.61 118.21 15.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.381 -0.827 . . . . 73.24 112.344 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.93 -163.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.802 -0.814 . . . . 75.3 108.802 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -108.84 138.14 45.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.958 -0.297 . . . . 61.52 110.612 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.8 -10.56 64.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.1 -0.571 . . . . 50.31 112.273 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.15 -28.36 64.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 72.23 110.532 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 80' ' ' GLN . 15.4 t-20 -67.64 -17.7 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.647 -0.706 . . . . 71.25 111.062 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 66.6 p 60.18 156.72 0.1 Allowed Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.375 1.07 . . . . 70.12 113.18 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.924 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 59.2 Cg_endo -72.37 -43.43 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.544 2.163 . . . . 73.22 112.431 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.68 -28.12 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.684 . . . . 74.52 111.966 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' ASN . 53.8 tt0 -83.32 -34.65 25.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.268 -0.423 . . . . 74.25 111.547 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.5 tp -89.56 -28.31 19.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 73.11 110.659 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.24 -18.63 38.79 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.672 -0.775 . . . . 62.2 111.509 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.5 tt -89.87 120.99 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.45 -0.574 . . . . 63.43 109.45 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.924 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -155.83 -154.16 0.47 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 118.974 -0.536 . . . . 64.03 110.353 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 84' ' ' GLU . 19.9 t70 -21.82 109.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.718 1.261 . . . . 63.13 113.276 -167.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.4 -6.88 20.84 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.919 -1.037 . . . . 60.32 111.819 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.65 170.91 15.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 70.52 110.882 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.89 158.17 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.637 0.732 . . . . 62.31 111.413 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 27' ' ' VAL . 66.1 mt -128.59 125.92 64.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.98 -1.009 . . . . 71.31 108.724 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.09 126.23 44.79 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.772 -0.455 . . . . 54.3 109.772 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.665 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -87.96 117.93 27.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.144 0.497 . . . . 62.41 111.377 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.7 ttt -101.74 150.7 22.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.738 -0.665 . . . . 71.52 109.973 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.21 102.98 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.942 0.401 . . . . 75.1 110.505 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 38.8 mt-30 . . . . . 0 C--N 1.332 -0.161 0 CA-C-N 115.046 -0.979 . . . . 74.3 112.206 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 110.059 -0.348 . . . . 71.14 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.2 mm -110.75 163.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.014 -0.539 . . . . 44.31 109.63 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 23' ' ' ILE . 58.6 tt0 -137.0 125.46 23.49 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.531 -0.544 . . . . 71.43 109.531 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 48' ' ' LEU . 7.0 p -130.99 139.16 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.2 -0.454 . . . . 73.23 110.502 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.783 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -110.5 118.43 36.22 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.699 -0.4 . . . . 74.44 110.714 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.5 t -94.95 104.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.314 -1.365 . . . . 73.33 107.314 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 72.8 ttt-85 -69.64 110.23 4.74 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.983 -1.117 . . . . 71.22 107.983 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 62.3 p -60.22 159.77 20.48 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 115.322 -0.854 . . . . 72.53 108.714 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 27.3 Cg_endo -62.1 22.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 123.353 2.702 . . . . 72.52 115.021 -174.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 29' ' ' SER . 31.8 t70 -131.78 -24.07 2.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 63.12 110.9 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.05 2.55 20.22 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.44 -0.886 . . . . 64.22 112.114 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 88.47 7.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.186 -0.672 . . . . 44.21 109.186 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.783 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 11.1 tt0 -82.5 113.5 20.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.787 -0.642 . . . . 70.41 110.187 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.02 134.32 44.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.708 -0.479 . . . . 73.02 109.708 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -79.35 121.69 25.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.92 0.867 . . . . 63.02 111.543 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -116.92 174.35 6.14 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.485 -1.234 . . . . 62.04 107.805 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -136.26 153.48 51.18 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.97 -0.456 . . . . 64.22 111.174 -167.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 55.1 mt -114.99 134.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.729 -0.841 . . . . 43.02 108.729 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -127.83 -58.52 1.23 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.912 0.387 . . . . 65.1 110.793 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -95.54 177.8 5.69 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.16 -1.052 . . . . 73.4 108.16 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.98 100.71 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.136 0.969 . . . . 73.02 109.073 172.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -138.95 102.17 4.48 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.307 -0.86 . . . . 71.22 110.606 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.74 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.4 pttp -68.56 -176.63 0.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.205 -0.907 . . . . 62.32 111.212 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 60.6 mt -55.67 -27.13 48.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 72.43 111.988 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 39.8 mt-10 -57.92 -35.48 71.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.01 0.434 . . . . 72.42 111.4 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 51' ' ' VAL . 46.3 tptt -69.9 -52.48 24.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 62.41 110.287 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 25' ' ' VAL . 26.8 mt -62.65 -28.36 69.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 70.35 111.32 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.61 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 14.2 ptm -85.59 -37.45 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 63.31 111.011 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 35.8 mm-40 -71.31 -30.43 66.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.829 0.307 . . . . 64.22 111.829 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 47' ' ' LYS . 87.8 t -62.98 -37.78 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.142 0.496 . . . . 72.35 109.706 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 55' ' ' ARG . 35.3 m-85 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.027 -0.533 . . . . 70.14 111.169 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 86.0 m -54.35 -48.59 71.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.315 0.579 . . . . 62.33 109.83 170.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.27 -40.52 67.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 62.25 110.833 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' A' ' 52' ' ' TYR . 55.1 ttt180 -65.79 -45.54 82.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.42 111.683 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.24 -13.79 42.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.685 0.278 . . . . 75.42 111.316 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.79 10.86 83.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.665 -0.779 . . . . 60.04 111.893 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 5.3 tp-100 -133.61 130.33 38.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.996 -0.742 . . . . 75.33 108.996 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 32.6 p -83.09 163.48 20.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.333 0.587 . . . . 31.2 112.263 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -15.69 63.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.245 -0.889 . . . . 74.42 112.328 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -87.02 -4.29 59.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 75.51 110.476 177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -115.81 -25.94 7.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.593 -0.73 . . . . 65.21 109.455 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.488 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 11.5 m -125.78 117.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.637 -0.71 . . . . 73.14 109.639 168.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -88.1 139.74 30.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.583 -0.525 . . . . 70.22 109.583 -174.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.565 ' HB3' ' CG2' ' A' ' 89' ' ' ILE . 60.9 m-85 -101.38 119.01 38.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.913 -0.585 . . . . 74.42 111.353 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.893 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.2 mp -99.34 127.1 45.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.193 -0.912 . . . . 63.15 108.784 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HE1' HG21 ' A' ' 83' ' ' ILE . 1.6 p90 -101.65 124.79 47.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.207 -0.997 . . . . 74.01 110.234 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.34 29.75 13.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.848 -1.069 . . . . 75.51 110.264 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.66 0.29 64.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.681 -0.69 . . . . 73.33 113.241 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.29 116.37 19.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.506 0.653 . . . . 72.13 111.368 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.893 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 22.6 ptt180 -66.68 137.81 56.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.286 -0.87 . . . . 73.24 112.408 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 73' ' ' HIS . 11.0 tp -162.63 164.86 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 75.3 109.741 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' N ' HG13 ' A' ' 72' ' ' ILE . 1.4 p-80 -70.39 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 61.52 110.919 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -65.76 -23.82 70.97 Favored Glycine 0 CA--C 1.518 0.242 0 CA-C-N 116.131 -0.486 . . . . 50.31 113.896 -171.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 7.0 p-10 -77.77 3.84 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.763 0.281 . . . . 72.23 111.501 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -67.39 -39.1 85.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.453 -0.203 . . . . 71.25 110.453 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 44' ' ' LYS . 49.9 p 62.41 143.0 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.596 1.158 . . . . 70.12 112.597 -178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.85 -42.22 15.64 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.049 2.499 . . . . 73.22 112.56 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.84 -14.76 55.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 74.52 111.802 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -59.9 -38.4 82.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 74.25 110.837 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB3' HG22 ' A' ' 83' ' ' ILE . 45.4 tp -104.85 -30.01 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 73.11 110.886 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.08 -19.32 13.62 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.774 -0.931 . . . . 62.2 110.774 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 81' ' ' LEU . 5.4 tt -66.48 112.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.719 -0.845 . . . . 63.43 108.719 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 15.8 tt0 -134.07 -152.8 0.49 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.751 -0.658 . . . . 64.03 109.864 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 33.1 t70 -30.57 112.9 0.09 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.254 0.971 . . . . 63.13 113.032 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.04 4.94 22.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.924 -0.58 . . . . 60.32 111.679 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -78.93 170.51 16.57 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.992 0.425 . . . . 70.52 111.094 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 13.7 m -138.27 154.83 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.31 111.013 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 36.4 mt -136.66 114.99 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.637 -0.71 . . . . 71.31 109.101 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.406 ' CG ' HH11 ' A' ' 28' ' ' ARG . 48.2 t0 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.446 -0.343 . . . . 54.3 110.372 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.2 131.69 53.15 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.148 0.425 . . . . 62.41 112.148 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.4 mpt? -126.21 163.28 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.449 -0.575 . . . . 71.52 109.449 173.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.53 95.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.564 0.221 . . . . 75.1 111.465 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 28.4 mt-30 . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 123.495 0.718 . . . . 74.3 112.113 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 30.7 m80 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 110.311 -0.255 . . . . 71.14 110.311 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 30.1 mt -108.93 159.39 8.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.983 0.42 . . . . 44.31 110.808 -169.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 26.0 mp0 -146.11 126.12 13.68 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.985 0.914 . . . . 71.43 109.238 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.39 144.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.741 -0.466 . . . . 73.23 109.741 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 1.002 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.51 115.9 31.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.977 0.418 . . . . 74.44 111.302 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 89' ' ' ILE . 47.0 t -99.93 101.99 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.92 -1.141 . . . . 73.33 107.92 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 2.1 ttp180 -69.91 111.16 5.43 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 107.893 -1.151 . . . . 71.22 107.893 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.646 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 93.1 p -62.47 165.66 8.69 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.696 -0.801 . . . . 72.53 108.871 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.646 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 43.7 Cg_endo -66.65 20.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 122.66 2.24 . . . . 72.52 113.909 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 29' ' ' SER . 36.0 t70 -131.26 -11.77 3.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.205 0.526 . . . . 63.12 110.892 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.52 -0.16 43.08 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.193 -1.003 . . . . 64.22 111.976 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 97.6 6.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.353 -0.61 . . . . 44.21 109.353 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 48.5 tt0 -115.98 97.45 6.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.882 -0.599 . . . . 70.41 110.29 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.6 t -102.97 145.0 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.444 -0.947 . . . . 73.02 108.444 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 1.002 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.3 p90 -67.3 123.54 20.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 63.02 110.231 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -110.52 170.11 8.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.943 -1.132 . . . . 62.04 107.943 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 34.8 mttt -140.71 165.87 26.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.46 0.573 . . . . 64.22 111.402 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 69.4 mt -122.68 135.21 63.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 43.02 108.877 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -117.44 -77.73 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.312 . . . . 65.1 110.969 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 42' ' ' LYS . 4.9 tpt180 -76.95 177.47 7.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.257 -1.016 . . . . 73.4 108.257 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 5.9 ttpm? -62.47 99.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.052 -1.092 . . . . 73.02 108.052 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 2.8 p -135.17 106.55 6.8 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.666 -0.697 . . . . 71.22 110.845 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 45.0 mttm -51.49 170.45 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.483 -1.235 . . . . 62.32 111.154 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 47.6 mt -62.61 -10.95 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.595 . . . . 72.43 110.487 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 5.3 mm-40 -53.94 -57.22 11.78 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.631 -0.713 . . . . 72.42 111.361 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG2' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.62 -23.92 63.57 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.427 . . . . 62.41 110.877 -175.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.7 mt -63.32 -35.3 79.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 70.35 110.558 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.5 ptt? -89.31 -33.91 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 63.31 110.564 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 9.2 mm-40 -66.48 -32.87 74.5 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.982 0.364 . . . . 64.22 111.982 -176.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' LYS . 93.2 t -60.89 -34.94 61.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.502 -0.479 . . . . 72.35 110.124 174.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -73.44 -44.47 58.14 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.873 -0.331 . . . . 70.14 110.315 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 61.7 m -48.1 -44.52 31.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.334 0.588 . . . . 62.33 110.409 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -64.62 -56.2 15.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.226 -0.897 . . . . 62.25 110.724 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -68.58 -42.96 77.5 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.494 0.553 . . . . 74.42 112.494 -171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.87 -20.32 53.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.721 -0.218 . . . . 75.42 111.01 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.5 19.28 74.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.686 -0.768 . . . . 60.04 111.254 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 35.1 tt0 -142.72 130.05 21.06 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.522 -0.918 . . . . 75.33 108.522 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.3 p -84.35 167.28 16.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 31.2 111.749 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.34 -15.15 59.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.475 -0.784 . . . . 74.42 112.39 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 12.5 pt-20 -59.28 -23.78 62.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.617 0.246 . . . . 75.51 110.489 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 1.045 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -105.74 -12.82 15.75 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.977 -0.556 . . . . 65.21 111.085 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.4 m -144.24 103.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 73.14 110.635 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -95.77 145.7 25.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.726 -0.39 . . . . 70.22 110.655 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.679 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 26.5 p90 -95.21 133.08 39.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 74.42 111.774 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.108 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -115.9 114.05 24.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 63.15 109.987 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -103.76 138.8 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.013 -0.675 . . . . 74.01 110.423 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 t70 54.53 22.89 4.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.822 0.82 . . . . 75.51 109.977 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.53 -18.73 56.54 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.652 -0.704 . . . . 73.33 113.367 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -118.16 120.66 38.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.742 0.771 . . . . 72.13 111.739 -176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 1.108 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -69.19 142.89 54.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.723 -0.672 . . . . 73.24 111.685 176.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 76' ' ' ASN . 37.6 pt -142.55 -163.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.151 -0.685 . . . . 75.3 109.151 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -98.21 140.35 32.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.009 -0.737 . . . . 61.52 109.009 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.885 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -60.33 -23.62 60.31 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.161 -0.542 . . . . 50.31 113.482 -172.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 23.8 t70 -63.06 -23.39 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.393 0.516 . . . . 72.23 112.393 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.682 ' HB3' HD12 ' A' ' 72' ' ' ILE . 64.1 t30 -74.13 -19.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.841 -0.344 . . . . 71.25 111.205 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 44' ' ' LYS . 7.7 p 59.15 151.79 0.08 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.063 1.135 . . . . 70.12 114.063 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 -32.76 23.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.821 2.347 . . . . 73.22 113.492 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.615 ' OE1' ' HB ' ' A' ' 77' ' ' THR . 4.3 pm0 -63.15 -14.85 53.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.674 0.273 . . . . 74.52 111.543 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -68.62 -30.93 69.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.301 -0.409 . . . . 74.25 111.006 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.18 -30.35 16.72 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.368 -0.533 . . . . 73.11 111.388 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 -18.99 32.52 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.472 -1.051 . . . . 62.2 110.472 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.506 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -84.47 148.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.95 -1.13 . . . . 63.43 107.95 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.7 tt0 -155.07 -149.19 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.817 -1.179 . . . . 64.03 107.817 -176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 5.2 p-10 -36.49 114.53 0.3 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.854 0.835 . . . . 63.13 112.194 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.45 -5.71 14.77 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.462 -0.79 . . . . 60.32 111.853 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.8 t0 -80.63 161.71 24.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.782 0.325 . . . . 70.52 110.38 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.09 154.8 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.356 0.598 . . . . 62.31 110.51 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 65' ' ' PHE . 59.5 mt -131.72 126.37 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.408 -0.814 . . . . 71.31 109.471 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.98 134.35 43.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.554 0.216 . . . . 54.3 110.855 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -99.69 119.06 37.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.05 0.452 . . . . 62.41 110.622 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 65.4 mtt -103.32 152.25 21.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 71.52 110.016 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.32 95.89 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.861 0.362 . . . . 75.1 110.288 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 1.045 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 44.7 mt-30 . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 115.334 -0.848 . . . . 74.3 110.852 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.101 -0.703 . . . . 55.35 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.67 104.87 2.03 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.753 -0.658 . . . . 72.34 114.004 -167.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -95.44 140.92 29.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.779 -0.822 . . . . 64.1 108.779 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.09 -26.81 33.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 73.11 111.209 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -58.96 -42.72 90.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 72.02 111.639 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 t -74.12 -10.95 60.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.578 -0.283 . . . . 75.43 111.557 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.41 15.04 6.63 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.942 -0.303 . . . . 62.41 111.659 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.62 -14.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.616 0.246 . . . . 74.32 111.61 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' A' ' 10' ' ' ASN . 62.7 t30 64.61 -163.65 0.26 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.249 -0.649 . . . . 75.34 109.249 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.533 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 46.1 m-80 67.81 24.11 8.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.126 0.489 . . . . 71.34 110.512 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -74.75 156.97 36.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 73.31 110.439 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.12 166.68 10.86 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.962 -0.637 . . . . 60.41 111.715 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 m -130.37 102.44 6.18 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.14 0.495 . . . . 73.34 110.525 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.404 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -80.83 159.39 68.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.78 -0.645 . . . . 63.33 109.753 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 14' ' ' SER . 60.2 Cg_endo -72.98 46.27 1.06 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 72.24 112.627 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 70.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 122.184 0.992 . . . . 73.43 109.959 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -172.39 138.38 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.812 -1.085 . . . . 70.0 109.372 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -114.11 157.17 22.95 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.428 -0.582 . . . . 63.4 109.428 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.8 -40.45 97.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.724 0.297 . . . . 74.43 111.565 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.1 21.23 28.84 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 65.4 113.005 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.11 -30.64 62.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.474 0.654 . . . . 73.1 109.925 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 38.9 m80 -90.6 -169.85 2.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.24 -0.891 . . . . 71.14 110.4 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 25.8 mm -109.4 158.18 9.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.913 -0.402 . . . . 44.31 109.913 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -144.43 134.67 24.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.585 -0.524 . . . . 71.43 109.585 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 48' ' ' LEU . 5.0 p -142.63 140.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 123.658 0.599 . . . . 73.23 109.646 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . 23.4 mtmt -110.41 118.86 37.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.244 0.545 . . . . 74.44 111.182 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.768 HG22 ' HB ' ' A' ' 89' ' ' ILE . 88.6 t -94.46 97.68 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 105.999 -1.852 . . . . 73.33 105.999 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 32.7 ttt-85 -67.76 106.13 2.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.189 -1.041 . . . . 71.22 108.189 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 p -58.46 124.54 72.18 Favored Pre-proline 0 N--CA 1.422 -1.863 0 N-CA-C 107.111 -1.44 . . . . 72.53 107.111 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 90.5 Cg_endo -71.43 38.49 0.34 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.357 2.704 . . . . 72.52 114.217 -162.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -131.13 15.63 5.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.3 0.572 . . . . 63.12 111.326 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.5 24.93 19.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.362 -0.923 . . . . 64.22 111.844 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.34 161.57 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.433 -0.58 . . . . 44.21 109.433 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 38.2 tt0 -151.12 115.35 5.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.87 -0.418 . . . . 70.41 109.87 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.34 128.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.771 -0.455 . . . . 73.02 109.771 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 24.5 p90 -72.25 119.85 17.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.698 0.761 . . . . 63.02 110.845 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -111.29 166.35 11.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.873 -1.058 . . . . 62.04 108.421 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -144.98 146.13 31.81 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.403 -0.519 . . . . 64.22 111.224 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 56.9 mt -115.13 134.89 56.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.507 -0.923 . . . . 43.02 108.507 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -109.0 -65.03 1.18 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.556 -0.457 . . . . 65.1 110.978 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -91.45 -177.79 4.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.192 -1.04 . . . . 73.4 108.192 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.546 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.95 101.26 0.37 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.776 0.798 . . . . 73.02 109.25 172.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.28 6.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.644 -0.707 . . . . 71.22 110.269 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 14.1 ptpt -58.99 -179.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.231 -0.895 . . . . 62.32 112.075 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 37.3 mt -67.34 -10.48 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 72.43 112.376 -169.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' ' HG2' ' A' ' 49' ' ' MET . 70.2 mt-10 -57.5 -53.79 54.22 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.835 0.309 . . . . 72.42 111.835 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -30.09 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.341 -0.543 . . . . 62.41 110.913 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 39' ' ' ILE . 95.2 mt -60.27 -36.86 78.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.943 0.401 . . . . 70.35 110.392 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.6 ptt? -85.78 -34.01 21.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.019 -0.537 . . . . 63.31 111.176 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 42.0 mt-10 -74.61 -39.65 62.04 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.817 0.303 . . . . 64.22 111.817 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.87 -29.37 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.152 -0.684 . . . . 72.35 109.152 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.94 -43.58 57.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.78 . . . . 70.14 109.999 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 84.5 m -50.11 -52.05 38.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.382 0.611 . . . . 62.33 110.699 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -27.34 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.834 . . . . 62.25 110.723 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -71.44 -41.57 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.453 -0.34 . . . . 74.42 111.586 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.38 -6.4 34.19 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.898 -0.321 . . . . 75.42 111.4 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.51 59.3 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.513 -0.851 . . . . 60.04 111.775 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.7 tt0 -150.83 129.73 12.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.592 -0.892 . . . . 75.33 108.592 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.0 p -87.9 178.23 6.75 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.834 0.679 . . . . 31.2 112.834 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -74.48 -16.16 60.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.982 1.104 . . . . 74.42 113.982 -164.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.02 -13.67 60.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.884 -0.726 . . . . 75.51 109.957 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.667 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.02 2.98 23.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.532 -0.758 . . . . 65.21 110.336 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.718 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 7.0 m -139.63 103.34 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.386 0.613 . . . . 73.14 110.73 171.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.673 ' HD2' HD11 ' A' ' 66' ' ' LEU . 25.8 ttm180 -69.24 112.05 5.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.759 -0.655 . . . . 70.22 109.616 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.76 109.95 21.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.551 0.691 . . . . 74.42 111.64 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 5.2 mp -106.21 130.94 53.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.333 -0.849 . . . . 63.15 109.481 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HE2' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -127.62 143.47 51.16 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.206 -0.998 . . . . 74.01 110.618 176.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB2' HG21 ' A' ' 83' ' ' ILE . 35.2 t70 59.67 21.9 10.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.921 0.867 . . . . 75.51 109.764 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.84 -17.49 58.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.543 -0.753 . . . . 73.33 113.237 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -122.72 125.78 46.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.15 0.475 . . . . 72.13 111.609 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.846 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -65.28 151.45 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 73.24 110.901 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG12 ' H ' ' A' ' 73' ' ' HIS . 12.5 tt -170.81 -173.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.942 -0.762 . . . . 75.3 108.942 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.623 ' H ' HG12 ' A' ' 72' ' ' ILE . 94.1 m-70 -86.01 149.23 25.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.254 0.479 . . . . 61.52 110.435 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.748 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -67.94 -20.9 73.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.632 -0.794 . . . . 50.31 112.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.921 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 4.6 p-10 -78.78 -4.66 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.599 0.222 . . . . 72.23 111.599 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -23.45 61.98 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.854 -0.157 . . . . 71.25 111.293 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.905 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.1 p 66.28 159.15 0.13 Allowed Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 70.12 111.788 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.43 -60.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 73.22 113.432 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -63.57 -19.07 64.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.901 0.334 . . . . 74.52 111.901 -170.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -63.24 -25.5 68.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.035 0.445 . . . . 74.25 110.811 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.42 -29.16 17.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.109 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.79 -18.87 8.52 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.842 -0.694 . . . . 62.2 111.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 87' ' ' ASP . 15.4 tt -101.92 136.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.999 -0.371 . . . . 63.43 109.999 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 26.5 tt0 -148.39 -153.32 0.48 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.942 -0.762 . . . . 64.03 108.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.789 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.3 p-10 -20.94 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.651 1.18 . . . . 63.13 113.792 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.5 5.16 30.06 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.993 -0.843 . . . . 60.32 110.993 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 83' ' ' ILE . 11.3 p-10 -85.79 173.09 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.151 -0.525 . . . . 70.52 110.915 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.32 158.59 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 62.31 111.137 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 27' ' ' VAL . 69.6 mt -134.64 138.46 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.649 -0.871 . . . . 71.31 108.649 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.51 126.42 51.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.433 -0.58 . . . . 54.3 109.433 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.718 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -111.89 116.8 31.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.695 -0.402 . . . . 62.41 110.388 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 62.6 mtt -101.26 168.82 9.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.109 -0.496 . . . . 71.52 110.114 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.24 101.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 75.1 111.311 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.667 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 43.4 mt-30 64.52 173.73 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 74.3 112.23 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -72.81 -40.07 66.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.2 111.941 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.32 9.83 27.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.195 0.522 . . . . 61.12 110.806 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.35 -13.71 61.25 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 53.25 111.289 -175.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 110.417 -1.073 . . . . 31.3 110.417 179.384 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.045 -0.354 . . . . 55.35 110.045 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.47 126.04 2.13 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.929 -0.653 . . . . 72.34 111.641 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.73 145.21 27.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.215 0.531 . . . . 64.1 111.011 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.44 -17.21 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.529 -0.76 . . . . 73.11 110.827 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.04 -24.13 51.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.549 -0.75 . . . . 72.02 112.876 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -56.21 -26.08 49.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.861 0.319 . . . . 75.43 111.861 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.88 78.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.236 -0.438 . . . . 62.41 111.695 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.44 -20.99 5.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.097 0.475 . . . . 74.32 110.391 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -64.37 -28.61 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 75.34 111.999 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -76.4 112.05 12.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.598 0.714 . . . . 71.34 111.306 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.33 89.12 3.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 73.31 110.49 174.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.75 75.79 2.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.874 -0.679 . . . . 60.41 112.136 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -99.4 -174.21 2.68 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -142.13 67.14 21.45 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.895 0.378 . . . . 63.33 111.458 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.674 ' HD2' ' HG2' ' A' ' 80' ' ' GLN . 3.6 Cg_exo -81.57 -62.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.796 2.331 . . . . 72.24 111.623 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.477 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . 21.8 t 57.87 74.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.499 -0.773 . . . . 73.43 111.521 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.457 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 53.5 t30 -84.65 69.91 10.7 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.697 -0.683 . . . . 70.0 109.518 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.75 101.33 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.57 -0.741 . . . . 63.4 110.462 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -112.06 -0.8 15.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.748 -0.66 . . . . 74.43 109.897 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.28 24.07 38.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.781 -0.723 . . . . 65.4 111.709 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.82 151.32 35.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 73.1 110.348 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -94.72 129.3 41.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.086 -0.506 . . . . 71.14 110.151 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 17.8 mt -110.59 166.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.402 -0.592 . . . . 44.31 109.402 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 60.9 tt0 -148.49 139.75 23.32 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.771 -0.455 . . . . 71.43 109.771 -174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 48' ' ' LEU . 29.0 m -140.82 172.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.077 0.465 . . . . 73.23 110.741 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 3.7 mtmt -141.71 115.42 9.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 74.44 109.487 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 89' ' ' ILE . 52.3 t -95.19 95.08 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.589 -1.634 . . . . 73.33 106.589 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -68.49 103.57 1.7 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.996 -1.483 . . . . 71.22 106.996 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 31' ' ' ASP . 67.6 m -62.86 158.38 53.35 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 113.498 -1.683 . . . . 72.53 109.03 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 35.9 Cg_endo -64.8 36.2 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.666 2.911 . . . . 72.52 114.051 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 29' ' ' SER . 30.7 t70 -131.75 -14.9 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.46 0.647 . . . . 63.12 110.282 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.85 -3.57 52.64 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.227 -0.749 . . . . 64.22 111.227 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.01 118.16 23.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.364 -0.418 . . . . 44.21 110.014 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 23.4 tt0 -116.04 101.43 8.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.396 -0.594 . . . . 70.41 109.396 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.564 ' HB ' ' OH ' ' A' ' 52' ' ' TYR . 44.3 t -102.75 135.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.801 -0.444 . . . . 73.02 109.801 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.2 p90 -71.25 132.04 44.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.578 0.704 . . . . 63.02 111.358 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -126.72 162.8 24.95 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.657 -1.238 . . . . 62.04 107.657 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -136.99 157.15 47.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.845 0.831 . . . . 64.22 112.712 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -119.68 136.1 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 43.02 108.11 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -111.75 -28.14 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.838 -0.745 . . . . 65.1 111.834 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 35.4 ttm180 -145.78 -177.6 5.67 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.055 -1.461 . . . . 73.4 107.055 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 20.5 pttp -60.57 99.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.527 -0.869 . . . . 73.02 110.0 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' HG23 ' A' ' 39' ' ' ILE . 74.0 p -129.38 114.46 16.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.77 -1.104 . . . . 71.22 108.893 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HA ' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -49.27 153.75 0.96 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 62.32 111.688 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.809 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 36.1 mt -63.0 -12.57 26.75 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.29 -0.868 . . . . 72.43 111.76 -173.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' OE1' ' HG3' ' A' ' 44' ' ' LYS . 54.5 mt-10 -57.36 -44.43 84.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 72.42 111.345 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -30.43 68.05 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.561 -0.456 . . . . 62.41 110.582 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 39' ' ' ILE . 98.0 mt -61.55 -33.06 73.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 70.35 110.356 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -98.3 -28.98 13.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 63.31 112.029 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.72 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 46.4 mt-10 -78.01 -33.73 51.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.478 -0.489 . . . . 64.22 111.257 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.14 -31.89 55.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.021 -0.733 . . . . 72.35 109.021 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.564 ' OH ' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -71.22 -31.91 68.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 70.14 111.151 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 66.3 m -50.28 -47.09 55.53 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 62.33 110.63 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.88 -31.99 51.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.02 -0.537 . . . . 62.25 110.728 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -68.57 -40.28 80.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 74.42 110.617 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.15 -21.71 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.415 -0.357 . . . . 75.42 111.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.08 -2.65 69.1 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.768 -0.729 . . . . 60.04 112.163 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 7.5 tp-100 -124.49 129.79 51.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.106 -0.702 . . . . 75.33 109.106 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.738 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.0 p -81.25 178.65 8.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 31.2 112.366 -174.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.676 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -76.64 -16.12 59.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.665 1.357 . . . . 74.42 114.665 -162.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -74.28 -9.88 59.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 75.51 110.363 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -109.38 10.62 25.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.765 -0.652 . . . . 65.21 110.268 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.889 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 18.0 m -139.38 121.74 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.59 . . . . 73.14 111.465 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 20.3 tpp180 -85.56 113.81 22.09 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.616 -0.513 . . . . 70.22 109.616 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -83.43 118.07 23.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.487 -0.779 . . . . 74.42 112.376 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 10.2 mp -110.42 129.38 55.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.618 -0.719 . . . . 63.15 109.863 172.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.497 ' HD2' ' HB ' ' A' ' 72' ' ' ILE . 62.4 m-85 -106.89 129.87 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.439 -0.208 . . . . 74.01 110.439 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.76 23.34 9.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.999 0.904 . . . . 75.51 109.77 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.03 -0.28 78.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.458 -0.792 . . . . 73.33 112.567 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 37.3 t0 -127.15 122.91 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.578 0.704 . . . . 72.13 111.14 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -59.61 110.6 1.17 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.125 -0.943 . . . . 73.24 112.37 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' H ' ' A' ' 73' ' ' HIS . 11.2 mm -125.68 -167.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.171 -1.418 . . . . 75.3 107.171 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.865 ' H ' HG22 ' A' ' 72' ' ' ILE . 3.6 p80 -116.41 149.25 39.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.205 0.457 . . . . 61.52 110.091 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.809 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -64.54 -34.47 89.98 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.705 -0.68 . . . . 50.31 114.295 -168.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.95 -12.12 52.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.853 0.327 . . . . 72.23 111.584 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.645 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 3.5 t30 -70.87 -25.7 62.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.04 -0.356 . . . . 71.25 110.04 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' HA ' ' A' ' 44' ' ' LYS . 44.8 p 61.16 153.74 0.11 Allowed Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.639 1.176 . . . . 70.12 112.627 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 30.8 Cg_endo -64.91 -46.79 5.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.462 2.108 . . . . 73.22 111.833 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 15.5 tp10 -46.17 -43.35 15.05 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.328 -0.851 . . . . 74.52 111.728 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.674 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 47.8 mt-30 -88.55 -15.7 34.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.25 111.704 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.7 -30.66 18.94 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.0 -0.28 . . . . 73.11 111.351 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.28 -18.93 25.18 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.315 -0.945 . . . . 62.2 110.916 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.3 tp -93.01 144.16 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.136 -1.061 . . . . 63.43 108.136 170.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CG ' ' H ' ' A' ' 85' ' ' ASP . 1.7 tt0 -141.09 -152.22 0.4 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.325 -0.62 . . . . 64.03 109.325 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 24' ' ' GLN . 7.2 t70 -45.99 118.41 1.86 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.06 0.457 . . . . 63.13 112.021 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.93 3.51 17.81 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.434 -0.803 . . . . 60.32 111.664 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.479 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.1 t0 -73.97 158.48 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 70.52 111.19 -175.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 32.7 m -129.96 147.28 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.815 -0.629 . . . . 62.31 110.357 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.4 mt -119.57 119.27 59.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.632 -0.713 . . . . 71.31 109.288 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -102.86 126.96 50.21 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.677 -0.49 . . . . 54.3 109.677 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.87 117.82 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.939 0.4 . . . . 62.41 111.786 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 1.8 mpt? -90.91 170.13 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 71.52 110.476 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.98 109.6 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 75.1 111.299 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.637 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 48.9 mt-30 61.97 -177.53 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.017 -0.992 . . . . 74.3 111.515 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.84 4.32 8.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.166 -0.47 . . . . 74.2 111.756 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 m 63.34 78.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.605 0.717 . . . . 61.12 110.193 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.3 -23.5 0.12 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.129 -0.941 . . . . 53.25 111.345 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.805 -0.997 . . . . 31.3 111.758 176.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.644 0.259 . . . . 55.35 110.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.45 -159.89 48.83 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.626 -0.797 . . . . 72.34 111.186 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -160.8 -159.33 0.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.988 -0.745 . . . . 64.1 108.988 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -79.02 -29.69 43.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.968 0.413 . . . . 73.11 110.598 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -69.49 -27.86 65.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 72.02 111.278 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.2 p -76.89 -10.71 59.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.542 -0.299 . . . . 75.43 111.775 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.46 11.81 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 62.41 111.621 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.56 -19.89 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.865 0.364 . . . . 74.32 111.315 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -90.65 24.08 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.046 0.451 . . . . 75.34 110.237 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.6 -58.99 5.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.138 -0.483 . . . . 71.34 111.106 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -157.19 77.51 0.87 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 73.31 110.571 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.67 -141.46 47.52 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.715 -0.675 . . . . 60.41 113.013 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -155.63 25.93 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.826 -0.435 . . . . 73.34 109.826 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t 71.94 102.59 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 115.061 -0.972 . . . . 63.33 110.497 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.36 23.3 0.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.071 2.514 . . . . 72.24 113.034 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.64 -8.28 10.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 73.43 109.64 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -78.53 89.95 4.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.356 -0.838 . . . . 70.0 110.924 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -117.23 75.97 1.01 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.589 0.709 . . . . 63.4 109.809 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -127.54 19.14 6.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.319 -0.855 . . . . 74.43 108.71 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.81 74.48 1.35 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.065 -0.971 . . . . 65.4 113.439 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.87 -31.33 66.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 73.1 108.602 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -129.5 158.79 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.915 -1.039 . . . . 71.14 109.805 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.5 mt -109.98 166.96 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.715 -0.846 . . . . 44.31 108.715 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.441 ' N ' HG22 ' A' ' 23' ' ' ILE . 41.6 tt0 -144.24 138.26 27.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.232 -0.284 . . . . 71.43 110.232 -173.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 48' ' ' LEU . 14.7 p -150.79 140.97 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.983 -0.553 . . . . 73.23 110.005 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.791 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 2.4 mtmp? -102.0 123.24 45.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.782 -0.451 . . . . 74.44 109.782 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.4 t -101.33 95.26 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 105.472 -2.047 . . . . 73.33 105.472 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 21.1 ttt180 -68.3 105.07 2.02 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 114.819 -1.082 . . . . 71.22 108.386 -172.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 68.5 m -63.38 139.39 97.57 Favored Pre-proline 0 N--CA 1.418 -2.037 0 N-CA-C 107.424 -1.325 . . . . 72.53 107.424 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.23 33.48 0.16 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.542 2.828 . . . . 72.52 114.643 -166.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -131.36 3.46 4.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.617 0.722 . . . . 63.12 109.567 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.26 16.52 53.25 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.885 -0.886 . . . . 64.22 110.885 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 29' ' ' SER . . . -99.44 74.91 1.93 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.618 . . . . 44.21 109.805 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.791 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 27.7 tt0 -87.44 102.67 14.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.843 -0.617 . . . . 70.41 109.822 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.36 136.34 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.976 -0.556 . . . . 73.02 109.71 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -80.47 121.68 26.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.464 0.65 . . . . 63.02 111.192 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.97 165.21 13.12 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.301 -1.37 . . . . 62.04 107.301 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -138.72 168.57 19.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.666 -0.814 . . . . 64.22 112.23 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 58.0 mt -114.2 134.93 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.662 -1.154 . . . . 43.02 109.369 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.92 -81.91 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.003 0.43 . . . . 65.1 109.992 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 59.6 ttt180 -101.97 -177.18 3.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.123 -1.436 . . . . 73.4 107.123 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 47.3 pttt -53.09 102.01 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.465 0.65 . . . . 73.02 111.42 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 39' ' ' ILE . 1.6 p -142.47 107.47 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 71.22 110.626 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 37.6 pttt -51.6 175.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.158 -0.928 . . . . 62.32 113.493 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 48' ' ' LEU . 44.7 mt -66.43 -21.69 66.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.657 -1.156 . . . . 72.43 113.03 -169.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.53 ' HA ' ' CE ' ' A' ' 49' ' ' MET . 34.0 mt-10 -58.5 -33.49 69.87 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.569 0.581 . . . . 72.42 112.569 -171.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -23.39 32.59 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.351 -0.54 . . . . 62.41 110.837 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.759 HD13 HG11 ' A' ' 25' ' ' VAL . 73.0 mt -64.84 -35.34 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.361 . . . . 70.35 111.456 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.3 -39.37 14.43 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.497 -0.881 . . . . 63.31 111.268 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' N ' ' HG2' ' A' ' 49' ' ' MET . 12.4 mm-40 -68.95 -37.96 79.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.431 0.53 . . . . 64.22 112.431 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 55' ' ' ARG . 69.8 t -60.48 -31.45 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.268 -0.573 . . . . 72.35 109.664 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.49 ' HD2' HD23 ' A' ' 56' ' ' LEU . 8.3 t80 -83.01 -29.84 28.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.149 -0.478 . . . . 70.14 110.13 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.031 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 73.6 m -58.34 -37.25 74.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.296 0.569 . . . . 62.33 110.758 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.17 -32.78 74.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 62.25 110.825 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 51' ' ' VAL . 9.4 mpt_? -73.25 -50.55 21.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 74.42 111.496 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 52' ' ' TYR . 2.9 pp -76.01 -20.99 57.37 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.713 -0.221 . . . . 75.42 111.583 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.83 13.24 37.9 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.755 -0.735 . . . . 60.04 113.527 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -150.3 130.12 13.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.083 -0.71 . . . . 75.33 109.083 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 1.031 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.2 p -78.37 167.13 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.447 0.641 . . . . 31.2 112.595 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.726 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -64.47 -15.85 61.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.821 -1.081 . . . . 74.42 112.897 -169.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.51 -17.36 62.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.052 0.453 . . . . 75.51 110.46 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.06 8.99 18.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.112 -0.494 . . . . 65.21 110.088 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 60' ' ' MET . 3.0 m -143.49 103.17 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.935 -0.575 . . . . 73.14 110.086 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 25.0 tpt180 -73.24 125.68 28.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.533 . . . . 70.22 110.378 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -87.03 112.4 21.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.459 -0.791 . . . . 74.42 112.314 -175.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.626 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 7.9 mp -93.79 124.89 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.865 -0.607 . . . . 63.15 109.538 172.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HD2' HG12 ' A' ' 89' ' ' ILE . 83.1 m-85 -103.3 113.69 27.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.323 -0.251 . . . . 74.01 110.323 -177.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 t70 57.88 26.99 13.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 122.079 0.942 . . . . 75.51 109.869 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.12 -16.89 58.79 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.228 -0.896 . . . . 73.33 112.787 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -111.96 116.41 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.513 0.673 . . . . 72.13 110.623 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 12.0 ptt-85 -80.24 111.5 16.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.655 -0.702 . . . . 73.24 111.401 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.9 -165.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.935 -0.575 . . . . 75.3 110.187 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -85.22 140.87 30.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.083 -0.34 . . . . 61.52 110.083 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.48 -18.14 76.8 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.225 -0.512 . . . . 50.31 113.005 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 33.9 t70 -70.08 -12.97 61.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.033 0.444 . . . . 72.23 111.084 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -66.33 -41.44 89.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.899 -0.591 . . . . 71.25 110.746 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 m 68.55 136.58 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.903 -0.589 . . . . 70.12 111.091 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD3' ' HG ' ' A' ' 45' ' ' LEU . 76.4 Cg_exo -51.66 -36.86 62.67 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.215 2.61 . . . . 73.22 113.725 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.63 -34.24 36.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.267 0.469 . . . . 74.52 112.267 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -88.6 -18.06 28.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 74.25 111.254 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.05 -30.37 19.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.497 -0.32 . . . . 73.11 111.756 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.76 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.24 -0.981 . . . . 62.2 110.654 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 84' ' ' GLU . 10.1 tp -91.85 159.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.235 -1.394 . . . . 63.43 107.235 169.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.647 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 25.0 tt0 -154.05 -171.62 3.94 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.763 -0.829 . . . . 64.03 108.763 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 23' ' ' ILE . 8.4 p-10 -47.51 126.28 9.58 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.77 0.795 . . . . 63.13 112.358 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.56 4.26 15.57 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.86 -1.064 . . . . 60.32 110.844 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.41 -173.58 4.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.088 0.471 . . . . 70.52 111.072 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.03 148.37 22.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.563 0.697 . . . . 62.31 111.348 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 27' ' ' VAL . 64.8 mt -119.0 114.04 43.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.036 -0.984 . . . . 71.31 108.976 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -99.81 118.0 35.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.721 -0.474 . . . . 54.3 109.721 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.81 117.36 33.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.107 0.48 . . . . 62.41 111.207 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.7 144.89 35.89 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.093 -0.706 . . . . 71.52 109.093 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.39 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.397 0.435 . . . . 75.1 111.356 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 3.2 pt20 26.99 57.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.658 1.224 . . . . 74.3 112.552 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -60.43 -38.06 82.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.827 -0.624 . . . . 74.2 110.579 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 m -129.3 119.76 24.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.51 -0.768 . . . . 61.12 109.632 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 59.59 1.77 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.379 -0.915 . . . . 53.25 112.28 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.905 -0.942 . . . . 31.3 111.656 178.199 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.847 -0.427 . . . . 55.35 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.38 -102.38 2.88 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.63 -0.795 . . . . 72.34 111.812 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.79 157.1 23.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.818 0.342 . . . . 64.1 110.29 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.72 -26.05 23.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.47 . . . . 73.11 111.449 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.31 -26.37 66.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 72.02 112.067 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -59.46 -27.54 66.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.751 0.31 . . . . 75.43 111.416 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.92 65.67 0.82 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.898 0.38 . . . . 62.41 110.974 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.21 89.28 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.037 -0.529 . . . . 74.32 110.66 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -85.25 85.15 7.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.295 -0.632 . . . . 75.34 109.295 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -164.85 74.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 71.34 109.489 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -94.1 171.43 8.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.73 -0.668 . . . . 73.31 110.883 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.72 123.99 2.62 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.706 -0.679 . . . . 60.41 111.407 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.9 t -90.39 -163.14 0.97 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.053 -0.351 . . . . 73.34 110.053 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.4 m -61.86 148.53 87.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.33 110.375 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 11.3 Cg_exo -70.3 75.16 1.46 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.909 2.406 . . . . 72.24 112.57 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.3 t -71.89 -33.56 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.189 0.519 . . . . 73.43 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.47 -55.47 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 70.0 109.377 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.47 ' O ' ' HE1' ' A' ' 22' ' ' HIS . 60.9 t30 68.62 -67.34 0.21 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.935 -1.03 . . . . 63.4 112.725 173.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -82.9 6.92 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 74.43 112.918 -170.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 124.3 30.8 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.908 -1.277 . . . . 65.4 109.908 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -48.56 124.44 8.22 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.248 0.547 . . . . 73.1 110.771 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 18' ' ' ASN . 3.0 m-70 -76.06 171.16 14.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 71.14 112.235 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 28.4 mt -110.5 166.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.734 -1.21 . . . . 44.31 107.734 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.684 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 21.1 tt0 -162.38 123.99 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 71.43 111.004 -171.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 48' ' ' LEU . 15.5 m -137.09 141.93 38.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.428 -0.582 . . . . 73.23 109.428 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.607 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.9 ttmt -100.01 111.32 23.63 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.793 -0.763 . . . . 74.44 109.02 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 89' ' ' ILE . 67.5 t -95.3 99.29 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.419 -0.956 . . . . 73.33 108.419 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.804 ' HE ' ' HA2' ' A' ' 32' ' ' GLY . 36.2 ttt180 -70.2 104.66 2.69 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.368 -1.345 . . . . 71.22 107.368 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.684 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 10.0 p -65.74 164.89 23.15 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.044 -0.98 . . . . 72.53 109.39 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 52.2 Cg_endo -67.69 30.63 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 123.115 2.543 . . . . 72.52 114.769 -169.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -131.74 -23.36 2.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.67 -0.492 . . . . 63.12 109.67 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.804 ' HA2' ' HE ' ' A' ' 28' ' ' ARG . . . 126.67 -11.25 7.07 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.757 -0.656 . . . . 64.22 112.293 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.33 94.67 3.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.158 0.504 . . . . 44.21 110.796 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.78 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 35.8 tt0 -92.5 99.33 12.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 70.41 109.586 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.22 134.31 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.191 -0.459 . . . . 73.02 110.173 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 21.0 p90 -75.98 105.14 6.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.589 0.709 . . . . 63.02 110.31 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.414 ' HD1' ' CD2' ' A' ' 48' ' ' LEU . 6.2 t80 -111.72 151.35 29.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.516 -0.92 . . . . 62.04 108.516 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 24' ' ' GLN . 78.4 mttt -125.87 168.64 13.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.664 0.745 . . . . 64.22 111.735 -169.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -115.42 134.22 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.397 -1.334 . . . . 43.02 107.397 170.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -103.03 -58.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.137 -0.625 . . . . 65.1 110.161 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -106.48 -178.95 3.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.93 101.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.999 0.363 . . . . 73.02 110.417 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.401 ' CG2' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -134.02 133.19 40.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.98 0.419 . . . . 71.22 110.515 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 167.3 21.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 62.32 111.081 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.705 HD21 ' HD3' ' A' ' 78' ' ' PRO . 96.6 mt -67.47 -23.87 65.55 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.464 0.542 . . . . 72.43 112.464 -170.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 34.0 mp0 -59.21 -24.68 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.033 0.383 . . . . 72.42 112.033 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -76.38 -37.66 56.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.202 -0.599 . . . . 62.41 109.949 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 39' ' ' ILE . 59.5 mt -62.53 -38.33 89.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.195 0.521 . . . . 70.35 109.99 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 20.0 ptm -80.01 -37.13 34.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.586 -0.734 . . . . 63.31 111.5 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 49.8 mm-40 -67.91 -30.46 69.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.955 -0.298 . . . . 64.22 111.719 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 47' ' ' LYS . 76.5 t -54.88 -39.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.465 -0.494 . . . . 72.35 110.296 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -75.97 -35.12 59.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 70.14 111.507 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 64.4 m -49.88 -48.13 51.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.909 0.385 . . . . 62.33 111.044 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.71 -32.77 62.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 62.25 111.289 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 74.42 111.08 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.49 -21.55 26.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.468 -0.333 . . . . 75.42 111.275 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.05 12.98 83.85 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.501 -1.04 . . . . 60.04 110.501 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.4 tt0 -136.2 129.94 32.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.492 -0.929 . . . . 75.33 108.492 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 6.2 p -81.42 171.64 14.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.456 0.646 . . . . 31.2 112.158 -173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.562 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.34 -15.08 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.902 -1.045 . . . . 74.42 112.935 -174.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.62 -15.28 57.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.976 0.361 . . . . 75.51 111.976 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HA ' ' CG ' ' A' ' 94' ' ' GLN . . . -109.95 9.25 24.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.125 0.488 . . . . 65.21 110.177 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.742 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 18.3 m -140.5 172.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.595 . . . . 73.14 110.495 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 tpp85 -143.75 130.49 20.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.607 -0.516 . . . . 70.22 109.607 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 49' ' ' MET . 91.3 m-85 -99.99 116.38 31.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 74.42 111.441 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -111.03 113.45 26.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.392 -0.822 . . . . 63.15 110.015 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.667 ' HB3' HG12 ' A' ' 89' ' ' ILE . 23.2 p90 -112.47 146.15 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.098 -0.641 . . . . 74.01 110.175 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.1 t70 60.44 21.94 11.58 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.352 1.072 . . . . 75.51 109.3 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.92 -12.09 68.57 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.118 -0.946 . . . . 73.33 113.109 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -130.63 127.55 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.427 0.613 . . . . 72.13 112.054 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -63.96 159.21 20.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.681 -0.69 . . . . 73.24 111.839 175.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.756 HG12 ' H ' ' A' ' 73' ' ' HIS . 10.2 tt -173.03 -171.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.428 -0.582 . . . . 75.3 109.428 175.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.756 ' H ' HG12 ' A' ' 72' ' ' ILE . 11.5 m170 -75.51 151.79 37.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.878 0.371 . . . . 61.52 110.687 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -72.69 -19.85 79.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.794 -0.717 . . . . 50.31 112.217 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.97 -19.21 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.57 0.211 . . . . 72.23 111.57 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.671 ' OD1' ' HB2' ' A' ' 73' ' ' HIS . 18.7 m120 -68.15 -44.14 76.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.018 -0.364 . . . . 71.25 110.018 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.0 p 61.96 162.54 0.11 Allowed Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.871 0.869 . . . . 70.12 111.512 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.705 ' HD3' HD21 ' A' ' 45' ' ' LEU . 24.9 Cg_exo -64.3 -39.21 30.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.463 2.109 . . . . 73.22 112.356 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.54 -49.11 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 74.52 110.976 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -67.06 -22.74 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.686 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.7 tp -86.63 -29.5 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 73.11 110.241 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.41 -18.44 27.72 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.112 -0.795 . . . . 62.2 111.112 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.61 126.87 54.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.089 -0.708 . . . . 63.43 109.089 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.0 tt0 -131.37 -151.52 0.47 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.408 -0.36 . . . . 64.03 110.344 -169.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 4.0 p-10 -43.4 131.73 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.551 0.691 . . . . 63.13 112.631 -172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.38 -9.5 24.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.547 -0.751 . . . . 60.32 112.007 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.68 169.86 10.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.945 -0.391 . . . . 70.52 109.945 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.9 161.95 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.306 0.574 . . . . 62.31 111.261 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.667 HG12 ' HB3' ' A' ' 67' ' ' TYR . 35.6 mt -132.94 117.22 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.424 -0.954 . . . . 71.31 108.424 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 3.4 t70 -98.69 125.98 44.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.84 -0.43 . . . . 54.3 109.84 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 64' ' ' ARG . . . -97.79 117.04 31.21 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.174 0.511 . . . . 62.41 110.512 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.0 163.64 12.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.713 -0.676 . . . . 71.52 109.37 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.06 101.42 3.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.912 -0.315 . . . . 75.1 111.345 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.742 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 45.2 mt-30 56.72 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.452 -0.794 . . . . 74.3 111.692 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.435 ' O ' ' HB ' ' A' ' 96' ' ' THR . 43.4 tt0 -173.24 36.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.489 -1.3 . . . . 74.2 107.489 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 95' ' ' GLN . 54.9 m 75.98 -45.17 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.042 -0.981 . . . . 61.12 110.419 -171.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.79 -58.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.378 -0.689 . . . . 53.25 111.378 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.851 0 CA-C-O 119.055 -0.858 . . . . 31.3 111.648 177.37 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.375 0.607 . . . . 55.35 110.028 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.56 -122.7 5.13 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.341 -1.104 . . . . 72.34 110.341 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -128.19 123.2 33.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.968 -0.382 . . . . 64.1 109.968 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -67.49 -22.09 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.221 -0.659 . . . . 73.11 109.221 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.441 ' HA ' HG23 ' A' ' 8' ' ' VAL . 30.0 m-20 -61.78 -25.06 67.24 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.381 -0.827 . . . . 72.02 111.181 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -82.87 -15.37 51.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.056 0.455 . . . . 75.43 110.9 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.32 14.33 17.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.137 -0.483 . . . . 62.41 111.35 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 5' ' ' ASP . 87.5 t -67.53 102.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.532 . . . . 74.32 110.639 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -127.89 73.11 1.44 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.111 -0.7 . . . . 75.34 109.111 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -100.38 -17.58 17.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.244 -0.889 . . . . 71.34 110.557 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -89.64 127.2 35.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.012 -0.54 . . . . 73.31 110.051 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.44 93.52 1.28 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.746 -0.74 . . . . 60.41 111.785 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.6 m -66.84 131.57 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.859 0.361 . . . . 73.34 110.632 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -120.49 93.34 48.3 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 63.33 110.839 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.35 93.69 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.63 2.22 . . . . 72.24 110.875 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.36 125.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.879 -0.601 . . . . 73.43 111.418 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -59.97 -71.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.087 -0.961 . . . . 70.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -99.33 88.35 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 63.4 110.659 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -127.39 -48.38 1.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.234 -0.893 . . . . 74.43 110.391 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.58 -12.33 1.01 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 65.4 111.572 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -85.37 3.61 39.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.47 0.652 . . . . 73.1 110.505 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 71.14 109.462 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 14.8 mt -110.76 168.1 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.909 -0.404 . . . . 44.31 109.909 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 41.7 mt-30 -150.8 131.72 14.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.877 0.471 . . . . 71.43 110.674 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 48' ' ' LEU . 35.8 m -130.35 -177.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.356 -0.609 . . . . 73.23 109.356 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.74 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mtmt -138.77 114.75 10.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.767 0.318 . . . . 74.44 110.554 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 89' ' ' ILE . 66.9 t -97.17 100.94 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -69.9 106.68 3.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.925 -1.139 . . . . 71.22 107.925 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 66.1 p -60.34 160.28 18.59 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.256 -0.884 . . . . 72.53 108.954 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 36.7 Cg_endo -65.2 31.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 123.165 2.576 . . . . 72.52 114.076 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 29' ' ' SER . 27.7 t70 -131.44 -21.45 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.272 0.558 . . . . 63.12 110.77 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.65 -15.73 24.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.268 -0.733 . . . . 64.22 111.268 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.09 104.17 1.71 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.539 -0.541 . . . . 44.21 109.539 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.74 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 34.0 tt0 -113.44 96.86 6.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.36 -0.836 . . . . 70.41 109.289 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.27 134.57 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.221 -0.659 . . . . 73.02 109.221 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 34.9 p90 -68.32 130.5 43.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.227 0.536 . . . . 63.02 110.191 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG11 ' A' ' 51' ' ' VAL . 3.9 t80 -128.12 130.17 47.72 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.983 -1.117 . . . . 62.04 107.983 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 44.4 pttt -105.29 163.69 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.88 0.848 . . . . 64.22 112.555 -165.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 65.2 mt -114.83 134.77 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.419 -1.264 . . . . 43.02 108.063 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.15 -81.68 0.37 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.281 0.562 . . . . 65.1 110.628 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -102.1 -176.57 3.16 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.022 -1.103 . . . . 73.4 108.022 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.76 101.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.258 0.551 . . . . 73.02 109.967 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 1.7 p -141.47 105.23 4.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.968 -1.015 . . . . 71.22 109.776 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -39.24 152.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.841 -1.072 . . . . 62.32 113.308 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.47 -15.4 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.118 -0.947 . . . . 72.43 111.236 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 42.5 mt-10 -62.73 -26.28 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 72.42 111.181 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -78.13 -36.24 48.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.44 -0.504 . . . . 62.41 109.905 177.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 25' ' ' VAL . 74.3 mt -59.38 -29.72 67.91 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.763 -0.828 . . . . 70.35 108.763 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.638 ' HG3' ' CD1' ' A' ' 65' ' ' PHE . 24.9 ttt -78.62 -51.09 10.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.111 -1.404 . . . . 63.31 111.049 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 42.7 mt-10 -70.43 -30.19 66.98 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.511 0.559 . . . . 64.22 112.511 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 47' ' ' LYS . 54.5 t -55.71 -38.47 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.442 -0.503 . . . . 72.35 111.101 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.8 -30.44 65.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.579 -0.282 . . . . 70.14 111.504 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 62.2 m -51.36 -39.78 57.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.33 0.586 . . . . 62.33 110.57 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -76.57 -41.26 47.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.533 -0.758 . . . . 62.25 111.147 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -64.22 -50.77 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.02 0.748 . . . . 74.42 113.02 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 58' ' ' GLN . 1.2 pp -98.63 8.51 44.83 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.564 -0.454 . . . . 75.42 111.914 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.17 27.36 72.89 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.158 -0.544 . . . . 60.04 113.386 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 58.3 tt0 -143.22 130.84 21.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.482 -0.933 . . . . 75.33 108.482 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 p -89.33 174.3 7.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.952 0.723 . . . . 31.2 112.952 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.461 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -70.11 -14.92 62.88 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 115.023 1.49 . . . . 74.42 115.023 -163.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.38 -12.68 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.08 -1.012 . . . . 75.51 109.76 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -101.54 -7.6 22.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.429 -0.805 . . . . 65.21 110.272 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 92' ' ' MET . 5.1 m -138.72 104.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.223 172.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 54.1 ttp180 -88.01 125.9 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.293 -0.412 . . . . 70.22 110.099 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 54.7 m-85 -92.93 122.95 35.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.18 0.514 . . . . 74.42 111.347 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.98 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -106.73 113.33 26.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.674 -0.693 . . . . 63.15 109.838 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 89' ' ' ILE . 47.1 p90 -112.73 145.71 40.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.836 -0.746 . . . . 74.01 111.149 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.26 22.51 11.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.071 0.938 . . . . 75.51 109.058 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.98 2.27 86.54 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.979 -1.009 . . . . 73.33 112.14 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -122.17 117.72 26.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.145 0.498 . . . . 72.13 111.324 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.98 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -66.74 119.26 11.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.219 0.533 . . . . 73.24 111.189 173.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.478 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 8.0 tt -161.3 157.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.407 -0.59 . . . . 75.3 109.407 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.34 135.37 48.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.099 0.476 . . . . 61.52 111.877 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.48 82.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.586 -0.734 . . . . 50.31 114.419 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.2 -33.35 75.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.207 0.503 . . . . 72.23 111.364 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -79.83 0.67 30.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.386 -0.37 . . . . 71.25 111.23 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.708 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 80.9 p 59.89 163.83 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.28 1.032 . . . . 70.12 112.833 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 73.0 Cg_endo -76.17 -31.73 4.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.149 1.899 . . . . 73.22 112.127 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.6 -34.34 67.11 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.786 -0.643 . . . . 74.52 110.758 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -77.09 -19.03 57.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.064 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -93.88 -30.88 14.57 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 73.11 111.23 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.16 -19.04 23.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.463 -0.875 . . . . 62.2 110.97 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.587 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -85.65 147.92 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.878 -1.156 . . . . 63.43 107.878 169.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.73 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 23.1 tt0 -151.23 -152.35 0.43 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.191 -0.67 . . . . 64.03 109.191 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.73 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t70 -47.32 114.84 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.865 0.364 . . . . 63.13 110.855 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.09 3.9 14.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.978 -0.629 . . . . 60.32 111.536 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HB2' HG13 ' A' ' 83' ' ' ILE . 17.7 t70 -76.09 142.05 41.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 70.52 111.049 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 17.7 m -114.47 141.47 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 121.345 0.593 . . . . 62.31 109.796 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.572 HG12 ' HB3' ' A' ' 67' ' ' TYR . 22.8 mt -121.37 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.497 -0.774 . . . . 71.31 109.651 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.64 -0.255 . . . . 54.3 110.906 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -94.93 118.16 31.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 62.41 111.282 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 66.9 mmm -105.37 168.04 9.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 71.52 110.621 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.05 109.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 75.1 111.371 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.792 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 89.6 mt-30 62.38 170.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 74.3 113.13 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 24.2 pt20 -72.37 -21.13 61.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.057 -0.974 . . . . 74.2 112.017 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 m -136.15 22.56 3.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.489 0.662 . . . . 61.12 110.96 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.71 4.52 84.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.448 -0.882 . . . . 53.25 111.891 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.105 -1.386 . . . . 31.3 110.777 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.027 -0.36 . . . . 55.35 110.027 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.11 4.46 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.732 -0.747 . . . . 72.34 111.293 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -65.73 162.62 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 64.1 111.673 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.01 -29.88 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.397 -0.82 . . . . 73.11 110.887 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 8' ' ' VAL . 60.2 m-20 -68.19 -17.17 64.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.947 0.404 . . . . 72.02 110.816 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.2 t -81.78 -15.26 54.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.576 0.703 . . . . 75.43 109.433 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.89 48.78 1.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.766 . . . . 62.41 110.333 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 5' ' ' ASP . 73.8 t -76.08 106.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.27 0.557 . . . . 74.32 110.311 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -125.84 12.92 7.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 75.34 109.322 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -76.98 64.79 2.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.497 -0.774 . . . . 71.34 111.267 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -143.55 87.97 1.97 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.813 -0.81 . . . . 73.31 108.813 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.1 58.23 4.34 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.998 -0.62 . . . . 60.41 112.9 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m 64.41 -174.7 0.17 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.038 0.535 . . . . 73.34 111.017 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 7.5 t -155.91 130.54 5.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.671 -0.492 . . . . 63.33 109.671 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 4.5 Cg_exo -76.76 77.92 3.54 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.089 2.526 . . . . 72.24 112.025 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.61 121.51 63.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 73.43 110.864 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 58.81 76.83 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 70.0 111.862 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -60.88 -35.18 75.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.692 -0.686 . . . . 63.4 110.493 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -94.23 16.52 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.49 0.662 . . . . 74.43 109.903 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.78 -83.93 0.42 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.744 -0.662 . . . . 65.4 111.476 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.87 34.26 5.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.891 0.853 . . . . 73.1 108.966 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -139.41 169.57 17.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.914 . . . . 71.14 110.061 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 23.6 mt -126.01 160.12 33.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.055 -1.091 . . . . 44.31 108.055 172.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 21.9 tt0 -145.8 135.85 23.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.567 0.222 . . . . 71.43 110.96 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 48' ' ' LEU . 26.8 m -139.47 149.07 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 73.23 110.196 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.635 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 mtmt -119.36 114.94 23.12 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.217 -0.302 . . . . 74.44 110.427 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 89' ' ' ILE . 53.2 t -97.36 98.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.946 -1.501 . . . . 73.33 106.946 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 27.6 ttp180 -68.99 103.74 1.92 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.055 -1.461 . . . . 71.22 107.055 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 70.8 m -64.63 158.46 67.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 114.073 -1.421 . . . . 72.53 108.699 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 37.1 Cg_endo -64.31 32.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 123.63 2.887 . . . . 72.52 114.756 -170.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 29' ' ' SER . 28.8 t70 -134.06 -8.58 2.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.449 0.642 . . . . 63.12 110.302 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.85 57.01 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.88 -0.888 . . . . 64.22 110.88 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 99.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 44.21 110.246 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 35.1 tt0 -104.92 99.78 9.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.526 -0.761 . . . . 70.41 109.515 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.56 134.77 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 73.02 110.338 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 20.8 p90 -76.59 117.37 18.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.78 0.8 . . . . 63.02 111.691 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -112.02 171.59 7.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.696 -1.224 . . . . 62.04 107.696 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -145.66 165.53 28.45 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.358 -0.937 . . . . 64.22 112.476 -170.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 48.5 mt -123.1 147.59 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.602 -1.181 . . . . 43.02 108.958 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -128.96 -77.63 0.56 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.2 -0.667 . . . . 65.1 109.2 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -72.62 150.14 43.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.185 -1.413 . . . . 73.4 107.185 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 59.7 pttt -56.64 101.24 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.902 0.858 . . . . 73.02 111.219 -175.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.46 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -134.68 103.31 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.063 -0.971 . . . . 71.22 109.465 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 13.1 pttp -63.54 -178.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.328 0.862 . . . . 62.32 113.328 -173.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.863 ' HA ' HD12 ' A' ' 48' ' ' LEU . 37.4 mt -60.91 -16.73 45.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.626 -1.17 . . . . 72.43 113.611 -164.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 49' ' ' MET . 53.1 mt-10 -58.09 -57.37 13.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.83 0.307 . . . . 72.42 111.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -68.2 -28.42 67.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.878 -0.329 . . . . 62.41 111.008 -175.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.1 mt -58.96 -37.59 77.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 70.35 110.73 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.1 ptt? -90.98 -32.79 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 63.31 110.628 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 27.6 mt-10 -67.91 -34.63 77.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.072 0.397 . . . . 64.22 112.072 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 62.3 t -55.8 -37.68 48.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.207 0.527 . . . . 72.35 109.946 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.86 -36.76 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 70.14 111.287 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.054 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 58.5 m -52.21 -53.44 43.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.15 0.5 . . . . 62.33 110.638 173.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -67.22 -32.32 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.652 . . . . 62.25 110.938 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -69.26 -38.87 78.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.297 -0.41 . . . . 74.42 111.244 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.03 -13.93 37.61 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.874 -0.33 . . . . 75.42 111.422 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.4 8.46 52.75 Favored Glycine 0 CA--C 1.517 0.158 0 C-N-CA 120.556 -0.831 . . . . 60.04 113.822 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -151.17 135.18 16.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.7 -0.481 . . . . 75.33 109.7 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 1.054 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 3.6 p -78.37 179.33 7.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.191 0.811 . . . . 31.2 113.191 -171.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.586 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.2 -14.15 62.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.893 1.442 . . . . 74.42 114.893 -163.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -1.8 27.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.093 -1.004 . . . . 75.51 109.982 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . . . -113.76 1.8 14.96 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 65.21 109.953 173.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.859 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -142.52 102.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.362 0.601 . . . . 73.14 110.19 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.642 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 22.9 tpt180 -71.17 114.19 8.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 70.22 111.192 -172.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -80.43 110.87 16.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.277 -0.874 . . . . 74.42 112.306 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 9.9 mp -104.8 125.51 50.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.797 -0.638 . . . . 63.15 109.783 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HD1' HG12 ' A' ' 89' ' ' ILE . 74.0 m-85 -103.26 123.77 47.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.211 -0.292 . . . . 74.01 110.211 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.2 t70 57.82 22.95 9.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.147 0.975 . . . . 75.51 110.039 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.75 63.17 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.5 -0.773 . . . . 73.33 112.691 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.42 117.88 26.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 72.13 111.523 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.99 122.43 16.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 73.24 111.467 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 67' ' ' TYR . 8.3 pt -147.66 -162.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.411 ' H ' ' HB ' ' A' ' 72' ' ' ILE . 38.8 m170 -89.64 159.52 17.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.862 0.363 . . . . 61.52 110.88 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.679 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -76.59 -17.56 79.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.883 -0.675 . . . . 50.31 111.496 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.714 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 p30 -74.61 -9.21 58.35 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.468 0.307 . . . . 72.23 111.387 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -67.7 -38.26 83.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.414 -0.357 . . . . 71.25 110.877 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.5 p 63.27 144.72 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 124.356 1.063 . . . . 70.12 111.461 -174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.0 -51.08 10.37 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.981 2.454 . . . . 73.22 113.219 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -56.95 -31.64 65.2 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.297 0.48 . . . . 74.52 112.297 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -75.83 -19.52 58.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.085 0.469 . . . . 74.25 110.667 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.4 tp -91.5 -30.88 16.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.356 . . . . 73.11 111.51 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.1 -18.85 13.91 Favored Glycine 0 CA--C 1.502 -0.767 0 N-CA-C 110.1 -1.2 . . . . 62.2 110.1 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tp -89.3 159.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.957 -1.127 . . . . 63.43 107.957 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 28.3 tt0 -154.55 -152.4 0.4 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.983 -1.117 . . . . 64.03 107.983 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.749 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.9 t70 -43.85 119.36 1.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.603 0.638 . . . . 63.13 111.616 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.46 4.71 32.47 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.724 -0.75 . . . . 60.32 111.539 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB3' HG12 ' A' ' 25' ' ' VAL . 18.3 t70 -60.67 151.52 28.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.607 -0.297 . . . . 70.52 110.644 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 23.5 m -128.61 148.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.432 0.634 . . . . 62.31 110.607 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 27' ' ' VAL . 54.6 mt -127.85 113.05 29.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.368 -0.975 . . . . 71.31 108.368 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -102.76 126.17 49.78 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.969 -0.382 . . . . 54.3 109.969 -173.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.859 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -104.62 118.01 35.53 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.429 0.455 . . . . 62.41 112.146 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.3 mpt? -95.14 171.23 8.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.565 -0.532 . . . . 71.52 109.565 172.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.94 117.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.719 0.295 . . . . 75.1 111.345 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 48.8 mt-30 59.05 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.013 0.925 . . . . 74.3 112.22 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 72.8 mt-30 -136.79 17.78 3.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 74.2 110.01 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 m 63.06 51.54 2.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.621 -0.718 . . . . 61.12 109.137 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.62 -71.41 0.49 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.304 -0.862 . . . . 53.25 111.622 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.26 -1.3 . . . . 31.3 111.474 -179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.882 0.372 . . . . 55.35 110.344 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.24 69.83 0.25 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.345 -0.702 . . . . 72.34 111.345 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.06 149.08 41.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.695 0.283 . . . . 64.1 110.626 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.45 -37.55 81.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 73.11 111.061 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.33 -31.09 69.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.381 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -83.04 -27.0 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.831 0.348 . . . . 75.43 110.961 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.27 -59.77 2.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.238 -0.437 . . . . 62.41 110.644 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.43 91.91 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.588 . . . . 74.32 110.861 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -136.61 -176.6 4.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.555 -0.748 . . . . 75.34 109.041 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.0 m120 63.18 32.28 15.15 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.871 -0.418 . . . . 71.34 109.871 -172.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -93.56 100.98 13.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 73.31 111.165 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.21 125.07 6.46 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.796 -0.922 . . . . 60.41 110.796 174.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.518 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 44.9 m -59.63 131.94 52.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 73.34 111.504 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.5 t -78.94 118.21 71.15 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 109.121 -0.696 . . . . 63.33 109.121 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 6.9 Cg_exo -73.6 64.66 4.71 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.234 2.622 . . . . 72.24 112.981 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.4 t 67.54 110.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 123.696 0.623 . . . . 73.43 111.609 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -109.4 111.34 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 70.0 111.07 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -156.05 36.08 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 63.4 110.081 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.75 23.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.867 -0.606 . . . . 74.43 112.261 -176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 10.36 63.53 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.904 -0.665 . . . . 65.4 112.126 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.57 155.03 21.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.944 0.402 . . . . 73.1 110.133 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -94.93 161.01 14.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.828 -0.624 . . . . 71.14 109.927 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 10.2 mt -109.83 169.63 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.614 -0.513 . . . . 44.31 109.614 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 23' ' ' ILE . 4.1 tt0 -145.9 138.26 25.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.483 -0.562 . . . . 71.43 109.483 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.862 HG11 HD13 ' A' ' 48' ' ' LEU . 7.4 p -150.73 138.38 13.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.188 0.518 . . . . 73.23 110.234 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' A' ' 36' ' ' PHE . 39.6 mttt -102.41 140.83 36.18 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.314 -0.403 . . . . 74.44 110.508 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 77.1 t -119.81 100.69 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.871 -1.529 . . . . 73.33 106.871 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 6.6 ttp180 -69.51 111.31 5.27 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.326 -0.99 . . . . 71.22 108.326 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 78.4 p -60.28 157.65 32.74 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.645 -0.872 . . . . 72.53 108.645 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 36.2 Cg_endo -64.68 27.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.31 2.673 . . . . 72.52 114.504 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 29' ' ' SER . 12.3 t70 -130.52 -22.64 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.25 0.547 . . . . 63.12 110.615 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.63 -5.56 24.49 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.604 -0.808 . . . . 64.22 111.577 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.56 91.61 3.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.311 0.576 . . . . 44.21 109.538 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 28' ' ' ARG . 37.9 tt0 -101.27 110.69 22.74 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.513 -0.767 . . . . 70.41 110.123 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.35 134.52 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.961 -0.563 . . . . 73.02 109.641 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 31.1 p90 -77.1 120.18 21.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.264 0.554 . . . . 63.02 110.509 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -111.69 170.33 8.21 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.339 -1.356 . . . . 62.04 107.339 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 42.4 mtmt -139.75 168.14 20.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.761 -0.776 . . . . 64.22 111.7 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 54.0 mt -117.41 134.66 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 43.02 108.875 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -115.69 -68.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.349 -0.611 . . . . 65.1 109.349 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -84.02 152.6 24.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.334 -1.728 . . . . 73.4 106.334 166.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -59.04 101.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 118.903 0.774 . . . . 73.02 109.764 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.478 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -126.03 118.82 26.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.758 -0.656 . . . . 71.22 111.653 -174.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -28.1 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.612 -1.631 . . . . 62.32 113.821 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.937 ' HA ' HD12 ' A' ' 48' ' ' LEU . 48.6 mt -65.18 -18.06 65.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.008 -0.997 . . . . 72.43 110.06 173.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 49' ' ' MET . 41.7 mt-10 -59.41 -52.47 65.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.646 -0.706 . . . . 72.42 111.025 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.44 -30.42 70.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 62.41 110.297 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 45' ' ' LEU . 73.4 mt -60.55 -32.29 71.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.966 -0.561 . . . . 70.35 110.62 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 21.3 ptp -95.74 -29.85 14.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.885 -0.326 . . . . 63.31 110.917 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 48.5 mt-10 -66.47 -34.08 77.14 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.45 0.167 . . . . 64.22 111.45 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 47' ' ' LYS . 78.7 t -57.64 -39.25 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.062 0.458 . . . . 72.35 110.027 173.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -76.81 -31.46 56.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 70.14 111.342 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.987 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 61.5 m -54.58 -49.5 70.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.443 0.639 . . . . 62.33 110.729 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -73.92 -23.4 59.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.678 -0.692 . . . . 62.25 111.006 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 2.6 tpm_? -80.54 -33.44 36.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.405 -0.361 . . . . 74.42 110.828 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.07 -21.57 31.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 75.42 110.812 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 1.22 64.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.871 -0.68 . . . . 60.04 111.891 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 6.5 tp-100 -136.32 131.1 33.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.148 -0.686 . . . . 75.33 109.148 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.987 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.6 p -86.84 179.32 6.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.066 0.765 . . . . 31.2 113.066 -168.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.825 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.48 -16.42 61.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.266 1.21 . . . . 74.42 114.266 -164.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.57 -0.29 37.13 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.453 -0.779 . . . . 75.51 110.409 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.882 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -115.11 11.4 16.35 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.481 -0.781 . . . . 65.21 109.835 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 60' ' ' MET . 33.2 m -134.13 153.44 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.9 -0.591 . . . . 73.14 110.382 173.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -113.32 112.46 23.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.212 -0.662 . . . . 70.22 109.212 175.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -85.67 116.41 23.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.287 0.565 . . . . 74.42 111.715 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.906 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -113.55 142.27 46.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 63.15 109.819 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -104.18 102.97 12.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.829 -0.168 . . . . 74.01 110.676 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 46.78 49.42 14.22 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.982 0.801 . . . . 75.51 111.557 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.13 -22.02 41.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.014 -0.612 . . . . 73.33 113.829 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.548 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 30.0 t70 -126.44 121.76 33.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.0 0.9 . . . . 72.13 111.638 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.906 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.33 143.38 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 73.24 111.74 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' HIS . 11.9 tt -135.33 -178.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.685 -0.689 . . . . 75.3 109.997 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' ILE . 98.1 m-70 -111.36 148.27 33.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.42 -0.585 . . . . 61.52 109.42 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -68.73 -16.96 70.66 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.287 0.475 . . . . 50.31 114.287 -171.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.67 -4.81 54.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.299 0.549 . . . . 72.23 111.386 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.95 -43.26 65.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.834 0.309 . . . . 71.25 111.834 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 28.1 p 67.68 148.11 0.11 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.74 1.216 . . . . 70.12 112.159 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.912 ' HD3' HD21 ' A' ' 45' ' ' LEU . 22.1 Cg_endo -61.57 -47.63 11.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.184 2.589 . . . . 73.22 113.618 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.98 -24.27 64.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.546 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -58.98 -39.95 83.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.938 -0.573 . . . . 74.25 110.81 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.65 -31.99 15.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 73.11 110.852 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 13' ' ' SER . . . 115.83 -19.91 13.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.685 -0.769 . . . . 62.2 111.798 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' A' ' 87' ' ' ASP . 10.1 tt -75.85 116.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.303 -0.999 . . . . 63.43 108.303 170.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.817 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 13.1 tt0 -131.2 -174.54 3.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.449 -0.341 . . . . 64.03 110.632 -168.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 26.0 t70 -4.71 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.768 1.627 . . . . 63.13 114.531 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.89 4.07 33.99 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.575 -0.739 . . . . 60.32 111.603 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.452 ' HB3' HG12 ' A' ' 83' ' ' ILE . 5.8 p-10 -79.56 167.15 21.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.745 0.307 . . . . 70.52 110.571 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 26' ' ' LYS . 20.5 m -137.32 153.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.561 0.696 . . . . 62.31 112.136 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 54.3 mt -129.68 127.63 64.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.868 -1.06 . . . . 71.31 108.439 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.18 136.7 39.68 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.439 -0.208 . . . . 54.3 110.439 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.49 117.71 34.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.018 0.437 . . . . 62.41 110.838 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 83.8 mtp -98.97 170.27 8.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 71.52 109.454 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -74.16 104.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.868 0.366 . . . . 75.1 111.203 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.882 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 90.8 mt-30 60.66 176.25 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 74.3 111.742 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.773 ' HA ' ' HG2' ' A' ' 64' ' ' ARG . 79.2 mt-30 -78.76 94.06 5.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 74.2 111.219 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m 78.54 -29.79 0.15 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.045 -0.98 . . . . 61.12 111.758 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.8 -39.5 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.607 -0.597 . . . . 53.25 111.607 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 CA-C-O 118.532 -1.149 . . . . 31.3 111.592 179.469 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.961 -0.385 . . . . 55.35 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.46 166.82 11.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.451 -0.88 . . . . 72.34 112.956 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.47 126.21 54.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.401 . . . . 64.1 110.072 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -86.47 -29.72 22.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 73.11 110.954 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.24 -35.87 80.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.957 -0.565 . . . . 72.02 111.995 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.5 p -77.06 -10.76 59.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.101 -0.499 . . . . 75.43 111.99 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 15.43 28.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.657 0.265 . . . . 62.41 111.632 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.32 -41.54 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.258 -0.275 . . . . 74.32 110.258 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 p30 44.37 44.97 7.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 75.34 112.209 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.14 83.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.17 0.51 . . . . 71.34 110.698 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -174.14 120.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.315 -0.857 . . . . 73.31 109.03 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.91 105.05 3.0 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.672 -0.775 . . . . 60.41 112.533 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 m -73.99 101.92 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.974 -0.38 . . . . 73.34 109.974 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 27.4 p -78.44 123.09 85.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.299 -0.41 . . . . 63.33 110.342 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 8.0 Cg_exo -73.31 10.68 1.14 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.265 2.643 . . . . 72.24 112.862 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.57 91.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.544 -0.298 . . . . 73.43 110.749 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 67.68 1.32 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.86 -0.609 . . . . 70.0 111.465 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 -69.71 0.31 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.115 0.484 . . . . 63.4 110.47 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -128.3 -53.67 1.28 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.84 -0.618 . . . . 74.43 110.913 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.51 -170.57 29.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.939 -0.648 . . . . 65.4 111.769 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.48 114.01 27.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.878 0.37 . . . . 73.1 110.217 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -67.4 127.23 31.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 71.14 111.205 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 31.6 mm -116.01 164.28 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.453 -0.794 . . . . 44.31 108.918 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.631 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 88.0 mt-30 -151.59 116.25 5.13 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.712 0.805 . . . . 71.43 109.681 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 48' ' ' LEU . 10.3 m -113.17 -179.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.199 -0.667 . . . . 73.23 109.199 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 mtmt -144.83 114.43 7.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 74.44 110.776 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 89' ' ' ILE . 94.8 t -93.71 94.8 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 107.082 -1.451 . . . . 73.33 107.082 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 9.0 ttp180 -69.62 105.58 2.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.517 -1.29 . . . . 71.22 107.517 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.569 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 59.4 p -59.1 163.03 6.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 114.678 -1.147 . . . . 72.53 108.941 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 46.1 Cg_endo -67.21 28.14 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.824 2.35 . . . . 72.52 113.759 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 29' ' ' SER . 18.0 t70 -130.52 -23.82 2.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 63.12 110.65 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.12 -7.62 27.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.521 -0.847 . . . . 64.22 111.108 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 29' ' ' SER . . . -71.33 90.34 0.94 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.17 -0.678 . . . . 44.21 109.17 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 38.1 tt0 -99.57 102.21 13.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.1 -0.955 . . . . 70.41 109.657 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.11 129.98 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.886 -0.597 . . . . 73.02 109.999 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 27.8 p90 -71.41 122.58 20.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.432 0.634 . . . . 63.02 110.554 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HD2' HD23 ' A' ' 48' ' ' LEU . 3.5 t80 -120.53 128.74 53.38 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.618 -1.252 . . . . 62.04 107.618 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 24' ' ' GLN . 21.6 mtmt -105.3 162.67 13.23 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.383 -0.527 . . . . 64.22 110.951 -165.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 43.1 mt -115.27 134.64 57.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.867 -0.79 . . . . 43.02 108.867 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -93.47 -78.75 0.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.784 -0.45 . . . . 65.1 109.784 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 41' ' ' ARG . 48.8 mtt180 -97.59 169.71 9.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.118 -1.438 . . . . 73.4 107.118 164.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.548 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -54.85 101.59 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 73.02 110.532 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.8 116.03 23.02 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.23 -0.895 . . . . 71.22 109.755 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' LYS . 23.5 mtpp -36.37 134.19 0.46 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.575 -1.193 . . . . 62.32 111.985 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' HD3' ' A' ' 78' ' ' PRO . 91.7 mt -57.11 -20.28 24.62 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.958 -1.019 . . . . 72.43 113.276 -168.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 58.6 mt-10 -65.59 -24.69 67.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.111 0.412 . . . . 72.42 112.111 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -71.22 -28.98 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.752 -0.379 . . . . 62.41 110.483 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 25' ' ' VAL . 28.3 mt -59.25 -39.49 82.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.975 -0.557 . . . . 70.35 111.512 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -94.47 -23.82 17.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.84 -0.744 . . . . 63.31 111.307 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 45.9 mt-10 -73.27 -37.74 66.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.276 -0.57 . . . . 64.22 111.046 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 88.6 t -63.99 -25.08 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.525 0.679 . . . . 72.35 109.512 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -81.72 -34.76 30.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.277 -0.874 . . . . 70.14 110.338 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.01 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 79.7 m -53.75 -56.96 12.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.335 0.588 . . . . 62.33 111.155 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -68.69 -19.99 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.585 -0.734 . . . . 62.25 110.993 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -66.59 -46.51 75.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 74.42 111.354 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -98.7 -11.09 22.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.973 0.36 . . . . 75.42 111.973 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 29.82 8.22 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.5 -0.857 . . . . 60.04 113.498 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -150.55 129.04 12.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.823 -0.806 . . . . 75.33 108.823 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 1.01 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 24.2 p -92.43 178.25 5.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.995 0.739 . . . . 31.2 112.995 -168.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.494 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -76.21 -13.8 60.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.006 1.113 . . . . 74.42 114.006 -163.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 3.9 pm0 -80.07 -9.14 59.68 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.403 -0.811 . . . . 75.51 109.659 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.66 -22.35 12.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.617 -0.72 . . . . 65.21 109.965 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.7 m -128.51 101.26 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 166.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 14.0 tpt180 -83.77 149.53 26.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.747 -0.66 . . . . 70.22 111.395 -168.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' HD2' ' HE1' ' A' ' 67' ' ' TYR . 1.6 p90 -94.74 104.27 16.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.28 -0.873 . . . . 74.42 111.96 -175.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.798 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.5 mp -99.58 131.96 45.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.468 -0.787 . . . . 63.15 109.015 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HE1' ' HD2' ' A' ' 65' ' ' PHE . 47.7 m-85 -103.42 110.35 22.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.485 -0.486 . . . . 74.01 110.99 -175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t70 54.19 37.16 26.63 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.103 -0.953 . . . . 75.51 110.228 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -21.48 45.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.399 -0.819 . . . . 73.33 112.985 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -113.49 116.28 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.364 0.602 . . . . 72.13 110.846 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.798 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 23.6 ptt180 -72.61 118.21 15.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.381 -0.827 . . . . 73.24 112.344 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.93 -163.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.802 -0.814 . . . . 75.3 108.802 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -108.84 138.14 45.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.958 -0.297 . . . . 61.52 110.612 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.8 -10.56 64.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.1 -0.571 . . . . 50.31 112.273 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.15 -28.36 64.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 72.23 110.532 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 80' ' ' GLN . 15.4 t-20 -67.64 -17.7 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.647 -0.706 . . . . 71.25 111.062 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 66.6 p 60.18 156.72 0.1 Allowed Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.375 1.07 . . . . 70.12 113.18 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.924 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 59.2 Cg_endo -72.37 -43.43 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.544 2.163 . . . . 73.22 112.431 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.68 -28.12 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.684 . . . . 74.52 111.966 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' ASN . 53.8 tt0 -83.32 -34.65 25.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.268 -0.423 . . . . 74.25 111.547 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.5 tp -89.56 -28.31 19.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 73.11 110.659 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.24 -18.63 38.79 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.672 -0.775 . . . . 62.2 111.509 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.5 tt -89.87 120.99 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.45 -0.574 . . . . 63.43 109.45 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.924 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -155.83 -154.16 0.47 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 118.974 -0.536 . . . . 64.03 110.353 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 84' ' ' GLU . 19.9 t70 -21.82 109.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.718 1.261 . . . . 63.13 113.276 -167.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.4 -6.88 20.84 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.919 -1.037 . . . . 60.32 111.819 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.65 170.91 15.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 70.52 110.882 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.89 158.17 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.637 0.732 . . . . 62.31 111.413 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 27' ' ' VAL . 66.1 mt -128.59 125.92 64.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.98 -1.009 . . . . 71.31 108.724 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.09 126.23 44.79 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.772 -0.455 . . . . 54.3 109.772 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.665 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -87.96 117.93 27.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.144 0.497 . . . . 62.41 111.377 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.7 ttt -101.74 150.7 22.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.738 -0.665 . . . . 71.52 109.973 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.21 102.98 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.942 0.401 . . . . 75.1 110.505 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 38.8 mt-30 62.21 179.52 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.046 -0.979 . . . . 74.3 112.206 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' O ' ' HB ' ' A' ' 96' ' ' THR . 25.7 pt20 -91.82 39.46 1.01 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.579 -0.737 . . . . 74.2 110.229 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 95' ' ' GLN . 94.2 m 74.89 -38.07 0.37 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.606 -0.725 . . . . 61.12 111.21 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.69 104.78 0.4 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.806 -0.712 . . . . 53.25 112.028 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.962 0 CA-C-O 118.784 -1.009 . . . . 31.3 111.742 177.026 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.029 -0.73 . . . . 55.35 109.029 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.53 58.22 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.73 -1.348 . . . . 72.34 109.73 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -87.37 -177.81 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.479 0.657 . . . . 64.1 112.72 -165.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.06 -12.16 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.765 -1.107 . . . . 73.11 112.234 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -51.34 -26.73 8.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.939 0.718 . . . . 72.02 112.939 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -71.63 -20.6 61.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 75.43 111.752 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.92 30.08 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.036 0.384 . . . . 62.41 112.036 -172.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -74.83 96.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.603 0.716 . . . . 74.32 110.633 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.06 17.06 4.18 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.008 -0.996 . . . . 75.34 110.921 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.62 85.57 3.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 71.34 109.305 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -138.21 121.85 17.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.239 -0.437 . . . . 73.31 111.071 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.76 179.87 30.4 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.006 -0.838 . . . . 60.41 111.006 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -78.05 -49.19 14.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.014 0.407 . . . . 73.34 110.556 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.451 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 37.5 t 67.76 108.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 123.914 0.759 . . . . 63.33 111.6 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 14' ' ' SER . 18.7 Cg_endo -61.62 -31.71 86.92 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.586 2.191 . . . . 72.24 111.205 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.1 t -81.56 129.25 37.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.567 -0.742 . . . . 73.43 109.976 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -145.41 139.44 26.93 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 70.0 109.949 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -99.7 23.51 9.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.49 . . . . 63.4 111.283 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -102.29 26.89 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.988 -0.551 . . . . 74.43 109.811 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.76 105.03 0.07 OUTLIER Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 65.4 113.94 -174.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.91 -16.55 15.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.502 0.668 . . . . 73.1 109.429 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -114.01 142.93 45.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.343 -0.844 . . . . 71.14 110.059 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.2 mm -110.75 163.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.014 -0.539 . . . . 44.31 109.63 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 23' ' ' ILE . 58.6 tt0 -137.0 125.46 23.49 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.531 -0.544 . . . . 71.43 109.531 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 48' ' ' LEU . 7.0 p -130.99 139.16 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.2 -0.454 . . . . 73.23 110.502 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.783 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -110.5 118.43 36.22 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.699 -0.4 . . . . 74.44 110.714 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.5 t -94.95 104.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.314 -1.365 . . . . 73.33 107.314 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 72.8 ttt-85 -69.64 110.23 4.74 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.983 -1.117 . . . . 71.22 107.983 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 62.3 p -60.22 159.77 20.48 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 115.322 -0.854 . . . . 72.53 108.714 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 27.3 Cg_endo -62.1 22.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 123.353 2.702 . . . . 72.52 115.021 -174.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 29' ' ' SER . 31.8 t70 -131.78 -24.07 2.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 63.12 110.9 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.05 2.55 20.22 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.44 -0.886 . . . . 64.22 112.114 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 88.47 7.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.186 -0.672 . . . . 44.21 109.186 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.783 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 11.1 tt0 -82.5 113.5 20.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.787 -0.642 . . . . 70.41 110.187 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.02 134.32 44.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.708 -0.479 . . . . 73.02 109.708 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -79.35 121.69 25.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.92 0.867 . . . . 63.02 111.543 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -116.92 174.35 6.14 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.485 -1.234 . . . . 62.04 107.805 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -136.26 153.48 51.18 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.97 -0.456 . . . . 64.22 111.174 -167.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 55.1 mt -114.99 134.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.729 -0.841 . . . . 43.02 108.729 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -127.83 -58.52 1.23 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.912 0.387 . . . . 65.1 110.793 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -95.54 177.8 5.69 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.16 -1.052 . . . . 73.4 108.16 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.98 100.71 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.136 0.969 . . . . 73.02 109.073 172.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -138.95 102.17 4.48 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.307 -0.86 . . . . 71.22 110.606 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.74 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.4 pttp -68.56 -176.63 0.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.205 -0.907 . . . . 62.32 111.212 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 60.6 mt -55.67 -27.13 48.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 72.43 111.988 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 39.8 mt-10 -57.92 -35.48 71.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.01 0.434 . . . . 72.42 111.4 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 51' ' ' VAL . 46.3 tptt -69.9 -52.48 24.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 62.41 110.287 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 25' ' ' VAL . 26.8 mt -62.65 -28.36 69.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 70.35 111.32 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.61 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 14.2 ptm -85.59 -37.45 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 63.31 111.011 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 35.8 mm-40 -71.31 -30.43 66.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.829 0.307 . . . . 64.22 111.829 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 47' ' ' LYS . 87.8 t -62.98 -37.78 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.142 0.496 . . . . 72.35 109.706 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 55' ' ' ARG . 35.3 m-85 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.027 -0.533 . . . . 70.14 111.169 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 86.0 m -54.35 -48.59 71.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.315 0.579 . . . . 62.33 109.83 170.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.27 -40.52 67.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 62.25 110.833 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' A' ' 52' ' ' TYR . 55.1 ttt180 -65.79 -45.54 82.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.42 111.683 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.24 -13.79 42.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.685 0.278 . . . . 75.42 111.316 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.79 10.86 83.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.665 -0.779 . . . . 60.04 111.893 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 5.3 tp-100 -133.61 130.33 38.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.996 -0.742 . . . . 75.33 108.996 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 32.6 p -83.09 163.48 20.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.333 0.587 . . . . 31.2 112.263 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -15.69 63.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.245 -0.889 . . . . 74.42 112.328 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -87.02 -4.29 59.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 75.51 110.476 177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -115.81 -25.94 7.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.593 -0.73 . . . . 65.21 109.455 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.488 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 11.5 m -125.78 117.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.637 -0.71 . . . . 73.14 109.639 168.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -88.1 139.74 30.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.583 -0.525 . . . . 70.22 109.583 -174.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.565 ' HB3' ' CG2' ' A' ' 89' ' ' ILE . 60.9 m-85 -101.38 119.01 38.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.913 -0.585 . . . . 74.42 111.353 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.893 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.2 mp -99.34 127.1 45.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.193 -0.912 . . . . 63.15 108.784 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HE1' HG21 ' A' ' 83' ' ' ILE . 1.6 p90 -101.65 124.79 47.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.207 -0.997 . . . . 74.01 110.234 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.34 29.75 13.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.848 -1.069 . . . . 75.51 110.264 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.66 0.29 64.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.681 -0.69 . . . . 73.33 113.241 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.29 116.37 19.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.506 0.653 . . . . 72.13 111.368 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.893 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 22.6 ptt180 -66.68 137.81 56.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.286 -0.87 . . . . 73.24 112.408 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 73' ' ' HIS . 11.0 tp -162.63 164.86 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 75.3 109.741 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' N ' HG13 ' A' ' 72' ' ' ILE . 1.4 p-80 -70.39 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 61.52 110.919 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -65.76 -23.82 70.97 Favored Glycine 0 CA--C 1.518 0.242 0 CA-C-N 116.131 -0.486 . . . . 50.31 113.896 -171.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 7.0 p-10 -77.77 3.84 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.763 0.281 . . . . 72.23 111.501 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -67.39 -39.1 85.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.453 -0.203 . . . . 71.25 110.453 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 44' ' ' LYS . 49.9 p 62.41 143.0 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.596 1.158 . . . . 70.12 112.597 -178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.85 -42.22 15.64 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.049 2.499 . . . . 73.22 112.56 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.84 -14.76 55.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 74.52 111.802 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -59.9 -38.4 82.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 74.25 110.837 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB3' HG22 ' A' ' 83' ' ' ILE . 45.4 tp -104.85 -30.01 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 73.11 110.886 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.08 -19.32 13.62 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.774 -0.931 . . . . 62.2 110.774 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 81' ' ' LEU . 5.4 tt -66.48 112.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.719 -0.845 . . . . 63.43 108.719 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 15.8 tt0 -134.07 -152.8 0.49 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.751 -0.658 . . . . 64.03 109.864 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 33.1 t70 -30.57 112.9 0.09 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.254 0.971 . . . . 63.13 113.032 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.04 4.94 22.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.924 -0.58 . . . . 60.32 111.679 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -78.93 170.51 16.57 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.992 0.425 . . . . 70.52 111.094 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 13.7 m -138.27 154.83 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.31 111.013 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 36.4 mt -136.66 114.99 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.637 -0.71 . . . . 71.31 109.101 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.406 ' CG ' HH11 ' A' ' 28' ' ' ARG . 48.2 t0 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.446 -0.343 . . . . 54.3 110.372 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.2 131.69 53.15 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.148 0.425 . . . . 62.41 112.148 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.4 mpt? -126.21 163.28 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.449 -0.575 . . . . 71.52 109.449 173.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.53 95.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.564 0.221 . . . . 75.1 111.465 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 28.4 mt-30 45.52 39.08 4.38 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.495 0.718 . . . . 74.3 112.113 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 92' ' ' MET . 50.3 tp60 -72.46 71.49 0.94 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.382 0.61 . . . . 74.2 111.304 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 64' ' ' ARG . 86.7 m -164.83 -40.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.508 -0.923 . . . . 61.12 108.508 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.33 52.05 0.77 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.17 -0.923 . . . . 53.25 111.175 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.224 -1.32 . . . . 31.3 111.453 -178.004 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.237 -0.283 . . . . 55.35 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.75 -155.16 12.36 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.405 -0.903 . . . . 72.34 112.346 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -152.97 161.97 41.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 64.1 110.323 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.35 -14.8 42.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 73.11 110.125 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.42 -28.32 69.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.679 . . . . 72.02 111.031 -174.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 p -78.44 -9.99 59.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 75.43 111.961 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.82 41.16 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.206 0.527 . . . . 62.41 110.184 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.23 105.87 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.574 . . . . 74.32 112.206 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 73.61 160.86 0.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.108 -0.951 . . . . 75.34 111.85 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.46 -71.9 0.13 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.584 0.754 . . . . 71.34 110.918 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -85.91 102.64 13.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.136 0.493 . . . . 73.31 109.841 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.25 77.2 1.57 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.791 -0.64 . . . . 60.41 112.734 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -89.69 8.58 30.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.303 0.573 . . . . 73.34 110.545 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 p -102.17 108.76 58.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.69 . . . . 63.33 110.283 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.95 168.22 15.96 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.871 2.381 . . . . 72.24 112.245 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 t -66.75 159.57 4.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 73.43 110.716 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -63.11 157.9 21.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.214 -0.448 . . . . 70.0 110.507 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 75.14 5.85 4.23 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.648 0.779 . . . . 63.4 111.431 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -88.35 -3.67 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.443 -0.344 . . . . 74.43 111.079 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.29 11.83 83.83 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.782 -0.723 . . . . 65.4 112.193 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -84.99 -37.13 20.79 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.597 . . . . 73.1 109.387 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 30.7 m80 -90.18 176.99 6.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 71.14 110.311 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 30.1 mt -108.93 159.39 8.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.983 0.42 . . . . 44.31 110.808 -169.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 26.0 mp0 -146.11 126.12 13.68 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.985 0.914 . . . . 71.43 109.238 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.39 144.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.741 -0.466 . . . . 73.23 109.741 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 1.002 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.51 115.9 31.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.977 0.418 . . . . 74.44 111.302 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 89' ' ' ILE . 47.0 t -99.93 101.99 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.92 -1.141 . . . . 73.33 107.92 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 2.1 ttp180 -69.91 111.16 5.43 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 107.893 -1.151 . . . . 71.22 107.893 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.646 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 93.1 p -62.47 165.66 8.69 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.696 -0.801 . . . . 72.53 108.871 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.646 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 43.7 Cg_endo -66.65 20.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 122.66 2.24 . . . . 72.52 113.909 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 29' ' ' SER . 36.0 t70 -131.26 -11.77 3.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.205 0.526 . . . . 63.12 110.892 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.52 -0.16 43.08 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.193 -1.003 . . . . 64.22 111.976 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 97.6 6.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.353 -0.61 . . . . 44.21 109.353 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 48.5 tt0 -115.98 97.45 6.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.882 -0.599 . . . . 70.41 110.29 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.6 t -102.97 145.0 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.444 -0.947 . . . . 73.02 108.444 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 1.002 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.3 p90 -67.3 123.54 20.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 63.02 110.231 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -110.52 170.11 8.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.943 -1.132 . . . . 62.04 107.943 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 34.8 mttt -140.71 165.87 26.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.46 0.573 . . . . 64.22 111.402 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 69.4 mt -122.68 135.21 63.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 43.02 108.877 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -117.44 -77.73 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.312 . . . . 65.1 110.969 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 42' ' ' LYS . 4.9 tpt180 -76.95 177.47 7.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.257 -1.016 . . . . 73.4 108.257 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 5.9 ttpm? -62.47 99.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.052 -1.092 . . . . 73.02 108.052 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 2.8 p -135.17 106.55 6.8 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.666 -0.697 . . . . 71.22 110.845 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 45.0 mttm -51.49 170.45 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.483 -1.235 . . . . 62.32 111.154 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 47.6 mt -62.61 -10.95 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.595 . . . . 72.43 110.487 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 5.3 mm-40 -53.94 -57.22 11.78 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.631 -0.713 . . . . 72.42 111.361 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG2' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.62 -23.92 63.57 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.427 . . . . 62.41 110.877 -175.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.7 mt -63.32 -35.3 79.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 70.35 110.558 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.5 ptt? -89.31 -33.91 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 63.31 110.564 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 9.2 mm-40 -66.48 -32.87 74.5 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.982 0.364 . . . . 64.22 111.982 -176.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' LYS . 93.2 t -60.89 -34.94 61.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.502 -0.479 . . . . 72.35 110.124 174.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -73.44 -44.47 58.14 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.873 -0.331 . . . . 70.14 110.315 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 61.7 m -48.1 -44.52 31.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.334 0.588 . . . . 62.33 110.409 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -64.62 -56.2 15.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.226 -0.897 . . . . 62.25 110.724 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -68.58 -42.96 77.5 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.494 0.553 . . . . 74.42 112.494 -171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.87 -20.32 53.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.721 -0.218 . . . . 75.42 111.01 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.5 19.28 74.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.686 -0.768 . . . . 60.04 111.254 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 35.1 tt0 -142.72 130.05 21.06 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.522 -0.918 . . . . 75.33 108.522 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.3 p -84.35 167.28 16.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 31.2 111.749 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.34 -15.15 59.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.475 -0.784 . . . . 74.42 112.39 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 12.5 pt-20 -59.28 -23.78 62.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.617 0.246 . . . . 75.51 110.489 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.045 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -105.74 -12.82 15.75 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.977 -0.556 . . . . 65.21 111.085 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.4 m -144.24 103.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 73.14 110.635 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -95.77 145.7 25.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.726 -0.39 . . . . 70.22 110.655 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.679 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 26.5 p90 -95.21 133.08 39.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 74.42 111.774 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.108 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -115.9 114.05 24.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 63.15 109.987 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -103.76 138.8 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.013 -0.675 . . . . 74.01 110.423 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 t70 54.53 22.89 4.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.822 0.82 . . . . 75.51 109.977 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.53 -18.73 56.54 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.652 -0.704 . . . . 73.33 113.367 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -118.16 120.66 38.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.742 0.771 . . . . 72.13 111.739 -176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 1.108 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -69.19 142.89 54.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.723 -0.672 . . . . 73.24 111.685 176.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 76' ' ' ASN . 37.6 pt -142.55 -163.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.151 -0.685 . . . . 75.3 109.151 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -98.21 140.35 32.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.009 -0.737 . . . . 61.52 109.009 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.885 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -60.33 -23.62 60.31 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.161 -0.542 . . . . 50.31 113.482 -172.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 23.8 t70 -63.06 -23.39 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.393 0.516 . . . . 72.23 112.393 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.682 ' HB3' HD12 ' A' ' 72' ' ' ILE . 64.1 t30 -74.13 -19.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.841 -0.344 . . . . 71.25 111.205 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 44' ' ' LYS . 7.7 p 59.15 151.79 0.08 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.063 1.135 . . . . 70.12 114.063 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 -32.76 23.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.821 2.347 . . . . 73.22 113.492 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.615 ' OE1' ' HB ' ' A' ' 77' ' ' THR . 4.3 pm0 -63.15 -14.85 53.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.674 0.273 . . . . 74.52 111.543 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -68.62 -30.93 69.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.301 -0.409 . . . . 74.25 111.006 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.18 -30.35 16.72 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.368 -0.533 . . . . 73.11 111.388 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 -18.99 32.52 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.472 -1.051 . . . . 62.2 110.472 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.506 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -84.47 148.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.95 -1.13 . . . . 63.43 107.95 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.7 tt0 -155.07 -149.19 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.817 -1.179 . . . . 64.03 107.817 -176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 5.2 p-10 -36.49 114.53 0.3 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.854 0.835 . . . . 63.13 112.194 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.45 -5.71 14.77 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.462 -0.79 . . . . 60.32 111.853 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.8 t0 -80.63 161.71 24.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.782 0.325 . . . . 70.52 110.38 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.09 154.8 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.356 0.598 . . . . 62.31 110.51 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 65' ' ' PHE . 59.5 mt -131.72 126.37 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.408 -0.814 . . . . 71.31 109.471 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.98 134.35 43.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.554 0.216 . . . . 54.3 110.855 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -99.69 119.06 37.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.05 0.452 . . . . 62.41 110.622 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 65.4 mtt -103.32 152.25 21.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 71.52 110.016 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.32 95.89 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.861 0.362 . . . . 75.1 110.288 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 1.045 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 44.7 mt-30 56.51 23.59 7.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.334 -0.848 . . . . 74.3 110.852 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.56 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 6.8 tt0 64.58 78.07 0.3 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.793 -0.64 . . . . 74.2 110.283 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p 59.45 10.55 1.9 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.268 1.027 . . . . 61.12 113.146 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 116.68 99.25 2.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.527 -0.844 . . . . 53.25 112.483 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 94' ' ' GLN . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.705 -1.053 . . . . 31.3 112.181 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 38.9 m80 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.681 0.277 . . . . 71.140000000000001 110.4 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 25.8 mm -109.4 158.18 9.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.913 -0.402 . . . . 44.310000000000002 109.913 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -144.43 134.67 24.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.585 -0.524 . . . . 71.430000000000007 109.585 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 48' ' ' LEU . 5.0 p -142.63 140.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 123.658 0.599 . . . . 73.230000000000004 109.646 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . 23.4 mtmt -110.41 118.86 37.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.244 0.545 . . . . 74.439999999999998 111.182 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.768 HG22 ' HB ' ' A' ' 89' ' ' ILE . 88.6 t -94.46 97.68 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 105.999 -1.852 . . . . 73.329999999999998 105.999 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 32.7 ttt-85 -67.76 106.13 2.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.189 -1.041 . . . . 71.219999999999999 108.189 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 p -58.46 124.54 72.18 Favored Pre-proline 0 N--CA 1.422 -1.863 0 N-CA-C 107.111 -1.44 . . . . 72.530000000000001 107.111 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 90.5 Cg_endo -71.43 38.49 0.34 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.357 2.704 . . . . 72.519999999999996 114.217 -162.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -131.13 15.63 5.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.3 0.572 . . . . 63.119999999999997 111.326 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.5 24.93 19.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.362 -0.923 . . . . 64.219999999999999 111.844 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.34 161.57 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.433 -0.58 . . . . 44.210000000000001 109.433 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 38.2 tt0 -151.12 115.35 5.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.87 -0.418 . . . . 70.409999999999997 109.87 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.34 128.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.771 -0.455 . . . . 73.019999999999996 109.771 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 24.5 p90 -72.25 119.85 17.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.698 0.761 . . . . 63.020000000000003 110.845 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -111.29 166.35 11.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.873 -1.058 . . . . 62.039999999999999 108.421 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -144.98 146.13 31.81 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.403 -0.519 . . . . 64.219999999999999 111.224 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 56.9 mt -115.13 134.89 56.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.507 -0.923 . . . . 43.020000000000003 108.507 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -109.0 -65.03 1.18 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.556 -0.457 . . . . 65.099999999999994 110.978 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -91.45 -177.79 4.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.192 -1.04 . . . . 73.400000000000006 108.192 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.546 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.95 101.26 0.37 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.776 0.798 . . . . 73.019999999999996 109.25 172.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.28 6.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.644 -0.707 . . . . 71.219999999999999 110.269 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 14.1 ptpt -58.99 -179.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.231 -0.895 . . . . 62.32 112.075 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 37.3 mt -67.34 -10.48 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 72.430000000000007 112.376 -169.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' ' HG2' ' A' ' 49' ' ' MET . 70.2 mt-10 -57.5 -53.79 54.22 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.835 0.309 . . . . 72.420000000000002 111.835 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -30.09 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.341 -0.543 . . . . 62.409999999999997 110.913 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 39' ' ' ILE . 95.2 mt -60.27 -36.86 78.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.943 0.401 . . . . 70.349999999999994 110.392 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.6 ptt? -85.78 -34.01 21.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.019 -0.537 . . . . 63.310000000000002 111.176 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 42.0 mt-10 -74.61 -39.65 62.04 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.817 0.303 . . . . 64.219999999999999 111.817 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.87 -29.37 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.152 -0.684 . . . . 72.349999999999994 109.152 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.94 -43.58 57.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.78 . . . . 70.140000000000001 109.999 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 84.5 m -50.11 -52.05 38.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.382 0.611 . . . . 62.329999999999998 110.699 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -27.34 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.834 . . . . 62.25 110.723 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -71.44 -41.57 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.453 -0.34 . . . . 74.420000000000002 111.586 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.38 -6.4 34.19 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.898 -0.321 . . . . 75.420000000000002 111.4 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.51 59.3 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.513 -0.851 . . . . 60.039999999999999 111.775 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.2 tt0 -150.83 129.73 12.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.592 -0.892 . . . . 75.329999999999998 108.592 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.0 p -87.9 178.23 6.75 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.834 0.679 . . . . 31.199999999999999 112.834 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -74.48 -16.16 60.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.982 1.104 . . . . 74.420000000000002 113.982 -164.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.02 -13.67 60.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.884 -0.726 . . . . 75.510000000000005 109.957 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.667 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.02 2.98 23.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.532 -0.758 . . . . 65.209999999999994 110.336 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.718 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 7.0 m -139.63 103.34 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.386 0.613 . . . . 73.140000000000001 110.73 171.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.673 ' HD2' HD11 ' A' ' 66' ' ' LEU . 25.8 ttm180 -69.24 112.05 5.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.759 -0.655 . . . . 70.219999999999999 109.616 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.76 109.95 21.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.551 0.691 . . . . 74.420000000000002 111.64 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 5.2 mp -106.21 130.94 53.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.333 -0.849 . . . . 63.149999999999999 109.481 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HE2' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -127.62 143.47 51.16 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.206 -0.998 . . . . 74.010000000000005 110.618 176.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB2' HG21 ' A' ' 83' ' ' ILE . 35.2 t70 59.67 21.9 10.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.921 0.867 . . . . 75.510000000000005 109.764 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.84 -17.49 58.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 113.237 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -122.72 125.78 46.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.15 0.475 . . . . 72.129999999999995 111.609 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.846 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -65.28 151.45 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 73.239999999999995 110.901 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG12 ' H ' ' A' ' 73' ' ' HIS . 12.5 tt -170.81 -173.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.942 -0.762 . . . . 75.299999999999997 108.942 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.623 ' H ' HG12 ' A' ' 72' ' ' ILE . 94.1 m-70 -86.01 149.23 25.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.254 0.479 . . . . 61.520000000000003 110.435 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.748 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -67.94 -20.9 73.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.632 -0.794 . . . . 50.310000000000002 112.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.921 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 4.6 p-10 -78.78 -4.66 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.599 0.222 . . . . 72.230000000000004 111.599 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -23.45 61.98 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.854 -0.157 . . . . 71.25 111.293 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.905 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.1 p 66.28 159.15 0.13 Allowed Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 70.120000000000005 111.788 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.43 -60.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 73.219999999999999 113.432 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -63.57 -19.07 64.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.901 0.334 . . . . 74.519999999999996 111.901 -170.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -63.24 -25.5 68.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.035 0.445 . . . . 74.25 110.811 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.42 -29.16 17.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.109 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.79 -18.87 8.52 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.842 -0.694 . . . . 62.200000000000003 111.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 87' ' ' ASP . 15.4 tt -101.92 136.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.999 -0.371 . . . . 63.43 109.999 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 26.5 tt0 -148.39 -153.32 0.48 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.942 -0.762 . . . . 64.030000000000001 108.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.789 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.3 p-10 -20.94 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.651 1.18 . . . . 63.130000000000003 113.792 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.5 5.16 30.06 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.993 -0.843 . . . . 60.32 110.993 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 83' ' ' ILE . 11.3 p-10 -85.79 173.09 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.151 -0.525 . . . . 70.519999999999996 110.915 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.32 158.59 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 62.310000000000002 111.137 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 27' ' ' VAL . 69.6 mt -134.64 138.46 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.649 -0.871 . . . . 71.310000000000002 108.649 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.51 126.42 51.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.433 -0.58 . . . . 54.299999999999997 109.433 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.718 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -111.89 116.8 31.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.695 -0.402 . . . . 62.409999999999997 110.388 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 62.6 mtt -101.26 168.82 9.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.109 -0.496 . . . . 71.519999999999996 110.114 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.24 101.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 75.099999999999994 111.311 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.667 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 43.4 mt-30 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 74.299999999999997 112.23 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 22.4 m170 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.889 0.376 . . . . 71.140000000000001 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 17.8 mt -110.59 166.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.402 -0.592 . . . . 44.310000000000002 109.402 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 8.6 tt0 -148.49 139.75 23.32 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.771 -0.455 . . . . 71.430000000000007 109.771 -174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 48' ' ' LEU . 29.0 m -140.82 172.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.077 0.465 . . . . 73.230000000000004 110.741 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 3.7 mtmt -141.71 115.42 9.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 74.439999999999998 109.487 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 89' ' ' ILE . 52.3 t -95.19 95.08 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.589 -1.634 . . . . 73.329999999999998 106.589 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -68.49 103.57 1.7 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.996 -1.483 . . . . 71.219999999999999 106.996 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 31' ' ' ASP . 67.6 m -62.86 158.38 53.35 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 113.498 -1.683 . . . . 72.530000000000001 109.03 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 35.9 Cg_endo -64.8 36.2 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.666 2.911 . . . . 72.519999999999996 114.051 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 29' ' ' SER . 30.7 t70 -131.75 -14.9 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.46 0.647 . . . . 63.119999999999997 110.282 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.85 -3.57 52.64 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.227 -0.749 . . . . 64.219999999999999 111.227 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.01 118.16 23.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.364 -0.418 . . . . 44.210000000000001 110.014 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 23.4 tt0 -116.04 101.43 8.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.396 -0.594 . . . . 70.409999999999997 109.396 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.564 ' HB ' ' OH ' ' A' ' 52' ' ' TYR . 44.3 t -102.75 135.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.801 -0.444 . . . . 73.019999999999996 109.801 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.2 p90 -71.25 132.04 44.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.578 0.704 . . . . 63.020000000000003 111.358 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -126.72 162.8 24.95 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.657 -1.238 . . . . 62.039999999999999 107.657 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -136.99 157.15 47.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.845 0.831 . . . . 64.219999999999999 112.712 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -119.68 136.1 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 43.020000000000003 108.11 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -111.75 -28.14 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.838 -0.745 . . . . 65.099999999999994 111.834 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 35.4 ttm180 -145.78 -177.6 5.67 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.055 -1.461 . . . . 73.400000000000006 107.055 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 20.5 pttp -60.57 99.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.527 -0.869 . . . . 73.019999999999996 110.0 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' HG23 ' A' ' 39' ' ' ILE . 74.0 p -129.38 114.46 16.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.77 -1.104 . . . . 71.219999999999999 108.893 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HA ' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -49.27 153.75 0.96 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 62.32 111.688 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.809 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 36.1 mt -63.0 -12.57 26.75 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.29 -0.868 . . . . 72.430000000000007 111.76 -173.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' OE1' ' HG3' ' A' ' 44' ' ' LYS . 54.5 mt-10 -57.36 -44.43 84.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 72.420000000000002 111.345 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -30.43 68.05 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.561 -0.456 . . . . 62.409999999999997 110.582 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 39' ' ' ILE . 98.0 mt -61.55 -33.06 73.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 70.349999999999994 110.356 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -98.3 -28.98 13.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 63.310000000000002 112.029 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.72 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 46.4 mt-10 -78.01 -33.73 51.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.478 -0.489 . . . . 64.219999999999999 111.257 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.14 -31.89 55.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.021 -0.733 . . . . 72.349999999999994 109.021 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.564 ' OH ' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -71.22 -31.91 68.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 70.140000000000001 111.151 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 66.3 m -50.28 -47.09 55.53 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 62.329999999999998 110.63 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.88 -31.99 51.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.02 -0.537 . . . . 62.25 110.728 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -68.57 -40.28 80.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 74.420000000000002 110.617 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.15 -21.71 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.415 -0.357 . . . . 75.420000000000002 111.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.08 -2.65 69.1 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.768 -0.729 . . . . 60.039999999999999 112.163 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.3 tp60 -124.49 129.79 51.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.106 -0.702 . . . . 75.329999999999998 109.106 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.738 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.0 p -81.25 178.65 8.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 31.199999999999999 112.366 -174.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.676 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -76.64 -16.12 59.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.665 1.357 . . . . 74.420000000000002 114.665 -162.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -74.28 -9.88 59.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 75.510000000000005 110.363 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -109.38 10.62 25.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.765 -0.652 . . . . 65.209999999999994 110.268 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.889 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 18.0 m -139.38 121.74 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.59 . . . . 73.140000000000001 111.465 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 20.3 tpp180 -85.56 113.81 22.09 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.616 -0.513 . . . . 70.219999999999999 109.616 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -83.43 118.07 23.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.487 -0.779 . . . . 74.420000000000002 112.376 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 10.2 mp -110.42 129.38 55.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.618 -0.719 . . . . 63.149999999999999 109.863 172.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.497 ' HD2' ' HB ' ' A' ' 72' ' ' ILE . 62.4 m-85 -106.89 129.87 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.439 -0.208 . . . . 74.010000000000005 110.439 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.76 23.34 9.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.999 0.904 . . . . 75.510000000000005 109.77 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.03 -0.28 78.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.458 -0.792 . . . . 73.329999999999998 112.567 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 37.3 t0 -127.15 122.91 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.578 0.704 . . . . 72.129999999999995 111.14 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -59.61 110.6 1.17 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.125 -0.943 . . . . 73.239999999999995 112.37 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' H ' ' A' ' 73' ' ' HIS . 11.2 mm -125.68 -167.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.171 -1.418 . . . . 75.299999999999997 107.171 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.865 ' H ' HG22 ' A' ' 72' ' ' ILE . 3.6 p80 -116.41 149.25 39.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.205 0.457 . . . . 61.520000000000003 110.091 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.809 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -64.54 -34.47 89.98 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.705 -0.68 . . . . 50.310000000000002 114.295 -168.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.95 -12.12 52.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.853 0.327 . . . . 72.230000000000004 111.584 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.645 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 3.5 t30 -70.87 -25.7 62.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.04 -0.356 . . . . 71.25 110.04 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' HA ' ' A' ' 44' ' ' LYS . 44.8 p 61.16 153.74 0.11 Allowed Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.639 1.176 . . . . 70.120000000000005 112.627 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 30.8 Cg_endo -64.91 -46.79 5.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.462 2.108 . . . . 73.219999999999999 111.833 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -46.17 -43.35 15.05 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.328 -0.851 . . . . 74.519999999999996 111.728 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.645 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 47.8 mt-30 -88.55 -15.7 34.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.25 111.704 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.7 -30.66 18.94 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.0 -0.28 . . . . 73.109999999999999 111.351 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.28 -18.93 25.18 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.315 -0.945 . . . . 62.200000000000003 110.916 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.3 tp -93.01 144.16 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.136 -1.061 . . . . 63.43 108.136 170.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CG ' ' H ' ' A' ' 85' ' ' ASP . 1.7 tt0 -141.09 -152.22 0.4 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.325 -0.62 . . . . 64.030000000000001 109.325 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 24' ' ' GLN . 7.2 t70 -45.99 118.41 1.86 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.06 0.457 . . . . 63.130000000000003 112.021 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.93 3.51 17.81 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.434 -0.803 . . . . 60.32 111.664 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.479 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.1 t0 -73.97 158.48 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 70.519999999999996 111.19 -175.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 32.7 m -129.96 147.28 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.815 -0.629 . . . . 62.310000000000002 110.357 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.4 mt -119.57 119.27 59.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.632 -0.713 . . . . 71.310000000000002 109.288 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -102.86 126.96 50.21 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.677 -0.49 . . . . 54.299999999999997 109.677 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.87 117.82 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.939 0.4 . . . . 62.409999999999997 111.786 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 1.8 mpt? -90.91 170.13 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 71.519999999999996 110.476 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.98 109.6 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 75.099999999999994 111.299 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.637 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 48.9 mt-30 . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.017 -0.992 . . . . 74.299999999999997 111.515 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.805 -0.443 . . . . 71.140000000000001 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.5 mt -109.98 166.96 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.715 -0.846 . . . . 44.310000000000002 108.715 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.441 ' N ' HG22 ' A' ' 23' ' ' ILE . 41.6 tt0 -144.24 138.26 27.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.232 -0.284 . . . . 71.430000000000007 110.232 -173.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 48' ' ' LEU . 14.7 p -150.79 140.97 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.983 -0.553 . . . . 73.230000000000004 110.005 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.791 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 2.4 mtmp? -102.0 123.24 45.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.782 -0.451 . . . . 74.439999999999998 109.782 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.4 t -101.33 95.26 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 105.472 -2.047 . . . . 73.329999999999998 105.472 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 21.1 ttt180 -68.3 105.07 2.02 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 114.819 -1.082 . . . . 71.219999999999999 108.386 -172.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 68.5 m -63.38 139.39 97.57 Favored Pre-proline 0 N--CA 1.418 -2.037 0 N-CA-C 107.424 -1.325 . . . . 72.530000000000001 107.424 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.23 33.48 0.16 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.542 2.828 . . . . 72.519999999999996 114.643 -166.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -131.36 3.46 4.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.617 0.722 . . . . 63.119999999999997 109.567 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.26 16.52 53.25 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.885 -0.886 . . . . 64.219999999999999 110.885 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 29' ' ' SER . . . -99.44 74.91 1.93 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.618 . . . . 44.210000000000001 109.805 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.791 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 27.7 tt0 -87.44 102.67 14.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.843 -0.617 . . . . 70.409999999999997 109.822 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.36 136.34 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.976 -0.556 . . . . 73.019999999999996 109.71 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -80.47 121.68 26.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.464 0.65 . . . . 63.020000000000003 111.192 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.97 165.21 13.12 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.301 -1.37 . . . . 62.039999999999999 107.301 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -138.72 168.57 19.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.666 -0.814 . . . . 64.219999999999999 112.23 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 58.0 mt -114.2 134.93 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.662 -1.154 . . . . 43.020000000000003 109.369 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.92 -81.91 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.003 0.43 . . . . 65.099999999999994 109.992 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 59.6 ttt180 -101.97 -177.18 3.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.123 -1.436 . . . . 73.400000000000006 107.123 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.497 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 47.3 pttt -53.09 102.01 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.465 0.65 . . . . 73.019999999999996 111.42 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 39' ' ' ILE . 1.6 p -142.47 107.47 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 71.219999999999999 110.626 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 37.6 pttt -51.6 175.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.158 -0.928 . . . . 62.32 113.493 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 48' ' ' LEU . 44.7 mt -66.43 -21.69 66.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.657 -1.156 . . . . 72.430000000000007 113.03 -169.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.53 ' HA ' ' CE ' ' A' ' 49' ' ' MET . 34.0 mt-10 -58.5 -33.49 69.87 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.569 0.581 . . . . 72.420000000000002 112.569 -171.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -23.39 32.59 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.351 -0.54 . . . . 62.409999999999997 110.837 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.759 HD13 HG11 ' A' ' 25' ' ' VAL . 73.0 mt -64.84 -35.34 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.361 . . . . 70.349999999999994 111.456 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.3 -39.37 14.43 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.497 -0.881 . . . . 63.310000000000002 111.268 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' N ' ' HG2' ' A' ' 49' ' ' MET . 12.4 mm-40 -68.95 -37.96 79.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.431 0.53 . . . . 64.219999999999999 112.431 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 55' ' ' ARG . 69.8 t -60.48 -31.45 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.268 -0.573 . . . . 72.349999999999994 109.664 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.49 ' HD2' HD23 ' A' ' 56' ' ' LEU . 8.3 t80 -83.01 -29.84 28.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.149 -0.478 . . . . 70.140000000000001 110.13 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.031 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 73.6 m -58.34 -37.25 74.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.296 0.569 . . . . 62.329999999999998 110.758 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.17 -32.78 74.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 62.25 110.825 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 51' ' ' VAL . 9.4 mpt_? -73.25 -50.55 21.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 111.496 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 52' ' ' TYR . 2.9 pp -76.01 -20.99 57.37 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.713 -0.221 . . . . 75.420000000000002 111.583 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.83 13.24 37.9 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.755 -0.735 . . . . 60.039999999999999 113.527 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -150.3 130.12 13.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.083 -0.71 . . . . 75.329999999999998 109.083 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 1.031 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.2 p -78.37 167.13 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.447 0.641 . . . . 31.199999999999999 112.595 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.726 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -64.47 -15.85 61.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.821 -1.081 . . . . 74.420000000000002 112.897 -169.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.51 -17.36 62.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.052 0.453 . . . . 75.510000000000005 110.46 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.06 8.99 18.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.112 -0.494 . . . . 65.209999999999994 110.088 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 60' ' ' MET . 3.0 m -143.49 103.17 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.935 -0.575 . . . . 73.140000000000001 110.086 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 25.0 tpt180 -73.24 125.68 28.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.533 . . . . 70.219999999999999 110.378 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -87.03 112.4 21.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.459 -0.791 . . . . 74.420000000000002 112.314 -175.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.626 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 7.9 mp -93.79 124.89 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.865 -0.607 . . . . 63.149999999999999 109.538 172.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HD2' HG12 ' A' ' 89' ' ' ILE . 83.1 m-85 -103.3 113.69 27.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.323 -0.251 . . . . 74.010000000000005 110.323 -177.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 t70 57.88 26.99 13.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 122.079 0.942 . . . . 75.510000000000005 109.869 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.12 -16.89 58.79 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.228 -0.896 . . . . 73.329999999999998 112.787 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -111.96 116.41 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.513 0.673 . . . . 72.129999999999995 110.623 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 12.0 ptt-85 -80.24 111.5 16.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.655 -0.702 . . . . 73.239999999999995 111.401 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.9 -165.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.935 -0.575 . . . . 75.299999999999997 110.187 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -85.22 140.87 30.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.083 -0.34 . . . . 61.520000000000003 110.083 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.48 -18.14 76.8 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.225 -0.512 . . . . 50.310000000000002 113.005 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 33.9 t70 -70.08 -12.97 61.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.033 0.444 . . . . 72.230000000000004 111.084 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -66.33 -41.44 89.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.899 -0.591 . . . . 71.25 110.746 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 m 68.55 136.58 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.903 -0.589 . . . . 70.120000000000005 111.091 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD3' ' HG ' ' A' ' 45' ' ' LEU . 76.4 Cg_exo -51.66 -36.86 62.67 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.215 2.61 . . . . 73.219999999999999 113.725 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.63 -34.24 36.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.267 0.469 . . . . 74.519999999999996 112.267 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -88.6 -18.06 28.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 74.25 111.254 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.05 -30.37 19.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.497 -0.32 . . . . 73.109999999999999 111.756 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.76 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.24 -0.981 . . . . 62.200000000000003 110.654 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 84' ' ' GLU . 10.1 tp -91.85 159.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.235 -1.394 . . . . 63.43 107.235 169.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.647 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 25.0 tt0 -154.05 -171.62 3.94 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.763 -0.829 . . . . 64.030000000000001 108.763 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 23' ' ' ILE . 8.4 p-10 -47.51 126.28 9.58 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.77 0.795 . . . . 63.130000000000003 112.358 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.56 4.26 15.57 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.86 -1.064 . . . . 60.32 110.844 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.41 -173.58 4.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.088 0.471 . . . . 70.519999999999996 111.072 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.03 148.37 22.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.563 0.697 . . . . 62.310000000000002 111.348 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 27' ' ' VAL . 64.8 mt -119.0 114.04 43.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.036 -0.984 . . . . 71.310000000000002 108.976 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -99.81 118.0 35.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.721 -0.474 . . . . 54.299999999999997 109.721 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.81 117.36 33.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.107 0.48 . . . . 62.409999999999997 111.207 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.7 144.89 35.89 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.093 -0.706 . . . . 71.519999999999996 109.093 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.39 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.397 0.435 . . . . 75.099999999999994 111.356 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 3.2 pt20 . . . . . 0 N--CA 1.469 0.513 0 O-C-N 124.658 1.224 . . . . 74.299999999999997 112.552 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.503 0.668 . . . . 71.140000000000001 112.235 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 28.4 mt -110.5 166.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.734 -1.21 . . . . 44.310000000000002 107.734 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.684 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 31.5 tt0 -162.38 123.99 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 71.430000000000007 111.004 -171.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 48' ' ' LEU . 15.5 m -137.09 141.93 38.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.428 -0.582 . . . . 73.230000000000004 109.428 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.607 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.9 ttmt -100.01 111.32 23.63 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.793 -0.763 . . . . 74.439999999999998 109.02 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 89' ' ' ILE . 67.5 t -95.3 99.29 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.419 -0.956 . . . . 73.329999999999998 108.419 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.804 ' HE ' ' HA2' ' A' ' 32' ' ' GLY . 36.2 ttt180 -70.2 104.66 2.69 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.368 -1.345 . . . . 71.219999999999999 107.368 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.684 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 10.0 p -65.74 164.89 23.15 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.044 -0.98 . . . . 72.530000000000001 109.39 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 52.2 Cg_endo -67.69 30.63 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 123.115 2.543 . . . . 72.519999999999996 114.769 -169.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -131.74 -23.36 2.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.67 -0.492 . . . . 63.119999999999997 109.67 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.804 ' HA2' ' HE ' ' A' ' 28' ' ' ARG . . . 126.67 -11.25 7.07 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.757 -0.656 . . . . 64.219999999999999 112.293 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.33 94.67 3.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.158 0.504 . . . . 44.210000000000001 110.796 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.78 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 35.8 tt0 -92.5 99.33 12.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 70.409999999999997 109.586 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.22 134.31 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.173 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 21.0 p90 -75.98 105.14 6.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.589 0.709 . . . . 63.020000000000003 110.31 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.414 ' HD1' ' CD2' ' A' ' 48' ' ' LEU . 6.2 t80 -111.72 151.35 29.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.516 -0.92 . . . . 62.039999999999999 108.516 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 24' ' ' GLN . 78.4 mttt -125.87 168.64 13.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.664 0.745 . . . . 64.219999999999999 111.735 -169.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -115.42 134.22 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.397 -1.334 . . . . 43.020000000000003 107.397 170.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -103.03 -58.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.137 -0.625 . . . . 65.099999999999994 110.161 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -106.48 -178.95 3.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.178 -1.045 . . . . 73.400000000000006 108.178 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.93 101.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.999 0.363 . . . . 73.019999999999996 110.417 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.401 ' CG2' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -134.02 133.19 40.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.98 0.419 . . . . 71.219999999999999 110.515 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 167.3 21.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 62.32 111.081 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.705 HD21 ' HD3' ' A' ' 78' ' ' PRO . 96.6 mt -67.47 -23.87 65.55 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.464 0.542 . . . . 72.430000000000007 112.464 -170.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 34.0 mp0 -59.21 -24.68 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.033 0.383 . . . . 72.420000000000002 112.033 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -76.38 -37.66 56.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.202 -0.599 . . . . 62.409999999999997 109.949 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 39' ' ' ILE . 59.5 mt -62.53 -38.33 89.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.195 0.521 . . . . 70.349999999999994 109.99 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 20.0 ptm -80.01 -37.13 34.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.586 -0.734 . . . . 63.310000000000002 111.5 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 49.8 mm-40 -67.91 -30.46 69.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.955 -0.298 . . . . 64.219999999999999 111.719 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 47' ' ' LYS . 76.5 t -54.88 -39.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.465 -0.494 . . . . 72.349999999999994 110.296 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -75.97 -35.12 59.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 70.140000000000001 111.507 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 64.4 m -49.88 -48.13 51.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.909 0.385 . . . . 62.329999999999998 111.044 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.71 -32.77 62.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 62.25 111.289 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 74.420000000000002 111.08 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.49 -21.55 26.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.468 -0.333 . . . . 75.420000000000002 111.275 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.05 12.98 83.85 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.501 -1.04 . . . . 60.039999999999999 110.501 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.4 tt0 -136.2 129.94 32.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.492 -0.929 . . . . 75.329999999999998 108.492 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 6.2 p -81.42 171.64 14.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.456 0.646 . . . . 31.199999999999999 112.158 -173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.562 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.34 -15.08 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.902 -1.045 . . . . 74.420000000000002 112.935 -174.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.62 -15.28 57.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.976 0.361 . . . . 75.510000000000005 111.976 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HA ' ' CG ' ' A' ' 94' ' ' GLN . . . -109.95 9.25 24.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.125 0.488 . . . . 65.209999999999994 110.177 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.742 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 18.3 m -140.5 172.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.595 . . . . 73.140000000000001 110.495 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 tpp85 -143.75 130.49 20.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.607 -0.516 . . . . 70.219999999999999 109.607 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 49' ' ' MET . 91.3 m-85 -99.99 116.38 31.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 74.420000000000002 111.441 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -111.03 113.45 26.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.392 -0.822 . . . . 63.149999999999999 110.015 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.667 ' HB3' HG12 ' A' ' 89' ' ' ILE . 23.2 p90 -112.47 146.15 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.098 -0.641 . . . . 74.010000000000005 110.175 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.1 t70 60.44 21.94 11.58 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.352 1.072 . . . . 75.510000000000005 109.3 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.92 -12.09 68.57 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.118 -0.946 . . . . 73.329999999999998 113.109 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -130.63 127.55 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.427 0.613 . . . . 72.129999999999995 112.054 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -63.96 159.21 20.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.681 -0.69 . . . . 73.239999999999995 111.839 175.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.756 HG12 ' H ' ' A' ' 73' ' ' HIS . 10.2 tt -173.03 -171.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.428 -0.582 . . . . 75.299999999999997 109.428 175.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.756 ' H ' HG12 ' A' ' 72' ' ' ILE . 11.5 m170 -75.51 151.79 37.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.878 0.371 . . . . 61.520000000000003 110.687 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -72.69 -19.85 79.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.794 -0.717 . . . . 50.310000000000002 112.217 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.97 -19.21 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.57 0.211 . . . . 72.230000000000004 111.57 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.671 ' OD1' ' HB2' ' A' ' 73' ' ' HIS . 18.7 m120 -68.15 -44.14 76.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.018 -0.364 . . . . 71.25 110.018 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.0 p 61.96 162.54 0.11 Allowed Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.871 0.869 . . . . 70.120000000000005 111.512 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.705 ' HD3' HD21 ' A' ' 45' ' ' LEU . 24.9 Cg_exo -64.3 -39.21 30.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.463 2.109 . . . . 73.219999999999999 112.356 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.54 -49.11 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 74.519999999999996 110.976 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.798 HE21 ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -67.06 -22.74 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.686 -173.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.7 tp -86.63 -29.5 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 73.109999999999999 110.241 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.41 -18.44 27.72 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.112 -0.795 . . . . 62.200000000000003 111.112 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.61 126.87 54.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.089 -0.708 . . . . 63.43 109.089 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.0 tt0 -131.37 -151.52 0.47 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.408 -0.36 . . . . 64.030000000000001 110.344 -169.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 4.0 p-10 -43.4 131.73 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.551 0.691 . . . . 63.130000000000003 112.631 -172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.38 -9.5 24.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.547 -0.751 . . . . 60.32 112.007 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.68 169.86 10.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.945 -0.391 . . . . 70.519999999999996 109.945 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.9 161.95 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.306 0.574 . . . . 62.310000000000002 111.261 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.667 HG12 ' HB3' ' A' ' 67' ' ' TYR . 35.6 mt -132.94 117.22 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.424 -0.954 . . . . 71.310000000000002 108.424 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 3.4 t70 -98.69 125.98 44.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.84 -0.43 . . . . 54.299999999999997 109.84 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 64' ' ' ARG . . . -97.79 117.04 31.21 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.174 0.511 . . . . 62.409999999999997 110.512 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.0 163.64 12.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.713 -0.676 . . . . 71.519999999999996 109.37 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.06 101.42 3.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.912 -0.315 . . . . 75.099999999999994 111.345 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.742 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 45.2 mt-30 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.452 -0.794 . . . . 74.299999999999997 111.692 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.462 -0.57 . . . . 71.140000000000001 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 14.8 mt -110.76 168.1 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.909 -0.404 . . . . 44.310000000000002 109.909 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 41.7 mt-30 -150.8 131.72 14.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.877 0.471 . . . . 71.430000000000007 110.674 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 48' ' ' LEU . 35.8 m -130.35 -177.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.356 -0.609 . . . . 73.230000000000004 109.356 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.74 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mtmt -138.77 114.75 10.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.767 0.318 . . . . 74.439999999999998 110.554 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 89' ' ' ILE . 66.9 t -97.17 100.94 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 107.73 -1.211 . . . . 73.329999999999998 107.73 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -69.9 106.68 3.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.925 -1.139 . . . . 71.219999999999999 107.925 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 66.1 p -60.34 160.28 18.59 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.256 -0.884 . . . . 72.530000000000001 108.954 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 36.7 Cg_endo -65.2 31.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 123.165 2.576 . . . . 72.519999999999996 114.076 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 29' ' ' SER . 27.7 t70 -131.44 -21.45 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.272 0.558 . . . . 63.119999999999997 110.77 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.65 -15.73 24.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.268 -0.733 . . . . 64.219999999999999 111.268 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.09 104.17 1.71 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.539 -0.541 . . . . 44.210000000000001 109.539 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.74 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 34.0 tt0 -113.44 96.86 6.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.36 -0.836 . . . . 70.409999999999997 109.289 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.27 134.57 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.221 -0.659 . . . . 73.019999999999996 109.221 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 34.9 p90 -68.32 130.5 43.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.227 0.536 . . . . 63.020000000000003 110.191 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG11 ' A' ' 51' ' ' VAL . 3.9 t80 -128.12 130.17 47.72 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.983 -1.117 . . . . 62.039999999999999 107.983 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 44.4 pttt -105.29 163.69 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.88 0.848 . . . . 64.219999999999999 112.555 -165.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 65.2 mt -114.83 134.77 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.419 -1.264 . . . . 43.020000000000003 108.063 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.15 -81.68 0.37 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.281 0.562 . . . . 65.099999999999994 110.628 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -102.1 -176.57 3.16 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.022 -1.103 . . . . 73.400000000000006 108.022 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.76 101.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.258 0.551 . . . . 73.019999999999996 109.967 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 1.7 p -141.47 105.23 4.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.968 -1.015 . . . . 71.219999999999999 109.776 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -39.24 152.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.841 -1.072 . . . . 62.32 113.308 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.47 -15.4 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.118 -0.947 . . . . 72.430000000000007 111.236 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 42.5 mt-10 -62.73 -26.28 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 72.420000000000002 111.181 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -78.13 -36.24 48.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.44 -0.504 . . . . 62.409999999999997 109.905 177.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 25' ' ' VAL . 74.3 mt -59.38 -29.72 67.91 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.763 -0.828 . . . . 70.349999999999994 108.763 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.638 ' HG3' ' CD1' ' A' ' 65' ' ' PHE . 24.9 ttt -78.62 -51.09 10.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.111 -1.404 . . . . 63.310000000000002 111.049 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 42.7 mt-10 -70.43 -30.19 66.98 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.511 0.559 . . . . 64.219999999999999 112.511 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 47' ' ' LYS . 54.5 t -55.71 -38.47 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.442 -0.503 . . . . 72.349999999999994 111.101 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.8 -30.44 65.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.579 -0.282 . . . . 70.140000000000001 111.504 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 62.2 m -51.36 -39.78 57.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.33 0.586 . . . . 62.329999999999998 110.57 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -76.57 -41.26 47.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.533 -0.758 . . . . 62.25 111.147 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -64.22 -50.77 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.02 0.748 . . . . 74.420000000000002 113.02 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 58' ' ' GLN . 1.2 pp -98.63 8.51 44.83 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.564 -0.454 . . . . 75.420000000000002 111.914 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.17 27.36 72.89 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.158 -0.544 . . . . 60.039999999999999 113.386 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 10.2 tt0 -143.22 130.84 21.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.482 -0.933 . . . . 75.329999999999998 108.482 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 p -89.33 174.3 7.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.952 0.723 . . . . 31.199999999999999 112.952 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.461 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -70.11 -14.92 62.88 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 115.023 1.49 . . . . 74.420000000000002 115.023 -163.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.38 -12.68 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.08 -1.012 . . . . 75.510000000000005 109.76 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -101.54 -7.6 22.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.429 -0.805 . . . . 65.209999999999994 110.272 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 92' ' ' MET . 5.1 m -138.72 104.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.911 -0.586 . . . . 73.140000000000001 110.223 172.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HE ' HD11 ' A' ' 66' ' ' LEU . 54.1 ttp180 -88.01 125.9 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.293 -0.412 . . . . 70.219999999999999 110.099 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 54.7 m-85 -92.93 122.95 35.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.18 0.514 . . . . 74.420000000000002 111.347 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.98 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -106.73 113.33 26.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.674 -0.693 . . . . 63.149999999999999 109.838 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 89' ' ' ILE . 47.1 p90 -112.73 145.71 40.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.836 -0.746 . . . . 74.010000000000005 111.149 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.26 22.51 11.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.071 0.938 . . . . 75.510000000000005 109.058 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.98 2.27 86.54 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.979 -1.009 . . . . 73.329999999999998 112.14 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -122.17 117.72 26.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.145 0.498 . . . . 72.129999999999995 111.324 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.98 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -66.74 119.26 11.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.219 0.533 . . . . 73.239999999999995 111.189 173.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.478 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 8.0 tt -161.3 157.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.407 -0.59 . . . . 75.299999999999997 109.407 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.34 135.37 48.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.099 0.476 . . . . 61.520000000000003 111.877 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.48 82.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.586 -0.734 . . . . 50.310000000000002 114.419 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.2 -33.35 75.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.207 0.503 . . . . 72.230000000000004 111.364 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' A' ' 76' ' ' ASN . 2.0 t-20 -79.83 0.67 30.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.386 -0.37 . . . . 71.25 111.23 -173.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.708 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 80.9 p 59.89 163.83 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.28 1.032 . . . . 70.120000000000005 112.833 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 73.0 Cg_endo -76.17 -31.73 4.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.149 1.899 . . . . 73.219999999999999 112.127 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.6 -34.34 67.11 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.786 -0.643 . . . . 74.519999999999996 110.758 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -77.09 -19.03 57.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.064 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -93.88 -30.88 14.57 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 73.109999999999999 111.23 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.16 -19.04 23.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.463 -0.875 . . . . 62.200000000000003 110.97 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.587 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -85.65 147.92 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.878 -1.156 . . . . 63.43 107.878 169.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.73 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 23.1 tt0 -151.23 -152.35 0.43 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.191 -0.67 . . . . 64.030000000000001 109.191 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.73 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t70 -47.32 114.84 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.865 0.364 . . . . 63.130000000000003 110.855 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.09 3.9 14.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.978 -0.629 . . . . 60.32 111.536 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HB2' HG13 ' A' ' 83' ' ' ILE . 17.7 t70 -76.09 142.05 41.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 70.519999999999996 111.049 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 17.7 m -114.47 141.47 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 121.345 0.593 . . . . 62.310000000000002 109.796 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.572 HG12 ' HB3' ' A' ' 67' ' ' TYR . 22.8 mt -121.37 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.497 -0.774 . . . . 71.310000000000002 109.651 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.64 -0.255 . . . . 54.299999999999997 110.906 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -94.93 118.16 31.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 62.409999999999997 111.282 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 66.9 mmm -105.37 168.04 9.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 71.519999999999996 110.621 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.05 109.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 75.099999999999994 111.371 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.792 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 89.6 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 74.299999999999997 113.13 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 110.061 -0.348 . . . . 71.140000000000001 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 23.6 mt -126.01 160.12 33.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.055 -1.091 . . . . 44.310000000000002 108.055 172.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 2.0 tt0 -145.8 135.85 23.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.567 0.222 . . . . 71.430000000000007 110.96 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 48' ' ' LEU . 26.8 m -139.47 149.07 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 73.230000000000004 110.196 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.635 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 mtmt -119.36 114.94 23.12 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.217 -0.302 . . . . 74.439999999999998 110.427 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 89' ' ' ILE . 53.2 t -97.36 98.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.946 -1.501 . . . . 73.329999999999998 106.946 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 27.6 ttp180 -68.99 103.74 1.92 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.055 -1.461 . . . . 71.219999999999999 107.055 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 70.8 m -64.63 158.46 67.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 114.073 -1.421 . . . . 72.530000000000001 108.699 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 37.1 Cg_endo -64.31 32.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 123.63 2.887 . . . . 72.519999999999996 114.756 -170.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 29' ' ' SER . 28.8 t70 -134.06 -8.58 2.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.449 0.642 . . . . 63.119999999999997 110.302 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.85 57.01 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.88 -0.888 . . . . 64.219999999999999 110.88 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 99.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 44.210000000000001 110.246 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 35.1 tt0 -104.92 99.78 9.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.526 -0.761 . . . . 70.409999999999997 109.515 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.56 134.77 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 73.019999999999996 110.338 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 20.8 p90 -76.59 117.37 18.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.78 0.8 . . . . 63.020000000000003 111.691 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -112.02 171.59 7.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.696 -1.224 . . . . 62.039999999999999 107.696 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -145.66 165.53 28.45 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.358 -0.937 . . . . 64.219999999999999 112.476 -170.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 48.5 mt -123.1 147.59 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.602 -1.181 . . . . 43.020000000000003 108.958 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -128.96 -77.63 0.56 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.2 -0.667 . . . . 65.099999999999994 109.2 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -72.62 150.14 43.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.185 -1.413 . . . . 73.400000000000006 107.185 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 42' ' ' LYS . 59.7 pttt -56.64 101.24 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.902 0.858 . . . . 73.019999999999996 111.219 -175.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.46 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -134.68 103.31 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.063 -0.971 . . . . 71.219999999999999 109.465 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 13.1 pttp -63.54 -178.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.328 0.862 . . . . 62.32 113.328 -173.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.863 ' HA ' HD12 ' A' ' 48' ' ' LEU . 37.4 mt -60.91 -16.73 45.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.626 -1.17 . . . . 72.430000000000007 113.611 -164.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 49' ' ' MET . 53.1 mt-10 -58.09 -57.37 13.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.83 0.307 . . . . 72.420000000000002 111.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -68.2 -28.42 67.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.878 -0.329 . . . . 62.409999999999997 111.008 -175.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.1 mt -58.96 -37.59 77.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 70.349999999999994 110.73 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.1 ptt? -90.98 -32.79 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.628 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 27.6 mt-10 -67.91 -34.63 77.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.072 0.397 . . . . 64.219999999999999 112.072 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 62.3 t -55.8 -37.68 48.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.207 0.527 . . . . 72.349999999999994 109.946 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.86 -36.76 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 70.140000000000001 111.287 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.054 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 58.5 m -52.21 -53.44 43.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.15 0.5 . . . . 62.329999999999998 110.638 173.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -67.22 -32.32 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.652 . . . . 62.25 110.938 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -69.26 -38.87 78.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.297 -0.41 . . . . 74.420000000000002 111.244 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.03 -13.93 37.61 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.874 -0.33 . . . . 75.420000000000002 111.422 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.4 8.46 52.75 Favored Glycine 0 CA--C 1.517 0.158 0 C-N-CA 120.556 -0.831 . . . . 60.039999999999999 113.822 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -151.17 135.18 16.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.7 -0.481 . . . . 75.329999999999998 109.7 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 1.054 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 3.6 p -78.37 179.33 7.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.191 0.811 . . . . 31.199999999999999 113.191 -171.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.586 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.2 -14.15 62.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.893 1.442 . . . . 74.420000000000002 114.893 -163.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -1.8 27.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.093 -1.004 . . . . 75.510000000000005 109.982 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . . . -113.76 1.8 14.96 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 65.209999999999994 109.953 173.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.859 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -142.52 102.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.362 0.601 . . . . 73.140000000000001 110.19 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.642 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 22.9 tpt180 -71.17 114.19 8.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 70.219999999999999 111.192 -172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -80.43 110.87 16.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.277 -0.874 . . . . 74.420000000000002 112.306 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 9.9 mp -104.8 125.51 50.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.797 -0.638 . . . . 63.149999999999999 109.783 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HD1' HG12 ' A' ' 89' ' ' ILE . 74.0 m-85 -103.26 123.77 47.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.211 -0.292 . . . . 74.010000000000005 110.211 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.2 t70 57.82 22.95 9.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.147 0.975 . . . . 75.510000000000005 110.039 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.75 63.17 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.5 -0.773 . . . . 73.329999999999998 112.691 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.42 117.88 26.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 72.129999999999995 111.523 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.99 122.43 16.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 73.239999999999995 111.467 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 67' ' ' TYR . 8.3 pt -147.66 -162.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.968 -0.753 . . . . 75.299999999999997 108.968 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.411 ' H ' ' HB ' ' A' ' 72' ' ' ILE . 38.8 m170 -89.64 159.52 17.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.862 0.363 . . . . 61.520000000000003 110.88 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.679 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -76.59 -17.56 79.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.883 -0.675 . . . . 50.310000000000002 111.496 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.714 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 p30 -74.61 -9.21 58.35 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.468 0.307 . . . . 72.230000000000004 111.387 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.431 HD21 ' HB2' ' A' ' 81' ' ' LEU . 7.2 t30 -67.7 -38.26 83.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.414 -0.357 . . . . 71.25 110.877 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.5 p 63.27 144.72 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 124.356 1.063 . . . . 70.120000000000005 111.461 -174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.0 -51.08 10.37 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.981 2.454 . . . . 73.219999999999999 113.219 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -56.95 -31.64 65.2 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.297 0.48 . . . . 74.519999999999996 112.297 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.83 -19.52 58.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.085 0.469 . . . . 74.25 110.667 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' HD21 ' A' ' 76' ' ' ASN . 44.4 tp -91.5 -30.88 16.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.356 . . . . 73.109999999999999 111.51 -171.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.1 -18.85 13.91 Favored Glycine 0 CA--C 1.502 -0.767 0 N-CA-C 110.1 -1.2 . . . . 62.200000000000003 110.1 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tp -89.3 159.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.957 -1.127 . . . . 63.43 107.957 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 28.3 tt0 -154.55 -152.4 0.4 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.983 -1.117 . . . . 64.030000000000001 107.983 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.749 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.9 t70 -43.85 119.36 1.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.603 0.638 . . . . 63.130000000000003 111.616 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.46 4.71 32.47 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.724 -0.75 . . . . 60.32 111.539 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB3' HG12 ' A' ' 25' ' ' VAL . 18.3 t70 -60.67 151.52 28.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.607 -0.297 . . . . 70.519999999999996 110.644 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 23.5 m -128.61 148.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.432 0.634 . . . . 62.310000000000002 110.607 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 27' ' ' VAL . 54.6 mt -127.85 113.05 29.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.368 -0.975 . . . . 71.310000000000002 108.368 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -102.76 126.17 49.78 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.969 -0.382 . . . . 54.299999999999997 109.969 -173.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.859 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -104.62 118.01 35.53 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.429 0.455 . . . . 62.409999999999997 112.146 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.3 mpt? -95.14 171.23 8.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.565 -0.532 . . . . 71.519999999999996 109.565 172.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.94 117.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.719 0.295 . . . . 75.099999999999994 111.345 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 48.8 mt-30 . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 124.013 0.925 . . . . 74.299999999999997 112.22 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.2 m80 . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.927 -0.397 . . . . 71.140000000000001 109.927 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 10.2 mt -109.83 169.63 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.614 -0.513 . . . . 44.310000000000002 109.614 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 23' ' ' ILE . 4.1 tt0 -145.9 138.26 25.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.483 -0.562 . . . . 71.430000000000007 109.483 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.862 HG11 HD13 ' A' ' 48' ' ' LEU . 7.4 p -150.73 138.38 13.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.188 0.518 . . . . 73.230000000000004 110.234 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' A' ' 36' ' ' PHE . 39.6 mttt -102.41 140.83 36.18 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.314 -0.403 . . . . 74.439999999999998 110.508 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 77.1 t -119.81 100.69 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.871 -1.529 . . . . 73.329999999999998 106.871 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 6.6 ttp180 -69.51 111.31 5.27 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.326 -0.99 . . . . 71.219999999999999 108.326 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 78.4 p -60.28 157.65 32.74 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.645 -0.872 . . . . 72.530000000000001 108.645 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 36.2 Cg_endo -64.68 27.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.31 2.673 . . . . 72.519999999999996 114.504 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 29' ' ' SER . 12.3 t70 -130.52 -22.64 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.25 0.547 . . . . 63.119999999999997 110.615 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.63 -5.56 24.49 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.604 -0.808 . . . . 64.219999999999999 111.577 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.56 91.61 3.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.311 0.576 . . . . 44.210000000000001 109.538 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 28' ' ' ARG . 37.9 tt0 -101.27 110.69 22.74 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.513 -0.767 . . . . 70.409999999999997 110.123 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.35 134.52 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.961 -0.563 . . . . 73.019999999999996 109.641 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 31.1 p90 -77.1 120.18 21.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.264 0.554 . . . . 63.020000000000003 110.509 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -111.69 170.33 8.21 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.339 -1.356 . . . . 62.039999999999999 107.339 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 42.4 mtmt -139.75 168.14 20.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.761 -0.776 . . . . 64.219999999999999 111.7 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 54.0 mt -117.41 134.66 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 43.020000000000003 108.875 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -115.69 -68.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.349 -0.611 . . . . 65.099999999999994 109.349 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -84.02 152.6 24.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.334 -1.728 . . . . 73.400000000000006 106.334 166.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -59.04 101.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 118.903 0.774 . . . . 73.019999999999996 109.764 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.478 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -126.03 118.82 26.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.758 -0.656 . . . . 71.219999999999999 111.653 -174.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -28.1 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.612 -1.631 . . . . 62.32 113.821 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.937 ' HA ' HD12 ' A' ' 48' ' ' LEU . 48.6 mt -65.18 -18.06 65.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.008 -0.997 . . . . 72.430000000000007 110.06 173.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 49' ' ' MET . 41.7 mt-10 -59.41 -52.47 65.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.646 -0.706 . . . . 72.420000000000002 111.025 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.44 -30.42 70.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 62.409999999999997 110.297 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 45' ' ' LEU . 73.4 mt -60.55 -32.29 71.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.966 -0.561 . . . . 70.349999999999994 110.62 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 21.3 ptp -95.74 -29.85 14.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.885 -0.326 . . . . 63.310000000000002 110.917 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 48.5 mt-10 -66.47 -34.08 77.14 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.45 0.167 . . . . 64.219999999999999 111.45 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 47' ' ' LYS . 78.7 t -57.64 -39.25 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.062 0.458 . . . . 72.349999999999994 110.027 173.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -76.81 -31.46 56.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 70.140000000000001 111.342 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.987 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 61.5 m -54.58 -49.5 70.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.443 0.639 . . . . 62.329999999999998 110.729 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -73.92 -23.4 59.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.678 -0.692 . . . . 62.25 111.006 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 2.6 tpm_? -80.54 -33.44 36.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.405 -0.361 . . . . 74.420000000000002 110.828 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.07 -21.57 31.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 75.420000000000002 110.812 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 1.22 64.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.871 -0.68 . . . . 60.039999999999999 111.891 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 6.5 tp-100 -136.32 131.1 33.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.148 -0.686 . . . . 75.329999999999998 109.148 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.987 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.6 p -86.84 179.32 6.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.066 0.765 . . . . 31.199999999999999 113.066 -168.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.825 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.48 -16.42 61.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.266 1.21 . . . . 74.420000000000002 114.266 -164.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.57 -0.29 37.13 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.453 -0.779 . . . . 75.510000000000005 110.409 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.882 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -115.11 11.4 16.35 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.481 -0.781 . . . . 65.209999999999994 109.835 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 60' ' ' MET . 33.2 m -134.13 153.44 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.9 -0.591 . . . . 73.140000000000001 110.382 173.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.611 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.2 OUTLIER -113.32 112.46 23.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.212 -0.662 . . . . 70.219999999999999 109.212 175.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -85.67 116.41 23.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.287 0.565 . . . . 74.420000000000002 111.715 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.906 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -113.55 142.27 46.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 63.149999999999999 109.819 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -104.18 102.97 12.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.829 -0.168 . . . . 74.010000000000005 110.676 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 46.78 49.42 14.22 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.982 0.801 . . . . 75.510000000000005 111.557 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.13 -22.02 41.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.014 -0.612 . . . . 73.329999999999998 113.829 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.548 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 30.0 t70 -126.44 121.76 33.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.0 0.9 . . . . 72.129999999999995 111.638 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.906 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.33 143.38 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 73.239999999999995 111.74 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' HIS . 11.9 tt -135.33 -178.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.685 -0.689 . . . . 75.299999999999997 109.997 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' ILE . 98.1 m-70 -111.36 148.27 33.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.42 -0.585 . . . . 61.520000000000003 109.42 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -68.73 -16.96 70.66 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.287 0.475 . . . . 50.310000000000002 114.287 -171.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.67 -4.81 54.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.299 0.549 . . . . 72.230000000000004 111.386 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.95 -43.26 65.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.834 0.309 . . . . 71.25 111.834 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 28.1 p 67.68 148.11 0.11 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.74 1.216 . . . . 70.120000000000005 112.159 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.912 ' HD3' HD21 ' A' ' 45' ' ' LEU . 22.1 Cg_endo -61.57 -47.63 11.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.184 2.589 . . . . 73.219999999999999 113.618 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.98 -24.27 64.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 111.546 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -58.98 -39.95 83.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.938 -0.573 . . . . 74.25 110.81 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.65 -31.99 15.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 110.852 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.83 -19.91 13.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.685 -0.769 . . . . 62.200000000000003 111.798 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' A' ' 87' ' ' ASP . 10.1 tt -75.85 116.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.303 -0.999 . . . . 63.43 108.303 170.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.817 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 13.1 tt0 -131.2 -174.54 3.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.449 -0.341 . . . . 64.030000000000001 110.632 -168.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 26.0 t70 -4.71 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.768 1.627 . . . . 63.130000000000003 114.531 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.89 4.07 33.99 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.575 -0.739 . . . . 60.32 111.603 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.452 ' HB3' HG12 ' A' ' 83' ' ' ILE . 5.8 p-10 -79.56 167.15 21.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.745 0.307 . . . . 70.519999999999996 110.571 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 26' ' ' LYS . 20.5 m -137.32 153.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.561 0.696 . . . . 62.310000000000002 112.136 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 54.3 mt -129.68 127.63 64.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.868 -1.06 . . . . 71.310000000000002 108.439 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.18 136.7 39.68 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.439 -0.208 . . . . 54.299999999999997 110.439 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.49 117.71 34.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.018 0.437 . . . . 62.409999999999997 110.838 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 83.8 mtp -98.97 170.27 8.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 71.519999999999996 109.454 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -74.16 104.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.868 0.366 . . . . 75.099999999999994 111.203 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.882 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 90.8 mt-30 . . . . . 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 74.299999999999997 111.742 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.9 m170 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 121.185 0.517 . . . . 71.140000000000001 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 31.6 mm -116.01 164.28 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.453 -0.794 . . . . 44.310000000000002 108.918 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.631 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 88.0 mt-30 -151.59 116.25 5.13 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.712 0.805 . . . . 71.430000000000007 109.681 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 48' ' ' LEU . 10.3 m -113.17 -179.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.199 -0.667 . . . . 73.230000000000004 109.199 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 mtmt -144.83 114.43 7.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 110.776 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 89' ' ' ILE . 94.8 t -93.71 94.8 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 107.082 -1.451 . . . . 73.329999999999998 107.082 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 9.0 ttp180 -69.62 105.58 2.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.517 -1.29 . . . . 71.219999999999999 107.517 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.569 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 59.4 p -59.1 163.03 6.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 114.678 -1.147 . . . . 72.530000000000001 108.941 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 46.1 Cg_endo -67.21 28.14 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.824 2.35 . . . . 72.519999999999996 113.759 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 29' ' ' SER . 18.0 t70 -130.52 -23.82 2.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 63.119999999999997 110.65 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.12 -7.62 27.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.521 -0.847 . . . . 64.219999999999999 111.108 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 29' ' ' SER . . . -71.33 90.34 0.94 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.17 -0.678 . . . . 44.210000000000001 109.17 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 38.1 tt0 -99.57 102.21 13.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.1 -0.955 . . . . 70.409999999999997 109.657 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.11 129.98 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.886 -0.597 . . . . 73.019999999999996 109.999 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 27.8 p90 -71.41 122.58 20.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.432 0.634 . . . . 63.020000000000003 110.554 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HD2' HD23 ' A' ' 48' ' ' LEU . 3.5 t80 -120.53 128.74 53.38 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.618 -1.252 . . . . 62.039999999999999 107.618 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 24' ' ' GLN . 21.6 mtmt -105.3 162.67 13.23 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.383 -0.527 . . . . 64.219999999999999 110.951 -165.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 43.1 mt -115.27 134.64 57.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.867 -0.79 . . . . 43.020000000000003 108.867 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -93.47 -78.75 0.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.784 -0.45 . . . . 65.099999999999994 109.784 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 41' ' ' ARG . 48.8 mtt180 -97.59 169.71 9.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.118 -1.438 . . . . 73.400000000000006 107.118 164.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.548 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -54.85 101.59 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 73.019999999999996 110.532 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.8 116.03 23.02 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.23 -0.895 . . . . 71.219999999999999 109.755 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' LYS . 23.5 mtpp -36.37 134.19 0.46 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.575 -1.193 . . . . 62.32 111.985 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' HD3' ' A' ' 78' ' ' PRO . 91.7 mt -57.11 -20.28 24.62 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.958 -1.019 . . . . 72.430000000000007 113.276 -168.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 58.6 mt-10 -65.59 -24.69 67.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.111 0.412 . . . . 72.420000000000002 112.111 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -71.22 -28.98 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.752 -0.379 . . . . 62.409999999999997 110.483 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 25' ' ' VAL . 28.3 mt -59.25 -39.49 82.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.975 -0.557 . . . . 70.349999999999994 111.512 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -94.47 -23.82 17.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.84 -0.744 . . . . 63.310000000000002 111.307 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 45.9 mt-10 -73.27 -37.74 66.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.276 -0.57 . . . . 64.219999999999999 111.046 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 88.6 t -63.99 -25.08 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.525 0.679 . . . . 72.349999999999994 109.512 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -81.72 -34.76 30.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.277 -0.874 . . . . 70.140000000000001 110.338 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.01 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 79.7 m -53.75 -56.96 12.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.335 0.588 . . . . 62.329999999999998 111.155 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -68.69 -19.99 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.585 -0.734 . . . . 62.25 110.993 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -66.59 -46.51 75.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 74.420000000000002 111.354 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -98.7 -11.09 22.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.973 0.36 . . . . 75.420000000000002 111.973 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 29.82 8.22 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.5 -0.857 . . . . 60.039999999999999 113.498 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 63' ' ' VAL . 28.5 tt0 -150.55 129.04 12.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.823 -0.806 . . . . 75.329999999999998 108.823 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 1.01 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 24.2 p -92.43 178.25 5.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.995 0.739 . . . . 31.199999999999999 112.995 -168.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.494 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -76.21 -13.8 60.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.006 1.113 . . . . 74.420000000000002 114.006 -163.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 3.9 pm0 -80.07 -9.14 59.68 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.403 -0.811 . . . . 75.510000000000005 109.659 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.66 -22.35 12.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.617 -0.72 . . . . 65.209999999999994 109.965 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HE21 ' A' ' 58' ' ' GLN . 3.7 m -128.51 101.26 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.317 -0.623 . . . . 73.140000000000001 109.317 166.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 14.0 tpt180 -83.77 149.53 26.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.747 -0.66 . . . . 70.219999999999999 111.395 -168.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' HD2' ' HE1' ' A' ' 67' ' ' TYR . 1.6 p90 -94.74 104.27 16.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.28 -0.873 . . . . 74.420000000000002 111.96 -175.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.798 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.5 mp -99.58 131.96 45.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.468 -0.787 . . . . 63.149999999999999 109.015 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HE1' ' HD2' ' A' ' 65' ' ' PHE . 47.7 m-85 -103.42 110.35 22.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.485 -0.486 . . . . 74.010000000000005 110.99 -175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t70 54.19 37.16 26.63 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.103 -0.953 . . . . 75.510000000000005 110.228 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -21.48 45.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.399 -0.819 . . . . 73.329999999999998 112.985 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -113.49 116.28 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.364 0.602 . . . . 72.129999999999995 110.846 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.798 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 23.6 ptt180 -72.61 118.21 15.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.381 -0.827 . . . . 73.239999999999995 112.344 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.93 -163.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.802 -0.814 . . . . 75.299999999999997 108.802 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -108.84 138.14 45.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.958 -0.297 . . . . 61.520000000000003 110.612 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.8 -10.56 64.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.1 -0.571 . . . . 50.310000000000002 112.273 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.15 -28.36 64.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 72.230000000000004 110.532 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 80' ' ' GLN . 6.1 t30 -67.64 -17.7 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.647 -0.706 . . . . 71.25 111.062 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 66.6 p 60.18 156.72 0.1 Allowed Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.375 1.07 . . . . 70.120000000000005 113.18 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.924 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 59.2 Cg_endo -72.37 -43.43 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.544 2.163 . . . . 73.219999999999999 112.431 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.68 -28.12 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.684 . . . . 74.519999999999996 111.966 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' ASN . 53.8 tt0 -83.32 -34.65 25.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.268 -0.423 . . . . 74.25 111.547 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 29.5 tp -89.56 -28.31 19.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 73.109999999999999 110.659 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.24 -18.63 38.79 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.672 -0.775 . . . . 62.200000000000003 111.509 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.5 tt -89.87 120.99 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.45 -0.574 . . . . 63.43 109.45 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.924 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -155.83 -154.16 0.47 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 118.974 -0.536 . . . . 64.030000000000001 110.353 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 84' ' ' GLU . 19.9 t70 -21.82 109.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.718 1.261 . . . . 63.130000000000003 113.276 -167.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.4 -6.88 20.84 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.919 -1.037 . . . . 60.32 111.819 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.65 170.91 15.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 70.519999999999996 110.882 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.89 158.17 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.637 0.732 . . . . 62.310000000000002 111.413 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 27' ' ' VAL . 66.1 mt -128.59 125.92 64.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.98 -1.009 . . . . 71.310000000000002 108.724 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.09 126.23 44.79 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.772 -0.455 . . . . 54.299999999999997 109.772 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.665 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -87.96 117.93 27.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.144 0.497 . . . . 62.409999999999997 111.377 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.7 ttt -101.74 150.7 22.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.738 -0.665 . . . . 71.519999999999996 109.973 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.21 102.98 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.942 0.401 . . . . 75.099999999999994 110.505 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 38.8 mt-30 . . . . . 0 C--N 1.332 -0.161 0 CA-C-N 115.046 -0.979 . . . . 74.299999999999997 112.206 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 38.3 m80 . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 110.059 -0.348 . . . . 71.140000000000001 110.059 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.2 mm -110.75 163.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.014 -0.539 . . . . 44.310000000000002 109.63 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 23' ' ' ILE . 58.6 tt0 -137.0 125.46 23.49 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.531 -0.544 . . . . 71.430000000000007 109.531 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 48' ' ' LEU . 7.0 p -130.99 139.16 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.2 -0.454 . . . . 73.230000000000004 110.502 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.783 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -110.5 118.43 36.22 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.699 -0.4 . . . . 74.439999999999998 110.714 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.5 t -94.95 104.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.314 -1.365 . . . . 73.329999999999998 107.314 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 72.8 ttt-85 -69.64 110.23 4.74 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.983 -1.117 . . . . 71.219999999999999 107.983 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 62.3 p -60.22 159.77 20.48 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 115.322 -0.854 . . . . 72.530000000000001 108.714 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 27.3 Cg_endo -62.1 22.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 123.353 2.702 . . . . 72.519999999999996 115.021 -174.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 29' ' ' SER . 31.8 t70 -131.78 -24.07 2.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 63.119999999999997 110.9 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.05 2.55 20.22 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.44 -0.886 . . . . 64.219999999999999 112.114 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 88.47 7.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.186 -0.672 . . . . 44.210000000000001 109.186 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.783 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 11.1 tt0 -82.5 113.5 20.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.787 -0.642 . . . . 70.409999999999997 110.187 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.02 134.32 44.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.708 -0.479 . . . . 73.019999999999996 109.708 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -79.35 121.69 25.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.92 0.867 . . . . 63.020000000000003 111.543 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -116.92 174.35 6.14 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.485 -1.234 . . . . 62.039999999999999 107.805 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -136.26 153.48 51.18 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.97 -0.456 . . . . 64.219999999999999 111.174 -167.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 55.1 mt -114.99 134.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.729 -0.841 . . . . 43.020000000000003 108.729 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 22' ' ' HIS . 55.0 mtpt -127.83 -58.52 1.23 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.912 0.387 . . . . 65.099999999999994 110.793 -171.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -95.54 177.8 5.69 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.16 -1.052 . . . . 73.400000000000006 108.16 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.98 100.71 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.136 0.969 . . . . 73.019999999999996 109.073 172.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -138.95 102.17 4.48 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.307 -0.86 . . . . 71.219999999999999 110.606 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.74 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.4 pttp -68.56 -176.63 0.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.205 -0.907 . . . . 62.32 111.212 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 60.6 mt -55.67 -27.13 48.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 72.430000000000007 111.988 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 39.8 mt-10 -57.92 -35.48 71.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.01 0.434 . . . . 72.420000000000002 111.4 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 51' ' ' VAL . 46.3 tptt -69.9 -52.48 24.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 62.409999999999997 110.287 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 25' ' ' VAL . 26.8 mt -62.65 -28.36 69.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 70.349999999999994 111.32 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.61 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 14.2 ptm -85.59 -37.45 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 63.310000000000002 111.011 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 35.8 mm-40 -71.31 -30.43 66.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.829 0.307 . . . . 64.219999999999999 111.829 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 47' ' ' LYS . 87.8 t -62.98 -37.78 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.142 0.496 . . . . 72.349999999999994 109.706 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 55' ' ' ARG . 35.3 m-85 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.027 -0.533 . . . . 70.140000000000001 111.169 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 86.0 m -54.35 -48.59 71.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.315 0.579 . . . . 62.329999999999998 109.83 170.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.27 -40.52 67.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 62.25 110.833 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' A' ' 52' ' ' TYR . 55.1 ttt180 -65.79 -45.54 82.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.420000000000002 111.683 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.24 -13.79 42.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.685 0.278 . . . . 75.420000000000002 111.316 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.79 10.86 83.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.665 -0.779 . . . . 60.039999999999999 111.893 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 5.3 tp-100 -133.61 130.33 38.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.996 -0.742 . . . . 75.329999999999998 108.996 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 32.6 p -83.09 163.48 20.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.333 0.587 . . . . 31.199999999999999 112.263 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -15.69 63.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.245 -0.889 . . . . 74.420000000000002 112.328 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -87.02 -4.29 59.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 75.510000000000005 110.476 177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -115.81 -25.94 7.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.593 -0.73 . . . . 65.209999999999994 109.455 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.488 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 11.5 m -125.78 117.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.637 -0.71 . . . . 73.140000000000001 109.639 168.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -88.1 139.74 30.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.583 -0.525 . . . . 70.219999999999999 109.583 -174.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.565 ' HB3' ' CG2' ' A' ' 89' ' ' ILE . 60.9 m-85 -101.38 119.01 38.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.913 -0.585 . . . . 74.420000000000002 111.353 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.893 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.2 mp -99.34 127.1 45.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.193 -0.912 . . . . 63.149999999999999 108.784 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HE1' HG21 ' A' ' 83' ' ' ILE . 1.6 p90 -101.65 124.79 47.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.207 -0.997 . . . . 74.010000000000005 110.234 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.34 29.75 13.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.848 -1.069 . . . . 75.510000000000005 110.264 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.66 0.29 64.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.681 -0.69 . . . . 73.329999999999998 113.241 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.29 116.37 19.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.506 0.653 . . . . 72.129999999999995 111.368 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.893 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 22.6 ptt180 -66.68 137.81 56.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.286 -0.87 . . . . 73.239999999999995 112.408 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 73' ' ' HIS . 11.0 tp -162.63 164.86 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 75.299999999999997 109.741 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' N ' HG13 ' A' ' 72' ' ' ILE . 1.4 p-80 -70.39 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 61.520000000000003 110.919 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -65.76 -23.82 70.97 Favored Glycine 0 CA--C 1.518 0.242 0 CA-C-N 116.131 -0.486 . . . . 50.310000000000002 113.896 -171.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 7.0 p-10 -77.77 3.84 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.763 0.281 . . . . 72.230000000000004 111.501 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -67.39 -39.1 85.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.453 -0.203 . . . . 71.25 110.453 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 44' ' ' LYS . 49.9 p 62.41 143.0 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.596 1.158 . . . . 70.120000000000005 112.597 -178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.85 -42.22 15.64 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.049 2.499 . . . . 73.219999999999999 112.56 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.84 -14.76 55.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 74.519999999999996 111.802 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -59.9 -38.4 82.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 74.25 110.837 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB3' HG22 ' A' ' 83' ' ' ILE . 45.4 tp -104.85 -30.01 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 73.109999999999999 110.886 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.08 -19.32 13.62 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.774 -0.931 . . . . 62.200000000000003 110.774 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 81' ' ' LEU . 5.4 tt -66.48 112.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.719 -0.845 . . . . 63.43 108.719 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 15.8 tt0 -134.07 -152.8 0.49 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.751 -0.658 . . . . 64.030000000000001 109.864 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 33.1 t70 -30.57 112.9 0.09 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.254 0.971 . . . . 63.130000000000003 113.032 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.04 4.94 22.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.924 -0.58 . . . . 60.32 111.679 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -78.93 170.51 16.57 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.992 0.425 . . . . 70.519999999999996 111.094 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 13.7 m -138.27 154.83 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.310000000000002 111.013 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 36.4 mt -136.66 114.99 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.637 -0.71 . . . . 71.310000000000002 109.101 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.406 ' CG ' HH11 ' A' ' 28' ' ' ARG . 48.2 t0 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.446 -0.343 . . . . 54.299999999999997 110.372 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.2 131.69 53.15 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.148 0.425 . . . . 62.409999999999997 112.148 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.4 mpt? -126.21 163.28 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.449 -0.575 . . . . 71.519999999999996 109.449 173.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.53 95.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.564 0.221 . . . . 75.099999999999994 111.465 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 28.4 mt-30 . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 123.495 0.718 . . . . 74.299999999999997 112.113 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 30.7 m80 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 110.311 -0.255 . . . . 71.140000000000001 110.311 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 30.1 mt -108.93 159.39 8.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.983 0.42 . . . . 44.310000000000002 110.808 -169.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp0 -146.11 126.12 13.68 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.985 0.914 . . . . 71.430000000000007 109.238 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.39 144.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.741 -0.466 . . . . 73.230000000000004 109.741 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 1.002 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.51 115.9 31.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.977 0.418 . . . . 74.439999999999998 111.302 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 89' ' ' ILE . 47.0 t -99.93 101.99 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.92 -1.141 . . . . 73.329999999999998 107.92 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 2.1 ttp180 -69.91 111.16 5.43 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 107.893 -1.151 . . . . 71.219999999999999 107.893 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.646 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 93.1 p -62.47 165.66 8.69 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.696 -0.801 . . . . 72.530000000000001 108.871 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.646 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 43.7 Cg_endo -66.65 20.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 122.66 2.24 . . . . 72.519999999999996 113.909 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 29' ' ' SER . 36.0 t70 -131.26 -11.77 3.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.205 0.526 . . . . 63.119999999999997 110.892 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.52 -0.16 43.08 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.193 -1.003 . . . . 64.219999999999999 111.976 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 97.6 6.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.353 -0.61 . . . . 44.210000000000001 109.353 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 48.5 tt0 -115.98 97.45 6.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.882 -0.599 . . . . 70.409999999999997 110.29 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.6 t -102.97 145.0 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.444 -0.947 . . . . 73.019999999999996 108.444 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 1.002 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.3 p90 -67.3 123.54 20.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 63.020000000000003 110.231 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -110.52 170.11 8.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.943 -1.132 . . . . 62.039999999999999 107.943 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 34.8 mttt -140.71 165.87 26.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.46 0.573 . . . . 64.219999999999999 111.402 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 69.4 mt -122.68 135.21 63.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 43.020000000000003 108.877 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -117.44 -77.73 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.312 . . . . 65.099999999999994 110.969 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 42' ' ' LYS . 4.9 tpt180 -76.95 177.47 7.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.257 -1.016 . . . . 73.400000000000006 108.257 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 5.9 ttpm? -62.47 99.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.052 -1.092 . . . . 73.019999999999996 108.052 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 2.8 p -135.17 106.55 6.8 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.666 -0.697 . . . . 71.219999999999999 110.845 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 45.0 mttm -51.49 170.45 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.483 -1.235 . . . . 62.32 111.154 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 47.6 mt -62.61 -10.95 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.595 . . . . 72.430000000000007 110.487 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 5.3 mm-40 -53.94 -57.22 11.78 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.631 -0.713 . . . . 72.420000000000002 111.361 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG2' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.62 -23.92 63.57 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.427 . . . . 62.409999999999997 110.877 -175.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.7 mt -63.32 -35.3 79.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 70.349999999999994 110.558 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.5 ptt? -89.31 -33.91 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 63.310000000000002 110.564 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 9.2 mm-40 -66.48 -32.87 74.5 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.982 0.364 . . . . 64.219999999999999 111.982 -176.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' LYS . 93.2 t -60.89 -34.94 61.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.502 -0.479 . . . . 72.349999999999994 110.124 174.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -73.44 -44.47 58.14 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.873 -0.331 . . . . 70.140000000000001 110.315 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 61.7 m -48.1 -44.52 31.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.334 0.588 . . . . 62.329999999999998 110.409 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -64.62 -56.2 15.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.226 -0.897 . . . . 62.25 110.724 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -68.58 -42.96 77.5 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.494 0.553 . . . . 74.420000000000002 112.494 -171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.87 -20.32 53.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.721 -0.218 . . . . 75.420000000000002 111.01 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.5 19.28 74.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.686 -0.768 . . . . 60.039999999999999 111.254 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 35.1 tt0 -142.72 130.05 21.06 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.522 -0.918 . . . . 75.329999999999998 108.522 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.3 p -84.35 167.28 16.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 31.199999999999999 111.749 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.34 -15.15 59.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.475 -0.784 . . . . 74.420000000000002 112.39 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 12.5 pt-20 -59.28 -23.78 62.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.617 0.246 . . . . 75.510000000000005 110.489 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 1.045 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -105.74 -12.82 15.75 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.977 -0.556 . . . . 65.209999999999994 111.085 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.4 m -144.24 103.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 73.140000000000001 110.635 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -95.77 145.7 25.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.726 -0.39 . . . . 70.219999999999999 110.655 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.679 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 26.5 p90 -95.21 133.08 39.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 74.420000000000002 111.774 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.108 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -115.9 114.05 24.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 63.149999999999999 109.987 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -103.76 138.8 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.013 -0.675 . . . . 74.010000000000005 110.423 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 t70 54.53 22.89 4.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.822 0.82 . . . . 75.510000000000005 109.977 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.53 -18.73 56.54 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.652 -0.704 . . . . 73.329999999999998 113.367 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -118.16 120.66 38.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.742 0.771 . . . . 72.129999999999995 111.739 -176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 1.108 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -69.19 142.89 54.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.723 -0.672 . . . . 73.239999999999995 111.685 176.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 76' ' ' ASN . 37.6 pt -142.55 -163.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.151 -0.685 . . . . 75.299999999999997 109.151 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -98.21 140.35 32.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.009 -0.737 . . . . 61.520000000000003 109.009 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.885 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -60.33 -23.62 60.31 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.161 -0.542 . . . . 50.310000000000002 113.482 -172.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 23.8 t70 -63.06 -23.39 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.393 0.516 . . . . 72.230000000000004 112.393 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.682 ' HB3' HD12 ' A' ' 72' ' ' ILE . 2.1 t-20 -74.13 -19.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.841 -0.344 . . . . 71.25 111.205 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 44' ' ' LYS . 7.7 p 59.15 151.79 0.08 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.063 1.135 . . . . 70.120000000000005 114.063 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 -32.76 23.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.821 2.347 . . . . 73.219999999999999 113.492 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.615 ' OE1' ' HB ' ' A' ' 77' ' ' THR . 4.3 pm0 -63.15 -14.85 53.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.674 0.273 . . . . 74.519999999999996 111.543 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -68.62 -30.93 69.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.301 -0.409 . . . . 74.25 111.006 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.18 -30.35 16.72 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.368 -0.533 . . . . 73.109999999999999 111.388 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 -18.99 32.52 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.472 -1.051 . . . . 62.200000000000003 110.472 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.506 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -84.47 148.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.95 -1.13 . . . . 63.43 107.95 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.7 tt0 -155.07 -149.19 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.817 -1.179 . . . . 64.030000000000001 107.817 -176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 5.2 p-10 -36.49 114.53 0.3 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.854 0.835 . . . . 63.130000000000003 112.194 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.45 -5.71 14.77 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.462 -0.79 . . . . 60.32 111.853 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.8 t0 -80.63 161.71 24.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.782 0.325 . . . . 70.519999999999996 110.38 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.09 154.8 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.356 0.598 . . . . 62.310000000000002 110.51 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 65' ' ' PHE . 59.5 mt -131.72 126.37 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.408 -0.814 . . . . 71.310000000000002 109.471 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.98 134.35 43.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.554 0.216 . . . . 54.299999999999997 110.855 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -99.69 119.06 37.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.05 0.452 . . . . 62.409999999999997 110.622 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 65.4 mtt -103.32 152.25 21.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 71.519999999999996 110.016 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.32 95.89 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.861 0.362 . . . . 75.099999999999994 110.288 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 1.045 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 44.7 mt-30 . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 115.334 -0.848 . . . . 74.299999999999997 110.852 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.101 -0.703 . . . . 55.350000000000001 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.67 104.87 2.03 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.753 -0.658 . . . . 72.340000000000003 114.004 -167.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -95.44 140.92 29.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.779 -0.822 . . . . 64.099999999999994 108.779 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.09 -26.81 33.29 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 73.109999999999999 111.209 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -58.96 -42.72 90.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 72.019999999999996 111.639 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 t -74.12 -10.95 60.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.578 -0.283 . . . . 75.430000000000007 111.557 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.41 15.04 6.63 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.942 -0.303 . . . . 62.409999999999997 111.659 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.62 -14.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.616 0.246 . . . . 74.319999999999993 111.61 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' A' ' 10' ' ' ASN . 62.7 t30 64.61 -163.65 0.26 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.249 -0.649 . . . . 75.340000000000003 109.249 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.533 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 46.1 m-80 67.81 24.11 8.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.126 0.489 . . . . 71.340000000000003 110.512 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -74.75 156.97 36.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.736 -0.665 . . . . 73.310000000000002 110.439 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.12 166.68 10.86 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.962 -0.637 . . . . 60.409999999999997 111.715 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 m -130.37 102.44 6.18 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.14 0.495 . . . . 73.340000000000003 110.525 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.404 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -80.83 159.39 68.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.78 -0.645 . . . . 63.329999999999998 109.753 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 14' ' ' SER . 60.2 Cg_endo -72.98 46.27 1.06 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 72.239999999999995 112.627 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 70.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 122.184 0.992 . . . . 73.430000000000007 109.959 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -172.39 138.38 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.812 -1.085 . . . . 70.0 109.372 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -114.11 157.17 22.95 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.428 -0.582 . . . . 63.399999999999999 109.428 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.8 -40.45 97.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.724 0.297 . . . . 74.430000000000007 111.565 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.1 21.23 28.84 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.898 -0.668 . . . . 65.400000000000006 113.005 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.11 -30.64 62.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.474 0.654 . . . . 73.099999999999994 109.925 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 38.9 m80 -90.6 -169.85 2.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.24 -0.891 . . . . 71.140000000000001 110.4 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 25.8 mm -109.4 158.18 9.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.913 -0.402 . . . . 44.310000000000002 109.913 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -144.43 134.67 24.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.585 -0.524 . . . . 71.430000000000007 109.585 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 48' ' ' LEU . 5.0 p -142.63 140.12 28.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 123.658 0.599 . . . . 73.230000000000004 109.646 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . 23.4 mtmt -110.41 118.86 37.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.244 0.545 . . . . 74.439999999999998 111.182 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.768 HG22 ' HB ' ' A' ' 89' ' ' ILE . 88.6 t -94.46 97.68 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 105.999 -1.852 . . . . 73.329999999999998 105.999 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 32.7 ttt-85 -67.76 106.13 2.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.189 -1.041 . . . . 71.219999999999999 108.189 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 p -58.46 124.54 72.18 Favored Pre-proline 0 N--CA 1.422 -1.863 0 N-CA-C 107.111 -1.44 . . . . 72.530000000000001 107.111 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 90.5 Cg_endo -71.43 38.49 0.34 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.357 2.704 . . . . 72.519999999999996 114.217 -162.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -131.13 15.63 5.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.3 0.572 . . . . 63.119999999999997 111.326 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.5 24.93 19.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.362 -0.923 . . . . 64.219999999999999 111.844 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.34 161.57 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.433 -0.58 . . . . 44.210000000000001 109.433 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 38.2 tt0 -151.12 115.35 5.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.87 -0.418 . . . . 70.409999999999997 109.87 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.34 128.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.771 -0.455 . . . . 73.019999999999996 109.771 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 24.5 p90 -72.25 119.85 17.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.698 0.761 . . . . 63.020000000000003 110.845 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -111.29 166.35 11.17 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.873 -1.058 . . . . 62.039999999999999 108.421 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -144.98 146.13 31.81 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.403 -0.519 . . . . 64.219999999999999 111.224 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.094 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 56.9 mt -115.13 134.89 56.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.507 -0.923 . . . . 43.020000000000003 108.507 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -109.0 -65.03 1.18 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.556 -0.457 . . . . 65.099999999999994 110.978 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -91.45 -177.79 4.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.192 -1.04 . . . . 73.400000000000006 108.192 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.546 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.95 101.26 0.37 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.776 0.798 . . . . 73.019999999999996 109.25 172.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.28 6.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.644 -0.707 . . . . 71.219999999999999 110.269 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 14.1 ptpt -58.99 -179.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.231 -0.895 . . . . 62.32 112.075 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.748 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 37.3 mt -67.34 -10.48 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.782 -0.645 . . . . 72.430000000000007 112.376 -169.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' ' HG2' ' A' ' 49' ' ' MET . 70.2 mt-10 -57.5 -53.79 54.22 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.835 0.309 . . . . 72.420000000000002 111.835 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -30.09 66.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.341 -0.543 . . . . 62.409999999999997 110.913 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 39' ' ' ILE . 95.2 mt -60.27 -36.86 78.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.943 0.401 . . . . 70.349999999999994 110.392 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.6 ptt? -85.78 -34.01 21.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.019 -0.537 . . . . 63.310000000000002 111.176 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 42.0 mt-10 -74.61 -39.65 62.04 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.817 0.303 . . . . 64.219999999999999 111.817 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.87 -29.37 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.152 -0.684 . . . . 72.349999999999994 109.152 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.94 -43.58 57.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.78 . . . . 70.140000000000001 109.999 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 84.5 m -50.11 -52.05 38.07 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.382 0.611 . . . . 62.329999999999998 110.699 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.28 -27.34 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.834 . . . . 62.25 110.723 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -71.44 -41.57 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.453 -0.34 . . . . 74.420000000000002 111.586 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.38 -6.4 34.19 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.898 -0.321 . . . . 75.420000000000002 111.4 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.51 59.3 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.513 -0.851 . . . . 60.039999999999999 111.775 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.2 tt0 -150.83 129.73 12.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.592 -0.892 . . . . 75.329999999999998 108.592 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.0 p -87.9 178.23 6.75 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.834 0.679 . . . . 31.199999999999999 112.834 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -74.48 -16.16 60.86 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.982 1.104 . . . . 74.420000000000002 113.982 -164.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.02 -13.67 60.22 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.884 -0.726 . . . . 75.510000000000005 109.957 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.667 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.02 2.98 23.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.532 -0.758 . . . . 65.209999999999994 110.336 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.718 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 7.0 m -139.63 103.34 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.386 0.613 . . . . 73.140000000000001 110.73 171.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.673 ' HD2' HD11 ' A' ' 66' ' ' LEU . 25.8 ttm180 -69.24 112.05 5.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.759 -0.655 . . . . 70.219999999999999 109.616 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -90.76 109.95 21.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.551 0.691 . . . . 74.420000000000002 111.64 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 5.2 mp -106.21 130.94 53.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.333 -0.849 . . . . 63.149999999999999 109.481 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HE2' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -127.62 143.47 51.16 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.206 -0.998 . . . . 74.010000000000005 110.618 176.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB2' HG21 ' A' ' 83' ' ' ILE . 35.2 t70 59.67 21.9 10.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.921 0.867 . . . . 75.510000000000005 109.764 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.84 -17.49 58.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 113.237 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -122.72 125.78 46.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.15 0.475 . . . . 72.129999999999995 111.609 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.846 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -65.28 151.45 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 73.239999999999995 110.901 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG12 ' H ' ' A' ' 73' ' ' HIS . 12.5 tt -170.81 -173.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.942 -0.762 . . . . 75.299999999999997 108.942 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.623 ' H ' HG12 ' A' ' 72' ' ' ILE . 94.1 m-70 -86.01 149.23 25.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.254 0.479 . . . . 61.520000000000003 110.435 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.748 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -67.94 -20.9 73.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.632 -0.794 . . . . 50.310000000000002 112.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.921 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 4.6 p-10 -78.78 -4.66 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.599 0.222 . . . . 72.230000000000004 111.599 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -23.45 61.98 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.854 -0.157 . . . . 71.25 111.293 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.905 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.1 p 66.28 159.15 0.13 Allowed Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 70.120000000000005 111.788 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.43 -60.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 73.219999999999999 113.432 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -63.57 -19.07 64.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.901 0.334 . . . . 74.519999999999996 111.901 -170.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -63.24 -25.5 68.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.035 0.445 . . . . 74.25 110.811 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.42 -29.16 17.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.109 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.79 -18.87 8.52 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.842 -0.694 . . . . 62.200000000000003 111.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 87' ' ' ASP . 15.4 tt -101.92 136.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.999 -0.371 . . . . 63.43 109.999 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.789 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 26.5 tt0 -148.39 -153.32 0.48 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.942 -0.762 . . . . 64.030000000000001 108.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.789 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.3 p-10 -20.94 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.651 1.18 . . . . 63.130000000000003 113.792 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.5 5.16 30.06 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.993 -0.843 . . . . 60.32 110.993 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 83' ' ' ILE . 11.3 p-10 -85.79 173.09 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.151 -0.525 . . . . 70.519999999999996 110.915 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.32 158.59 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 62.310000000000002 111.137 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 27' ' ' VAL . 69.6 mt -134.64 138.46 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.649 -0.871 . . . . 71.310000000000002 108.649 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.51 126.42 51.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.433 -0.58 . . . . 54.299999999999997 109.433 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.718 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -111.89 116.8 31.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.695 -0.402 . . . . 62.409999999999997 110.388 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 62.6 mtt -101.26 168.82 9.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.109 -0.496 . . . . 71.519999999999996 110.114 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.24 101.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.888 0.375 . . . . 75.099999999999994 111.311 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.667 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 43.4 mt-30 64.52 173.73 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 74.299999999999997 112.23 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -72.81 -40.07 66.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.200000000000003 111.941 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.32 9.83 27.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.195 0.522 . . . . 61.119999999999997 110.806 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.35 -13.71 61.25 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 53.25 111.289 -175.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 110.417 -1.073 . . . . 31.300000000000001 110.417 179.384 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.045 -0.354 . . . . 55.350000000000001 110.045 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.47 126.04 2.13 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.929 -0.653 . . . . 72.340000000000003 111.641 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.73 145.21 27.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.215 0.531 . . . . 64.099999999999994 111.011 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.44 -17.21 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.529 -0.76 . . . . 73.109999999999999 110.827 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.04 -24.13 51.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.549 -0.75 . . . . 72.019999999999996 112.876 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 m -56.21 -26.08 49.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.861 0.319 . . . . 75.430000000000007 111.861 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.88 78.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.236 -0.438 . . . . 62.409999999999997 111.695 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.44 -20.99 5.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.097 0.475 . . . . 74.319999999999993 110.391 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -64.37 -28.61 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 75.340000000000003 111.999 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -76.4 112.05 12.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.598 0.714 . . . . 71.340000000000003 111.306 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.33 89.12 3.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.805 -0.634 . . . . 73.310000000000002 110.49 174.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.75 75.79 2.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.874 -0.679 . . . . 60.409999999999997 112.136 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -99.4 -174.21 2.68 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.713 -0.477 . . . . 73.340000000000003 109.713 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 p -142.13 67.14 21.45 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.895 0.378 . . . . 63.329999999999998 111.458 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.674 ' HD2' ' HG2' ' A' ' 80' ' ' GLN . 3.6 Cg_exo -81.57 -62.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.796 2.331 . . . . 72.239999999999995 111.623 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.477 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . 21.8 t 57.87 74.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.499 -0.773 . . . . 73.430000000000007 111.521 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.457 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 53.5 t30 -84.65 69.91 10.7 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.697 -0.683 . . . . 70.0 109.518 173.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.75 101.33 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.57 -0.741 . . . . 63.399999999999999 110.462 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -112.06 -0.8 15.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 109.897 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.28 24.07 38.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.781 -0.723 . . . . 65.400000000000006 111.709 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.82 151.32 35.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 73.099999999999994 110.348 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -94.72 129.3 41.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.086 -0.506 . . . . 71.140000000000001 110.151 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 17.8 mt -110.59 166.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.402 -0.592 . . . . 44.310000000000002 109.402 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 8.6 tt0 -148.49 139.75 23.32 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.771 -0.455 . . . . 71.430000000000007 109.771 -174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 48' ' ' LEU . 29.0 m -140.82 172.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.077 0.465 . . . . 73.230000000000004 110.741 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 3.7 mtmt -141.71 115.42 9.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 74.439999999999998 109.487 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 89' ' ' ILE . 52.3 t -95.19 95.08 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.589 -1.634 . . . . 73.329999999999998 106.589 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -68.49 103.57 1.7 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.996 -1.483 . . . . 71.219999999999999 106.996 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 31' ' ' ASP . 67.6 m -62.86 158.38 53.35 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 113.498 -1.683 . . . . 72.530000000000001 109.03 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 35.9 Cg_endo -64.8 36.2 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.666 2.911 . . . . 72.519999999999996 114.051 -174.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 29' ' ' SER . 30.7 t70 -131.75 -14.9 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.46 0.647 . . . . 63.119999999999997 110.282 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.85 -3.57 52.64 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.227 -0.749 . . . . 64.219999999999999 111.227 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.01 118.16 23.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.364 -0.418 . . . . 44.210000000000001 110.014 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 23.4 tt0 -116.04 101.43 8.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.396 -0.594 . . . . 70.409999999999997 109.396 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.564 ' HB ' ' OH ' ' A' ' 52' ' ' TYR . 44.3 t -102.75 135.64 39.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.801 -0.444 . . . . 73.019999999999996 109.801 -177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.2 p90 -71.25 132.04 44.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.578 0.704 . . . . 63.020000000000003 111.358 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -126.72 162.8 24.95 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.657 -1.238 . . . . 62.039999999999999 107.657 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -136.99 157.15 47.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.845 0.831 . . . . 64.219999999999999 112.712 -171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.93 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -119.68 136.1 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 43.020000000000003 108.11 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -111.75 -28.14 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.838 -0.745 . . . . 65.099999999999994 111.834 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 35.4 ttm180 -145.78 -177.6 5.67 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.055 -1.461 . . . . 73.400000000000006 107.055 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 20.5 pttp -60.57 99.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.527 -0.869 . . . . 73.019999999999996 110.0 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.534 ' OG1' HG23 ' A' ' 39' ' ' ILE . 74.0 p -129.38 114.46 16.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.77 -1.104 . . . . 71.219999999999999 108.893 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HA ' HG22 ' A' ' 77' ' ' THR . 0.4 OUTLIER -49.27 153.75 0.96 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 62.32 111.688 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.809 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 36.1 mt -63.0 -12.57 26.75 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.29 -0.868 . . . . 72.430000000000007 111.76 -173.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' OE1' ' HG3' ' A' ' 44' ' ' LYS . 54.5 mt-10 -57.36 -44.43 84.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 72.420000000000002 111.345 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -30.43 68.05 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.561 -0.456 . . . . 62.409999999999997 110.582 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 39' ' ' ILE . 98.0 mt -61.55 -33.06 73.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 70.349999999999994 110.356 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -98.3 -28.98 13.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.06 -0.518 . . . . 63.310000000000002 112.029 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.72 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 46.4 mt-10 -78.01 -33.73 51.07 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.478 -0.489 . . . . 64.219999999999999 111.257 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.14 -31.89 55.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.021 -0.733 . . . . 72.349999999999994 109.021 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.564 ' OH ' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -71.22 -31.91 68.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 70.140000000000001 111.151 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 66.3 m -50.28 -47.09 55.53 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 62.329999999999998 110.63 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.88 -31.99 51.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.02 -0.537 . . . . 62.25 110.728 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -68.57 -40.28 80.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.067 -0.515 . . . . 74.420000000000002 110.617 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.15 -21.71 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.415 -0.357 . . . . 75.420000000000002 111.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.08 -2.65 69.1 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.768 -0.729 . . . . 60.039999999999999 112.163 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 29.3 tp60 -124.49 129.79 51.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.106 -0.702 . . . . 75.329999999999998 109.106 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.738 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.0 p -81.25 178.65 8.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 31.199999999999999 112.366 -174.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.676 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -76.64 -16.12 59.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.665 1.357 . . . . 74.420000000000002 114.665 -162.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -74.28 -9.88 59.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 75.510000000000005 110.363 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -109.38 10.62 25.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.765 -0.652 . . . . 65.209999999999994 110.268 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.889 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 18.0 m -139.38 121.74 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.59 . . . . 73.140000000000001 111.465 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 20.3 tpp180 -85.56 113.81 22.09 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.616 -0.513 . . . . 70.219999999999999 109.616 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -83.43 118.07 23.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.487 -0.779 . . . . 74.420000000000002 112.376 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 10.2 mp -110.42 129.38 55.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.618 -0.719 . . . . 63.149999999999999 109.863 172.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.497 ' HD2' ' HB ' ' A' ' 72' ' ' ILE . 62.4 m-85 -106.89 129.87 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.439 -0.208 . . . . 74.010000000000005 110.439 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.76 23.34 9.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.999 0.904 . . . . 75.510000000000005 109.77 -174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.03 -0.28 78.73 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.458 -0.792 . . . . 73.329999999999998 112.567 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 72' ' ' ILE . 37.3 t0 -127.15 122.91 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.578 0.704 . . . . 72.129999999999995 111.14 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -59.61 110.6 1.17 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.125 -0.943 . . . . 73.239999999999995 112.37 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' H ' ' A' ' 73' ' ' HIS . 11.2 mm -125.68 -167.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.171 -1.418 . . . . 75.299999999999997 107.171 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.865 ' H ' HG22 ' A' ' 72' ' ' ILE . 3.6 p80 -116.41 149.25 39.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.205 0.457 . . . . 61.520000000000003 110.091 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.809 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -64.54 -34.47 89.98 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.705 -0.68 . . . . 50.310000000000002 114.295 -168.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.95 -12.12 52.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.853 0.327 . . . . 72.230000000000004 111.584 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.645 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 3.5 t30 -70.87 -25.7 62.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.04 -0.356 . . . . 71.25 110.04 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' HA ' ' A' ' 44' ' ' LYS . 44.8 p 61.16 153.74 0.11 Allowed Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.639 1.176 . . . . 70.120000000000005 112.627 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 30.8 Cg_endo -64.91 -46.79 5.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.462 2.108 . . . . 73.219999999999999 111.833 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 15.5 tp10 -46.17 -43.35 15.05 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.328 -0.851 . . . . 74.519999999999996 111.728 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.674 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 47.8 mt-30 -88.55 -15.7 34.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.25 111.704 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 tp -88.7 -30.66 18.94 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.0 -0.28 . . . . 73.109999999999999 111.351 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.28 -18.93 25.18 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.315 -0.945 . . . . 62.200000000000003 110.916 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.3 tp -93.01 144.16 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.136 -1.061 . . . . 63.43 108.136 170.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CG ' ' H ' ' A' ' 85' ' ' ASP . 1.7 tt0 -141.09 -152.22 0.4 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.325 -0.62 . . . . 64.030000000000001 109.325 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 24' ' ' GLN . 7.2 t70 -45.99 118.41 1.86 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.06 0.457 . . . . 63.130000000000003 112.021 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.93 3.51 17.81 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.434 -0.803 . . . . 60.32 111.664 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.479 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.1 t0 -73.97 158.48 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 70.519999999999996 111.19 -175.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 32.7 m -129.96 147.28 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.815 -0.629 . . . . 62.310000000000002 110.357 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.4 mt -119.57 119.27 59.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.632 -0.713 . . . . 71.310000000000002 109.288 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -102.86 126.96 50.21 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.677 -0.49 . . . . 54.299999999999997 109.677 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.87 117.82 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.939 0.4 . . . . 62.409999999999997 111.786 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 1.8 mpt? -90.91 170.13 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 71.519999999999996 110.476 175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.98 109.6 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 75.099999999999994 111.299 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.637 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 48.9 mt-30 61.97 -177.53 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.017 -0.992 . . . . 74.299999999999997 111.515 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.84 4.32 8.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.166 -0.47 . . . . 74.200000000000003 111.756 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 m 63.34 78.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.605 0.717 . . . . 61.119999999999997 110.193 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.3 -23.5 0.12 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.129 -0.941 . . . . 53.25 111.345 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.805 -0.997 . . . . 31.300000000000001 111.758 176.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.644 0.259 . . . . 55.350000000000001 110.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.45 -159.89 48.83 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.626 -0.797 . . . . 72.340000000000003 111.186 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -160.8 -159.33 0.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.988 -0.745 . . . . 64.099999999999994 108.988 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -79.02 -29.69 43.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.968 0.413 . . . . 73.109999999999999 110.598 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -69.49 -27.86 65.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 72.019999999999996 111.278 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.2 p -76.89 -10.71 59.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.542 -0.299 . . . . 75.430000000000007 111.775 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.46 11.81 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 62.409999999999997 111.621 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.56 -19.89 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.865 0.364 . . . . 74.319999999999993 111.315 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -90.65 24.08 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.046 0.451 . . . . 75.340000000000003 110.237 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.6 -58.99 5.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 111.106 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -157.19 77.51 0.87 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 73.310000000000002 110.571 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.67 -141.46 47.52 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.715 -0.675 . . . . 60.409999999999997 113.013 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -155.63 25.93 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.826 -0.435 . . . . 73.340000000000003 109.826 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t 71.94 102.59 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 115.061 -0.972 . . . . 63.329999999999998 110.497 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.36 23.3 0.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.071 2.514 . . . . 72.239999999999995 113.034 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.64 -8.28 10.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.575 0.702 . . . . 73.430000000000007 109.64 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -78.53 89.95 4.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.356 -0.838 . . . . 70.0 110.924 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -117.23 75.97 1.01 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.589 0.709 . . . . 63.399999999999999 109.809 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -127.54 19.14 6.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.319 -0.855 . . . . 74.430000000000007 108.71 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.81 74.48 1.35 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.065 -0.971 . . . . 65.400000000000006 113.439 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.87 -31.33 66.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 73.099999999999994 108.602 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -129.5 158.79 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.915 -1.039 . . . . 71.140000000000001 109.805 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.5 mt -109.98 166.96 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.715 -0.846 . . . . 44.310000000000002 108.715 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.441 ' N ' HG22 ' A' ' 23' ' ' ILE . 41.6 tt0 -144.24 138.26 27.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.232 -0.284 . . . . 71.430000000000007 110.232 -173.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 48' ' ' LEU . 14.7 p -150.79 140.97 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.983 -0.553 . . . . 73.230000000000004 110.005 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.791 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 2.4 mtmp? -102.0 123.24 45.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.782 -0.451 . . . . 74.439999999999998 109.782 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.4 t -101.33 95.26 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 105.472 -2.047 . . . . 73.329999999999998 105.472 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 21.1 ttt180 -68.3 105.07 2.02 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 114.819 -1.082 . . . . 71.219999999999999 108.386 -172.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 33' ' ' ALA . 68.5 m -63.38 139.39 97.57 Favored Pre-proline 0 N--CA 1.418 -2.037 0 N-CA-C 107.424 -1.325 . . . . 72.530000000000001 107.424 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.23 33.48 0.16 Allowed 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.542 2.828 . . . . 72.519999999999996 114.643 -166.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -131.36 3.46 4.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.617 0.722 . . . . 63.119999999999997 109.567 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.26 16.52 53.25 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.885 -0.886 . . . . 64.219999999999999 110.885 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 29' ' ' SER . . . -99.44 74.91 1.93 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.618 . . . . 44.210000000000001 109.805 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.791 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 27.7 tt0 -87.44 102.67 14.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.843 -0.617 . . . . 70.409999999999997 109.822 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.36 136.34 35.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.976 -0.556 . . . . 73.019999999999996 109.71 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -80.47 121.68 26.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.464 0.65 . . . . 63.020000000000003 111.192 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -114.97 165.21 13.12 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.301 -1.37 . . . . 62.039999999999999 107.301 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -138.72 168.57 19.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.666 -0.814 . . . . 64.219999999999999 112.23 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.874 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 58.0 mt -114.2 134.93 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.662 -1.154 . . . . 43.020000000000003 109.369 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.92 -81.91 0.28 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.003 0.43 . . . . 65.099999999999994 109.992 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 42' ' ' LYS . 59.6 ttt180 -101.97 -177.18 3.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.123 -1.436 . . . . 73.400000000000006 107.123 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' H ' ' HG2' ' A' ' 41' ' ' ARG . 47.3 pttt -53.09 102.01 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.465 0.65 . . . . 73.019999999999996 111.42 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 39' ' ' ILE . 1.6 p -142.47 107.47 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 71.219999999999999 110.626 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 37.6 pttt -51.6 175.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.158 -0.928 . . . . 62.32 113.493 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.754 ' HA ' HD12 ' A' ' 48' ' ' LEU . 44.7 mt -66.43 -21.69 66.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.657 -1.156 . . . . 72.430000000000007 113.03 -169.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.53 ' HA ' ' CE ' ' A' ' 49' ' ' MET . 34.0 mt-10 -58.5 -33.49 69.87 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.569 0.581 . . . . 72.420000000000002 112.569 -171.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -23.39 32.59 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.351 -0.54 . . . . 62.409999999999997 110.837 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.759 HD13 HG11 ' A' ' 25' ' ' VAL . 73.0 mt -64.84 -35.34 80.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.361 . . . . 70.349999999999994 111.456 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -88.3 -39.37 14.43 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.497 -0.881 . . . . 63.310000000000002 111.268 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' N ' ' HG2' ' A' ' 49' ' ' MET . 12.4 mm-40 -68.95 -37.96 79.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.431 0.53 . . . . 64.219999999999999 112.431 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 55' ' ' ARG . 69.8 t -60.48 -31.45 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.268 -0.573 . . . . 72.349999999999994 109.664 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.49 ' HD2' HD23 ' A' ' 56' ' ' LEU . 8.3 t80 -83.01 -29.84 28.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.149 -0.478 . . . . 70.140000000000001 110.13 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.031 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 73.6 m -58.34 -37.25 74.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.296 0.569 . . . . 62.329999999999998 110.758 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.17 -32.78 74.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 62.25 110.825 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 51' ' ' VAL . 9.4 mpt_? -73.25 -50.55 21.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 111.496 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 52' ' ' TYR . 2.9 pp -76.01 -20.99 57.37 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.713 -0.221 . . . . 75.420000000000002 111.583 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.83 13.24 37.9 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.755 -0.735 . . . . 60.039999999999999 113.527 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -150.3 130.12 13.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.083 -0.71 . . . . 75.329999999999998 109.083 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 1.031 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 25.2 p -78.37 167.13 21.8 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.447 0.641 . . . . 31.199999999999999 112.595 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.726 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -64.47 -15.85 61.45 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.821 -1.081 . . . . 74.420000000000002 112.897 -169.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.51 -17.36 62.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.052 0.453 . . . . 75.510000000000005 110.46 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.06 8.99 18.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.112 -0.494 . . . . 65.209999999999994 110.088 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 60' ' ' MET . 3.0 m -143.49 103.17 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.935 -0.575 . . . . 73.140000000000001 110.086 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 25.0 tpt180 -73.24 125.68 28.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.533 . . . . 70.219999999999999 110.378 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.5 OUTLIER -87.03 112.4 21.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.459 -0.791 . . . . 74.420000000000002 112.314 -175.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.626 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 7.9 mp -93.79 124.89 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.865 -0.607 . . . . 63.149999999999999 109.538 172.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HD2' HG12 ' A' ' 89' ' ' ILE . 83.1 m-85 -103.3 113.69 27.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.323 -0.251 . . . . 74.010000000000005 110.323 -177.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 t70 57.88 26.99 13.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 122.079 0.942 . . . . 75.510000000000005 109.869 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.12 -16.89 58.79 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.228 -0.896 . . . . 73.329999999999998 112.787 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -111.96 116.41 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.513 0.673 . . . . 72.129999999999995 110.623 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 12.0 ptt-85 -80.24 111.5 16.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.655 -0.702 . . . . 73.239999999999995 111.401 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.9 -165.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.935 -0.575 . . . . 75.299999999999997 110.187 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -85.22 140.87 30.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.083 -0.34 . . . . 61.520000000000003 110.083 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.48 -18.14 76.8 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.225 -0.512 . . . . 50.310000000000002 113.005 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 33.9 t70 -70.08 -12.97 61.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.033 0.444 . . . . 72.230000000000004 111.084 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -66.33 -41.44 89.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.899 -0.591 . . . . 71.25 110.746 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 m 68.55 136.58 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.903 -0.589 . . . . 70.120000000000005 111.091 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HD3' ' HG ' ' A' ' 45' ' ' LEU . 76.4 Cg_exo -51.66 -36.86 62.67 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.215 2.61 . . . . 73.219999999999999 113.725 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.63 -34.24 36.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.267 0.469 . . . . 74.519999999999996 112.267 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -88.6 -18.06 28.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 74.25 111.254 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.05 -30.37 19.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.497 -0.32 . . . . 73.109999999999999 111.756 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.76 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.24 -0.981 . . . . 62.200000000000003 110.654 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 84' ' ' GLU . 10.1 tp -91.85 159.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.235 -1.394 . . . . 63.43 107.235 169.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.647 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 25.0 tt0 -154.05 -171.62 3.94 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.763 -0.829 . . . . 64.030000000000001 108.763 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 23' ' ' ILE . 8.4 p-10 -47.51 126.28 9.58 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.77 0.795 . . . . 63.130000000000003 112.358 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.56 4.26 15.57 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.86 -1.064 . . . . 60.32 110.844 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.41 -173.58 4.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.088 0.471 . . . . 70.519999999999996 111.072 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.03 148.37 22.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.563 0.697 . . . . 62.310000000000002 111.348 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 27' ' ' VAL . 64.8 mt -119.0 114.04 43.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.036 -0.984 . . . . 71.310000000000002 108.976 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -99.81 118.0 35.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.721 -0.474 . . . . 54.299999999999997 109.721 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -109.81 117.36 33.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.107 0.48 . . . . 62.409999999999997 111.207 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.7 144.89 35.89 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.093 -0.706 . . . . 71.519999999999996 109.093 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.39 97.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.397 0.435 . . . . 75.099999999999994 111.356 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 3.2 pt20 26.99 57.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.658 1.224 . . . . 74.299999999999997 112.552 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -60.43 -38.06 82.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.827 -0.624 . . . . 74.200000000000003 110.579 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 m -129.3 119.76 24.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.51 -0.768 . . . . 61.119999999999997 109.632 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 59.59 1.77 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.379 -0.915 . . . . 53.25 112.28 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.905 -0.942 . . . . 31.300000000000001 111.656 178.199 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.847 -0.427 . . . . 55.350000000000001 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.38 -102.38 2.88 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.63 -0.795 . . . . 72.340000000000003 111.812 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.79 157.1 23.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.818 0.342 . . . . 64.099999999999994 110.29 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.72 -26.05 23.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.47 . . . . 73.109999999999999 111.449 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.31 -26.37 66.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 72.019999999999996 112.067 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -59.46 -27.54 66.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.751 0.31 . . . . 75.430000000000007 111.416 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.92 65.67 0.82 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.898 0.38 . . . . 62.409999999999997 110.974 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.21 89.28 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.037 -0.529 . . . . 74.319999999999993 110.66 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -85.25 85.15 7.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.295 -0.632 . . . . 75.340000000000003 109.295 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -164.85 74.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 71.340000000000003 109.489 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -94.1 171.43 8.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.73 -0.668 . . . . 73.310000000000002 110.883 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.72 123.99 2.62 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.706 -0.679 . . . . 60.409999999999997 111.407 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.9 t -90.39 -163.14 0.97 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.053 -0.351 . . . . 73.340000000000003 110.053 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.4 m -61.86 148.53 87.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.329999999999998 110.375 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 11.3 Cg_exo -70.3 75.16 1.46 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.909 2.406 . . . . 72.239999999999995 112.57 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.3 t -71.89 -33.56 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.189 0.519 . . . . 73.430000000000007 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -61.47 -55.47 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.653 -0.703 . . . . 70.0 109.377 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.47 ' O ' ' HE1' ' A' ' 22' ' ' HIS . 60.9 t30 68.62 -67.34 0.21 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.935 -1.03 . . . . 63.399999999999999 112.725 173.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -82.9 6.92 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 74.430000000000007 112.918 -170.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.65 124.3 30.8 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.908 -1.277 . . . . 65.400000000000006 109.908 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -48.56 124.44 8.22 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.248 0.547 . . . . 73.099999999999994 110.771 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 18' ' ' ASN . 3.0 m-70 -76.06 171.16 14.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 71.140000000000001 112.235 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 28.4 mt -110.5 166.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.734 -1.21 . . . . 44.310000000000002 107.734 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.684 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 31.5 tt0 -162.38 123.99 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 71.430000000000007 111.004 -171.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 48' ' ' LEU . 15.5 m -137.09 141.93 38.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.428 -0.582 . . . . 73.230000000000004 109.428 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.607 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.9 ttmt -100.01 111.32 23.63 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.793 -0.763 . . . . 74.439999999999998 109.02 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 89' ' ' ILE . 67.5 t -95.3 99.29 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.419 -0.956 . . . . 73.329999999999998 108.419 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.804 ' HE ' ' HA2' ' A' ' 32' ' ' GLY . 36.2 ttt180 -70.2 104.66 2.69 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.368 -1.345 . . . . 71.219999999999999 107.368 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.684 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 10.0 p -65.74 164.89 23.15 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.044 -0.98 . . . . 72.530000000000001 109.39 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 52.2 Cg_endo -67.69 30.63 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 123.115 2.543 . . . . 72.519999999999996 114.769 -169.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -131.74 -23.36 2.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.67 -0.492 . . . . 63.119999999999997 109.67 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.804 ' HA2' ' HE ' ' A' ' 28' ' ' ARG . . . 126.67 -11.25 7.07 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.757 -0.656 . . . . 64.219999999999999 112.293 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.33 94.67 3.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.158 0.504 . . . . 44.210000000000001 110.796 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.78 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 35.8 tt0 -92.5 99.33 12.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 70.409999999999997 109.586 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.22 134.31 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.173 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 21.0 p90 -75.98 105.14 6.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.589 0.709 . . . . 63.020000000000003 110.31 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.414 ' HD1' ' CD2' ' A' ' 48' ' ' LEU . 6.2 t80 -111.72 151.35 29.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.516 -0.92 . . . . 62.039999999999999 108.516 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 24' ' ' GLN . 78.4 mttt -125.87 168.64 13.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.664 0.745 . . . . 64.219999999999999 111.735 -169.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.759 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 53.8 mt -115.42 134.22 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.397 -1.334 . . . . 43.020000000000003 107.397 170.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -103.03 -58.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.137 -0.625 . . . . 65.099999999999994 110.161 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -106.48 -178.95 3.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.178 -1.045 . . . . 73.400000000000006 108.178 169.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.93 101.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.999 0.363 . . . . 73.019999999999996 110.417 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.401 ' CG2' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -134.02 133.19 40.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.98 0.419 . . . . 71.219999999999999 110.515 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 167.3 21.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 62.32 111.081 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.705 HD21 ' HD3' ' A' ' 78' ' ' PRO . 96.6 mt -67.47 -23.87 65.55 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.464 0.542 . . . . 72.430000000000007 112.464 -170.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 34.0 mp0 -59.21 -24.68 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.033 0.383 . . . . 72.420000000000002 112.033 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -76.38 -37.66 56.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.202 -0.599 . . . . 62.409999999999997 109.949 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 39' ' ' ILE . 59.5 mt -62.53 -38.33 89.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.195 0.521 . . . . 70.349999999999994 109.99 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 20.0 ptm -80.01 -37.13 34.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.586 -0.734 . . . . 63.310000000000002 111.5 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 49.8 mm-40 -67.91 -30.46 69.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.955 -0.298 . . . . 64.219999999999999 111.719 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 47' ' ' LYS . 76.5 t -54.88 -39.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.465 -0.494 . . . . 72.349999999999994 110.296 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -75.97 -35.12 59.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 70.140000000000001 111.507 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 64.4 m -49.88 -48.13 51.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.909 0.385 . . . . 62.329999999999998 111.044 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.71 -32.77 62.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 62.25 111.289 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -67.55 -37.33 82.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 74.420000000000002 111.08 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.49 -21.55 26.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.468 -0.333 . . . . 75.420000000000002 111.275 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.05 12.98 83.85 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.501 -1.04 . . . . 60.039999999999999 110.501 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 34.4 tt0 -136.2 129.94 32.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.492 -0.929 . . . . 75.329999999999998 108.492 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 6.2 p -81.42 171.64 14.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.456 0.646 . . . . 31.199999999999999 112.158 -173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.562 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.34 -15.08 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.902 -1.045 . . . . 74.420000000000002 112.935 -174.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.62 -15.28 57.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.976 0.361 . . . . 75.510000000000005 111.976 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HA ' ' CG ' ' A' ' 94' ' ' GLN . . . -109.95 9.25 24.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.125 0.488 . . . . 65.209999999999994 110.177 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.742 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 18.3 m -140.5 172.37 11.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.595 . . . . 73.140000000000001 110.495 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 tpp85 -143.75 130.49 20.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.607 -0.516 . . . . 70.219999999999999 109.607 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 49' ' ' MET . 91.3 m-85 -99.99 116.38 31.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.209 0.528 . . . . 74.420000000000002 111.441 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -111.03 113.45 26.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.392 -0.822 . . . . 63.149999999999999 110.015 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.667 ' HB3' HG12 ' A' ' 89' ' ' ILE . 23.2 p90 -112.47 146.15 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.098 -0.641 . . . . 74.010000000000005 110.175 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.1 t70 60.44 21.94 11.58 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.352 1.072 . . . . 75.510000000000005 109.3 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.92 -12.09 68.57 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.118 -0.946 . . . . 73.329999999999998 113.109 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -130.63 127.55 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.427 0.613 . . . . 72.129999999999995 112.054 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -63.96 159.21 20.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.681 -0.69 . . . . 73.239999999999995 111.839 175.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.756 HG12 ' H ' ' A' ' 73' ' ' HIS . 10.2 tt -173.03 -171.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.428 -0.582 . . . . 75.299999999999997 109.428 175.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.756 ' H ' HG12 ' A' ' 72' ' ' ILE . 11.5 m170 -75.51 151.79 37.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.878 0.371 . . . . 61.520000000000003 110.687 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -72.69 -19.85 79.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.794 -0.717 . . . . 50.310000000000002 112.217 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.97 -19.21 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.57 0.211 . . . . 72.230000000000004 111.57 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.671 ' OD1' ' HB2' ' A' ' 73' ' ' HIS . 18.7 m120 -68.15 -44.14 76.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.018 -0.364 . . . . 71.25 110.018 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.0 p 61.96 162.54 0.11 Allowed Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.871 0.869 . . . . 70.120000000000005 111.512 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.705 ' HD3' HD21 ' A' ' 45' ' ' LEU . 24.9 Cg_exo -64.3 -39.21 30.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.463 2.109 . . . . 73.219999999999999 112.356 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.54 -49.11 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.716 -0.674 . . . . 74.519999999999996 110.976 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.798 HE21 ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -67.06 -22.74 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 74.25 111.686 -173.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.7 tp -86.63 -29.5 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 73.109999999999999 110.241 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.41 -18.44 27.72 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.112 -0.795 . . . . 62.200000000000003 111.112 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -100.61 126.87 54.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.089 -0.708 . . . . 63.43 109.089 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.0 tt0 -131.37 -151.52 0.47 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.408 -0.36 . . . . 64.030000000000001 110.344 -169.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 4.0 p-10 -43.4 131.73 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.551 0.691 . . . . 63.130000000000003 112.631 -172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.38 -9.5 24.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.547 -0.751 . . . . 60.32 112.007 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.68 169.86 10.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.945 -0.391 . . . . 70.519999999999996 109.945 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.9 161.95 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.306 0.574 . . . . 62.310000000000002 111.261 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.667 HG12 ' HB3' ' A' ' 67' ' ' TYR . 35.6 mt -132.94 117.22 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.424 -0.954 . . . . 71.310000000000002 108.424 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 28' ' ' ARG . 3.4 t70 -98.69 125.98 44.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.84 -0.43 . . . . 54.299999999999997 109.84 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 64' ' ' ARG . . . -97.79 117.04 31.21 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.174 0.511 . . . . 62.409999999999997 110.512 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.0 163.64 12.24 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.713 -0.676 . . . . 71.519999999999996 109.37 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.06 101.42 3.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.912 -0.315 . . . . 75.099999999999994 111.345 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.742 ' H ' ' HA ' ' A' ' 63' ' ' VAL . 45.2 mt-30 56.72 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.452 -0.794 . . . . 74.299999999999997 111.692 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.435 ' O ' ' HB ' ' A' ' 96' ' ' THR . 8.2 tt0 -173.24 36.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.489 -1.3 . . . . 74.200000000000003 107.489 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 95' ' ' GLN . 54.9 m 75.98 -45.17 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.042 -0.981 . . . . 61.119999999999997 110.419 -171.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.79 -58.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.378 -0.689 . . . . 53.25 111.378 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.851 0 CA-C-O 119.055 -0.858 . . . . 31.300000000000001 111.648 177.37 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.375 0.607 . . . . 55.350000000000001 110.028 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.56 -122.7 5.13 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.341 -1.104 . . . . 72.340000000000003 110.341 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -128.19 123.2 33.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.968 -0.382 . . . . 64.099999999999994 109.968 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -67.49 -22.09 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.221 -0.659 . . . . 73.109999999999999 109.221 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.441 ' HA ' HG23 ' A' ' 8' ' ' VAL . 30.0 m-20 -61.78 -25.06 67.24 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.381 -0.827 . . . . 72.019999999999996 111.181 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -82.87 -15.37 51.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.056 0.455 . . . . 75.430000000000007 110.9 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.32 14.33 17.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.137 -0.483 . . . . 62.409999999999997 111.35 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 5' ' ' ASP . 87.5 t -67.53 102.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.532 . . . . 74.319999999999993 110.639 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -127.89 73.11 1.44 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.111 -0.7 . . . . 75.340000000000003 109.111 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -100.38 -17.58 17.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.244 -0.889 . . . . 71.340000000000003 110.557 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -89.64 127.2 35.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.012 -0.54 . . . . 73.310000000000002 110.051 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.44 93.52 1.28 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.746 -0.74 . . . . 60.409999999999997 111.785 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.6 m -66.84 131.57 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.859 0.361 . . . . 73.340000000000003 110.632 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -120.49 93.34 48.3 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.18 -0.464 . . . . 63.329999999999998 110.839 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.35 93.69 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.63 2.22 . . . . 72.239999999999995 110.875 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.36 125.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.879 -0.601 . . . . 73.430000000000007 111.418 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -59.97 -71.51 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.087 -0.961 . . . . 70.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -99.33 88.35 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 63.399999999999999 110.659 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -127.39 -48.38 1.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.234 -0.893 . . . . 74.430000000000007 110.391 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.58 -12.33 1.01 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.941 -0.647 . . . . 65.400000000000006 111.572 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -85.37 3.61 39.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.47 0.652 . . . . 73.099999999999994 110.505 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 71.140000000000001 109.462 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 14.8 mt -110.76 168.1 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.909 -0.404 . . . . 44.310000000000002 109.909 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 41.7 mt-30 -150.8 131.72 14.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.877 0.471 . . . . 71.430000000000007 110.674 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 48' ' ' LEU . 35.8 m -130.35 -177.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.356 -0.609 . . . . 73.230000000000004 109.356 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.74 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mtmt -138.77 114.75 10.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.767 0.318 . . . . 74.439999999999998 110.554 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 89' ' ' ILE . 66.9 t -97.17 100.94 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 107.73 -1.211 . . . . 73.329999999999998 107.73 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -69.9 106.68 3.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.925 -1.139 . . . . 71.219999999999999 107.925 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.482 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 66.1 p -60.34 160.28 18.59 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.256 -0.884 . . . . 72.530000000000001 108.954 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 36.7 Cg_endo -65.2 31.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 123.165 2.576 . . . . 72.519999999999996 114.076 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 29' ' ' SER . 27.7 t70 -131.44 -21.45 2.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.272 0.558 . . . . 63.119999999999997 110.77 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.65 -15.73 24.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.268 -0.733 . . . . 64.219999999999999 111.268 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.09 104.17 1.71 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.539 -0.541 . . . . 44.210000000000001 109.539 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.74 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 34.0 tt0 -113.44 96.86 6.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.36 -0.836 . . . . 70.409999999999997 109.289 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.27 134.57 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.221 -0.659 . . . . 73.019999999999996 109.221 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 34.9 p90 -68.32 130.5 43.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.227 0.536 . . . . 63.020000000000003 110.191 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG11 ' A' ' 51' ' ' VAL . 3.9 t80 -128.12 130.17 47.72 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.983 -1.117 . . . . 62.039999999999999 107.983 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 44.4 pttt -105.29 163.69 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.88 0.848 . . . . 64.219999999999999 112.555 -165.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.763 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 65.2 mt -114.83 134.77 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.419 -1.264 . . . . 43.020000000000003 108.063 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.15 -81.68 0.37 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.281 0.562 . . . . 65.099999999999994 110.628 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -102.1 -176.57 3.16 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.022 -1.103 . . . . 73.400000000000006 108.022 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -53.76 101.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.258 0.551 . . . . 73.019999999999996 109.967 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 1.7 p -141.47 105.23 4.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.968 -1.015 . . . . 71.219999999999999 109.776 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -39.24 152.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.841 -1.072 . . . . 62.32 113.308 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.47 -15.4 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.118 -0.947 . . . . 72.430000000000007 111.236 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 42.5 mt-10 -62.73 -26.28 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 72.420000000000002 111.181 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -78.13 -36.24 48.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.44 -0.504 . . . . 62.409999999999997 109.905 177.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 25' ' ' VAL . 74.3 mt -59.38 -29.72 67.91 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.763 -0.828 . . . . 70.349999999999994 108.763 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.638 ' HG3' ' CD1' ' A' ' 65' ' ' PHE . 24.9 ttt -78.62 -51.09 10.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.111 -1.404 . . . . 63.310000000000002 111.049 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 42.7 mt-10 -70.43 -30.19 66.98 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.511 0.559 . . . . 64.219999999999999 112.511 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 47' ' ' LYS . 54.5 t -55.71 -38.47 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.442 -0.503 . . . . 72.349999999999994 111.101 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -71.8 -30.44 65.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.579 -0.282 . . . . 70.140000000000001 111.504 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 62.2 m -51.36 -39.78 57.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.33 0.586 . . . . 62.329999999999998 110.57 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -76.57 -41.26 47.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.533 -0.758 . . . . 62.25 111.147 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -64.22 -50.77 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.02 0.748 . . . . 74.420000000000002 113.02 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 58' ' ' GLN . 1.2 pp -98.63 8.51 44.83 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.564 -0.454 . . . . 75.420000000000002 111.914 -174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.17 27.36 72.89 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.158 -0.544 . . . . 60.039999999999999 113.386 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 10.2 tt0 -143.22 130.84 21.26 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.482 -0.933 . . . . 75.329999999999998 108.482 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 p -89.33 174.3 7.9 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.952 0.723 . . . . 31.199999999999999 112.952 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.461 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -70.11 -14.92 62.88 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 115.023 1.49 . . . . 74.420000000000002 115.023 -163.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.38 -12.68 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.08 -1.012 . . . . 75.510000000000005 109.76 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -101.54 -7.6 22.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.429 -0.805 . . . . 65.209999999999994 110.272 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 92' ' ' MET . 5.1 m -138.72 104.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.911 -0.586 . . . . 73.140000000000001 110.223 172.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 54.1 ttp180 -88.01 125.9 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.293 -0.412 . . . . 70.219999999999999 110.099 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 49' ' ' MET . 54.7 m-85 -92.93 122.95 35.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.18 0.514 . . . . 74.420000000000002 111.347 -176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.98 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -106.73 113.33 26.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.674 -0.693 . . . . 63.149999999999999 109.838 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 89' ' ' ILE . 47.1 p90 -112.73 145.71 40.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.836 -0.746 . . . . 74.010000000000005 111.149 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.26 22.51 11.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.071 0.938 . . . . 75.510000000000005 109.058 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.98 2.27 86.54 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.979 -1.009 . . . . 73.329999999999998 112.14 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -122.17 117.72 26.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.145 0.498 . . . . 72.129999999999995 111.324 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.98 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -66.74 119.26 11.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.219 0.533 . . . . 73.239999999999995 111.189 173.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.478 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 8.0 tt -161.3 157.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.407 -0.59 . . . . 75.299999999999997 109.407 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.34 135.37 48.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.099 0.476 . . . . 61.520000000000003 111.877 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.04 -2.48 82.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.586 -0.734 . . . . 50.310000000000002 114.419 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.2 -33.35 75.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.207 0.503 . . . . 72.230000000000004 111.364 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' A' ' 76' ' ' ASN . 2.0 t-20 -79.83 0.67 30.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.386 -0.37 . . . . 71.25 111.23 -173.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.708 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 80.9 p 59.89 163.83 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.28 1.032 . . . . 70.120000000000005 112.833 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 73.0 Cg_endo -76.17 -31.73 4.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.149 1.899 . . . . 73.219999999999999 112.127 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.6 -34.34 67.11 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.786 -0.643 . . . . 74.519999999999996 110.758 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -77.09 -19.03 57.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.064 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -93.88 -30.88 14.57 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 73.109999999999999 111.23 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.16 -19.04 23.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.463 -0.875 . . . . 62.200000000000003 110.97 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.587 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -85.65 147.92 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.878 -1.156 . . . . 63.43 107.878 169.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.73 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 23.1 tt0 -151.23 -152.35 0.43 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.191 -0.67 . . . . 64.030000000000001 109.191 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.73 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 t70 -47.32 114.84 0.95 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.865 0.364 . . . . 63.130000000000003 110.855 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.09 3.9 14.88 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.978 -0.629 . . . . 60.32 111.536 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HB2' HG13 ' A' ' 83' ' ' ILE . 17.7 t70 -76.09 142.05 41.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 70.519999999999996 111.049 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 17.7 m -114.47 141.47 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 121.345 0.593 . . . . 62.310000000000002 109.796 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.572 HG12 ' HB3' ' A' ' 67' ' ' TYR . 22.8 mt -121.37 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.497 -0.774 . . . . 71.310000000000002 109.651 -174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.64 -0.255 . . . . 54.299999999999997 110.906 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -94.93 118.16 31.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 62.409999999999997 111.282 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 66.9 mmm -105.37 168.04 9.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 71.519999999999996 110.621 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.05 109.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 75.099999999999994 111.371 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.792 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 89.6 mt-30 62.38 170.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 74.299999999999997 113.13 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 4.7 pt20 -72.37 -21.13 61.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.057 -0.974 . . . . 74.200000000000003 112.017 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 m -136.15 22.56 3.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.489 0.662 . . . . 61.119999999999997 110.96 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.71 4.52 84.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.448 -0.882 . . . . 53.25 111.891 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.105 -1.386 . . . . 31.300000000000001 110.777 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.027 -0.36 . . . . 55.350000000000001 110.027 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.11 4.46 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.732 -0.747 . . . . 72.340000000000003 111.293 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -65.73 162.62 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 64.099999999999994 111.673 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.01 -29.88 68.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.397 -0.82 . . . . 73.109999999999999 110.887 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 8' ' ' VAL . 60.2 m-20 -68.19 -17.17 64.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.947 0.404 . . . . 72.019999999999996 110.816 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.2 t -81.78 -15.26 54.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.576 0.703 . . . . 75.430000000000007 109.433 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.89 48.78 1.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.766 . . . . 62.409999999999997 110.333 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 5' ' ' ASP . 73.8 t -76.08 106.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.27 0.557 . . . . 74.319999999999993 110.311 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -125.84 12.92 7.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 75.340000000000003 109.322 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -76.98 64.79 2.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.497 -0.774 . . . . 71.340000000000003 111.267 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -143.55 87.97 1.97 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.813 -0.81 . . . . 73.310000000000002 108.813 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.1 58.23 4.34 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.998 -0.62 . . . . 60.409999999999997 112.9 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m 64.41 -174.7 0.17 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.038 0.535 . . . . 73.340000000000003 111.017 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 7.5 t -155.91 130.54 5.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.671 -0.492 . . . . 63.329999999999998 109.671 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 4.5 Cg_exo -76.76 77.92 3.54 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.089 2.526 . . . . 72.239999999999995 112.025 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.61 121.51 63.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 73.430000000000007 110.864 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.408 HD22 ' HA ' ' A' ' 17' ' ' ASN . 11.3 m120 58.81 76.83 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 70.0 111.862 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.452 HD22 ' NE2' ' A' ' 24' ' ' GLN . 23.4 p-10 -60.88 -35.18 75.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.692 -0.686 . . . . 63.399999999999999 110.493 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -94.23 16.52 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.49 0.662 . . . . 74.430000000000007 109.903 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.78 -83.93 0.42 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.744 -0.662 . . . . 65.400000000000006 111.476 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.87 34.26 5.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.891 0.853 . . . . 73.099999999999994 108.966 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -139.41 169.57 17.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.914 . . . . 71.140000000000001 110.061 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 23.6 mt -126.01 160.12 33.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.055 -1.091 . . . . 44.310000000000002 108.055 172.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 2.0 tt0 -145.8 135.85 23.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.567 0.222 . . . . 71.430000000000007 110.96 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 48' ' ' LEU . 26.8 m -139.47 149.07 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.895 -0.593 . . . . 73.230000000000004 110.196 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.635 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 mtmt -119.36 114.94 23.12 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.217 -0.302 . . . . 74.439999999999998 110.427 177.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 89' ' ' ILE . 53.2 t -97.36 98.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.946 -1.501 . . . . 73.329999999999998 106.946 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 27.6 ttp180 -68.99 103.74 1.92 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.055 -1.461 . . . . 71.219999999999999 107.055 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 70.8 m -64.63 158.46 67.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 114.073 -1.421 . . . . 72.530000000000001 108.699 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 37.1 Cg_endo -64.31 32.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 123.63 2.887 . . . . 72.519999999999996 114.756 -170.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 29' ' ' SER . 28.8 t70 -134.06 -8.58 2.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.449 0.642 . . . . 63.119999999999997 110.302 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.85 57.01 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.88 -0.888 . . . . 64.219999999999999 110.88 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 99.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.351 0.596 . . . . 44.210000000000001 110.246 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 35.1 tt0 -104.92 99.78 9.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.526 -0.761 . . . . 70.409999999999997 109.515 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.56 134.77 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 73.019999999999996 110.338 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 20.8 p90 -76.59 117.37 18.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.78 0.8 . . . . 63.020000000000003 111.691 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -112.02 171.59 7.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.696 -1.224 . . . . 62.039999999999999 107.696 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -145.66 165.53 28.45 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.358 -0.937 . . . . 64.219999999999999 112.476 -170.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.096 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 48.5 mt -123.1 147.59 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.602 -1.181 . . . . 43.020000000000003 108.958 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -128.96 -77.63 0.56 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.2 -0.667 . . . . 65.099999999999994 109.2 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -72.62 150.14 43.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.185 -1.413 . . . . 73.400000000000006 107.185 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 42' ' ' LYS . 59.7 pttt -56.64 101.24 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.902 0.858 . . . . 73.019999999999996 111.219 -175.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.46 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -134.68 103.31 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.063 -0.971 . . . . 71.219999999999999 109.465 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 13.1 pttp -63.54 -178.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.328 0.862 . . . . 62.32 113.328 -173.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.863 ' HA ' HD12 ' A' ' 48' ' ' LEU . 37.4 mt -60.91 -16.73 45.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.626 -1.17 . . . . 72.430000000000007 113.611 -164.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 49' ' ' MET . 53.1 mt-10 -58.09 -57.37 13.12 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.83 0.307 . . . . 72.420000000000002 111.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -68.2 -28.42 67.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.878 -0.329 . . . . 62.409999999999997 111.008 -175.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.1 mt -58.96 -37.59 77.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 70.349999999999994 110.73 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.1 ptt? -90.98 -32.79 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.628 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 27.6 mt-10 -67.91 -34.63 77.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.072 0.397 . . . . 64.219999999999999 112.072 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 47' ' ' LYS . 62.3 t -55.8 -37.68 48.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.207 0.527 . . . . 72.349999999999994 109.946 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.86 -36.76 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 70.140000000000001 111.287 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.054 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 58.5 m -52.21 -53.44 43.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.15 0.5 . . . . 62.329999999999998 110.638 173.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -67.22 -32.32 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.652 . . . . 62.25 110.938 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -69.26 -38.87 78.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.297 -0.41 . . . . 74.420000000000002 111.244 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.03 -13.93 37.61 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.874 -0.33 . . . . 75.420000000000002 111.422 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.4 8.46 52.75 Favored Glycine 0 CA--C 1.517 0.158 0 C-N-CA 120.556 -0.831 . . . . 60.039999999999999 113.822 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -151.17 135.18 16.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.7 -0.481 . . . . 75.329999999999998 109.7 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 1.054 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 3.6 p -78.37 179.33 7.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.191 0.811 . . . . 31.199999999999999 113.191 -171.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.586 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.2 -14.15 62.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.893 1.442 . . . . 74.420000000000002 114.893 -163.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -1.8 27.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.093 -1.004 . . . . 75.510000000000005 109.982 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . . . -113.76 1.8 14.96 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 65.209999999999994 109.953 173.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.859 ' HB ' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -142.52 102.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.362 0.601 . . . . 73.140000000000001 110.19 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.642 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 22.9 tpt180 -71.17 114.19 8.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 70.219999999999999 111.192 -172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -80.43 110.87 16.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.277 -0.874 . . . . 74.420000000000002 112.306 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 9.9 mp -104.8 125.51 50.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.797 -0.638 . . . . 63.149999999999999 109.783 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' HD1' HG12 ' A' ' 89' ' ' ILE . 74.0 m-85 -103.26 123.77 47.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.211 -0.292 . . . . 74.010000000000005 110.211 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.2 t70 57.82 22.95 9.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.147 0.975 . . . . 75.510000000000005 110.039 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.75 63.17 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.5 -0.773 . . . . 73.329999999999998 112.691 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.42 117.88 26.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 72.129999999999995 111.523 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.99 122.43 16.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 73.239999999999995 111.467 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 67' ' ' TYR . 8.3 pt -147.66 -162.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.968 -0.753 . . . . 75.299999999999997 108.968 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.411 ' H ' ' HB ' ' A' ' 72' ' ' ILE . 38.8 m170 -89.64 159.52 17.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.862 0.363 . . . . 61.520000000000003 110.88 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.679 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -76.59 -17.56 79.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.883 -0.675 . . . . 50.310000000000002 111.496 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.714 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 p30 -74.61 -9.21 58.35 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 122.468 0.307 . . . . 72.230000000000004 111.387 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.431 HD21 ' HB2' ' A' ' 81' ' ' LEU . 7.2 t30 -67.7 -38.26 83.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.414 -0.357 . . . . 71.25 110.877 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.5 p 63.27 144.72 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 124.356 1.063 . . . . 70.120000000000005 111.461 -174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.0 -51.08 10.37 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.981 2.454 . . . . 73.219999999999999 113.219 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -56.95 -31.64 65.2 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.297 0.48 . . . . 74.519999999999996 112.297 -171.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.83 -19.52 58.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.085 0.469 . . . . 74.25 110.667 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' HD21 ' A' ' 76' ' ' ASN . 44.4 tp -91.5 -30.88 16.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.356 . . . . 73.109999999999999 111.51 -171.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.1 -18.85 13.91 Favored Glycine 0 CA--C 1.502 -0.767 0 N-CA-C 110.1 -1.2 . . . . 62.200000000000003 110.1 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tp -89.3 159.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.957 -1.127 . . . . 63.43 107.957 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 28.3 tt0 -154.55 -152.4 0.4 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.983 -1.117 . . . . 64.030000000000001 107.983 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.749 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 7.9 t70 -43.85 119.36 1.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.603 0.638 . . . . 63.130000000000003 111.616 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.46 4.71 32.47 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.724 -0.75 . . . . 60.32 111.539 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB3' HG12 ' A' ' 25' ' ' VAL . 18.3 t70 -60.67 151.52 28.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.607 -0.297 . . . . 70.519999999999996 110.644 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 23.5 m -128.61 148.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.432 0.634 . . . . 62.310000000000002 110.607 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 27' ' ' VAL . 54.6 mt -127.85 113.05 29.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.368 -0.975 . . . . 71.310000000000002 108.368 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -102.76 126.17 49.78 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.969 -0.382 . . . . 54.299999999999997 109.969 -173.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.859 ' HB1' ' HB ' ' A' ' 63' ' ' VAL . . . -104.62 118.01 35.53 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.429 0.455 . . . . 62.409999999999997 112.146 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.3 mpt? -95.14 171.23 8.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.565 -0.532 . . . . 71.519999999999996 109.565 172.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.94 117.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.719 0.295 . . . . 75.099999999999994 111.345 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 62' ' ' ALA . 48.8 mt-30 59.05 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.013 0.925 . . . . 74.299999999999997 112.22 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 72.8 mt-30 -136.79 17.78 3.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 74.200000000000003 110.01 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 m 63.06 51.54 2.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.621 -0.718 . . . . 61.119999999999997 109.137 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.62 -71.41 0.49 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.304 -0.862 . . . . 53.25 111.622 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.26 -1.3 . . . . 31.300000000000001 111.474 -179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.882 0.372 . . . . 55.350000000000001 110.344 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.24 69.83 0.25 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.345 -0.702 . . . . 72.340000000000003 111.345 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.06 149.08 41.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.695 0.283 . . . . 64.099999999999994 110.626 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.45 -37.55 81.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 73.109999999999999 111.061 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.33 -31.09 69.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 72.019999999999996 111.381 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.0 m -83.04 -27.0 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.831 0.348 . . . . 75.430000000000007 110.961 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.27 -59.77 2.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.238 -0.437 . . . . 62.409999999999997 110.644 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.43 91.91 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.588 . . . . 74.319999999999993 110.861 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -136.61 -176.6 4.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.555 -0.748 . . . . 75.340000000000003 109.041 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 63.18 32.28 15.15 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.871 -0.418 . . . . 71.340000000000003 109.871 -172.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -93.56 100.98 13.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 73.310000000000002 111.165 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.21 125.07 6.46 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.796 -0.922 . . . . 60.409999999999997 110.796 174.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.518 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 44.9 m -59.63 131.94 52.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 73.340000000000003 111.504 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.5 t -78.94 118.21 71.15 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 109.121 -0.696 . . . . 63.329999999999998 109.121 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 6.9 Cg_exo -73.6 64.66 4.71 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.234 2.622 . . . . 72.239999999999995 112.981 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.4 t 67.54 110.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 123.696 0.623 . . . . 73.430000000000007 111.609 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -109.4 111.34 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 70.0 111.07 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -156.05 36.08 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 63.399999999999999 110.081 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.75 23.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.867 -0.606 . . . . 74.430000000000007 112.261 -176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 10.36 63.53 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.904 -0.665 . . . . 65.400000000000006 112.126 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.57 155.03 21.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.944 0.402 . . . . 73.099999999999994 110.133 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -94.93 161.01 14.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.828 -0.624 . . . . 71.140000000000001 109.927 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 10.2 mt -109.83 169.63 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.614 -0.513 . . . . 44.310000000000002 109.614 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 23' ' ' ILE . 4.1 tt0 -145.9 138.26 25.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.483 -0.562 . . . . 71.430000000000007 109.483 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.862 HG11 HD13 ' A' ' 48' ' ' LEU . 7.4 p -150.73 138.38 13.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.188 0.518 . . . . 73.230000000000004 110.234 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' A' ' 36' ' ' PHE . 39.6 mttt -102.41 140.83 36.18 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.314 -0.403 . . . . 74.439999999999998 110.508 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 77.1 t -119.81 100.69 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.871 -1.529 . . . . 73.329999999999998 106.871 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 6.6 ttp180 -69.51 111.31 5.27 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.326 -0.99 . . . . 71.219999999999999 108.326 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 78.4 p -60.28 157.65 32.74 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.645 -0.872 . . . . 72.530000000000001 108.645 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 36.2 Cg_endo -64.68 27.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.31 2.673 . . . . 72.519999999999996 114.504 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 29' ' ' SER . 12.3 t70 -130.52 -22.64 2.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.25 0.547 . . . . 63.119999999999997 110.615 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.63 -5.56 24.49 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.604 -0.808 . . . . 64.219999999999999 111.577 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.56 91.61 3.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.311 0.576 . . . . 44.210000000000001 109.538 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 28' ' ' ARG . 37.9 tt0 -101.27 110.69 22.74 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.513 -0.767 . . . . 70.409999999999997 110.123 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.35 134.52 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.961 -0.563 . . . . 73.019999999999996 109.641 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 31.1 p90 -77.1 120.18 21.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.264 0.554 . . . . 63.020000000000003 110.509 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -111.69 170.33 8.21 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.339 -1.356 . . . . 62.039999999999999 107.339 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 42.4 mtmt -139.75 168.14 20.49 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.761 -0.776 . . . . 64.219999999999999 111.7 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 54.0 mt -117.41 134.66 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 43.020000000000003 108.875 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -115.69 -68.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.349 -0.611 . . . . 65.099999999999994 109.349 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -84.02 152.6 24.32 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.334 -1.728 . . . . 73.400000000000006 106.334 166.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -59.04 101.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 118.903 0.774 . . . . 73.019999999999996 109.764 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.478 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -126.03 118.82 26.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.758 -0.656 . . . . 71.219999999999999 111.653 -174.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -28.1 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.612 -1.631 . . . . 62.32 113.821 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.937 ' HA ' HD12 ' A' ' 48' ' ' LEU . 48.6 mt -65.18 -18.06 65.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.008 -0.997 . . . . 72.430000000000007 110.06 173.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 49' ' ' MET . 41.7 mt-10 -59.41 -52.47 65.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.646 -0.706 . . . . 72.420000000000002 111.025 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.44 -30.42 70.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 62.409999999999997 110.297 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 45' ' ' LEU . 73.4 mt -60.55 -32.29 71.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.966 -0.561 . . . . 70.349999999999994 110.62 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 21.3 ptp -95.74 -29.85 14.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.885 -0.326 . . . . 63.310000000000002 110.917 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 48.5 mt-10 -66.47 -34.08 77.14 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.45 0.167 . . . . 64.219999999999999 111.45 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 47' ' ' LYS . 78.7 t -57.64 -39.25 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.062 0.458 . . . . 72.349999999999994 110.027 173.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -76.81 -31.46 56.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 70.140000000000001 111.342 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.987 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 61.5 m -54.58 -49.5 70.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.443 0.639 . . . . 62.329999999999998 110.729 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -73.92 -23.4 59.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.678 -0.692 . . . . 62.25 111.006 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 2.6 tpm_? -80.54 -33.44 36.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.405 -0.361 . . . . 74.420000000000002 110.828 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.07 -21.57 31.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 75.420000000000002 110.812 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 1.22 64.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.871 -0.68 . . . . 60.039999999999999 111.891 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 6.5 tp-100 -136.32 131.1 33.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.148 -0.686 . . . . 75.329999999999998 109.148 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.987 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 16.6 p -86.84 179.32 6.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.066 0.765 . . . . 31.199999999999999 113.066 -168.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.825 ' HA ' HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.48 -16.42 61.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.266 1.21 . . . . 74.420000000000002 114.266 -164.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.57 -0.29 37.13 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.453 -0.779 . . . . 75.510000000000005 110.409 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.882 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -115.11 11.4 16.35 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.481 -0.781 . . . . 65.209999999999994 109.835 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 60' ' ' MET . 33.2 m -134.13 153.44 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.9 -0.591 . . . . 73.140000000000001 110.382 173.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -113.32 112.46 23.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.212 -0.662 . . . . 70.219999999999999 109.212 175.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -85.67 116.41 23.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.287 0.565 . . . . 74.420000000000002 111.715 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.906 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 7.0 mp -113.55 142.27 46.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 63.149999999999999 109.819 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -104.18 102.97 12.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.829 -0.168 . . . . 74.010000000000005 110.676 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 46.78 49.42 14.22 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.982 0.801 . . . . 75.510000000000005 111.557 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.13 -22.02 41.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.014 -0.612 . . . . 73.329999999999998 113.829 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.548 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 30.0 t70 -126.44 121.76 33.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.0 0.9 . . . . 72.129999999999995 111.638 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.906 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.33 143.38 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 73.239999999999995 111.74 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' HIS . 11.9 tt -135.33 -178.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.685 -0.689 . . . . 75.299999999999997 109.997 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' ILE . 98.1 m-70 -111.36 148.27 33.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.42 -0.585 . . . . 61.520000000000003 109.42 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -68.73 -16.96 70.66 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.287 0.475 . . . . 50.310000000000002 114.287 -171.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.67 -4.81 54.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.299 0.549 . . . . 72.230000000000004 111.386 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.95 -43.26 65.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.834 0.309 . . . . 71.25 111.834 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 28.1 p 67.68 148.11 0.11 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.74 1.216 . . . . 70.120000000000005 112.159 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.912 ' HD3' HD21 ' A' ' 45' ' ' LEU . 22.1 Cg_endo -61.57 -47.63 11.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.184 2.589 . . . . 73.219999999999999 113.618 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.98 -24.27 64.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 111.546 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -58.98 -39.95 83.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.938 -0.573 . . . . 74.25 110.81 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.65 -31.99 15.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 110.852 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 13' ' ' SER . . . 115.83 -19.91 13.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.685 -0.769 . . . . 62.200000000000003 111.798 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' A' ' 87' ' ' ASP . 10.1 tt -75.85 116.43 18.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.303 -0.999 . . . . 63.43 108.303 170.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.817 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 13.1 tt0 -131.2 -174.54 3.42 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.449 -0.341 . . . . 64.030000000000001 110.632 -168.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 26.0 t70 -4.71 111.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.768 1.627 . . . . 63.130000000000003 114.531 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.89 4.07 33.99 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.575 -0.739 . . . . 60.32 111.603 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.452 ' HB3' HG12 ' A' ' 83' ' ' ILE . 5.8 p-10 -79.56 167.15 21.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.745 0.307 . . . . 70.519999999999996 110.571 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 26' ' ' LYS . 20.5 m -137.32 153.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.561 0.696 . . . . 62.310000000000002 112.136 -173.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 54.3 mt -129.68 127.63 64.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.868 -1.06 . . . . 71.310000000000002 108.439 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.18 136.7 39.68 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.439 -0.208 . . . . 54.299999999999997 110.439 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.49 117.71 34.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.018 0.437 . . . . 62.409999999999997 110.838 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 83.8 mtp -98.97 170.27 8.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 71.519999999999996 109.454 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -74.16 104.9 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.868 0.366 . . . . 75.099999999999994 111.203 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.882 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 90.8 mt-30 60.66 176.25 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.249 1.02 . . . . 74.299999999999997 111.742 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.773 ' HA ' ' HG2' ' A' ' 64' ' ' ARG . 79.2 mt-30 -78.76 94.06 5.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 74.200000000000003 111.219 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m 78.54 -29.79 0.15 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.045 -0.98 . . . . 61.119999999999997 111.758 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.8 -39.5 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.607 -0.597 . . . . 53.25 111.607 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 CA-C-O 118.532 -1.149 . . . . 31.300000000000001 111.592 179.469 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.961 -0.385 . . . . 55.350000000000001 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.46 166.82 11.98 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.451 -0.88 . . . . 72.340000000000003 112.956 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -110.47 126.21 54.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.943 0.401 . . . . 64.099999999999994 110.072 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -86.47 -29.72 22.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 73.109999999999999 110.954 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.24 -35.87 80.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.957 -0.565 . . . . 72.019999999999996 111.995 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.5 p -77.06 -10.76 59.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.101 -0.499 . . . . 75.430000000000007 111.99 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.01 15.43 28.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.657 0.265 . . . . 62.409999999999997 111.632 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.32 -41.54 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.258 -0.275 . . . . 74.319999999999993 110.258 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 p30 44.37 44.97 7.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 75.340000000000003 112.209 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.14 83.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.17 0.51 . . . . 71.340000000000003 110.698 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -174.14 120.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.315 -0.857 . . . . 73.310000000000002 109.03 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.91 105.05 3.0 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.672 -0.775 . . . . 60.409999999999997 112.533 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 m -73.99 101.92 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.974 -0.38 . . . . 73.340000000000003 109.974 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 27.4 p -78.44 123.09 85.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.299 -0.41 . . . . 63.329999999999998 110.342 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' SER . 8.0 Cg_exo -73.31 10.68 1.14 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.265 2.643 . . . . 72.239999999999995 112.862 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.57 91.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.544 -0.298 . . . . 73.430000000000007 110.749 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 67.68 1.32 2.57 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.86 -0.609 . . . . 70.0 111.465 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 -69.71 0.31 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.115 0.484 . . . . 63.399999999999999 110.47 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -128.3 -53.67 1.28 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.84 -0.618 . . . . 74.430000000000007 110.913 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.51 -170.57 29.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.939 -0.648 . . . . 65.400000000000006 111.769 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.48 114.01 27.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.878 0.37 . . . . 73.099999999999994 110.217 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -67.4 127.23 31.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 71.140000000000001 111.205 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 31.6 mm -116.01 164.28 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.453 -0.794 . . . . 44.310000000000002 108.918 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.631 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 88.0 mt-30 -151.59 116.25 5.13 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.712 0.805 . . . . 71.430000000000007 109.681 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.646 HG21 HD13 ' A' ' 48' ' ' LEU . 10.3 m -113.17 -179.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.199 -0.667 . . . . 73.230000000000004 109.199 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.625 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 mtmt -144.83 114.43 7.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 110.776 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 89' ' ' ILE . 94.8 t -93.71 94.8 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 107.082 -1.451 . . . . 73.329999999999998 107.082 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 9.0 ttp180 -69.62 105.58 2.73 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.517 -1.29 . . . . 71.219999999999999 107.517 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.569 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 59.4 p -59.1 163.03 6.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 114.678 -1.147 . . . . 72.530000000000001 108.941 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 91' ' ' ALA . 46.1 Cg_endo -67.21 28.14 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.824 2.35 . . . . 72.519999999999996 113.759 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 29' ' ' SER . 18.0 t70 -130.52 -23.82 2.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 63.119999999999997 110.65 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.12 -7.62 27.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.521 -0.847 . . . . 64.219999999999999 111.108 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 29' ' ' SER . . . -71.33 90.34 0.94 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.17 -0.678 . . . . 44.210000000000001 109.17 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 38.1 tt0 -99.57 102.21 13.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.1 -0.955 . . . . 70.409999999999997 109.657 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.11 129.98 52.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.886 -0.597 . . . . 73.019999999999996 109.999 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 27.8 p90 -71.41 122.58 20.63 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.432 0.634 . . . . 63.020000000000003 110.554 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HD2' HD23 ' A' ' 48' ' ' LEU . 3.5 t80 -120.53 128.74 53.38 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.618 -1.252 . . . . 62.039999999999999 107.618 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 24' ' ' GLN . 21.6 mtmt -105.3 162.67 13.23 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.383 -0.527 . . . . 64.219999999999999 110.951 -165.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 43.1 mt -115.27 134.64 57.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.867 -0.79 . . . . 43.020000000000003 108.867 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -93.47 -78.75 0.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.784 -0.45 . . . . 65.099999999999994 109.784 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 41' ' ' ARG . 48.8 mtt180 -97.59 169.71 9.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.118 -1.438 . . . . 73.400000000000006 107.118 164.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.548 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -54.85 101.59 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 73.019999999999996 110.532 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.8 116.03 23.02 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.23 -0.895 . . . . 71.219999999999999 109.755 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 44' ' ' LYS . 23.5 mtpp -36.37 134.19 0.46 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.575 -1.193 . . . . 62.32 111.985 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' HD3' ' A' ' 78' ' ' PRO . 91.7 mt -57.11 -20.28 24.62 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.958 -1.019 . . . . 72.430000000000007 113.276 -168.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 58.6 mt-10 -65.59 -24.69 67.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.111 0.412 . . . . 72.420000000000002 112.111 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -71.22 -28.98 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.752 -0.379 . . . . 62.409999999999997 110.483 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 25' ' ' VAL . 28.3 mt -59.25 -39.49 82.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.975 -0.557 . . . . 70.349999999999994 111.512 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -94.47 -23.82 17.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.84 -0.744 . . . . 63.310000000000002 111.307 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 45.9 mt-10 -73.27 -37.74 66.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.276 -0.57 . . . . 64.219999999999999 111.046 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 88.6 t -63.99 -25.08 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.525 0.679 . . . . 72.349999999999994 109.512 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -81.72 -34.76 30.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.277 -0.874 . . . . 70.140000000000001 110.338 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.01 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 79.7 m -53.75 -56.96 12.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.335 0.588 . . . . 62.329999999999998 111.155 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -68.69 -19.99 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.585 -0.734 . . . . 62.25 110.993 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -66.59 -46.51 75.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.069 -0.514 . . . . 74.420000000000002 111.354 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -98.7 -11.09 22.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.973 0.36 . . . . 75.420000000000002 111.973 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 29.82 8.22 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.5 -0.857 . . . . 60.039999999999999 113.498 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.548 HE21 HG13 ' A' ' 63' ' ' VAL . 28.5 tt0 -150.55 129.04 12.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.823 -0.806 . . . . 75.329999999999998 108.823 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 1.01 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 24.2 p -92.43 178.25 5.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.995 0.739 . . . . 31.199999999999999 112.995 -168.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.494 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -76.21 -13.8 60.17 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.006 1.113 . . . . 74.420000000000002 114.006 -163.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 3.9 pm0 -80.07 -9.14 59.68 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.403 -0.811 . . . . 75.510000000000005 109.659 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -108.66 -22.35 12.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.617 -0.72 . . . . 65.209999999999994 109.965 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HE21 ' A' ' 58' ' ' GLN . 3.7 m -128.51 101.26 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.317 -0.623 . . . . 73.140000000000001 109.317 166.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 14.0 tpt180 -83.77 149.53 26.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.747 -0.66 . . . . 70.219999999999999 111.395 -168.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' HD2' ' HE1' ' A' ' 67' ' ' TYR . 1.6 p90 -94.74 104.27 16.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.28 -0.873 . . . . 74.420000000000002 111.96 -175.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.798 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.5 mp -99.58 131.96 45.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.468 -0.787 . . . . 63.149999999999999 109.015 172.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HE1' ' HD2' ' A' ' 65' ' ' PHE . 47.7 m-85 -103.42 110.35 22.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.485 -0.486 . . . . 74.010000000000005 110.99 -175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.9 t70 54.19 37.16 26.63 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.103 -0.953 . . . . 75.510000000000005 110.228 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -21.48 45.79 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.399 -0.819 . . . . 73.329999999999998 112.985 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -113.49 116.28 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.364 0.602 . . . . 72.129999999999995 110.846 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.798 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 23.6 ptt180 -72.61 118.21 15.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.381 -0.827 . . . . 73.239999999999995 112.344 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.93 -163.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.802 -0.814 . . . . 75.299999999999997 108.802 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -108.84 138.14 45.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.958 -0.297 . . . . 61.520000000000003 110.612 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.8 -10.56 64.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.1 -0.571 . . . . 50.310000000000002 112.273 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.15 -28.36 64.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 72.230000000000004 110.532 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 80' ' ' GLN . 6.1 t30 -67.64 -17.7 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.647 -0.706 . . . . 71.25 111.062 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 66.6 p 60.18 156.72 0.1 Allowed Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.375 1.07 . . . . 70.120000000000005 113.18 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.924 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 59.2 Cg_endo -72.37 -43.43 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.544 2.163 . . . . 73.219999999999999 112.431 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.68 -28.12 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.684 . . . . 74.519999999999996 111.966 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' ASN . 53.8 tt0 -83.32 -34.65 25.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.268 -0.423 . . . . 74.25 111.547 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 29.5 tp -89.56 -28.31 19.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.939 0.399 . . . . 73.109999999999999 110.659 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.24 -18.63 38.79 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.672 -0.775 . . . . 62.200000000000003 111.509 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.5 tt -89.87 120.99 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.45 -0.574 . . . . 63.43 109.45 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.924 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -155.83 -154.16 0.47 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 118.974 -0.536 . . . . 64.030000000000001 110.353 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 84' ' ' GLU . 19.9 t70 -21.82 109.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.718 1.261 . . . . 63.130000000000003 113.276 -167.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.4 -6.88 20.84 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 114.919 -1.037 . . . . 60.32 111.819 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.65 170.91 15.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 70.519999999999996 110.882 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.89 158.17 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.637 0.732 . . . . 62.310000000000002 111.413 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 27' ' ' VAL . 66.1 mt -128.59 125.92 64.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.98 -1.009 . . . . 71.310000000000002 108.724 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.09 126.23 44.79 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.772 -0.455 . . . . 54.299999999999997 109.772 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.665 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -87.96 117.93 27.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.144 0.497 . . . . 62.409999999999997 111.377 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.7 ttt -101.74 150.7 22.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.738 -0.665 . . . . 71.519999999999996 109.973 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.21 102.98 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.942 0.401 . . . . 75.099999999999994 110.505 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 38.8 mt-30 62.21 179.52 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.046 -0.979 . . . . 74.299999999999997 112.206 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' O ' ' HB ' ' A' ' 96' ' ' THR . 25.7 pt20 -91.82 39.46 1.01 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.579 -0.737 . . . . 74.200000000000003 110.229 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 95' ' ' GLN . 94.2 m 74.89 -38.07 0.37 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.606 -0.725 . . . . 61.119999999999997 111.21 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.69 104.78 0.4 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.806 -0.712 . . . . 53.25 112.028 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.962 0 CA-C-O 118.784 -1.009 . . . . 31.300000000000001 111.742 177.026 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.029 -0.73 . . . . 55.350000000000001 109.029 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.53 58.22 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.73 -1.348 . . . . 72.340000000000003 109.73 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -87.37 -177.81 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.479 0.657 . . . . 64.099999999999994 112.72 -165.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.06 -12.16 60.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.765 -1.107 . . . . 73.109999999999999 112.234 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -51.34 -26.73 8.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.939 0.718 . . . . 72.019999999999996 112.939 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -71.63 -20.6 61.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 75.430000000000007 111.752 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.92 30.08 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.036 0.384 . . . . 62.409999999999997 112.036 -172.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -74.83 96.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.603 0.716 . . . . 74.319999999999993 110.633 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.06 17.06 4.18 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.008 -0.996 . . . . 75.340000000000003 110.921 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.62 85.57 3.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 71.340000000000003 109.305 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -138.21 121.85 17.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.239 -0.437 . . . . 73.310000000000002 111.071 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.76 179.87 30.4 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.006 -0.838 . . . . 60.409999999999997 111.006 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -78.05 -49.19 14.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.014 0.407 . . . . 73.340000000000003 110.556 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.451 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 37.5 t 67.76 108.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 123.914 0.759 . . . . 63.329999999999998 111.6 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 14' ' ' SER . 18.7 Cg_endo -61.62 -31.71 86.92 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.586 2.191 . . . . 72.239999999999995 111.205 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.1 t -81.56 129.25 37.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.567 -0.742 . . . . 73.430000000000007 109.976 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -145.41 139.44 26.93 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.949 -0.389 . . . . 70.0 109.949 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -99.7 23.51 9.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.49 . . . . 63.399999999999999 111.283 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -102.29 26.89 7.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.988 -0.551 . . . . 74.430000000000007 109.811 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -44.76 105.03 0.07 OUTLIER Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 65.400000000000006 113.94 -174.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.91 -16.55 15.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.502 0.668 . . . . 73.099999999999994 109.429 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 38.3 m80 -114.01 142.93 45.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.343 -0.844 . . . . 71.140000000000001 110.059 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 33.2 mm -110.75 163.59 7.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.014 -0.539 . . . . 44.310000000000002 109.63 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' HG22 ' A' ' 23' ' ' ILE . 58.6 tt0 -137.0 125.46 23.49 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.531 -0.544 . . . . 71.430000000000007 109.531 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 48' ' ' LEU . 7.0 p -130.99 139.16 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.2 -0.454 . . . . 73.230000000000004 110.502 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.783 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -110.5 118.43 36.22 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.699 -0.4 . . . . 74.439999999999998 110.714 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HB ' ' A' ' 89' ' ' ILE . 73.5 t -94.95 104.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.314 -1.365 . . . . 73.329999999999998 107.314 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 72.8 ttt-85 -69.64 110.23 4.74 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.983 -1.117 . . . . 71.219999999999999 107.983 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 62.3 p -60.22 159.77 20.48 Favored Pre-proline 0 N--CA 1.437 -1.124 0 CA-C-N 115.322 -0.854 . . . . 72.530000000000001 108.714 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 27.3 Cg_endo -62.1 22.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 123.353 2.702 . . . . 72.519999999999996 115.021 -174.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 29' ' ' SER . 31.8 t70 -131.78 -24.07 2.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 63.119999999999997 110.9 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.05 2.55 20.22 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.44 -0.886 . . . . 64.219999999999999 112.114 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.6 88.47 7.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.186 -0.672 . . . . 44.210000000000001 109.186 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.783 ' HG2' ' HB3' ' A' ' 26' ' ' LYS . 11.1 tt0 -82.5 113.5 20.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.787 -0.642 . . . . 70.409999999999997 110.187 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.02 134.32 44.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.708 -0.479 . . . . 73.019999999999996 109.708 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -79.35 121.69 25.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.92 0.867 . . . . 63.020000000000003 111.543 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -116.92 174.35 6.14 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.485 -1.234 . . . . 62.039999999999999 107.805 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -136.26 153.48 51.18 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.97 -0.456 . . . . 64.219999999999999 111.174 -167.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.034 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 55.1 mt -114.99 134.91 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.729 -0.841 . . . . 43.020000000000003 108.729 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 22' ' ' HIS . 55.0 mtpt -127.83 -58.52 1.23 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.912 0.387 . . . . 65.099999999999994 110.793 -171.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -95.54 177.8 5.69 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.16 -1.052 . . . . 73.400000000000006 108.16 173.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -63.98 100.71 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.136 0.969 . . . . 73.019999999999996 109.073 172.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -138.95 102.17 4.48 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.307 -0.86 . . . . 71.219999999999999 110.606 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.74 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.4 pttp -68.56 -176.63 0.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.205 -0.907 . . . . 62.32 111.212 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 60.6 mt -55.67 -27.13 48.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 72.430000000000007 111.988 -170.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' ' SD ' ' A' ' 49' ' ' MET . 39.8 mt-10 -57.92 -35.48 71.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.01 0.434 . . . . 72.420000000000002 111.4 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 51' ' ' VAL . 46.3 tptt -69.9 -52.48 24.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 62.409999999999997 110.287 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 25' ' ' VAL . 26.8 mt -62.65 -28.36 69.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 70.349999999999994 111.32 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.61 ' SD ' ' HA ' ' A' ' 46' ' ' GLU . 14.2 ptm -85.59 -37.45 19.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 63.310000000000002 111.011 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 35.8 mm-40 -71.31 -30.43 66.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.829 0.307 . . . . 64.219999999999999 111.829 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 47' ' ' LYS . 87.8 t -62.98 -37.78 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.142 0.496 . . . . 72.349999999999994 109.706 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 55' ' ' ARG . 35.3 m-85 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.027 -0.533 . . . . 70.140000000000001 111.169 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 50' ' ' GLU . 86.0 m -54.35 -48.59 71.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.315 0.579 . . . . 62.329999999999998 109.83 170.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.27 -40.52 67.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 62.25 110.833 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' A' ' 52' ' ' TYR . 55.1 ttt180 -65.79 -45.54 82.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.420000000000002 111.683 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.24 -13.79 42.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.685 0.278 . . . . 75.420000000000002 111.316 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.79 10.86 83.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.665 -0.779 . . . . 60.039999999999999 111.893 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 5.3 tp-100 -133.61 130.33 38.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.996 -0.742 . . . . 75.329999999999998 108.996 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 53' ' ' CYS . 32.6 p -83.09 163.48 20.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.333 0.587 . . . . 31.199999999999999 112.263 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -15.69 63.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.245 -0.889 . . . . 74.420000000000002 112.328 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -87.02 -4.29 59.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 75.510000000000005 110.476 177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -115.81 -25.94 7.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.593 -0.73 . . . . 65.209999999999994 109.455 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.488 ' HA ' ' H ' ' A' ' 94' ' ' GLN . 11.5 m -125.78 117.45 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.637 -0.71 . . . . 73.140000000000001 109.639 168.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -88.1 139.74 30.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.583 -0.525 . . . . 70.219999999999999 109.583 -174.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.565 ' HB3' ' CG2' ' A' ' 89' ' ' ILE . 60.9 m-85 -101.38 119.01 38.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.913 -0.585 . . . . 74.420000000000002 111.353 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.893 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 8.2 mp -99.34 127.1 45.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.193 -0.912 . . . . 63.149999999999999 108.784 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HE1' HG21 ' A' ' 83' ' ' ILE . 1.6 p90 -101.65 124.79 47.89 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.207 -0.997 . . . . 74.010000000000005 110.234 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.34 29.75 13.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.848 -1.069 . . . . 75.510000000000005 110.264 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.66 0.29 64.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.681 -0.69 . . . . 73.329999999999998 113.241 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.29 116.37 19.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.506 0.653 . . . . 72.129999999999995 111.368 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.893 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 22.6 ptt180 -66.68 137.81 56.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.286 -0.87 . . . . 73.239999999999995 112.408 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 73' ' ' HIS . 11.0 tp -162.63 164.86 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 75.299999999999997 109.741 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' N ' HG13 ' A' ' 72' ' ' ILE . 1.4 p-80 -70.39 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 61.520000000000003 110.919 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -65.76 -23.82 70.97 Favored Glycine 0 CA--C 1.518 0.242 0 CA-C-N 116.131 -0.486 . . . . 50.310000000000002 113.896 -171.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 7.0 p-10 -77.77 3.84 13.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.763 0.281 . . . . 72.230000000000004 111.501 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -67.39 -39.1 85.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.453 -0.203 . . . . 71.25 110.453 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.74 HG22 ' HB3' ' A' ' 44' ' ' LYS . 49.9 p 62.41 143.0 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.596 1.158 . . . . 70.120000000000005 112.597 -178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.85 -42.22 15.64 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.049 2.499 . . . . 73.219999999999999 112.56 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.84 -14.76 55.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 74.519999999999996 111.802 -176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -59.9 -38.4 82.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 74.25 110.837 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB3' HG22 ' A' ' 83' ' ' ILE . 45.4 tp -104.85 -30.01 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.092 0.472 . . . . 73.109999999999999 110.886 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.08 -19.32 13.62 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.774 -0.931 . . . . 62.200000000000003 110.774 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 81' ' ' LEU . 5.4 tt -66.48 112.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.719 -0.845 . . . . 63.43 108.719 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 15.8 tt0 -134.07 -152.8 0.49 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.751 -0.658 . . . . 64.030000000000001 109.864 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 33.1 t70 -30.57 112.9 0.09 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.254 0.971 . . . . 63.130000000000003 113.032 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.04 4.94 22.21 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.924 -0.58 . . . . 60.32 111.679 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -78.93 170.51 16.57 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.992 0.425 . . . . 70.519999999999996 111.094 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 13.7 m -138.27 154.83 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.310000000000002 111.013 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 36.4 mt -136.66 114.99 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.637 -0.71 . . . . 71.310000000000002 109.101 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.406 ' CG ' HH11 ' A' ' 28' ' ' ARG . 48.2 t0 -100.97 127.21 47.56 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.446 -0.343 . . . . 54.299999999999997 110.372 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.2 131.69 53.15 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.148 0.425 . . . . 62.409999999999997 112.148 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 66' ' ' LEU . 2.4 mpt? -126.21 163.28 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.449 -0.575 . . . . 71.519999999999996 109.449 173.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.53 95.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.564 0.221 . . . . 75.099999999999994 111.465 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 28.4 mt-30 45.52 39.08 4.38 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.495 0.718 . . . . 74.299999999999997 112.113 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 92' ' ' MET . 50.3 tp60 -72.46 71.49 0.94 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.382 0.61 . . . . 74.200000000000003 111.304 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 64' ' ' ARG . 86.7 m -164.83 -40.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.508 -0.923 . . . . 61.119999999999997 108.508 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.33 52.05 0.77 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.17 -0.923 . . . . 53.25 111.175 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.224 -1.32 . . . . 31.300000000000001 111.453 -178.004 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.237 -0.283 . . . . 55.350000000000001 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.75 -155.16 12.36 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.405 -0.903 . . . . 72.340000000000003 112.346 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -152.97 161.97 41.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.774 0.321 . . . . 64.099999999999994 110.323 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.35 -14.8 42.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.151 -0.477 . . . . 73.109999999999999 110.125 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.42 -28.32 69.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.707 -0.679 . . . . 72.019999999999996 111.031 -174.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 p -78.44 -9.99 59.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 75.430000000000007 111.961 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.82 41.16 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.206 0.527 . . . . 62.409999999999997 110.184 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.23 105.87 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.574 . . . . 74.319999999999993 112.206 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 73.61 160.86 0.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.108 -0.951 . . . . 75.340000000000003 111.85 171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.46 -71.9 0.13 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.584 0.754 . . . . 71.340000000000003 110.918 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -85.91 102.64 13.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.136 0.493 . . . . 73.310000000000002 109.841 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.25 77.2 1.57 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.791 -0.64 . . . . 60.409999999999997 112.734 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.8 m -89.69 8.58 30.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.303 0.573 . . . . 73.340000000000003 110.545 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 p -102.17 108.76 58.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.69 . . . . 63.329999999999998 110.283 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.95 168.22 15.96 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.871 2.381 . . . . 72.239999999999995 112.245 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 t -66.75 159.57 4.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 73.430000000000007 110.716 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -63.11 157.9 21.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.214 -0.448 . . . . 70.0 110.507 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 75.14 5.85 4.23 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.648 0.779 . . . . 63.399999999999999 111.431 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -88.35 -3.67 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.443 -0.344 . . . . 74.430000000000007 111.079 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.29 11.83 83.83 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.782 -0.723 . . . . 65.400000000000006 112.193 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -84.99 -37.13 20.79 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.597 . . . . 73.099999999999994 109.387 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 30.7 m80 -90.18 176.99 6.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 71.140000000000001 110.311 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 30.1 mt -108.93 159.39 8.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.983 0.42 . . . . 44.310000000000002 110.808 -169.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp0 -146.11 126.12 13.68 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.985 0.914 . . . . 71.430000000000007 109.238 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.39 144.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.741 -0.466 . . . . 73.230000000000004 109.741 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 1.002 ' HG3' ' HA ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.51 115.9 31.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.977 0.418 . . . . 74.439999999999998 111.302 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 89' ' ' ILE . 47.0 t -99.93 101.99 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.92 -1.141 . . . . 73.329999999999998 107.92 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 2.1 ttp180 -69.91 111.16 5.43 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 107.893 -1.151 . . . . 71.219999999999999 107.893 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.646 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 93.1 p -62.47 165.66 8.69 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 119.696 -0.801 . . . . 72.530000000000001 108.871 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.646 ' HD2' ' HB2' ' A' ' 29' ' ' SER . 43.7 Cg_endo -66.65 20.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 122.66 2.24 . . . . 72.519999999999996 113.909 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 29' ' ' SER . 36.0 t70 -131.26 -11.77 3.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.205 0.526 . . . . 63.119999999999997 110.892 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.52 -0.16 43.08 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.193 -1.003 . . . . 64.219999999999999 111.976 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.06 97.6 6.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.353 -0.61 . . . . 44.210000000000001 109.353 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 48.5 tt0 -115.98 97.45 6.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.882 -0.599 . . . . 70.409999999999997 110.29 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.6 t -102.97 145.0 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.444 -0.947 . . . . 73.019999999999996 108.444 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 1.002 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 37.3 p90 -67.3 123.54 20.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 63.020000000000003 110.231 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -110.52 170.11 8.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.943 -1.132 . . . . 62.039999999999999 107.943 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 34.8 mttt -140.71 165.87 26.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.46 0.573 . . . . 64.219999999999999 111.402 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.961 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 69.4 mt -122.68 135.21 63.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 43.020000000000003 108.877 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -117.44 -77.73 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.312 . . . . 65.099999999999994 110.969 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 42' ' ' LYS . 4.9 tpt180 -76.95 177.47 7.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.257 -1.016 . . . . 73.400000000000006 108.257 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 5.9 ttpm? -62.47 99.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.052 -1.092 . . . . 73.019999999999996 108.052 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 47' ' ' LYS . 2.8 p -135.17 106.55 6.8 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.666 -0.697 . . . . 71.219999999999999 110.845 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 45.0 mttm -51.49 170.45 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.483 -1.235 . . . . 62.32 111.154 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 47.6 mt -62.61 -10.95 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.595 . . . . 72.430000000000007 110.487 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 5.3 mm-40 -53.94 -57.22 11.78 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.631 -0.713 . . . . 72.420000000000002 111.361 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG2' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.62 -23.92 63.57 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.427 . . . . 62.409999999999997 110.877 -175.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 45' ' ' LEU . 86.7 mt -63.32 -35.3 79.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 70.349999999999994 110.558 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 26.5 ptt? -89.31 -33.91 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 63.310000000000002 110.564 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 9.2 mm-40 -66.48 -32.87 74.5 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.982 0.364 . . . . 64.219999999999999 111.982 -176.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' LYS . 93.2 t -60.89 -34.94 61.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.502 -0.479 . . . . 72.349999999999994 110.124 174.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -73.44 -44.47 58.14 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.873 -0.331 . . . . 70.140000000000001 110.315 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 61.7 m -48.1 -44.52 31.84 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.334 0.588 . . . . 62.329999999999998 110.409 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -64.62 -56.2 15.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.226 -0.897 . . . . 62.25 110.724 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -68.58 -42.96 77.5 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.494 0.553 . . . . 74.420000000000002 112.494 -171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.87 -20.32 53.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.721 -0.218 . . . . 75.420000000000002 111.01 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.5 19.28 74.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.686 -0.768 . . . . 60.039999999999999 111.254 -177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.679 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 35.1 tt0 -142.72 130.05 21.06 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.522 -0.918 . . . . 75.329999999999998 108.522 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.3 p -84.35 167.28 16.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 31.199999999999999 111.749 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.34 -15.15 59.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.475 -0.784 . . . . 74.420000000000002 112.39 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 94' ' ' GLN . 12.5 pt-20 -59.28 -23.78 62.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.617 0.246 . . . . 75.510000000000005 110.489 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.045 ' HA ' ' HG2' ' A' ' 94' ' ' GLN . . . -105.74 -12.82 15.75 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.977 -0.556 . . . . 65.209999999999994 111.085 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' MET . 3.4 m -144.24 103.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 73.140000000000001 110.635 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -95.77 145.7 25.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.726 -0.39 . . . . 70.219999999999999 110.655 -176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.679 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 26.5 p90 -95.21 133.08 39.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 74.420000000000002 111.774 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.108 ' HG ' ' HB3' ' A' ' 71' ' ' ARG . 6.5 mp -115.9 114.05 24.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 63.149999999999999 109.987 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -103.76 138.8 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.013 -0.675 . . . . 74.010000000000005 110.423 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 t70 54.53 22.89 4.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.822 0.82 . . . . 75.510000000000005 109.977 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.53 -18.73 56.54 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.652 -0.704 . . . . 73.329999999999998 113.367 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -118.16 120.66 38.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.742 0.771 . . . . 72.129999999999995 111.739 -176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 1.108 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -69.19 142.89 54.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.723 -0.672 . . . . 73.239999999999995 111.685 176.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 76' ' ' ASN . 37.6 pt -142.55 -163.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.151 -0.685 . . . . 75.299999999999997 109.151 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -98.21 140.35 32.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.009 -0.737 . . . . 61.520000000000003 109.009 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.885 ' HA2' ' HB2' ' A' ' 45' ' ' LEU . . . -60.33 -23.62 60.31 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.161 -0.542 . . . . 50.310000000000002 113.482 -172.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 23.8 t70 -63.06 -23.39 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.393 0.516 . . . . 72.230000000000004 112.393 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.682 ' HB3' HD12 ' A' ' 72' ' ' ILE . 2.1 t-20 -74.13 -19.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.841 -0.344 . . . . 71.25 111.205 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 44' ' ' LYS . 7.7 p 59.15 151.79 0.08 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.063 1.135 . . . . 70.120000000000005 114.063 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 -32.76 23.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.821 2.347 . . . . 73.219999999999999 113.492 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.615 ' OE1' ' HB ' ' A' ' 77' ' ' THR . 4.3 pm0 -63.15 -14.85 53.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.674 0.273 . . . . 74.519999999999996 111.543 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -68.62 -30.93 69.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.301 -0.409 . . . . 74.25 111.006 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.18 -30.35 16.72 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.368 -0.533 . . . . 73.109999999999999 111.388 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 -18.99 32.52 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.472 -1.051 . . . . 62.200000000000003 110.472 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.506 HG13 ' HB2' ' A' ' 87' ' ' ASP . 9.4 tp -84.47 148.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.95 -1.13 . . . . 63.43 107.95 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 22.7 tt0 -155.07 -149.19 0.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.817 -1.179 . . . . 64.030000000000001 107.817 -176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' H ' ' HG2' ' A' ' 84' ' ' GLU . 5.2 p-10 -36.49 114.53 0.3 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.854 0.835 . . . . 63.130000000000003 112.194 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.45 -5.71 14.77 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.462 -0.79 . . . . 60.32 111.853 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB2' HG13 ' A' ' 83' ' ' ILE . 22.8 t0 -80.63 161.71 24.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.782 0.325 . . . . 70.519999999999996 110.38 175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.09 154.8 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.356 0.598 . . . . 62.310000000000002 110.51 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 65' ' ' PHE . 59.5 mt -131.72 126.37 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.408 -0.814 . . . . 71.310000000000002 109.471 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.98 134.35 43.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.554 0.216 . . . . 54.299999999999997 110.855 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . . . -99.69 119.06 37.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.05 0.452 . . . . 62.409999999999997 110.622 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 65.4 mtt -103.32 152.25 21.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 71.519999999999996 110.016 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.32 95.89 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.861 0.362 . . . . 75.099999999999994 110.288 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 1.045 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 44.7 mt-30 56.51 23.59 7.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.334 -0.848 . . . . 74.299999999999997 110.852 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.56 ' OE1' ' HD2' ' A' ' 71' ' ' ARG . 6.8 tt0 64.58 78.07 0.3 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.793 -0.64 . . . . 74.200000000000003 110.283 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p 59.45 10.55 1.9 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.268 1.027 . . . . 61.119999999999997 113.146 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 116.68 99.25 2.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.527 -0.844 . . . . 53.25 112.483 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 94' ' ' GLN . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.705 -1.053 . . . . 31.300000000000001 112.181 -178.996 . . . . . . . . 1 1 . 1 stop_ save_